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OBJECTIVE: Personalized genomic medicine (PGM) has been lauded as the future of 
medicine, as new human genomic research findings are applied towards the development of 
screenings, diagnostic tools and treatments that are tailored to the genomic profiles of 
individuals.  However, the development of PGM is still in its nascent stages, therefore, some 
have supported the development of clinical tools and treatments based on population-level 
characteristics, such as race or ethnicity.  Race-based medicine (RBM), has been, and continues 
to be, promoted as an interim form of PGM, and although an academic debate has flourished 
over medical, social and ethical concerns related to RBM, to date, there have only been a few 
small studies that have examined lay beliefs and attitudes regarding RBM.  The extent to which 
the greater American public would believe in the effectiveness of RBM and indicate an intention 
to use RBM is unclear.  Furthermore, it is possible that racial and ethnic groups would differ in 
their beliefs and attitudes regarding RBM, considering RBM implies the controversial and 
contested conceptualization of race as having some genetic basis.  Therefore, the purpose of this 
dissertation study was to use, for the first time, a nationally representative sample of adult 
Americans and examine the importance of race with respect to the following: beliefs and 
attitudes regarding RBM; the extent to which these beliefs and attitudes can be influenced by 
mass media messages about the relationship between race and genetics; and how beliefs and 
attitudes regarding RBM compare with those regarding PGM.   
  
METHODS: In order to answer these questions, this dissertation study used a nationally 
representative sample of self-identified non-Hispanic white, non-Hispanic black and Hispanic 
U.S. residents who participated in an online survey examining beliefs and attitudes regarding 
RBM and PGM, and the effect of a vignette experiment using mock news articles that varied in 
their messages about the relationship between race and genes on these beliefs and attitudes.  The 
survey assessed the following constructs using new measures designed for this dissertation study: 
RBM’s effectiveness at the individual, clinical level; PGM’s effectiveness at the individual, 
clinical level; preferences for using RBM; preferences for using PGM; and RBM’s ability to 
address health inequalities in the U.S.  Means, frequencies, mean-difference tests and multiple 
regression were used to examine the effect of race and/or the vignette experiment on beliefs and 
attitudes regarding RBM and PGM.   
RESULTS: The results of this dissertation study show that the majority of white, black 
and Hispanic Americans equally agreed that RBM would not be clinically effective at the 
individual level, but the majority of all groups also equally agreed that they would prefer to use 
RBM if it was available.  More than forty percent of all respondents who did not believe RBM 
would be effective at the individual level, still preferred to use a race-specific treatment if it was 
available.  The three racial/ethnic groups examined in this study did diverge in belief in RBM’s 
ability to reduce health inequalities.  Greater portions of the black and Hispanic respondents 
believed RBM would be effective at reducing health inequalities than white respondents.  Racial 
differences were also seen in the effect of the vignette experiment on RBM beliefs and attitudes.  
While the vignette experiment had no effect on whites’ beliefs and attitudes regarding RBM, 
vignettes that stated or implied a genetic basis to racial difference were associated with lower 
endorsement of RBM beliefs and attitudes among the black respondents.  Finally, the results 
  
indicated that both white and black Americans endorsed PGM’s effectiveness at the individual 
level at greater levels than RBM’s effectiveness, and both groups indicated greater preferences 
for using PGM than RBM.  However, while most white respondents indicated that they believed 
PGM would be effective at the individual level and that they would prefer to use PGM if it was 
available, nearly half of the black respondents did not believe PGM would be clinically effective, 
and 1 out of 4 black respondents did not prefer to use PGM. 
CONCLUSIONS:  The results suggest that white, black and Hispanic Americans do not 
significantly differ in their beliefs and attitudes regarding the effectiveness of or preferences for 
using RBM.  This finding diverges from prior studies that showed racial differences in beliefs 
and attitudes regarding RBM.  The lack of racial difference may be due to a lack of familiarity 
with this concept, for the results also suggested that once respondents were exposed to varying 
mock news article messages about the relationship between race and genes, racial differences 
began to emerge. The results also showed discordance between belief in RBM’s effectiveness 
and preferences for using RBM.  This finding suggests that there is still an incentive for the 
pharmaceutical and diagnostic testing industries to develop and market RBM even if there is 
generally low public opinion regarding RBM’s effectiveness.   
PGM has been promoted by the biomedical industry as a potential solution to racial and 
ethnic health disparities both in the U.S. and globally, and RBM has been promoted as an interim 
form of PGM until it is further developed.  Despite noted clinical, social and ethical concerns 
regarding RBM specifically, proponents of RBM have focused on promoting the message of its 
potential to mitigate racial and ethnic health disparities.  The results from this study indicate that 
on the surface at least, this argument may in fact resonate with black and Hispanic Americans.   
  
In addition to being the first nationally representative study to examine potential racial 
differences in RBM beliefs and attitudes, this dissertation was also the first nationally 
representative study to examine potential racial differences in beliefs and attitudes regarding 
PGM.  Although the results clearly showed that all Americans endorsed the effectiveness of and 
preferences for using PGM at greater levels than RBM, whites were significantly more likely 
than blacks to believe PGM would be clinically effective and to indicate a preference for using 
PGM. Thus, while the merits of PGM may seem apparent to the clinical and academic 
communities, the results of this study indicate that there is not universal support for PGM among 
the public.  Cautious support for PGM from black respondents may reflect more general mistrust 
towards the medical community and new forms of health technologies.  Even though racial and 
ethnic minority populations seem open to RBM and PGM as potential strategies to address health 
inequalities, support for both could change as the public becomes more familiar with both 
concepts, whether through exposure to mass media messages, mass marketing of treatments and 
genetic testing, or through their clinical providers.   
The findings from this dissertation study significantly advance our knowledge of the 
American public’s beliefs and attitudes regarding RBM and PGM, particularly with respect to 
racial differences, and should be considered by stakeholders in current and future debates 
surrounding efforts to develop and promote both. 
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1.1  Introduction 
 Personalized genomic medicine (PGM) has been lauded as the future of medicine, as new 
human genomic research findings are being applied towards the development of screenings, 
diagnostic tools and treatments that are tailored to the genomic profiles of individuals.  As racial 
and ethnic disparities in health outcomes continue to persist, PGM is considered to be an 
important potential variable in the equation to improve the quality of medical care available to 
racial and ethnic minority populations.  However, the development of PGM is still in its nascent 
stages.  Consequently, some have supported the development of clinical tools and treatments 
based on population-level characteristics, such as race or ethnicity.  Race- or ethnicity-specific 
prescribing, more commonly known as race-based medicine (RBM), has been, and continues to 
be, promoted as an interim form of PGM, where diagnostic tools and treatment options are 
developed and approved for use in specific racial and ethnic groups in an effort to improve 
clinical options that are available beyond conventional forms of treatments.  Scientists and 
scholars, however, are divided over whether RBM is conceptually and realistically possible 
considering the fact that RBM implies there is some genetic or biological basis to racial 
categories.  Meanwhile, the concept of race in and of itself remains controversial and contested. 
Even if race- and ethnicity-targeted screening tools, diagnostic tools and pharmaceutical products 
are proven to be more effective than conventional forms of clinical tools and treatments, there 
are a number of social and ethical concerns associated with RBM that raise the question of 
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whether potential social and ethical costs are worth RBM’s development and administration, 
even on an interim basis. 
 Although an academic debate over RBM has flourished, there have only been a few small 
studies that have examined lay beliefs and attitudes regarding RBM.  The controversial nature of 
RBM has been clearly established in the academic literature, as well as in some mainstream 
media coverage of RBM, however, the extent to which the American public would believe in the 
effectiveness of RBM and indicate an intention to use RBM if it was available is unclear.  
Therefore, the purpose of this dissertation study was to use, for the first time, a nationally 
representative sample of self-identified white, black and Hispanic adults who reside in the U.S. 
to examine the following: beliefs and attitudes regarding RBM; the extent to which these beliefs 
and attitudes can be influenced by mass media messages about the relationship between race and 
genetics; and how beliefs and attitudes regarding RBM compare with those regarding PGM.  The 
primary independent variable that is examined in this dissertation study is race.1  Prior 
exploratory studies have identified racial and ethnic differences in beliefs and attitudes regarding 
RBM.  Because the concept of race is at the center of scientific, social, and ethical concerns and 
considerations surrounding RBM, and, racial and ethnic health disparities continue to persist, an 
examination of the extent to which racial differences exist in RBM- and PGM-related 
conceptions among a nationally representative sample enables stakeholders in the RBM debate to 
                                                           
1
 Although there are many ways in which “race” and “ethnicity” can be conceptualized and operationalized, and 
certainly the two concepts are generally conceptualized as distinctly different, for the purposes of brevity I will use 
the word “race” in this dissertation as an encompassing term to include both the concepts of race and ethnicity.  I am 
aware of the need for precision in language, so even though “race” will be used, for the most part, as an all-
encompassing term for race and ethnicity, when specificity is necessitated, I will use the word “ethnicity” in order to 
refer to concepts and ideas that are distinctly related to that concept (for more on “race” versus “ethnicity”, see 
pages 19-21 in this dissertation). 
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better understand whether racial and ethnic minority populations specifically believe RBM and 
PGM would be effective and whether they would use either or both forms of treatment.   
 
1.2  Specific Aims 
 In order to better understand lay beliefs and attitudes regarding RBM and PGM, and the 
extent to which racial differences exist in these beliefs and attitudes, I used a nationally 
representative sample of white, black and Hispanic Americans and unique measures of RBM- 
and PGM-related beliefs and attitudes to examine the following: 
1. Whether racial groups differ in terms of beliefs about RBM’s individual-level 
effectiveness, behavioral orientation towards using RBM, and beliefs about RBM’s 
population-level effectiveness. 
2. Whether racial groups differ in terms of genetic essentialist beliefs, and if so, whether 
genetic essentialist beliefs explain any differences between racial groups in RBM-related 
individual-level effectiveness, behavioral orientation and population-level effectiveness 
beliefs and attitudes. 
3. Whether implicit racist attitudes and explicit racist attitudes towards African Americans 
explain some of the differences in these beliefs and attitudes between whites and 
Hispanics. 
4. Whether experimentally varying information about the degree of genetic similarity 
between races affects RBM individual-level effectiveness, behavioral orientation and 
population-level effectiveness beliefs among white and black respondents. 
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5. Whether accepting the validity of an assigned vignette about a described relationship 
between race and genes is associated with differences in RBM individual-level 
effectiveness, behavioral orientation and population-level effectiveness beliefs and 
attitudes.   
6. Whether there are racial differences in PGM individual-level effectiveness and behavioral 
orientation beliefs and attitudes. 
7. And, to what extent PGM individual-level effectiveness and behavioral orientation 
beliefs and attitudes compare to RBM individual-level effectiveness and behavioral 
orientation beliefs and attitudes. 
By developing a greater understanding of the American public’s beliefs and attitudes 
regarding RBM and PGM, stakeholders from both sides of the RBM debate will better 
understand whether RBM is, or has the potential to be, accepted by the lay public.  Assuming 
RBM is proven to be clinically more effective than conventional forms of treatments, if 
Americans hold positive attitudes towards RBM, this receptivity, particularly from underserved 
and historically mistreated populations, could improve medical treatment adherence and 
potentially improve overall health outcomes.  However, negative attitudes towards RBM means 
that its promotion by the pharmaceutical and biomedical industries could backfire, influencing 
populations who have traditionally mistrusted the healthcare system to hold even more negative 
attitudes towards the healthcare system.  The mere existence of RBM, which suggests biological 
and possibly genetic distinctions between racial groups, could also lead to the re-inscription of a 
biological definition of race that should otherwise not exist, potentially leading to increased 
racist beliefs that have been associated with beliefs in genetic racial differences.  Although this 
dissertation study will not examine these potential positive and/or negative outcomes of the 
 5 
 
promotion of RBM, it will, for the first time, provide evidence from a nationally representative 
sample of white, black and Hispanic Americans of their beliefs and attitudes regarding RBM. 
This evidence, in turn, will enable us to better understand to what extent the lay American public 
would be receptive of RBM, which in turn could not only influence RBM’s trajectory but, 




Chapter 2:  
BACKGROUND AND SIGNIFICANCE 
 
2.1  The Human Genome Project and the Promise of Personalized Genomic Medicine 
An important goal for the Human Genome Project (HGP) was to identify genetic 
components of common diseases, with the hope of eventually developing treatments that could 
be tailored to individuals’ genetic profiles.  Also known as “personalized genomic medicine” 
(PGM), leaders and supporters of this goal have touted PGM as the future of medicine (Collins, 
1999).  Numerous researchers have noted, however, that the scientific and technological 
challenges of developing diagnostic tools and treatments individualized to the genomic profiles 
of individuals indicate that the goal of moving towards a biomedical system of PGM may not 
materialize for some time (for example, see Davies, 2006; Vera-Ramirez et al., 2010; 
Winkelmann and Herrington, 2010).  Consequently, there is interest in the development of 
treatments that work more effectively in populations that share similar characteristics, such as 
race or ethnicity (Burchard et al., 2003; Nguyen, Desta & Flockhart, 2007; Risch, Burchard, Ziv 
& Tang, 2002).  Significant concerns, however, have been expressed about how race-targeted 
pharmacogenomic products have been researched and developed, their true effectiveness for 
specific racial groups, and the social and ethical implications of administering different 
treatments based on self-identified or physician-assessed racial or ethnic identity (Benjamin, 
2009; Condit & Bates, 2005; Foster, Sharp & Mulvihill, 2001; Foster & Sharp, 2002, 2004; 
Fujimara, Duster & Rajagopalan, 2008; Hamilton, 2008; Kahn, 2005a, 2005b, 2006, 2008, 2009, 
2011; Kittles &Weiss, 2003; Lee, 2005, 2007; Lee & Mudalier, 2009; Ng, Zhao, Levy, 
Strausberg & Venter, 2008; Roberts, 2011).  Despite these concerns expressed by social and 
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natural scientists, physicians, and other stakeholders, race-based medicine (RBM) continues to 
be a growing field, evidenced by the increasing number of patents filed by the pharmaceutical 
industry for new “racial” or “ethnic” drugs (Kahn, 2006).  The following is a review of the 
literature with respect to RBM, PGM and lay conceptions about these two nascent systems of 
medicine. 
 
2.2  Race: Social, Biological, or Both? 
Many social and natural scientists contend that race and ethnicity are socially produced 
systems of classification that can have biological consequences (such as health outcome 
disparities) but do not necessarily reflect distinct genetic categories (Braun, 2002; Duster, 2005; 
Foster & Sharp, 2002, 2004; Kittles & Weiss, 2003; Reardon, 2004).  In 1972, the population 
geneticist Richard Lewontin demonstrated that over 85 percent of observed human genetic 
variation occurred within racial groups while only 6 percent occurred between racial groups and 
8 percent occurred between population groups (i.e., nationalities, ethnicities or tribes) within a 
race (Lewontin, 1972).  Since that time, human genetic research has advanced significantly in 
large part due to the mapping of the human genome and related research through the HGP.  The 
HGP has shown that 99.9 percent of human DNA is shared by all human beings (Collins & 
McKusick, 2001).  Despite past and recent findings suggesting that there is little genetic 
variability between racial groups (however such groups are defined), a number of researchers 
maintain the position that there is a genetic basis to race, and some assert that there are genetic 
differences between races in specific traits, such as intelligence (Herrnstein & Murray, 1994; 
Risch et al., 2002; Rushton & Jenson, 2005; Tang et al., 2005). 
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The predominant understanding among most geneticists is that human genetic variation is 
the result of historic reasons of drift, selection and demographic history (Kittles & Weiss, 2003; 
Risch et al., 2002).  Kittles and Weiss (2003) describe genetic differences as “isolation by 
distance”, meaning, human genetic variation is fairly proportional to the geographic distance 
between human beings.  “Isolation by distance” relates to the concept of “clinal”, which suggests 
that there is gradual genetic variation among populations across the globe (Relethford, 2009).  
From a clinal perspective, how categories of race are distinguished is arbitrary, as there are no 
obvious distinctions among a continuum of genetic variation that could provide cut-off points for 
racial categories.  Variations may have occurred as a result of adaptations made to one’s physical 
environment, as well as mating between geographically distant individuals.  The extent to which 
this variation across human beings can and should be classified into biologically distinct races is 
both arguable and controversial, however, many geneticists agree that the geographic origins of 
individuals’ ancestors, migration, and mating patterns have had an impact on genetic variation 
among human beings (Kittles and Weiss, 2003; Risch et al., 2002).  
Foster and Sharp (2002) are among those who contend that currently, there are no self-
evident biological criteria that can be used to recruit a sufficiently heterogeneous population for 
the study of human genetic variation.  Consequently, social categories like race, ethnicity, 
nationality and geographic residence are often used as proxy variables to approximate the range 
of variation that could exist among populations. They note an inherent paradox in the use of 
social classifications – while using social categories can be helpful in assembling a biologically 
diverse sample for genomic research, these categories imply a substantive biological significance 
that they do not necessarily possess.   A number of scholars contend that genomic research 
studies examining the diversity of the human race are problematic because of their reliance on 
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socially produced systems of racial and/or ethnic categorization that do not accurately reflect the 
spectrum of diversity globally (Lee, 2005; Hamilton, 2008).  While notably, there are very real 
challenges to designing a study of human genomic variation, Lee (2005) suggests that inclusion 
of populations such as people from the Middle East, South Asia and multiple regions in Africa 
would better capture clinal variation, thereby minimizing genomic isolation by distance among a 
study sample’s gene pool and providing a fuller picture of genetic diversity that is not limited to 
only a handful of populations intentionally studied for their relatively substantial geographic 
distance from each other.  For example, the International Haplotype Map Project (HapMap) was 
created to examine human genetic variation with the primary – although not exclusive – goal of 
understanding the haplotype blocks of single-nucleotide polymorphisms (SNPs) that contribute 
to human variations in disease susceptibility and treatment response (National Human Genome 
Research Institute, 2013).  Despite the HapMap’s claim that its research was sensitive to 
concerns about how a sample should be selected to study genomic diversity, Lee contends that 
the selection of sample populations that are geographically extremely separated from each other 
(in the case of the HapMap, people of Chinese, Japanese, Yoruban and Northern European 
ancestry) accentuates the genetic distance between groups, thereby reinforcing the age-old – and 
problematic - categorization of populations as Asian, white or black.   
Genetics research thus far has employed several types of sampling and analytical 
strategies.  However, most studies, including the HapMap, have focused on population-based 
sampling techniques that use self-identified race as a basis to make conclusions about genetic 
differences between socially-defined racial groups (Kittles & Weiss, 2003).  As Duster (2005) 
notes, “…the particular groups of individuals chosen to represent each region of the world are 
often chosen because of their convenience and accessibility…” (p. 1050).  This form of sampling 
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has been controversial for a number of reasons, including migration and mating patterns that 
have resulted in increasingly more heterogeneous populations globally, thereby challenging the 
so-called genomic “purity” of populations.  In the United States, for example, racial 
categorization has followed the “one-drop” rule, where people are classified into a single racial 
category, such as black or Native American, regardless of the extent to which these populations 
are part of individuals’ genetic ancestries (Kittles & Weiss, 2003).  Therefore, self-identified race 
as a proxy for identifying genetic differences between populations has been considered 
questionable in that it ignores the variations in genetic admixture of individuals who identify 
with a specific racial or ethnic group.  A person whose admixture is predominantly African in 
lineage and someone whose admixture is predominantly European may both identify as African 
Americans in the United States because of their phenotypes and/or shared social, cultural and 
familial experiences.  While these two individuals may self-identify as the same racially, a 
mapping of the two individuals’ genotypes may indicate relatively significant variation 
(considering the context that human beings share 99.9 percent of their DNA).  Consequently, the 
participation of one or the other of the two in a population-based genomic research study sample 
could result in different conclusions about race-specific genetic differences and similarities. 
Other researchers have attempted to approach genetics research from a “race-neutral” 
perspective (Wilson et al., 2001).  Wilson and colleagues (2001) used a model-based clustering 
method to create genetic clusters based on the genotypes of eight ethnic populations: South 
African Bantu speakers; Amharic- and Oromo-speaking Ethiopians from the Shewa and Wollo 
provinces collected in Addis Ababa; Ashkenazi Jews; Armenians; Norwegian speakers from 
Oslo; Chinese from Sichuan in southwestern China; Papua New Guineans from Madang; and 
Afro-Caribbeans from London.  Wilson et al. found through this model that the eight populations 
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clustered into four groups in a way that was discordant with traditional racial labels that would 
be used to classify these eight populations.  According to their analysis, these four groups 
correspond to four geographical areas: Western Eurasia, Sub-Saharan Africa, China, and New 
Guinea. Sixty-two percent of the Ethiopians clustered into the Western Eurasia group, which also 
included the majority of the Jews, Norwegians and Armenians.  This indicated that 
categorization of nearly two-thirds of the Ethiopians from this sample as “black” would not 
accurately reflect their genomic make-up.  Other clustering results that would conflict with 
traditional socially-constructed race categories included the clustering of 21 percent of Afro-
Caribbeans with the Western Eurasia group, and nearly all of the Chinese and Papua New 
Guineans clustering into separate groups instead of as a single “Asian” group.  The researchers 
of this study conclude that clusters based on genetic structures can be more informative than 
racial labels for the development of pharmaceutical drugs, as well as the evaluation of these 
drugs for effectiveness and adverse effects. 
Risch and colleagues (2002), proponents of using social race categories for genetic 
research, responded to Wilson and colleague’s findings by contending that the clusters 
correspond for the most part with social race categories and that the most striking finding – that 
62 percent of the Ethiopians clustered with Western Eurasia – is, in fact, not striking at all.  “But 
it is known that African populations with close contact with Middle East populations, including 
Ethiopians and North Africans, have had significant admixture from Middle Eastern (Caucasian) 
groups, and are thus more closely related to Caucasians” (p. 4).  They noted that overall, the 
results corresponded to the “major races” (i.e. black, white and Asian), and that the bottom line 
is, “Two Caucasians are more similar to each other genetically than a Caucasian and an Asian.” 
(p. 5).   
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 A review of the literature examining genomic research studies’ sampling methodology, 
results, and conclusions about the relationship between race and genes clearly shows a lack of 
consensus regarding the relationship between race and genes.  The literature also shows distinct 
efforts among some researchers to move from what was once understood to be the academic 
consensus that race is a socially constructed system of population categorization to a search for 
genetic verification of racial difference. The following examines the academic literature 
regarding RBM, including how the justification of RBM’s development relates back to the 
bigger picture regarding the relationship between race and genes.  
 
2.3  Race-Based Medicine 
As much as the science of race remains controversial and contested, so does the concept 
of RBM.  On the one hand, RBM presents an opportunity to redress years of unequal treatment 
towards racial and ethnic minority populations by the healthcare system through the provision of 
tailored treatments that purportedly seem to be more effective in certain populations than others 
(Burchard et al., 2003).  In addition, there is the belief that RBM more generally could be an 
effective strategy for reducing racial health disparities (Risch et al., 2002; Burchard et al., 2003).  
On the other hand, there are a number of serious scientific, ethical and social concerns that must 
be considered.  The following is a review of the literature regarding the scientific, medical, social 
and ethical concerns related to RBM.  This is followed by a review of the literature on 
“ethnicity” as an alternative to “race” in the development of RBM.  This section begins, 
however, with a summary of the case of BiDil, which provides an example of a number of 
concerns generally associated with RBM. 
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2.3.1  The Case of BiDil 
In 2005, the United States Food and Drug Administration (FDA) approved the drug BiDil 
for use in treating heart failure among African Americans (Lee, 2005).  BiDil is unique in that it 
is the first race-specific drug to have been approved by the FDA.  While research has indicated 
that BiDil seems to help the prevention of heart failure among many people, according to Kahn 
(2005a, 2005b, 2008), the concept of race was exploited in order to bring this drug to the market.  
Kahn points out several concerns related to the approval of this drug for race-specific purposes, 
which both separately and in combination point to a number of scientific, social and ethical 
concerns that can be applied more generally to the field of RBM.   
Kahn describes in detail the problems related to the clinical trial that was undertaken to 
test BiDil’s safety and effectiveness in African Americans.  Known as the African American 
Heart Failure Trial (A-HeFT), this clinical trial only tested BiDil’s effectiveness among African 
Americans.  By only using African Americans, the trial could not show whether BiDil had a 
differential level of effectiveness among African Americans compared to other racial or ethnic 
groups.  Kahn contends that NitroMed, the company who owned BiDil’s patent, was likely 
concerned that the clinical trial could possibly show equivalent levels of effectiveness in a 
comparison population, which would have meant that BiDil could be interpreted as effective for 
the general population.  With its patent covering BiDil’s approval for use in the general 
population set to expire in 2007, but potential patent approval through 2020 on the line for 
BiDil’s exclusive use in the African American population if a clinical trial could prove that it is 
more effective among that population, NitroMed had a lot to gain financially if the clinical trial 
was crafted to only show BiDil’s effectiveness among African Americans.  Clinical trial results 
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showing equivalent levels of effectiveness among more than just the African American 
population would have meant that NitroMed would lose its patent over the drug in 2007.  In 
addition to the questionable scientific validity of A-HeFT’s results and the clear profit motive for 
NitroMed to gain patent approval for BiDil as an African American drug, an additional problem 
identified by Kahn was the loss to potential beneficiaries of BiDil who are not African American, 
because the clinical trial results implied that the drug is only effective among African Americans.   
The case of BiDil elucidates the scientific concerns associated with a poorly designed 
clinical trial, medical and ethical concerns associated with recommending a drug’s use in only 
one population when it has the potential to be effective in other populations, and ethical concerns 
surrounding the pharmaceutical industry’s motivations behind re-branding an existing 
medication as a race-specific drug.  BiDil, however, also taps into other social concerns, such as 
the potential for RBM to promote beliefs that if there are biological/genetic differences between 
racial and ethnic groups in their response to different medications, perhaps there are additional 
biological or genetic differences between racial groups in other traits, such as athletic ability, 
intelligence or success in life.  
 
2.3.2  Race-Based Medicine: Scientific and Medical Considerations 
The application of genetic findings based on socially constructed racial categories to the 
development of race-specific drugs is at the heart of the debate regarding the clinical 
effectiveness of RBM (Caulfield et al., 2009; Dorr & Jones, 2008; Duster, 2005; Foster and 
Sharp, 2002; Fujimura, Duster and Rajagopalan, 2008; Kahn, 2006, 2008, 2009, 2012; Lee, 
2005, 2007; Ng, Zhao, Levy, Strausberg & Venter, 2008; Roberts, 2011).  The extent to which 
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the genomic profiles of individuals who participate in genomic research compare to the identity 
of the social (i.e. racial or ethnic) groups that they self-identify with is at a minimum, 
inconsistent, and yet, race-specific diagnostic tools and treatments are being developed and 
tested for use by specific racial and ethnic groups.  This is despite the fact that individuals within 
these groups can genetically vary as much as, if not more so than, the genetic variation between 
racial and ethnic groups.  
In addition to scientific concerns regarding the internal and external validity of race-
related genomic research and RBM clinical trials, concerns regarding the medical implications of 
RBM development and promotion have also been noted.  One concern is that clinical providers 
may be less-inclined to consider alternative forms of treatment for their patients with conditions 
for which a race-specific drug exists that matches the patient’s self-identified and/or physician-
assessed racial identity.  Another concern relates to people who could use a drug, but it is not 
prescribed to them because their self-identified or physician-assessed race does not concord with 
the race of those for whom the drug is meant to be used (Lee, 2005).   
 
2.3.3  Race-Based Medicine: Social and Ethical Implications 
A portion of the scientific literature concerning RBM has examined the social and ethical 
implications of developing RBM.  One major concern is the stratification of individuals into 
patient groups based on both genotypic and phenotypic information (Lee, 2005).  If certain 
phenotypes corresponding to racial or ethnic minority populations are more commonly 
associated with relatively rare alleles for genetic conditions, there is the potential for 
pharmaceutical companies to be less likely to develop treatments and diagnostic tools for those 
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genetic health conditions.  Pharmaceutical companies may make decisions about which patient 
groups are financially worth investing in, resulting in smaller populations that possess rare alleles 
being viewed as less attractive for pharmaceutical investment.  Pharmaceutical companies may 
decide it’s not worth investing in pharmacogenomic products for relatively smaller populations 
like Native Americans or certain Pacific Islander populations.  Additionally, because the 
ancestral admixture of Latinos runs the gamut, it becomes practically impossible to develop 
ethnicity-specific treatments for such a heterogeneous population.  Lee (2005) notes that there 
are concerns that the number and types of drugs developed for different racial and ethnic groups 
may simply not be equivalent. 
Although some have expressed concerns that RBM has the potential to exacerbate health 
disparities because focusing on the development of drugs for only certain racial groups or 
genomic profiles may mean that other populations will have even fewer treatment options, others 
have defended RBM as an important approach towards eliminating health disparities and 
therefore an integral contribution to the delivery of medicine. A number of researchers have 
called for increased genomic research using social categories of race and ethnicity in order to 
identify common variations in alleles between these groups and use this information to develop 
more diagnostic tools and treatments for racial and ethnic minority populations (Burchard, 2003; 
Risch et al., 2002).  They maintain that social categories of race and ethnicity are relatively good 
approximations of group-level genomic differences that could benefit from RBM as a more 
tailored approach to practicing medicine than currently available conventional treatments.   
Some researchers who defend the use of race as a legitimate classification system for 
biological research contend that the study of variations in rare alleles found among different 
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racial and ethnic groups will eventually enable science to mitigate health disparities (Burchard, 
2003; Risch, 2002).  Lee warns, however, that labeling relatively minor differences as “racial” 
could be both dangerous and dishonest.  She notes that promotion of minor genetic differences 
related to these rare alleles could lead to a redefinition of social inequalities in health as 
biologically-based, resulting in a shift of interventions towards the clinical level, rather than the 
social and environmental levels that likely contain many, if not most, of the factors contributing 
to health disparities.  
In addition to concerns that health disparities could be exacerbated if RBM leads to 
unequal development of treatments for different racial and ethnic groups, others have noted that 
increased attention to biological differences could also exacerbate health disparities.  Condit and 
Bates (2005) contend that RBM requires heightened attention to biological differences by 
physicians, and because the notion of difference is a core component of racist attitudes, this 
attention could exacerbate discriminatory treatment by medical personnel towards minority 
populations. They also note that RBM could increase the already relatively high levels of 
mistrust towards medical authority on the part of ethnic and racial minorities, further 
exacerbating the reluctance of these populations to turn to the medical profession for care. 
There is also the concern that the public may perceive genetic information associated 
with race and ethnicity as having more authority than social science information (Foster and 
Sharp, 2002).  According to Foster and Sharp (2002), “…public perceptions of genetic 
information tend to collapse categories and distinctions that scientists use to maintain distance 
between social and genetic definitions of populations….Hence, there is a likelihood that genetic 
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information associated with race and ethnicity will result in the reductionary reconfiguration of 
those categories along simplified biological lines.” (p. 848).  
Duster (1990/2003) in his seminal book entitled “Backdoor to Eugenics” contends that 
one harmful consequence of efforts to search for race- or ethnicity-specific genetic differences in 
disease is that this search for what might be considered neutral and unbiased forms of difference, 
can in fact lead the lay public to infer that race-specific genetic differences may not stop at just 
disease susceptibility and health outcomes, but may include other broader human characteristics. 
The implications for this is that exposure to information linking race, genes and health can have 
as strong an effect on heightening racist beliefs and attitudes towards certain populations as 
linking race to genetic differences in more controversial domains, such as intelligence.  Phelan, 
Link and Feldman (2013) tested Duster’s theory through a vignette experiment using mock news 
articles that discussed varying types of relationships between race and genes, and found that the 
vignette that discussed a race-specific genetic health difference had as strong an effect on belief 
in essential racial differences as the vignette that broadly stated that there is a genetic basis to 
race.  One implication of this finding is that because RBM implies that there are genetic 
differences between racial and ethnic groups in disease susceptibility, response to treatments and 
health outcomes, it is possible that the development and existence of RBM may not only reify 
race as a scientifically legitimate system of categorization for populations but, could also 






2.3.4 The Conceptual Role of Ethnicity in Race-Based Medicine 
“Race” and “ethnicity” are overlapping, but separate, concepts that are often used 
interchangeably, particularly within biomedical research (Lee, 2009; Sankar, Cho & Mountain, 
2007).  Perhaps because there are distinct variations in how both race and ethnicity are 
conceptualized, there is no simple way to define differences between the two concepts.  The 
concept of race is extremely controversial and ranges from the biological essentialist perspective 
that conceptualizes race as having some biological or genetic component, to the social 
constructionist/constructivist perspective that conceptualizes race as being entirely a social 
phenomenon, albeit one with very real social and biological consequences such as race-specific 
health inequalities (Morning, 2011).  Ethnicity, meanwhile, has generally been defined as a 
collective identity where the collective often shares not only a common biological ancestry, but 
also various beliefs and cultural symbols and practices, including language, dress, diet, religious 
beliefs and other norms and values (Barth, 1996; Lee, 2009; Cornell & Hartmann, 1998).   
Cornell and Hartmann (1998) provide one theoretical framework by which race can be 
distinguished from ethnicity.  They contend that ethnicity is defined by its group members and is 
voluntaristic – group members opt in to their ethnic identity, thereby make ethnicity an 
“achieved status”.  Meanwhile, they assert that race is a classification system imposed on people 
– individuals cannot opt in to or out of their racial label. They therefore describe race as an 
“ascribed status”.  Because of the history of scientific racism and biological reductionism 
associated with the concept of race, there have been calls for abandoning the use of race as a 
biomedical research variable and replacing it with ethnicity (British Medical Journal Editorial, 
1996; JAMA Editorial, 2005).  Others have taken this idea a step further, calling for an entirely 
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new method of describing populations that focuses on providing the fullest description possible 
of the studied population’s characteristics (Bhopal & Donaldson, 1998; Fullilove, 1998).  
Despite the calls for abandoning race as a variable in biomedical research, race continues to be a 
salient and prominent focus of population research (Lee, 2009).   
With respect to pharmacogenomics, the conceptual framework and related language that 
is used in the development of pharmaceutical products also continues to be based on the concept 
of race.  Ethnicity is sometimes included as part of the descriptive narrative surrounding the 
development of pharmaceutical products tailored for use in specific racial and/or ethnic 
populations, but it is rarely conceptually defined as different from race or used in lieu of race 
(Lee, 2009; Sankar, Cho & Mountain, 2007).  The conceptual challenges involved with 
untangling the concepts of ethnicity and race from each other point to the question of how 
ethnicity fits in to the development of population-targeted pharmacogenomic medicine.  On the 
one hand, there could be a sizable number of researchers and physicians who would accept the 
idea that so-called “ethnic” drugs could be clinically effective for genetically more homogenous 
populations, such as certain indigenous tribal populations.   On the other hand, it seems 
practically impossible to develop “ethnic” drugs for highly admixed populations such as the 
world’s Hispanic/Latino population.  Despite this latter point, FDA patent application records 
show that there have been efforts to develop so-called "Hispanic medications" (Kahn, 2006).   
Even with scientifically valid scenarios that can be envisioned for the development of “ethnic” 
drugs as a more nuanced alternative to the development of RBM, the many scientific, social and 
ethical concerns that exist surrounding RBM could still exist for ethnicity-based medicine, as 
evidenced by the questionable clinical effectiveness of developing medications that are meant to 
be broadly used only by populations who identify as Hispanic or Latino.   
 21 
 
Unlike the calls for using ethnicity instead of race as a variable in biomedical research, 
there does not seem to be evidence of similar efforts to move away from the development of 
RBM towards the development of ethnicity-based medicine as the interim alternative to 
personalized genomic medicine.  It is possible that this idea has not been fully explored within 
the literature because opponents of RBM foresee scientific, social and ethical concerns arising 
from the development of pharmacogenomic products for specific ethnic groups that are similar to 
those associated with the development of RBM. 
 
2.4  Global, National and Corporate Stakes in Developing Race-Based Medicine 
2.4.1  Global Stakes in Developing Race-Based Medicine 
RBM has been touted as not only a solution to addressing health disparities between 
different populations within the US, but also global health disparities across different nations.  In 
the early 1990s, the Human Genome Diversity Project (HGDP) was launched in order to study 
“…how and when patterns of diversity were formed [in human populations].” (p. 333, Cavalli-
Sforza, 2005).  HGDP, however, received numerous criticisms related to its study design and 
concerns about problematic assumptions made about the “composition of populations, the 
ontology of races and the relationship between ancient and modern people…” (p. 473, Hamilton, 
2008).  These and other criticisms in fact stalled the project until 2005, when the HGDP 
eventually received approval from the U.S. National Research Council to collect genetic data 
from 52 different populations in an effort to study genomic diversity, including its relationship to 
disease, after agreeing to follow careful informed consent and ethical procedures.   
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The HapMap (see page 9 for its description) was designed in part to address the critiques 
of the HGDP (Hamilton, 2008).  However, concerns that were originally expressed about the 
HGDP have also been associated with HapMap.  Hamilton (2008) argues that socially-
constructed categories of race were integral to the HapMap’s development with respect to the 
following: (1) the conceptualization and practice of HapMap itself and (2) the scientific and 
economic viability of HapMap samples, both now and in the future.  Hamilton notes that socially 
constructed categories of race and ethnicity were involved in the selection of participants in the 
HapMap, which, far from being a random selection of global populations, instead was an 
intentional selection of distinct populations, identified by national and diasporic categories for 
defining populations.  The HapMap’s development based on socially-defined group categories 
inherently meant that related research findings have been shaped by HapMap’s focus on certain 
populations.  This effort to map haplotype blocks among certain national and ethnic groups has 
also had the potential to encourage the development of disease-specific diagnostic tools and 
treatments that are defined by the same racial or ethnic labels that were used to recruit the sample 
for the HapMap study. Although the HapMap study has not had a specific hand in the 
development of RBM, findings from this, the HGDP and other research studies examining the 
relationship between race and genes are meant to be applied to the development of new 
diagnostic tools and treatments, which may include race-specific genetic testing 





2.4.2 “Genomic Sovereignty” and Nationalist Stakes in the Development of Race-Based 
Medicine 
Benjamin (2009) has examined the concept of “genomic sovereignty”, generally defined 
as postcolonial nation-states’ legislative or policy initiatives implemented to regulate the 
sampling and/or transport of genetic material from their citizens. These initiatives from nations 
like Mexico and India are, in part, responses to their exclusion from the HapMap project. Some 
of these nations have also developed their own national consortiums to map haplotype blocks of 
their own citizens. The goal has been to develop pharmaceutical products tailored to the genomic 
profiles of their citizens, including individual genomic profiles (for the development of 
personalized genomic medicine) as well as markers to distinguish larger groups of people (for 
the development of RBM). The belief is that by regulating and maintaining ownership of 
national genetic material, these nations are then able to develop pharmacogenomic products 
within their borders, thereby generating domestic profits that remain in these nations. There is 
also the hope that the development of tailored pharmacogenomic products will improve 
diagnosis, decrease side effects and their ensuing costs, and therefore lower national health care 
expenditures.  
 
2.4.3  The Pharmaceutical Industry and Developing Race-Based Medicine 
BiDil is the most well-known example of RBM, perhaps in part due to the fact that it was 
the first race- or ethnicity-specific drug approved by the FDA. However, there have been 
additional signs that the pharmaceutical industry has pushed for FDA approval of increasingly 
more race- or ethnicity-targeted pharmaceutical products.  Kahn (2006) has shown after 
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examining FDA patent applications and approvals that the number of applications and patents 
approved for race-/ethnicity-targeted drugs skyrocketed following the completion of the HGP 
and in the wake of the approval of BiDil as a “racial” drug. According to Kahn, RBM-related 
patents were not issued at all between 1976 and 1997, but 12 such patents were issued between 
1998 and 2005.  Following the issuance of these patents, 65 race- and ethnicity-specific 
pharmaceutical patent applications were filed in the five-year period between 2001 and 2005. 
Several scholars have examined the pharmaceutical industry’s role and influence in 
RBM’s development, noting that it has been an instrumental leader in shaping RBM’s existence. 
For example, it has been argued that the first RBM-specific product approved for use in the U.S. 
occurred not as a result of biomedical leaders’ and researchers’ efforts to develop RBM as a new 
paradigm in the practice of medicine, but because of a pharmaceutical company’s desire to 
extend its hold on a drug whose patent was about to expire (Kahn 2008, 2009).     
Kahn (2009) notes that efforts to extend patents in the U.S. on previously-approved drugs 
haven’t remained a focus within the pharmaceutical industry since BiDil’s approval.  However, 
he does argue that race and ethnicity have continued to hold featured roles in the approval of 
pharmaceutical product patents, as well as the marketing of products whose effectiveness has 
been shown to be associated with specific variations in individuals’ genomic profiles.   Kahn 
contends that companies have found ways to layer race and ethnicity on diagnostic tools and 
treatments that are known to be differentially effective depending on the genomic profile of 
individuals. Therefore, despite the availability of genetic information to target a drug’s use, 
which is the goal of personalized genomic medicine, there have been efforts to assert that rare 
alleles associated with a drug’s effectiveness are more prevalent in certain racial and ethnic 
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populations.  By making this connection between alleles, race/ethnicity and a drug’s 
effectiveness, the drug or its related genetic test’s marketing potential thereby increases from a 
smaller pool of genomic profiles to a larger pool of racial and ethnic populations cited as being 
more likely to carry these alleles.  This was the case with the marketing of genetic tests for the 
effectiveness of the widely used blood thinner warfarin, which has been documented as the 
second-most common drug responsible for emergency room visits in the U.S. (after insulin) and 
is associated with an estimated 43,000 adverse drug-related events each year (Budnitz et al., 
2006).  In an effort, in part, to minimize adverse episodes related to using warfarin, researchers 
were able to identify and isolate variations in the alleles responsible for adverse responses to the 
drug.  Genetic tests have since been developed to identify these variants, enabling physicians to 
determine whether patients are more or less likely to have adverse responses to use of warfarin 
and thereby adjust dosing levels in order avoid an adverse reaction. However one company, 
AutoGenomics, has coupled its warfarin test for the three alleles most associated with warfarin 
response with a test for more common variants associated with specific races and ethnicities 
(specifically African American, Caucasian and Japanese).  By expanding the profile of these 
tests and marketing them as being particularly effective in diagnosing warfarin response in three 
racial and ethnic populations representing the world’s major medical markets (i.e. the U.S., 
Europe and Japan), Kahn contends that AutoGenomics has sought to increase its market share of 
pharmacogenomic diagnostic testing by linking its effectiveness to large racial and ethnic 
populations.  
 Although efforts to extend the life of U.S. patents by redirecting drugs’ target populations 
to specific racial and ethnic groups have not been common since BiDil, Benjamin (2009) notes 
that the pharmaceutical industry has made significant efforts to redirect a drug’s reach in 
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populations outside of the U.S. by seeking patent approval in other nations.  Mexico, India and 
other nations have been targeted as “Pharma’s Promised Land”, where drugs that have failed in 
North American clinical trials or whose patents are about to expire have opportunities to be 
proven effective in ethnic populations outside of the U.S.  Benjamin contends the pharmaceutical 
industry promotes investments in “niche ethnic markets” as having a dual purpose of both 
recouping companies’ investments in drug research and development while also (theoretically) 
addressing the health needs of medically marginalized populations outside of North America. 
These efforts enable the pharmaceutical industry to minimize losses and expand profits, but they 
also have the subsequent effect of labeling certain drugs as “ethnic drugs” because of their 
purported effectiveness in allegedly more genomically homogenous populations. 
 
2.5  Scientific and Medical Community’s Beliefs and Attitudes towards Race and RBM 
Among scholars who have written about RBM, there are both proponents (Burchard et 
al., 2003; Maglo, 2001; Nguyen, Desta & Flockhart, 2007; Risch et al., 2002) and opponents 
(Lee, 2005, 2007, 2009; Kahn, 2005a, 2005b, 2008, 2009;  Ng, Zhao, Levy, Strausberg & 
Venter, 2008; Roberts, 2008, 2011) of implementing RBM.  Scientists and physicians are among 
those at the frontlines of both developing RBM and integrating RBM into the practice of 
medicine.  Understanding scientists’ and physicians’ conceptions regarding the relationship 
between race and genes generally, and RBM specifically, provides insight into the rationale 
behind scientists’ beliefs regarding the application of racial and ethnic categories to human 
genomic research, ensuing efforts to develop RBM, and physicians’ attitudes towards RBM 
conceptually and as a part of their clinical toolkit. The following is a review of the literature 
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regarding the scientific and medical communities’ conceptions regarding the relationship 
between race and genes generally, and RBM specifically.   
 
2.5.1  Scientists’ Conceptions Regarding Race and Genes 
 Recent research findings seem to indicate that there is little consensus regarding 
scientists’ conceptions of race, both within and between biological and social science disciplines.  
Morning’s (2011) study of how scientists conceptualize and teach their students about race 
highlights this lack of consensus.  Morning provides a framework for how diverse conceptions 
regarding race can be understood. She contends that race conceptualization can be categorized as 
based in “essentialism” or “constructivism”.  Essentialism contends that a given group’s 
members share “…one or more defining qualities – “essences” – that are inherent, innate or 
otherwise fixed.” (p. 12)  These “essences” do not necessarily need to be rooted in biology, 
rather, they could also be whatever we believe the essence of human beings to be, for example, 
one’s soul or psyche (Nelkin and Lindee, 1995).  Morning notes that in the U.S., however, 
essentialism usually translates back to biological, and in particular, genetic characteristics of 
human beings.  
 Morning explains that constructivism (also known as “constructionism”) runs counter to 
essentialism’s contention that social categories reflect natural and stable differences between 
human groups, by asserting that social categories are “man-made” or artificial, created through a 
process of “social construction”.  She notes that constructivists do not view social groups as 
being unreal just because their existence is not rooted in biology.  Critics of constructivism, 
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however, contend that this conceptualization of race denies important truths about biological 
reality (Frank, 2011; Gergen, 1998). 
Despite prior beliefs that the academic consensus surrounding the conceptualization of 
race is a constructivist perspective (see Bliss, 2011 for more on this), Morning’s research 
indicates that a constructivist/anti-essentialist view has not, in fact, taken over social and 
biological scientists’ conceptions of race, even within her highly purposive sample of natural and 
social scientists, half of whom were anthropologists.  There was a range of opinions in her study, 
from a constructivist to an essentialist perspective on race, the latter of which suggesting that 
there are genetic differences between racial groups.  Morning also found in her examination of 
high school and undergraduate-level biology textbooks that the constructivist message on race 
was, for all intents and purposes, absent.  Instead, she asserts that racial essentialism is reinforced 
both directly and indirectly in biology textbooks, and contends that even most social science 
textbooks generally fail to make a strong constructivist case for the conception of race.  Her 
interviews with university-level students found that most students clearly identified racial 
constructivism with the discipline of anthropology and not nearly as much with teachings of any 
other discipline.  She summarizes her findings on how race is taught by asserting that scientific 
instruction challenging biological/essentialist notions of race do not currently appear to be a 
pervasive feature of formal education in the U.S.  
The lack of clarity regarding conceptions of race, also seems to be evident among 
geneticists. Hunt and Megyesi (2008) interviewed 30 human genetics researchers who used race 
as a variable in their genetic research about their beliefs regarding the use of race in research.  
Their findings showed that most geneticists in their study viewed racial variables as poorly 
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defined and scientifically inadequate.  At the same time, they defended using these variables, 
arguing that race serves as a useful proxy indicator for examining human difference, until 
“imminent medical progress” can be made that enables scientists to move beyond the use of race 
as a distinguishing variable. Hunt and Megyesi found that none of the geneticists had strategies 
to address the inadequacies of using race as a variable, but many believed that science will 
eventually correct itself as progress is made. 
 Bliss’ (2011) study of elite genomics researchers found that researchers were highly 
reflexive of their personal experiences as racialized subjects and, in consideration of the complex 
social and political forces that shape biomedical research and its technological and clinical 
applications, engaged in what she termed as “reflexive biosociality”.  She defines this concept as: 
 
…researchers’ conscious efforts to create analytics that contribute to a future they 
themselves want to live in… They oscillate between policy frameworks and experiential 
rationales to fashion taxonomies that square with dominant values about minority 
inclusion and medical equality. Most use a racial taxonomy when they believe it can help 
racial minorities. These reflexive representation processes allow researchers to produce a 
social order that benefits themselves and their kin, while offering avenues for race-based 




But Bliss also notes that reflexive biosociality paradoxically led the researchers in her study to 
simultaneously put forth social explanations for race conceptions while investing in genomics as 
a solution to racial quandaries. 
 There has been a fair amount of ethnographic work of leading pharmacogenomic 
laboratories and population-based biobanks that have shown that genomics researchers often 
uncritically align federal inclusionary standards for racial and ethnic minorities in population-
based research with genomic population categories (Fullwiley, 2008; Montoya, 2011; Smart et 
al., 2008; Tutton, 2007; Tutton and Corrigan, 2004; Whitmarsh, 2008).  Bliss notes that this 
practice has, in turn, produced a system where research populations are stratified by race as part 
of the design of the genomic research, and then targeted for race-based treatments and cures.  
Overall, the literature regarding scientists’ conceptions of race and its relationship with 
genetics indicates diverging perspectives on race conceptions, ranging from constructivist 
positions on race to biologically essentialized conceptions.  Many scientists, particularly 
genomics researchers, may qualify that scientifically adequate definitions of race are lacking, but 
there is also a strong defense of using race in genomic research, which in turn has been justified 
as efforts to redress inequalities and be more inclusive of racial and ethnic minority populations 
in the benefits of the “genetic revolution” (Hunt and Megyesi, 2008; Fullwiley, 2008).  
 
2.5.2 Scientists’ and Physicians’ Conceptions Regarding RBM 
Similar to the findings on scientists’ conceptions regarding the relationship between race 
and genetics, there seem to be diverse conceptions among scientists and physicians regarding 
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RBM and the importance of race and genomics in medicine.  Bonham et al.’s (2009) focus group 
study of white and black internists found that while all of the physicians agreed that the race of 
patients is medically relevant, there was no consensus on why race is important. Black 
physicians in this study were more likely than white physicians to question the extent to which 
genetic research is a productive means to examine racial disparities in health, although some 
physicians asserted that genetics had a role to play in explaining race differences in health.  
Frank et al.’s (2010) study of white and black general internists’ attitudes towards RBM 
found that those who supported RBM believed a number of benefits could derive from race-
based prescribing, including motivating patients to comply with therapy and promoting changes 
in health behaviors by creating the perception that the medications and therapies are tailored for 
them. Supporters of RBM also cited the lack of effectiveness of ace inhibitors in treating 
hypertension among African American patients as a specific example of differential responses to 
medications by race that could benefit from the development of race-targeted therapies.  Some 
physicians, however, were concerned that there would be patients who could benefit from a 
“racial” drug but would not receive it because their racial heritage did not concord with the 
drug’s targeted population.  Specifically regarding BiDil, some physicians were concerned that 
commercial interests were the primary impetus behind the push to have it approved as an African 
American heart failure drug.  Finally, there were physicians who indicated that they were wary 
that race reflected any meaningful difference at the genetic level, thereby questioning the 
motives behind and clinical effectiveness of RBM.  
Akinniyi and Payne (2011) interviewed board-certified members of the American 
Association of Black Cardiologists about their BiDil prescribing patterns and found that a 
majority of the physicians (63.9 percent) had prescribed BiDil at some point to patients.  Of 
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those who had prescribed BiDil, a majority of physicians used medical history (68.4 percent) to 
determine who should use BiDil. Some (42.1 percent) additionally, or instead, used patient’s race 
based on the physician’s own assessment to determine whether to prescribe BiDil.  Nearly 37 
percent of physicians used race based on a patient’s self-identification to determine whether to 
prescribe BiDil. Also of note, 58.6 percent of the surveyed physicians believed racial groups are 
biologically distinct.  
Égalité, zdemir and Godard (2007) interviewed genomics researchers on their views 
regarding the relationship between pharmacogenomics and race.  Researchers in this study noted 
the double-edged nature of linking pharmacogenomics and race.  On the one hand, they 
expressed their concerns regarding the potential for racism and abuses related to prescribing 
race-specific treatments.  On the other hand, many believed that RBM had the potential to 
improve health outcomes and reduce race-specific health disparities.  Researchers indicated the 
need to follow precautionary measures related to interpreting and applying racially-categorized 
research findings.  They also believed that their purview as genomics researchers is to provide 
new scientific data, and to leave the examination of socio-ethical concerns regarding their 
findings to bioethicists. 
 
2.6  Lay Beliefs about and Attitudes towards Race-Based Medicine 
The biomedical and ethical debates regarding RBM will continue, however, as the 
pharmaceutical industry moves forward to develop race-specific screening and diagnostic tools 
and treatments, attention should turn to whether these products will even be used.  This will 
largely be affected by clinicians’ decisions regarding whether and how to use these tools and 
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treatments and, notwithstanding multiple factors that affect access to healthcare services, the 
patient population’s acceptance of and adherence to the RBM-related treatment protocols.  
Furthermore, patients’ acceptance and use of RBM will be influenced by what they’ve heard 
about RBM.  Some may be familiar with RBM because they’ve followed news media reporting 
on RBM generally, or news stories about products like BiDil, specifically (Caulfield & Harry, 
2008).  However because RBM is still in its nascent stages, it is more likely that most people will 
not be familiar with the concept until it is introduced to them by their healthcare providers or 
through direct-to-consumer marketing by drug companies.   
           The concept of race as having a genetic basis remains controversial and contested, thus, 
there is reason to believe that lay conceptions regarding RBM – which implies that there may be 
a genetic basis to racial groupings – could vary as well (Braun, 2002; Burchard et al., 2003; 
Duster, 2005; Foster & Sharp, 2002, 2004; Kittles & Weiss, 2003; Reardon, 2004; Risch et al., 
2002; Rushton & Jenson, 2005; Tang et al., 2005).  The long history of scientific racism in the 
United States and Europe, the details of which may not be well-known to the general public, 
nonetheless, is a history with which many may have some familiarity, whether it is some 
knowledge of efforts like the Tuskegee syphilis experiments on African American men, the Nazi 
experiments on Jews, or the ongoing efforts to prove that there are genetically-based intelligence 
differences between racial groups, which were well publicized by the mass media after the 
release of Herrnstein and Murray’s The Bell Curve in 1994 (Burt, 1972; Ellis, 1998; Galton, 
1869; Gould, 1981; Rushton & Jensen, 2005; Shockley, 1967; Tucker, 1994). Thus, there is 
reason to believe that attitudes and beliefs about race and genetics generally, and RBM 
specifically, could vary by race and ethnicity.  
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The little research that has examined lay conceptions regarding RBM’s effectiveness 
does seem to indicate that these conceptions vary by race and ethnicity (Bevan et al., 2003; 
Condit et al., 2003; Marco, 2010).  Bevan and colleagues (2003) reported that African American, 
Hispanic and multiracial American focus group participants were, on average, moderately to 
highly “suspicious” about drugs specifically designated for African Americans, and more 
suspicious than European Americans.  European American respondents, while not as suspicious 
as their study counterparts, were nonetheless slightly suspicious.  Some respondents noted their 
suspicions were grounded in concerns that RBM would be less effective than other drugs. Other 
reasons included concerns that race is more a cultural/environmental construct than genetically-
based and that RBM could be damaging to one’s health.  This study not only found racial 
differences in suspicious attitudes towards RBM, but that gender modified race in these attitudes 
as well. Hispanic and multiracial males were the most suspicious of race-based prescribing 
compared to any other racial/ethnic-gender group in the study, while white males indicated the 
least amount of suspicion towards RBM.  Another study of focus group participants also found 
that African American and Hispanic respondents were more suspicious than European American 
respondents about the safety and effectiveness of drugs designated for African Americans 
compared with drugs designated for European Americans (Condit et al., 2003). 
            To date, there is very little research that has examined whether or not the general public 
would use RBM.  Four percent of Bevan et al.’s (2003) focus group study mentioned RBM as a 
preferred treatment option compared to 75 percent preferring individualized genetic testing (i.e., 
personalized genomic medicine) and 9 percent preferring uniform initial drug assignment (i.e., 
the usual course of treatment).  It is unclear to what extent those who preferred individualized 
genetic testing would prefer either RBM or uniform initial drug assignment if individualized 
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genetic testing was not an option, but these data indicate a low preference for using RBM. It 
would be logical to assume that a preference to use RBM would be consistent with the belief that 
RBM is clinically effective, however, Lynch and Dubriwny (2006) found in the aforementioned 
study that despite suspicious attitudes towards RBM, a substantial minority of African American 
and Hispanic respondents believed that either they or other members of their minority group 
would still use RBM.  Thus, past research indicates that attitudes about RBM may not always be 
concordant with behavioral orientation towards using RBM, particularly among racial and ethnic 
minority populations. 
Marco’s (2010) focus group study examining white and black Americans’ beliefs and 
attitudes regarding RBM and PGM also found racial differences in attitudes towards RBM.  
Black respondents were generally distrustful of race-based prescribing, while white respondents 
expressed more positive attitudes towards RBM.  Whites did express equity concerns related to 
RBM’s development and access, but many agreed that it would be bad to miss out on more 
treatment options.  Black respondents generally believed that RBM is inherently racist and would 
lead to blacks receiving inferior medications.   
 Butrick and colleagues (2011) conducted a vignette experiment of Americans who 
attended a primary care facility in the Baltimore area examining beliefs and attitudes towards 
RBM in comparison to PGM and conventional treatments.  Unlike prior studies based on 
qualitative data examining beliefs and attitudes regarding RBM, this study found that whites, 
blacks and other racial minority groups that the sample comprised held equally negative attitudes 
towards RBM with respect to belief in medication efficacy and adherence intention.  They note 
that while there are a number of plausible reasons for why racial and ethnic minority populations 
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would hold negative attitudes towards RBM (including concerns surrounding racial 
discrimination and beliefs that race is a poor proxy for underlying biology), the reasons for why 
whites would hold negative attitudes are less clear.  They suggest that the reasons may be 
overlapping for whites and racial/ethnic minorities, but this similarity in beliefs could also be 
because of a lack of racial identity for white Americans, perhaps because they are in the racial 
majority.  They suggest that RBM may seem irrelevant for people with little awareness of their 
own race. 
 Public support for RBM may also be affected by the extent to which Americans believe it 
can reduce racial inequalities in health.  As health disparities continue to persist, there is hope 
that RBM will help close the health divide between whites and minority populations (Bevan et 
al., 2003; Burchard et al., 2003; Mensah, Mokdad, Ford, Greenlund & Croft, 2005; National 
Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention, 2010; Risch et al., 2002; Ward et 
al., 2004).  To date, there has been no research that has examined whether the public believes 
this is possible, however, it may be reasonable to expect that beliefs about RBM’s ability to 
reduce population-level inequalities would be consistent with beliefs about its individual-level 
effectiveness. 
 
2.7  Factors Potentially Associated with Racial Differences in Race-Based Medicine Beliefs 
As previously noted, there is some evidence to suggest that there are racial differences in 
RBM-related beliefs and attitudes (Bevan et al., 2003; Condit et al., 2003).  Because there is 
relatively little empirical data available on lay conceptions about RBM in general, and by race 
and ethnicity specifically, significant scholarship is needed to learn more about RBM beliefs and 
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attitudes, including factors that may contribute to racial differences in these beliefs and attitudes.  
Two potential factors that may contribute to racial differences in RBM beliefs and attitudes are 
genetic essentialist beliefs and racial attitudes.  The following is a brief summary of the literature 
on these two constructs.  
 
2.7.1  Genetic Essentialist Beliefs and Race 
Keller (2005) defines essentialist beliefs as “laypeople’s beliefs that social categories are 
natural and entitative in nature.” (p.686)  Although there is a rich theoretical and empirical 
foundation for the study of psychological essentialist beliefs, particularly in how they relate to 
stereotyping and prejudice (for example, see Medin, 1989; Yzerbyt, Rocher & Schadron, 1997), 
the literature is relatively thin with respect to lay beliefs about the biological component of 
psychological essentialism, specifically genetic essentialist beliefs and the idea that racial 
differences in human characteristics are genetically-based.  To date, there has been no research 
examining the relationship between genetic essentialist beliefs and RBM beliefs and attitudes 
among the lay public.  However, because the clinical effectiveness of RBM would presumably 
be based on its ability to address biological factors associated with health conditions and 
diseases, it is possible that individuals who espouse genetic essentialist beliefs about physical 
and non-physical characteristics could be more likely than those who do not hold these beliefs to 
also believe that RBM should be an effective method of practicing medicine. 
There are several studies that have examined lay beliefs about the relationship between 
genes and race.  Condit and colleagues (2004) developed a model of lay understandings of the 
relationship between race and genetics based on findings from focus groups, a community-based 
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survey and a random-digit-dial telephone survey.  They concluded the following from their 
findings: (1) most lay people identify race as being based primarily on physical features; (2) they 
believe that physical features are primarily genetically-based, therefore, there is a genetic basis to 
race; (3) they believe that “non-physical” differences in traits are caused by non-genetic factors; 
and (4) although they believe that there are hierarchies of races, they do not necessarily attribute 
these hierarchies to genetic differences.  Dubriwny, Bates and Bevan (2004) found in their focus 
group study on lay conceptions of race and genetics that lay participants have a multifactorial 
definition of race where genetic variation among populations is primarily interpreted as 
phenotypic differences among individuals. They also found racial differences in understandings 
of race. African Americans were said to have a more “fluid” understanding of race that 
emphasized culture and included ideas of “self-definition”.  European Americans, however, were 
more likely to use physical characteristics to describe and define race.  
Jayaratne and colleagues (2006) found in their study of white Americans’ beliefs about 
the genetic basis for racial differences, that half of the respondents believed racial differences in 
the drive to succeed, math ability, tendency to act violently and intelligence were not due to 
genetic factors.  Twenty-four percent indicated genetic factors had “very little” influence over 
these differences, 20 percent indicated “some” influence, 6 percent indicated “a lot” of influence, 
and less than 1 percent indicated that genes accounted for “just about all” of the perceived racial 
differences for these four traits.  In Sheldon, Jayaratne, Feldbaum, DiNardo, and Petty’s (2007) 
study of African Americans’ beliefs about the relationship between genetics and race, the authors 
found that while only 25 percent of study participants believed that most black people think 
perceived racial differences are due at least in part to genes, 58 percent believed this to be the 
case for most white people.  Reasons cited for why they believed blacks do not perceive race to 
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be genetic at all include: blacks’ upbringing and environment; differential effects of 
discrimination and lack of opportunities; beliefs that there are no differences between races; and 
the fact that blacks are stereotyped and/or seen as different. Reasons cited for why whites might 
believe racial differences are due at least in part to genetics include: whites thinking that they’re 
superior; whites’ upbringing and environment; ignorance and/or not knowing blacks; and media 
portrayals.   
 
2.7.2  Racial Attitudes and Beliefs about Race and Genes 
To date, there is no research examining the relationship between racial attitudes and 
RBM beliefs and attitudes, and very little research examining the relationship between these 
attitudes and genetic beliefs about race.  To the extent that beliefs about a genetic basis for race 
are positively associated with beliefs in RBM’s clinical effectiveness, it seems logical to examine 
the literature on racial attitudes and their association with genetic essentialist beliefs about race 
in order to identify whether there is empirical evidence to suggest that racial attitudes may also 
influence beliefs about RBM’s effectiveness. 
Two studies have shown an association between genetic explanations for race and 
prejudice towards blacks.  The 1986 National Election study (Kinder & Sanders, 1996) found a 
positive, albeit weak, association between the two constructs.  Keller (2005) also found genetic 
explanations of race to be positively associated with racist attitudes towards African Americans.  
Jayaratne et al. (2006) found that white Americans who endorsed genetic explanations for 
perceived racial differences in the drive to succeed, math ability, the tendency to act violently 
and intelligence were more likely to hold traditional racial prejudice attitudes (measured as 
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attitudes about their hypothetical child dating or marrying a black person) as well as modern 
racial prejudice attitudes (which measured belief in the extent to which blacks are responsible for 
their lower social status).  Sheldon, Jayaratne and Petty (2007) found that white Americans’ 
endorsement of a genetic basis for a perceived race difference in athleticism between whites and 
blacks was associated with greater levels of prejudice towards and negative stereotyping of 
blacks.  The findings from these four studies provide evidence that beliefs in genetic 
explanations for racial differences are associated with greater negative attitudes towards blacks.  
If genetic explanations for racial differences are positively associated with belief in RBM’s 
effectiveness, then it is possible that racist attitudes are associated with this belief as well.  
 
2.8 Lay Beliefs about Personalized Genomic Medicine 
Similar to the literature regarding lay conceptions of RBM, the literature on lay beliefs 
and attitudes regarding PGM is somewhat thin.  Nonetheless, there are several studies that have 
examined lay conceptions about PGM.  As previously noted, Bevan et al. (2003) in their study of 
lay beliefs about RBM versus PGM or the usual course of treatment found that when given the 
choice, 75 percent of study participants indicated a preference for using treatment based on 
individualized genetic testing (i.e., PGM).   
Haddy, Ward, Angley and McKinnon’s (2010) focus group study of members of the 
public who had a chronic medical condition and/or had family members with a chronic medical 
condition were asked about their views on the implementation of PGM.  Overall, participants 
believed that PGM had the potential to improve treatments, but they were concerned about issues 
of storage and privacy of genetic information and t
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Prause, Schallenberg, Brockmöller and Himmel’s (2006) study of attitudes towards 
pharmacogenetic testing among German asthma and chronic pulmonary disease patients found 
that 96 percent of study participants appreciated the availability of pharmacogenetic testing for 
diseases like asthma, but 35 percent were fearful of potential adverse results and 36 percent were 
concerned about privacy issues surrounding the results.  They also found social differences in 
attitudes – females were more likely to have fearful attitudes towards pharmacogenetic testing 
than males, while younger participants were more likely to be hopeful about the usefulness of 
pharmacogenetic testing.  Meanwhile, Almarsdóttir, Björnsdóttir and Traulsenc (2005) found 
that focus group participants in their study on PGM attitudes were generally concerned about the 
ethical implications of pharmacogenomic drug development and use, mostly with respect to 
equitable access to these drugs and implications for local and global health inequalities.  
 
2.8.1 Race-Based Medicine versus Personalized Genomic Medicine Beliefs and Attitudes 
Several studies have examined respondents’ beliefs and attitudes regarding RBM in 
comparison with PGM.  In Bevan et al.’s study (2003) of racial differences in RBM and PGM 
beliefs and attitudes, PGM was substantially preferred over RBM by all study participants, 
however, there were several concerns associated with using PGM, including potential high costs 
of genetic testing and related treatment, possible privacy violations and the potential for 
discrimination.  These concerns, however, were not as pronounced as those expressed regarding 
RBM.  Respondents, in particular black respondents, were concerned about the following related 
to administration of RBM: racism; race being a “cultural” construct and therefore not an accurate 
proxy for differential treatment effectiveness; economic discrimination (e.g., drugs costing more 
 42 
 
for certain racial groups); increased mistrust towards medical professionals who prescribe RBM; 
differential levels of effectiveness; and race-specific treatments being damaging to one’s health.  
Some respondents discussed RBM as being akin to racial profiling, and therefore something 
worth avoiding. 
Marco’s (2010) focus group study examining white and black Americans’ beliefs and 
attitudes regarding PGM and RBM found racial differences in its comparison of the two forms of 
treatment. While both whites and blacks held generally favorable views towards PGM, and both 
groups noted concerns about potential costs, blacks were more concerned about mistrust towards 
physicians being a barrier to using PGM, while whites were more concerned about possible 
insurance and/or employment discrimination resulting from genetic test results (the author noted 
a possible confusion among some respondents regarding genetic testing for disease versus 
genetic testing for treatment effectiveness). When discussing RBM, black respondents were very 
distrustful of race-based prescribing, while white respondents expressed more positive attitudes.  
Whites, however, did express equity concerns deriving from RBM, but many agreed that it 
would be bad to miss out on more treatment options.  Black respondents generally believed that 
RBM is inherently racist and would lead to blacks receiving inferior medications.  In general, 
both whites and blacks held more positive views towards PGM than RBM, however, whites’ 
concerns regarding both forms of treatment seemed to focus on cost, while blacks additionally 
expressed concerns about racism, receipt of inferior care and mistrust towards medical providers. 
Butrick and colleagues’ study (2011) comparing attitudes towards PGM, RBM and 
conventional treatments (i.e. usual course of treatment) following a vignette experiment 
describing these different forms of treatments also found that respondents generally appraised 
RBM more negatively than PGM and the usual course of treatment.  No difference was found in 
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attitudes towards PGM versus conventional treatment.  The study found that specific to PGM, 
although viewed favorably, intention to adhere to such treatments was lower than adherence 
intention towards conventional treatment; there was no difference between white, black and 
other racial minorities in PGM adherence intention.  Black and other racial minorities were more 
reluctant than whites to use PGM.  The results indicated that this may be attributed to lower trust 
levels towards physicians among the racial minority respondents in the study.  When comparing 
RBM to conventional treatment, the findings showed statistically significantly more negative 
emotion, less belief that the medicine would work, lower perceptions of respect from the RBM 
vignette doctor, and less willingness to take the medication for respondents assigned to the RBM 
vignette condition. There was no difference in these attitudes and beliefs between white and 
minority respondents.  This study differed from prior focus group studies to the extent that both 
white and racial minority respondents expressed equally negative attitudes towards RBM, 
whereas the focus group studies (Bevan et al., 2003; Condit et al., 2003; Marco, 2010) indicated 
that black and other minority respondents expressed more negative attitudes towards RBM than 
white respondents.  
 
2.9  Mass Media, Race and Genetics 
Attitudes and beliefs about a given topic can be influenced by numerous inputs over time.  
Mass media, in particular, has been shown to be an important source of information and 
communication (Scheufele and Tewksbury, 2007; Zaller, 1992).  Media coverage has also been 
shown to increase the importance of various topics in the public’s mind, although the evidence 
seems to vary as to whether it can substantively influence public attitudes about a topic (Fiske, 
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1987; Gerbner, Gross, Morgan & Signorielli, 1980; McCombs & Shaw, 1972).  Because RBM is 
in its early stages, it is likely that most members of the public are unfamiliar with the concept 
(although it should be noted that to date, RBM knowledge levels have not been studied among 
the general public).  It is quite possible that many individuals’ first introduction to this concept 
will be through mass media.  Therefore, a review of how mass media has portrayed race, race 
and genetics research, and RBM is warranted in order to better understand how media coverage 
of RBM has the potential to influence the lay public’s beliefs and attitudes about RBM.  Before 
doing so, the following is a brief review of the literature examining mass media’s influence over 
public opinion. 
 
2.9.1 Mass Media’s Influence over Public Opinion 
As previously noted, mass media, in particular news coverage, has been shown to 
increase the importance of various topics in the public’s mind (Fiske, 1987; Gerbner, Gross, 
Morgan & Signorielli, 1980; McCombs & Shaw, 1972).  According to Scheufele and Tewksbury 
(2007), there are three major theoretical frameworks to explain how news information is relayed, 
processed and accepted.  Agenda-setting, put forth by McCombs and Shaw (1972), contends that 
there is a strong correlation between mass media’s emphasis of certain issues and the level of 
importance attributed to such issues by mass media’s audiences.  Priming is when news content 
suggests to its audience that specific issues should be used as benchmarks for evaluating the 
performance of leaders or the government (Iyengar and Kinder, 1987; Scheufele and Tewksbury, 
2007).  Priming is generally considered to be related to and an extension of agenda-setting 
(Scheufele and Tewksbury, 2007).  The third theoretical framework for mass media’s 
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relationship with public opinion is framing. Framing puts forth the idea that how an issue is 
characterized in news reports can have an influence over how it is understood by its audiences 
(Pan and Kosicki, 1993; Scheufele and Tewksbury, 2007).  Framing as a macro-construct refers 
to presentation modes that mass media uses to present information in a way that comports with 
existing underlying schema among the target audience.  As a micro-construct, framing refers to 
how people use information presented by mass media to form impressions on issues that were 
presented to them. 
 McQuail (1979, 1985), in his analysis of mass media’s effects on public opinions, 
contends that subject matter that is more distant or novel to the audience and less defined by 
prior conceptions and personal experiences will be more successful at shaping the public’s 
beliefs and attitudes than subject matter that is more familiar to them.  Meanwhile, Zaller’s 
(1992) research on the effects of mass media on political campaigns shows that the public tends 
to resist arguments that are inconsistent with their own political predispositions.  Therefore, if the 
individual has some familiarity with or specific opinions about the subject matter, then the extent 
to which one is likely to accept mass media’s message on this topic may have to do whether the 
message is consistent with his or her own beliefs and attitudes regarding that topic.  However, if 
the topic discussed by mass media is one with which the individual has little to no familiarity, 
then he or she is more likely to accept the message about the topic at face value. 
 
2.9.2  Mass Media and Race 
Most research on mass media and its portrayal of race has focused on African Americans, 
and for that matter, television portrayals of African Americans.  Past research on television 
 46 
 
portrayals of African Americans has shown that there tends to be a focus on negative stereotypes 
that neither objectively nor accurately portray reality, such as depicting African Americans as 
inferior, lazy, unintelligent, unethical, dishonest and comical (Corea, 1993; Entman 1990, 1994; 
Rada, 1996).   According to Rada (2000), many of the stereotypes of African Americans often 
seen in earlier years on television have been replaced with more subtle representations of African 
Americans that are consistent with the attributes of symbolic racism.  This construct, according 
to Sears (1988), is characterized by three main attributes: antagonism toward African Americans 
for trying so hard to quickly achieve equal rights; resentment towards what is perceived as 
special treatment for African Americans, such as quotas for education admissions or excessive 
access to social welfare resources; and denial of the ongoing existence of discrimination. 
 
2.9.3  Mass Media Portrayals of Genetics 
There have been several major studies on media portrayals of genetics.  Nelkin and 
Lindee (1995) examined the portrayal of genetics in mass media and popular culture broadly in 
newspapers, television, magazines, advertisements, comic books and cartoons and concluded that 
lay public discourse about genetics relied on genetic “essentialism” and “determinism” (note, 
genetic determinism is conceptualized as being akin to genetic predisposition that destines 
people to follow a course that cannot be altered by other factors).  Conrad (1999, 2001) in his 
content analysis of newspapers and magazines during the 30-year period from 1965 to 1994 had 
several major findings. First, he found “genetic optimism” to be a predominant frame of articles 
that discussed genetics and mental illness during the period from the mid-1980s to mid-1990s 
(Conrad, 2001).  The idea behind genetic optimism is simple – a gene for the disease exists; the 
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gene will be found; and its finding will be good.  Second, Conrad concluded that news articles 
tended to emphasize simplistic genetic etiologies of disease (one gene, one disease) rather than 
more complex genomic etiologies (1999).  Condit (2001), like Conrad and Nelkin and Lindee, 
also found that the news media tended to focus on positive portrayals of genetics, although she 
along with her colleagues have cautioned that the theme of genetic determinism is not as 
prevalent in recent years as perhaps in the past (Condit, Ofulue & Sheedy, 1998) and that 
fortunately, there has been an increasing emphasis on genetics-related ethical issues (Condit, 
1999).  
 
2.9.4  Mass Media Portrayals of Race and Genetics 
Lynch and Condit (2006) in their analysis of newspaper articles about the relationship 
between race and genetics published between 1991 and 1993 (the beginning of the HGP) and 
2001-2003 (the end of the HGP) found a substantial portion of articles presenting both the 
position that race is genetic and that race is a social construct.  These articles tended to be slanted 
in one of the two directions, however, they concluded that the ideologically dominant position in 
the news during those time periods was that race is genetic, with more articles seemingly slanted 
in that direction.  They conclude that while a wide array of scientific accounts about race and 
genetics were presented in the media during those time periods, many of these accounts were 
presented positively and only a small number of scientific accounts were challenged in the 
articles.  
Caulfield and Harry (2008) conducted a content analysis on news articles published 
between 2001 and 2007 about BiDil.  They found that slightly more than half of the news articles 
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did not mention the race controversy surrounding this drug. Among the remaining articles that 
did mention the race controversy, 90 percent of them explicitly discredited or questioned race as 
a biological construct. Thirty-two percent of the articles that focused on the controversy 
explicitly supported the idea of race as a social construct while most of the remaining articles 
raised concerns about the idea of a biological basis for race without explicitly promoting either 
position on the topic. They also found that the majority of articles that discussed the idea of race 
as a proxy for genomic variation criticized this idea.  They conclude that for most of the articles 
that discussed race and genetics in the context of BiDil, “cautious skepticism” was the approach 
taken, where the relevance of genetics was not dismissed but they did not provide a deterministic 
view of its role.  Phelan, Link and Feldman (2013) in their analysis of newspaper articles about 
race and genomics generally, and race, genomics and health specifically, found that race and 
genomics articles that focused on health issues were significantly less likely to mention racism or 
discuss ethical issues than articles that were not focused on health.  In addition, articles that 
discussed health were presented in a way that much more strongly endorsed the importance of 
genetics than articles that did not discuss health. 
 
2.9.5  Mass Media Influences on Lay Beliefs about Race and Genetics 
There has been some examination of mass media influences on beliefs about race and 
genetics, particularly with respect to how they relate to health.  Phelan and colleagues (2013) 
conducted a vignette experiment that examined the effect of varying mock news articles about 
the relationship between race and genes on beliefs in essential racial differences.  They found 
that respondents exposed to a vignette about a race-specific genetic difference in heart attack risk 
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indicated greater belief in essential racial differences than respondents assigned to a vignette 
indicating race is socially constructed and respondents who were assigned to a no-vignette 
condition. This level of belief in essential racial differences was also virtually equal to that of 
respondents who were assigned to a vignette asserting that race is a genetic reality.   
Condit et al. (2004) found that messages linking race, genes and health can increase racist 
attitudes among some audiences. They found an increase in genetically-based racism as a result 
of hearing such messages, although it was unclear whether this was due to increases in racism 
generally or an increased attribution of genes as the cause of perceived racial difference.  Bates, 
Poirot, Harris, Condit and Achter’s (2004) findings from a focus group study of lay people 
responding to public messages about race-specific medications indicated that people may be 
skeptical about messages that link race to genetics and health.  They found that only 20 percent 
of study participants indicated belief in a mock advertising message about a drug called “Fairdil” 
that is supposed to be effective in reducing blood pressure among people of African descent. 
Reasons for resisting the message’s claims about the drug included belief in individual-level 
genetic variation, resistance of an overgeneralization of group membership, admixture, and the 
perception that the message is racist.  Meanwhile, a controlled experimental study that examined 
the effect of listening to a public service announcement linking African Americans, race, genes 
and health on racist attitudes found that the message increased levels of racism by almost a full 
point on a 5-point scale adapted from Entman and Rojecki’s (2000) “Racial Denial Scale” 
(Parrott et al., 2005).  
Lynch, Bevan, Achter, Harris and Condit (2008) examined the effect of multiple 
exposures to messages about genetics on general racist affect, genetically-based racism (defined 
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as a combination of racist affect with the belief that perceived differences in human 
characteristics are primarily influenced by genetics) and genetic determinism (defined as the 
belief that genes are the primary forces shaping individuals’ lives).  After multiple exposures 
across three time intervals to genetics messages in the form of headlines, news articles and 
documentaries (with topics ranging widely from genetic modification of new farm crops to the 
mapping of a human chromosome) the results showed that while general racist affect and genetic 
determinism belief did not change after repeated exposure, genetically-based racist attitudes did 
increase.  
 
2.10  Summary 
 A review of the literature suggests that RBM is as controversial and contested as 
biological and genetic conceptions of race.  Although to date RBM has not become the paradigm 
by which medicine has evolved and is practiced, the development of race- and ethnicity-targeted 
pharmacogenomic tools and treatments still continue (Kahn 2009, 2011).  Additionally, there is 
evidence that physicians have integrated RBM into their clinical practices, as seen in the recent 
survey of board-certified physician members of the American Association of Black 
Cardiologists, which showed that a majority of physicians prescribed BiDil to their patients 
(Akinniyi & Payne, 2011).  While many physicians, geneticists, and other natural and social 
scientists who have some hand in race and/or genomic studies may be familiar with, or 
knowledgeable about, RBM, it is unclear the extent to which the lay public is familiar with 
RBM, believes in its clinical effectiveness, and would be likely to use it.   
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 There have been several qualitative exploratory research studies on RBM beliefs and 
attitudes, and most of the findings indicated that there are racial differences in these beliefs and 
attitudes (Bevan et al., 2003; Condit et al., 2003; Marco, 2010).  One quantitative experimental 
study, however, diverged from these other studies by indicating that whites and racial and ethnic 
minorities are equally likely to hold negative attitudes towards RBM (Butrick et al., 2011).  To 
date, however, there has been no nationally representative study of Americans’ beliefs and 
attitudes regarding RBM.  A study of this type, therefore, is warranted in order to better 
understand the extent to which Americans throughout the nation believe RBM could be clinically 
effective and whether they would even use RBM.  
 Because RBM is, in all likelihood, a fairly novel concept to much of the lay public, 
knowledge levels of and attitudes regarding RBM are most likely the result of exposure to mass 
media, which is among the most important sources of information regarding scientific and 
medical research findings and applications (Anderson, Scheufele, Brossard & Corley, 2012; 
Gerbner, Gross, Morgan & Signorielli, 1980; Ho, Brossard & Scheufele, 2008). A review of the 
literature shows that news articles about the relationship between race and genes generally, and 
race, genes and health specifically, have been on the rise during and following the completion of 
the HGP (Caulfield & Harry, 2008; Phelan, Link & Feldman, 2013).  In addition, mass opinion 
theory suggests that members of the lay public are more likely to have their beliefs and attitudes 
about a topic influenced by news media and other mass communication outlets if the topic is new 
or less familiar to them than topics for which they have already formed opinions (Zaller, 1992).  
If RBM is indeed a concept with which much of the lay American public is unfamiliar, then this 
would suggest that even minimal exposure to news stories about RBM, or the relationship 
between race and genes more generally, could influence lay beliefs and attitudes regarding RBM.   
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 Finally, if RBM is simply an interim system of medicine until PGM has developed 
enough to become the paradigm by which medicine is practiced, a better understanding of the lay 
public’s beliefs and attitudes regarding PGM and how they compare to beliefs and attitudes 
regarding RBM is needed in order for various stakeholders to develop goals and implement 
strategies for ways to integrate PGM into the practice of medicine that is sensitive to the needs 
and concerns of the lay public. A review of the literature shows a couple of studies that have 
directly compared RBM with PGM, with one study (Bevan et al., 2003) indicating that the study 
respondents overwhelmingly indicated they would be more likely to use PGM over RBM or 
conventional forms of treatment, but a different study (Butrick et al., 2011) indicating that 
although respondents viewed PGM and conventional treatment more favorably than RBM, 
intention to adhere to PGM treatment was lower than adherence intention towards conventional 
treatment.  These studies clearly show stronger support for PGM over RBM, but stakeholders 
interested in moving towards a medical system based on PGM should note that the support for 








RESEARCH DESIGN AND METHODS 
 
3.1 Study Overview 
The data for this dissertation study were collected from the “Genetics & Stigma Study” 
(Jo Phelan—PI), which is a study that I was involved with as a graduate research assistant.  My 
responsibilities included assisting with instrument development, data collection, data analysis 
and various administrative tasks.  The aims of the Genetics & Stigma Study were twofold – first, 
to examine the content and volume of news articles about genetic and non-genetic causes of 
certain diseases and genetic causes of racial differences, and second, to examine to what extent 
news articles that discuss genetic or non-genetic causes of diseases or racial differences may 
influence stigma-related attitudes towards disease and racial attitudes and beliefs.   
The second aim of the Genetics & Stigma Study was analyzed using data collected from 
an internet-based survey that included two different vignette experiments.  This survey was part 
of a web panel study created by Knowledge Networks, Inc. (KN) for the American National 
Election Studies (ANES) Panel Study, funded by the National Science Foundation.  ANES was 
funded to collect political information during several waves of data collection (January 2008, 
February 2008, June 2008, September 2008, October 2008, November 2008, and May 2009). 
The panel is an omnibus, meaning that in addition to the seven ANES surveys administered 
between January 2008 and May 2009, KN sold access to fourteen additional surveys to other 
clients.  One of these surveys was sold to Columbia University for the Genetics & Stigma Study.   
These additional surveys covered a range of topics, many of which had no association with 
politics.  The off-wave data collection months were January 2009, February 2009, March 2009, 
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April 2009, June 2009, July 2009, August 2009, and September 2009. Columbia University 
established a subcontract with KN for the company to administer the surveys that the Genetics & 
Stigma Study research group had developed.  It was during the April 2009 wave that the 
Genetics & Stigma Study survey was administered.   
Members of the ANES panel were recruited to participate on the panel via a phone call or 
a combination of a letter and phone call. Participants were told that their household had been 
selected to participate in a “national research study”.  They were also told that, “...the monthly 
surveys will be really interesting and they will be on a wide variety of topics that change from 
month to month.”  The panel recruitment letter and the recruitment phone script did not mention 
any specific type of topic that would be covered in the monthly surveys, thereby minimizing the 
potential for any sample selection bias due to varying levels of interest in specific survey topics.  
For the Genetics & Stigma study survey, ANES panel members received an email from 
KN asking them to click on a link and participate in a special topic survey. Respondents were 
then randomized to one of seventeen different vignette experiment conditions that varied based 
on the Genetics & Stigma Study’s two experimental variables - characteristic type and cause of 
characteristic discussed.  Twelve of the seventeen different survey versions were for the health 
vignette experiment. The other five versions of the survey were for the race vignette experiment. 
Respondents were told via written instructions that researchers are interested in assessing how 
effectively print-based media conveys news-related information. The respondents were asked to 
read a vignette in the form of a mock news story and then answer questions about the vignette 
and other related topics of interest to researchers (see Appendix A for a copy of the full health 




Upon completion of the survey, KN mailed a $10 check to the respondents' home 
addresses to compensate respondents for the time they committed to participating in the Genetics 
& Stigma Study.  
 
3.2  Vignette Experiment 
As previously noted, each Genetics & Stigma Study participant was randomized to only 
one of the two vignette experiments in the study.  The following sections describe the health 
vignette experiment and the race vignette experiment. 
 
3.2.1  Health Vignette Experiment  
In the health vignette experiment (N = 1687), participants were randomized to read one 
vignette in the form of a mock news article that varied based on two different variables – health 
condition and cause of the health condition. The three health conditions that varied in the 
vignettes were coronary artery disease, major depressive disorder and obesity.  Genes, 
environment, personal behavior and “no cause” were the four different health condition causes 
that varied in this experiment. A different vignette was developed matching each of the three 
health conditions with each of the four health condition causes, for a total of twelve different 
vignettes in this experiment.  Table 3.1 summarizes the different types of vignettes in the health 
vignette experiment and their corresponding mock news article titles.   
It should be noted that in each vignette a lay person with the health condition was 
featured. The sex of the person with the described health condition was randomly varied in order 
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to minimize any sex-related biases that may be associated with describing a person who has 
coronary artery disease, major depressive disorder or obesity. Therefore, approximately half of 
the respondents randomized to each vignette read about a person named “Daniel Link” who had 
the described health condition, and the other half of the respondents read about a person named 
“Katherine Link” with the described health condition.  
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Table 3.1: Summary of vignette conditions and corresponding mock news article titles for 
the health vignette experiment. 
Vignette Condition Mock News Article Title 
1. Coronary Artery Disease – Genetic Cause Coronary Artery Disease linked to Genes 
2. Coronary Artery Disease – Environment 
Cause 
Coronary Artery Disease linked to Pressures of 
Modern Life 
3. Coronary Artery Disease – Personal 
Behavior Cause 
Coronary Artery Disease linked to Individuals’ 
Own Choices and Behavior 
4. Coronary Artery Disease – No Cause Coronary Artery Disease focus of New Research 
Initiative 
5. Major Depressive Disorder – Genetic 
Cause 
Major Depressive Disorder linked to Genes 
6. Major Depressive Disorder – Environment 
Cause 
Major Depressive Disorder linked to Pressures of 
Modern Life 
7. Major Depressive Disorder – Personal 
Behavior Cause 
Major Depressive Disorder linked to Individuals’ 
Own Choices and Behavior 
8. Major Depressive Disorder – No Cause Major Depressive Disorder focus of New Research 
Initiative 
9. Obesity – Genetic Cause Obesity linked to Genes 
10. Obesity – Environment Cause Obesity linked to Pressures of Modern Life 
11. Obesity – Personal Behavior Cause Obesity linked to Individuals’ Own Choices and 
Behavior 
12. Obesity – No Cause Obesity focus of New Research Initiative 
 
Each vignette was based on news articles written by either The New York Times or the 
Associated Press.  The vignettes were similar in content, with most differences in the text related 
to insertion of the characteristic and cause of characteristic variables of interest, that is, health 
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condition and cause of the health condition.  The vignettes were written so that their lengths were 
approximately the same. Flesch-Kincaid readability evaluations were conducted on the vignettes 
in order to assess the reading level required for each mock newspaper article. All of the vignettes 
were written at approximately the 9th or 10th grade reading level, which is about the reading level 
at which similar articles in the New York Times and the Associated Press were written (Smith & 
Smith, 1984).  The vignettes were formatted using a two-column format to simulate how articles 
are formatted in print versions of newspapers. 
With the exception of the “no cause” vignettes, each vignette discussed its assigned cause 
of the health condition (i.e., genes, environment or personal behavior) as the primary cause of the 
health condition featured in the vignette.  “No cause” vignettes comprised the control arm of the 
health vignette experiment.  Respondents randomized to one of the “no cause” vignettes read a 
mock news article about one of the three health conditions becoming the focus of a new research 
initiative.  For the purposes of this dissertation study, only respondents who received a health 
vignette experiment vignette with no cause discussed were included in the study’s analyses.  All 
of the health vignette experiment “no cause” vignettes can be found in Appendix C.   
Respondents were first asked several demographic questions before they were instructed 
to read the vignette. After reading the vignette, they were then asked a series of closed-ended 
questions regarding the following concepts specific to the health condition discussed in the 
vignette: 
1. causes of the health condition and other human traits (i.e., how important are genes, the 
social and physical environment, and personal behaviors in causing the health condition 
in question, as well as other human traits, such as, general level of health); 
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2. genetic essentialism (transmissibility, persistence, control over and seriousness of health 
condition discussed in the vignette); 
3. setting apart/differentness attitudes; 
4. emotions (disgust, pity, anger, fear and blame related to people with the health 
condition); 
5. helping attitudes (e.g., government assistance, health insurance coverage for people with 
the health condition); 
6. punishment attitudes (e.g., people with the health condition should pay more for health 
insurance); 
7. stereotypes about people with the health condition; 
8. medical definition of the health condition and attitudes about medical/other types of 
interventions; 
9. courtesy stigma (i.e. stigmatizing attitudes towards individuals who interact with people 
with the health condition); 
10. eugenic attitudes; 
11. social distancing attitudes; 
12. personal exposure to the characteristic; and 
13. media exposure. 
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Among respondents assigned to the health vignette experiment, only those who received a "no 
cause discussed" mock news article vignette for major depressive disorder, obesity or coronary 
artery disease were included in this dissertation study’s analysis of RBM-related beliefs and 
attitudes.  Therefore, in addition to items related to the above concepts, respondents assigned to 
the “no cause” vignette conditions also answered questions related to the following: 
14. beliefs and attitudes regarding race-based medicine. 
 
3.2.2  Race Vignette Experiment 
In the race vignette experiment (N = 722), most respondents were randomized to read 
vignettes in the form of mock news articles about either a genetic or non-genetic cause of racial 
differences.  Respondents were randomized to one of five different arms. Four of the five arms 
received a mock newspaper article that discussed some type of relationship between genes and 
race.  The remaining arm did not receive a vignette and was therefore considered the control arm 
of the experiment.  
Each vignette was constructed based on the content of real newspaper articles in the New 
York Times and The Associated Press that discussed race and genetics.  Table 3.2 summarizes 
the five different arms of the race vignette experiment.  The first vignette was entitled “Is race 
real? Genes say ‘yes’”, and will be referred to as the race is genetic vignette.  This vignette 
makes the case that there are broad genetic differences between racial groups such as 
“Caucasians, Africans and Asians”.  The second vignette was entitled “Is race real? Genes say 
‘no’”.  This vignette will be referred to as the social construction vignette.  In this vignette, the 
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readers are told that there are virtually no genetic differences between racial groups and that the 
labels used to distinguish people by race have little or no biological meaning.   
The third vignette was entitled “Is it all black and white? Genes say ‘no’”.  This vignette 
will be referred to as the admixture vignette.  This vignette discusses ancestry testing, that is, a 
genetic test that purportedly shows from where a person’s ancestors likely derived.  The vignette 
states that people of mixed ancestry will be able to learn the proportion of each “race” that 
contributes to their genetic make-up, that is, their genetic admixture. It also states that mixed 
ancestry is common and people who take the test are often surprised to learn that they share 
genetic markers with people with different skin colors.   
The fourth vignette was entitled “Genes may cause racial difference in heart attacks”.  
This vignette will be referred to as the genetic health difference vignette.  This mock news article 
states that geneticists have found a gene that raises the risk of a heart attack among African 
Americans by 250 percent.  The vignette also states that this gene may explain why African 
Americans are more likely to suffer heart attacks and why such events are more likely to be fatal 





Table 3.2: Summary of vignette conditions and corresponding mock news article titles for 
the race vignette experiment. 
Vignette Condition Mock News Article Title 
1. Race is Genetic Is race real? Genes say ‘yes’ 
2. Social Construction Is race real? Genes say ‘no’ 
3. Admixture Is it all black and white? Genes say ‘no’ 
4. Genetic Health Difference Genes may cause racial difference in heart attacks 
5. No-Vignette Control Group N/A 
 
All respondents first answered questions about their feelings towards blacks or whites 
(non-Hispanic white respondents were asked about their feelings towards blacks, while all other 
respondents were asked about their feelings towards whites).  All of the respondents, with the 
exception of those randomized to the control arm, were then instructed to read the vignette that 
they were randomized to receive. Among those assigned to read a vignette, after reading the 
vignette, respondents answered closed-ended questions that assessed their interpretation of the 
mock news article.  All respondents were then asked to answer a series of closed-ended questions 
related to the following concepts: 
1. beliefs about health-related racial differences; 
2. beliefs about non-health-related racial differences; 




4. beliefs about genetic and other factors as causes of racial differences; 
5. feelings towards blacks and whites (unlike the feelings towards blacks/whites questions 
asked prior to reading the vignette, all respondents regardless of their self-identified race 
were asked the same questions); 
6. beliefs about the importance of genetic and non-genetic causes of human traits (e.g., 
general level of health, level of intelligence, success in life); 
7. social distancing attitudes; 
8. beliefs and attitudes regarding race-based medicine and personalized genomic medicine; 
9. contact with people of the same or different race as the respondent; and 
10. media exposure. 
 
3.3  Aims and Hypotheses  
 As noted previously in Chapter 1, this dissertation study is in three parts. Part 1 examines 
baseline beliefs and attitudes regarding RBM among non-Hispanic whites, non-Hispanic blacks 
and Hispanics residing in the U.S. as well as several possible mediating variables that could help 
explain potential racial differences in these beliefs and attitudes.  Aims 1-3 and their associated 
hypotheses will be examined in Part 1. Part 2 examines the effects of a vignette experiment 
involving mock news articles that discuss genetic or non-genetic causes of racial differences on 
RBM-related beliefs and attitudes.  Part 2 builds on Part 1 by assessing how varying information 
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about the relationship between genes and race potentially changes RBM-related beliefs and 
attitudes.  Aims 4-5 and their associated hypotheses will be examined in Part 2.  Part 3 examines 
beliefs and attitudes regarding personalized genomic medicine (PGM) and compares these 
beliefs and attitudes with RBM-related beliefs and attitudes.  Part 3 also builds on Part 1 by 
examining whether there are similarities or differences in Americans’ beliefs and attitudes 
regarding RBM and PGM.  Aims 6-7 and their associated hypothesis will be examined in Part 3.  
The following are the dissertation study’s aims and hypotheses based on evidence and 
ideas that are described in the literature.  Although this dissertation study examines some 
relatively unchartered territory, I believe that there is sufficient evidence based on prior research 
and broader ideas to warrant hypotheses for the dissertation’s aims.  It should also be noted that 
some of the aims and hypotheses are contingent on whether statistically significant results were 
found in other analyses within this study.  In particular, Aims 2-3 are contingency aims that were 
only examined for those RBM dependent variables for which I had found racial/ethnic 
differences. 
 
3.3.1  Part 1 Aims and Hypotheses: RBM-Related Beliefs and Attitudes 
Aim 1. For Aim 1, I examined whether racial groups differ in terms of beliefs about 
RBM’s individual-level effectiveness, behavioral orientation towards using RBM, and RBM’s 
population-level effectiveness. Previous research has found that non-Hispanic blacks and 
Hispanics were more “suspicious” about RBM than non-Hispanic whites for a variety of reasons, 
including concerns that RBM would be less effective than other types of treatments (Bevan et al., 
2003; Condit et al., 2003). Therefore, I expected to find that non-Hispanic whites are more likely 
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than non-Hispanic blacks and Hispanics to endorse RBM effectiveness beliefs and preferences 
for using RBM.  The hypothesis for this aim is the following:  
Hypothesis 1:  Non-Hispanic whites are more likely than non-Hispanic blacks and 
Hispanics to endorse beliefs relating to and attitudes towards RBM-related individual-
level effectiveness, behavioral orientation and population-level effectiveness.  
Aims 2 and 3 are contingency aims that were only examined for those RBM dependent 
variables for which racial differences are found in Aim 1. These aims looked at two different 
potential mediators of racial differences in RBM-related beliefs and attitudes. 
Aim 2. If racial differences were found in Aim 1, Aim 2 examined whether genetic 
essentialist beliefs explain any differences between racial groups in RBM-related individual-
level effectiveness, behavioral orientation and population-level effectiveness beliefs and 
attitudes.  
Several have theorized that people in socially privileged positions are more likely to 
endorse genetic essentialist beliefs in order to justify existing social hierarchies (Jayaratne et al., 
2006; Nelkin & Lindee, 1995).  Jayaratne and colleagues’ (2006) study provides some support 
for this theory, finding that genetic essentialist beliefs among white study participants were 
associated with greater prejudice towards blacks.  However, a study by Shostak, Freese, Link and 
Phelan (2009) found that, contrary to their expectations, white, socioeconomically advantaged 
and politically conservative study participants were not more likely than non-white, 
socioeconomically disadvantaged or politically liberal study participants to believe that genes are 
important for social or health outcomes.   The evidence is therefore mixed regarding the socially 
advantaged being more likely to endorse genetic essentialist beliefs than the social 
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disadvantaged.  However as previously noted, Aim 2 will only be examined if Aim 1 results 
indicate racial differences in RBM beliefs and attitudes.  Therefore, because there has been some 
prior evidence that associates race with genetic essentialist beliefs, if racial differences are found 
in Aim 1, then it remains a possibility that genetic essentialist beliefs do mediate the relationship 
between race and the RBM-related dependent variables.  The assumption here is that whites 
would be more likely to endorse genetic essentialist beliefs and that genetic essentialist beliefs 
would be positively associated with RBM beliefs and attitudes. 
Hypothesis 2: Genetic essentialist beliefs partially mediate the association between race 
and RBM individual-level effectiveness belief, behavioral orientation and population-
level effectiveness belief.  Endorsement of genetic essentialist beliefs will be associated 
with endorsement of the three aforementioned RBM-related dependent variables.  
Aim 3. If non-Hispanic white respondents were found to endorse RBM-related 
individual-level effectiveness, behavioral orientation and/or population-level effectiveness 
beliefs and attitudes at higher levels than non-Hispanic black or Hispanic respondents in Aim 1, 
then Aim 3 examined whether implicit racist attitudes and explicit racist attitudes towards 
African Americans explain some of the differences in these beliefs and attitudes between non-
Hispanic whites and Hispanics specifically.  I expected to find that non-Hispanic whites 
compared with Hispanics will hold more racist attitudes towards African Americans, and that 
these attitudes will be associated with greater endorsement of RBM’s effectiveness and 
preferences for using RBM.  Previous research has shown that whites hold more racist attitudes 
than Hispanics towards African Americans (Hunt, 2007).  There is also some evidence that has 
linked racist attitudes with beliefs in biological/essential racial differences (Kinder & Sanders, 
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1996; Keller, 2005; Jayaratne et al., 2006).  In turn, belief in biological and essential racial 
differences may be associated with greater endorsement of RBM’s effectiveness and preferences 
for using it among those who assume that race-specific differences in the efficacy of biomedical 
treatments are due to biological differences between racial groups.  Aim 3’s hypotheses are in 
two parts: 
Hypothesis 3a:  Implicit racist attitudes and explicit racist attitudes towards African 
Americans will be associated with endorsement of RBM-related individual-level 
effectiveness, behavioral orientation and population-level effectiveness. 
Hypothesis 3b:  Implicit racist attitudes and explicit racist attitudes will mediate the 
relationship between race and RBM-related individual-level effectiveness, behavioral 
orientation and population-level effectiveness.  
Hypothesis 3b was only tested if the analysis for Hypothesis 3a indicated an association between 
implicit racist attitudes and/or explicit racist attitudes and any of the tested RBM-related 
dependent variables.  
 
3.3.2  Part 2 Aims and Hypotheses: Vignette Experiment’s Effects on RBM Beliefs and 
Attitudes 
Aim 4.  For Aim 4, I examined whether experimentally varying information about the 
type of relationship between race and genes affects RBM individual-level effectiveness, 
behavioral orientation and population-level effectiveness beliefs among white and black 
respondents.  For this aim, I compared the effects of vignettes in the form of mock news articles 
about the relationship between race and genes on RBM beliefs and attitudes.  If I found that the 
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vignettes had an overall effect on RBM beliefs and attitudes, I would then test to see if genetic 
essentialist beliefs in racial differences mediates the relationship between the vignettes and the 
RBM dependent variables.  I would then test several hypotheses that compare the effects of 
individual vignettes on RBM beliefs and attitudes (Hypotheses 4a-4e).   
I first expected to find that the race is genetic and genetic health difference vignettes 
should make respondents equally likely to believe that RBM is effective and worth using because 
of the rationale that both vignettes underscore the idea that there are genetic differences between 
races, which in turn could make the lay public believe that differential responses to biomedical 
treatments between races are possible.  
Hypothesis 4a: There will be no significant difference in endorsement of RBM 
individual-level effectiveness, behavioral orientation and population-level effectiveness 
beliefs and attitudes between the race is genetic and genetic health difference vignettes.  
I then expected to find that the race is genetic and genetic health difference vignettes 
made respondents more likely to believe that RBM is effective and worth using compared to the 
admixture vignette.  The admixture vignette could affect the lay public’s beliefs about race in 
two different ways.  On the one hand, it could make some respondents believe that RBM is 
implausible since the vignette states that most people are racially mixed.  On the other hand, it 
could also underscore the idea that there is some genetic basis to race, thereby validating the 
potential effectiveness of RBM.   Because reading the admixture vignette could influence 
different segments of the public to infer opposing conceptions about the genetic basis of race 
(and therefore the efficacy of RBM), I expected to find that endorsement of RBM beliefs and 
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attitudes is lower for respondents assigned to the admixture vignette compared to the race is 
genetic vignette and genetic health difference vignette.   
Hypothesis 4b:  The race is genetic and genetic health difference vignettes will be 
associated with greater endorsement of RBM individual-level effectiveness, behavioral 
orientation and population-level effectiveness beliefs and attitudes than the admixture 
vignette.   
I also expected to find that the social construction vignette does not change baseline 
beliefs about RBM.  I predicted that those who believe races are similar will have their belief 
reinforced by this vignette and those who believe races are genetically different will not change 
their views as a result of the vignette.  This is because the social construction vignette message 
has been viewed as the generally-accepted conceptualization of race and is therefore not 
presenting a new perspective to the lay public.  If this is in fact the case, there should be no 
difference between those who received the social construction vignette and those assigned to the 
control condition for RBM beliefs and attitudes. 
Hypothesis 4c: There will be no significant difference for RBM individual-level 
effectiveness, behavioral orientation and population-level effectiveness beliefs and 
attitudes between the social construction vignette and control condition.  
 If no significant differences in RBM beliefs and attitudes are found between respondents 
who received the social construction vignette and those randomized to the control condition, 
then I also expect to find that respondents who received the admixture vignette are more likely to 
endorse RBM beliefs and attitudes than respondents who received the social construction 
vignette or were assigned to the control condition.  This is because for some admixture vignette 
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respondents, the vignette could underscore the idea that there is some genetic basis to race, 
thereby validating the potential effectiveness of RBM. 
Hypothesis 4d: The admixture vignette will be associated with greater endorsement of 
RBM individual-level effectiveness, behavioral orientation and population-level 
effectiveness beliefs and attitudes than the social construction vignette and the control 
condition. 
 I will then directly test to see if exposure to either the race is genetic or genetic health 
difference vignettes is associated with higher endorsement of RBM beliefs and attitudes then 
either exposure to the social construction vignette or the no-vignette control condition.   
Hypothesis 4e: The race is genetic and genetic health difference vignettes will be 
associated with greater endorsement of RBM individual-level effectiveness, behavioral 
orientation and population-level effectiveness than the social construction vignette or the 
no-vignette control condition. 
Figure 3.1 visually summarizes hypotheses 4a through 4e by displaying the hypothesized 


















Aim 5.  For this aim, I examined whether acceptance of the vignette is associated with 
differences in RBM individual-level effectiveness, behavioral orientation and population-level 
effectiveness beliefs and attitudes.  Specifically, I examined whether acceptance of the 
information provided in the vignette modified the relationship between the vignette and RBM 
beliefs and attitudes.  Exposure to one mock news article that discusses the relationship between 
race and genetics may not have been enough to influence beliefs and attitudes about RBM.  The 
extent to which the respondent accepted the information provided in the vignette could be the 










RBM Beliefs and Attitudes Endorsement Levels 
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Hypothesis 5a: There will be a significant difference between the social construction and 
race is genetic vignettes in the association between vignette acceptance and RBM 
individual-level effectiveness, behavioral orientation and population-level effectiveness 
beliefs and attitudes such that greater vignette acceptance will be associated with lower 
endorsement of RBM beliefs and attitudes for the social construction vignette while 
greater vignette acceptance will be associated with higher endorsement of RBM beliefs 
and attitudes for the race is genetic vignette. 
Hypothesis 5b: There will not be a significant difference between the genetic health 
difference vignette and the race is genetic vignette in the association between vignette 
acceptance and RBM individual-level effectiveness, behavioral orientation and 
population-level effectiveness beliefs and attitudes.  Greater vignette acceptance should 
be associated with greater endorsement of RBM beliefs and attitudes for both vignettes. 
Hypothesis 5c:  There will be a significant difference between the admixture vignette and 
the race is genetic vignette in the association between vignette acceptance and RBM 
individual-level effectiveness, behavioral orientation and population-level effectiveness 
beliefs and attitudes.  Greater acceptance of the admixture vignette will be associated 
with relatively lower endorsement of RBM beliefs and attitudes while greater acceptance 
of the race is genetic vignette will be associated with higher endorsement of these 
attitudes and beliefs. 
Hypotheses 5a through 5c are based on the conceptual framework visualized in Figure 3.1, which 
hypothesizes that the social construction vignette will be associated with the lowest endorsement 
levels of RBM beliefs and attitudes, the admixture vignette will be associated with mid-range 
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endorsement levels of RBM beliefs and attitudes, and the race is genetic and genetic health 
difference vignettes will be associated with the highest endorsement levels of RBM beliefs and 
attitudes. 
 
3.3.3  Part 3 Aims and Hypotheses: PGM Beliefs and Attitudes 
Aim 6.  For Aim 6, I examined whether there are racial differences in personalized 
genomic medicine (PGM) individual-level effectiveness and behavioral orientation beliefs and 
attitudes.  Past research has shown some racial differences in genetic technology-related beliefs 
and attitudes.  Differences in genetic testing rates among different racial and ethnic groups have 
been reported (Singer, Antonucci & Van Hoewyk, 2004). Utilization of PGM is predicated on 
genetic testing in order for treatment to be personalized to one’s genomic profile.  If there 
currently are racial and ethnic differences in utilization of genetic technology, it is possible that 
there are racial and ethnic differences in beliefs about PGM’s effectiveness.  According to Singer 
and colleagues (2004), although whites were more likely to use genetic testing, blacks and 
Hispanics were more likely to express preferences for prenatal and adult genetic testing than 
whites.  However, blacks may also hold other beliefs and attitudes that conflict with or over-ride 
these attitudes in specific situations, such as concerns about cost, discrimination or general 
mistrust towards medical authority (Hipps, Roberts, Farrer & Green, 2003; Robert, 2011; 
Thompson, Valdimarsdottir, Jandorf & Redd, 2003). Therefore, on the one hand it is possible 
that blacks are more likely to believe in PGM’s effectiveness and to be behaviorally oriented 
towards using PGM.  On the other hand, it is possible that whites are more likely than blacks to 
endorse PGM’s effectiveness if whites’ higher rates of genetic testing reflect (at least in part) 
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greater belief in the effectiveness of treatments that result from genetic testing, or, because 
concerns like cost, discrimination and medical mistrust regarding health care and health-related 
technologies more broadly are extended towards blacks’ beliefs regarding the effectiveness of 
PGM.  It therefore seems logical to predict that non-Hispanic blacks would be less likely to 
endorse the effectiveness of PGM and less likely to prefer using PGM than non-Hispanic whites.  
Hypothesis 6: Non-Hispanic whites will be more likely than non-Hispanic blacks to 
endorse the individual-level effectiveness of PGM and to prefer to use PGM. 
Aim 7.   Aim 7 examines PGM individual-level effectiveness and behavioral orientation 
beliefs and attitudes in comparison to RBM individual-level effectiveness and behavioral 
orientation beliefs and attitudes.  Much of the support among researchers and clinicians for RBM 
has been grounded in the belief that it is an acceptable interim alternative until a system based on 
PGM can be realized (Burchard et al., 2003; Risch et al., 2002).  There is currently very little 
data that examines public beliefs about PGM on its own and in comparison to RBM.  Because 
some in the biomedical industry support the idea of RBM as an interim alternative for PGM, it 
seems reasonable to examine the extent to which the public would support this idea.  One focus 
group study found that respondents overwhelmingly preferred PGM in comparison to RBM. 
Based on this prior research study, I expected to find that respondents in this dissertation study 
will also endorse PGM beliefs and attitudes at greater levels than RBM beliefs and attitudes. 
Hypothesis 7: Mean endorsement levels of PGM individual-level effectiveness and 
behavioral orientation will be greater than the mean endorsement levels of RBM 
individual-level effectiveness and behavioral orientation.   
Table 3.3 summarizes all of the aims and hypotheses for Parts 1-3 of this dissertation study.
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Table 3.3:  Summary of Aims and Hypotheses. 
Part 1 -- RBM Beliefs and Attitudes Research Questions: 
• Do white, black and Hispanic Americans hold similar or differing beliefs and attitudes 
regarding RBM? 
• What factors influence potential racial differences in beliefs and attitudes regarding RBM? 
 
Aims Hypotheses 
Aim 1: Examine whether racial 
groups differ in terms of beliefs about 
RBM’s individual-level effectiveness, 
behavioral orientation towards using 
RBM, and RBM’s population-level 
effectiveness. 
Hypothesis 1:  Whites are more likely than blacks and Hispanics 
to endorse beliefs relating to and attitudes towards RBM-related 
individual-level effectiveness, behavioral orientation and 
population-level effectiveness.  
Aim 2: First, examine whether racial 
groups differ in terms of genetic 
essentialist beliefs.  Second, if racial 
differences were found for genetic 
essentialist beliefs, examine whether 
genetic essentialist beliefs explain any 
differences between racial groups in 
RBM-related individual-level 
effectiveness, behavioral orientation 
and population-level effectiveness 
beliefs and attitudes.  
Hypothesis 2: Genetic essentialist beliefs partially mediate the 
association between race and RBM individual-level effectiveness 
belief, behavioral orientation and population-level effectiveness 
belief.  Endorsement of genetic essentialist beliefs will be 
associated with endorsement of the three aforementioned RBM-
related dependent variables.  
 
Aim 3:  Examine whether implicit 
racist attitudes and explicit racist 
attitudes towards African Americans 
explain some of the differences in 
these beliefs and attitudes between 
whites and Hispanics. 
Hypothesis 3a:  Implicit racist attitudes and explicit racist 
attitudes towards African Americans will be associated with 
endorsement of RBM-related individual-level effectiveness, 
behavioral orientation and population-level effectiveness. 
Hypothesis 3b:  Implicit racist attitudes and explicit racist 
attitudes will mediate the relationship between race and RBM-
related individual-level effectiveness, behavioral orientation and 






Table 3.3:  Summary of Aims and Hypotheses. 
Part 2 -- Mass Media’s Effects on RBM Beliefs and Attitudes Research Question: 
• Does varying messages about the relationship between race and genes influence RBM 
beliefs and attitudes? 
Aims Hypotheses 
Aim 4:  Examine whether 
experimentally varying information 
about the degree of genetic similarity 
between races affects RBM 
individual-level effectiveness, 
behavioral orientation and 
population-level effectiveness beliefs 
among white and black respondents. 
Hypothesis 4a: There will be no significant difference in 
endorsement of RBM individual-level effectiveness, behavioral 
orientation and population-level effectiveness beliefs and 
attitudes between the race is genetic and genetic health 
difference vignettes. 
Hypothesis 4b:  The race is genetic and genetic health difference 
vignettes will be associated with greater endorsement of RBM 
individual-level effectiveness, behavioral orientation and 
population-level effectiveness beliefs and attitudes than the 
admixture vignette.    
Hypothesis 4c: There will be no significant difference for RBM 
individual-level effectiveness, behavioral orientation and 
population-level effectiveness beliefs and attitudes between the 
social construction vignette and control condition.  
Hypothesis 4d: The admixture vignette will be associated with 
greater endorsement of RBM individual-level effectiveness, 
behavioral orientation and population effectiveness beliefs and 
attitudes than the social construction vignette and the control 
condition. 
Hypothesis 4e: The race is genetic and genetic health difference 
vignettes will be associated with greater endorsement of RBM 
individual-level effectiveness, behavioral orientation and 
population-level effectiveness than the social construction 
vignette or the control condition. 
Aim 5:  Examine whether acceptance 
of the vignette is associated with 
differences in RBM individual-level 
effectiveness, behavioral orientation 
and population-level effectiveness 
beliefs and attitudes.   
Hypothesis 5a: There will be a significant difference between 
the social construction and race is genetic vignettes in the 
association between vignette acceptance and RBM individual-
level effectiveness, behavioral orientation and population-level 
effectiveness beliefs and attitudes such that greater vignette 
acceptance will be associated with lower RBM belief levels for 
the social construction vignette while greater vignette acceptance 
will be associated with higher RBM belief levels for the race is 
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Table 3.3:  Summary of Aims and Hypotheses. 
genetic vignette. 
Hypothesis 5b: There will not be a significant difference 
between the genetic health difference vignette and the race is 
genetic vignette in the association between vignette acceptance 
and RBM individual-level effectiveness, behavioral orientation 
and population-level effectiveness beliefs and attitudes.  Greater 
vignette acceptance should be associated with greater 
endorsement of RBM individual-level effectiveness, behavioral 
orientation and population-level effectiveness beliefs and 
attitudes for both vignettes. 
Hypothesis 5c:  There will be a significant difference between 
the admixture vignette and the race is genetic vignette in the 
association between vignette acceptance and RBM individual-
level effectiveness, behavioral orientation and population-level 
effectiveness beliefs and attitudes.  Greater acceptance of the 
admixture vignette will be associated with relatively lower 
endorsement of RBM individual-level effectiveness, behavioral 
orientation and population-level effectiveness beliefs and 
attitudes while greater acceptance of the race is genetic vignette 
will be associated with higher endorsement of these attitudes and 
beliefs. 
Part 3 -- PGM Beliefs and Attitudes Research Questions: 
• Do white and black Americans hold similar or different beliefs and attitudes regarding 
PGM? 
• How do beliefs and attitudes regarding PGM compare with those regarding RBM? 
 
Aims Hypotheses 
Aim 6: Examine whether there are 
racial differences in PGM individual-
level effectiveness and behavioral 
orientation beliefs and attitudes. 
Hypothesis 6: Non-Hispanic whites will be more likely than 
non-Hispanic blacks to endorse the individual-level 
effectiveness of PGM and to prefer to use PGM. 
Aim 7: Examine PGM individual-level 
effectiveness and behavioral 
orientation beliefs in comparison to 
RBM individual-level effectiveness 
and behavioral orientation beliefs. 
Hypothesis 7: Mean endorsement levels of PGM individual-
level effectiveness and behavioral orientation will be greater 
than the mean endorsement levels of RBM individual-level 
effectiveness and behavioral orientation.   
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3.4  Sample Overview 
In this chapter I will provide an overview of the survey’s sample. Different sub-samples 
were used to analyze the aims in this study, depending on with which of the three study parts the 
aims are associated.  Socio-demographic analyses of the sub-samples will be described in the 
separate results chapters for Parts 1-3 (i.e., Chapters 4-6).  Reasons for why different sub-
samples had to be used are discussed below.  
The target population for the survey’s sample was persons aged 18 or older living in 
households with telephones in the United States.  The sampling frame was a list-assisted 
random-digit-dialed telephone frame.  Two strata were designated using 2000 Census Decennial 
data. The first stratum had a higher concentration of black and Hispanic households and the 
second stratum had a lower concentration relative to national estimates, however, the first 
stratum was sampled at a higher rate.  KN was able to obtain a valid postal address for 60-70 
percent of telephone numbers in the two stratums. Those telephone numbers for which addresses 
were available were selected with certainty into the sample, while 75 percent of the remaining 
telephone numbers were subsampled at random.  The address-matched phone numbers received 
an advance mailing informing them that their household was selected to participate in an ongoing 
monthly study sponsored by Stanford University, the University of Michigan and the National 
Science Foundation. 
The telephone recruitment process began for all sampled phone numbers after the 
advance mailing. The cases that were sent to interviewers were dialed for up to 90 days, with at 
least 19 dial attempts made for cases where the phone went unanswered, as well as for numbers 
known to be associated with households.  KN interviewers attempted extensive refusal 
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conversions in those cases where it was necessary.  Within each household, all members aged 18 
and older were enumerated and a member was selected at random to participate on the panel.   
Recruitment interviews typically took about 10 minutes.  
The Genetics & Stigma Study, as well as all other waves of the ANES study, was 
conducted as an online survey.  Thus, households that did not have internet access were offered 
access via the MSN TV service network.  In these cases, the household was sent a MSN TV2 
unit that was custom configured with an individual email account so that it was ready for 
immediate use by the selected panelist.  All new MSN TV2 panel members were sent an initial 
survey to confirm proper installation of the equipment and help familiarize them with the unit. 
Following recruitment onto the panel, all new panel members completed a follow-up 
survey asking for demographic information such as sex, age, race, income and educational 
attainment, which were used to create member profiles.  Panel members received $10 for each 
completed survey.  The Genetics & Stigma Study survey was conducted in English between 
April 9 and May 7, 2009 with 2,409 respondents.  The completion rate was 66 percent.  
As previously noted, panel members were randomized to participate in only one of the 
two vignette experiments.  The health vignette experiment had 1,687 respondents and the race 
vignette experiment had 722 respondents.  Sub-samples of both vignette experiments were used 
for the analyses in this dissertation.  Analyses for Aims 1-3, which focus on racial differences in 
baseline attitudes and beliefs regarding RBM, were conducted on data collected from 411 self-
identified non-Hispanic white (from here on out referred to as “white”), non-Hispanic black 
(from here on out referred to as “black”) and Hispanic adults who were randomized to the 
control arm of the health vignette experiment.  Analyses for Aims 4-7 were conducted on data 
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collected from 632 self-identified white and black adults who were randomized to the race 
vignette experiment.  The reason for why Aims 1-3 used the control group from the health 
vignette experiment instead of the race vignette experiment is because the former experiment’s 
control condition had a substantially larger sample size and a relatively greater proportion of 
black and Hispanic respondents compared to the race vignette experiment’s control arm.  In 
addition, while combining the control arms of both experiments was possible for examining 
baseline RBM beliefs and attitudes, doing so meant that I would be unable to test the 
hypothesized mediating variable in Aim 2 (genetic essentialist beliefs) because the race vignette 
experiment sample did not receive the items for this construct in its survey.   
 
3.5  Measures  
With the assistance of Jo Phelan and her research team, I have developed new measures 
assessing beliefs about, and behavioral orientation towards using, RBM and PGM.  In all, five 
new measures were constructed and used in the analyses for this dissertation.  These five 
measures are the dependent variables that were used for all of the dissertation’s analyses.  I 
should note that although I was involved with the Genetics & Stigma Study from the start, this 
dissertation’s data needs was not the primary focus of that study, therefore, I was limited as far 
as the number of items that could be inserted into the survey. I was able to insert what I predicted 
would be the minimum number of items required to be able to test the hypotheses presented in 
this study, however, some items – such as ones needed to measure RBM and PGM knowledge 
levels – would have been useful to include, but could not be included due to limited space 
available in the survey for items needed in this dissertation. 
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 The following describes the independent variables, dependent variables, mediators, 
moderator and covariate variables that were used in this dissertation study. 
 
3.5.1  Independent Variables  
For Aims 1-3, parts of Aims 4-5, and Aims 6-7, race/ethnicity was the primary 
independent variable used.  Race/ethnicity was self-reported by the respondent and was obtained 
through the initial recruitment interview.  Respondents were asked during the recruitment 
interview, “For classification purposes, can you please tell me if you are of Spanish or Hispanic 
origin?”  They were then asked about their race, “Now I’m going to read you a list of categories.  
Please choose one or more of the following categories to describe your race. Are you white, 
black or African American, American Indian, Alaska Native, Asian, Native Hawaiian or Pacific 
Islander?”  “Dummy” variables were created for the categories of “white”, “black” and 
“Hispanic” for the multiple linear regression analyses, with “black” and “Hispanic” valued at 1 
and “white” valued at 0 (the referent category).   
The independent variable for Aim 4 is the race vignette.  For this analysis, “dummy” 
variables were created using the no-vignette control condition as the referent category, except 
when indicated.  Dummy variables were created for all four vignettes to which respondents were 
randomized in this experiment – the race is genetic, social construction, admixture, and genetic 





3.5.2  Dependent Variables  
The dependent variables are measures of beliefs about and behavioral orientation towards 
using RBM and PGM.  The measures are: RBM individual-level effectiveness, RBM behavioral 
orientation, RBM population-level effectiveness, PGM individual-level effectiveness, and PGM 
behavioral orientation.  These measures are new constructs that I developed along with Jo Phelan 
and her research team.  It should be noted that multi-item measures in the form of scales are 
generally preferable to single-item measures because they are more likely to capture the 
complexity of the underlying construct that is being measured (DeVellis, 2003). Although I was 
able to develop two scales to respectively measure RBM individual-level effectiveness and PGM 
individual-level effectiveness, because I was limited in the overall number of items that I could 
include in the survey, the RBM and PGM behavioral orientation measures, and the RBM 
population-level effectiveness measure, are single-item measures. 
I was unable to collect data on knowledge levels about RBM or PGM, however, I believe 
it is reasonable to assume that much, if not most, of the American public is unfamiliar with these 
concepts.  Thus, a brief introduction that defined RBM and PGM to respondents was provided 
prior to the section of the survey with the related items.   Respondents who participated in the 
control arm of the health vignette experiment were only administered RBM-related items and 
therefore received the following introduction prior to this section of the survey: 
 
The following questions ask about race-based medicine.  Race-based medicine customizes 
medical treatments for specific racial groups.  For example, the drug BiDil was developed by a 
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company for use among only African Americans as a treatment for heart failure. Even if you are 
unfamiliar with these topics, we are interested in your opinions.  
 
Respondents who participated in the race vignette experiment were administered both the RBM- 
and PGM-related items and therefore read the following in their introduction to these items: 
 
The following questions ask about race-based medicine and personalized medicine.  Race-based 
medicine customizes medical treatments for specific racial groups.  For example, the drug BiDil 
was developed by a company for use among only African Americans as a treatment for heart 
failure.  Personalized medicine is individualized medical care based on a person’s genetic 
profile.  Whereas race-based medicine is medical care that is customized to meet the needs of 
specific racial groups, personalized medicine is medical care that is customized to meet the 
needs of individual people based on their genetic differences.  Even if you are unfamiliar with 
these topics, we are interested in your opinions.  
 
The response format for all of the dependent variables was the following: “strongly agree”, 






3.5.2.1 Race-Based Medicine Individual-Level Effectiveness 
A factor analysis was conducted in order to evaluate the extent to which the four items 
developed to assess RBM individual-level effectiveness related to each other.  The number of 
factors was not specified in the analysis.  All four RBM-related items loaded onto one factor. 
Two of the items, however, did not fit as well as the other two items within the factor solution.  
Item loadings for the one factor solution ranged from .499 to .913.   
Despite the factor analysis’ results indicating that two of the items are weaker at 
measuring the underlying construct, the one factor solution still suggested that all of the items are 
related. Therefore, a scale was constructed using all four items to measure the construct of RBM 
individual-level effectiveness.  The individual items that the scale comprises are:  
(1) “We could do a better job of treating coronary artery disease if drugs were developed 
for specific racial groups.” 
(2) “Medications would work better if they were created for use in specific racial 
groups.”  
(3) “In my opinion, we should only develop drugs that can be used by everyone 
regardless of their race.” (reverse-coded) 
(4) “If coronary artery disease drugs were made for use with different racial groups, I 
would prefer to use the one designed for my racial group.”  
An internal consistency reliability analysis of the RBM individual-level effectiveness scale 
indicated that internal consistency reliability is good for this measure.  Cronbach’s alpha for the 
sample as a whole was .76.  For the white respondents it was .77, for black respondents it was 
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.73 and for Hispanic respondents it was .88.  Cronbach’s alpha was also assessed by educational 
level for the total sample.  For respondents with less than a high school education, it was .70.  
For those with a high school diploma or the equivalent, it was .76.  Cronbach’s alpha was .82 for 
both respondents with an Associate’s degree or a Bachelor’s degree.  Respondents with a 
graduate or professional degree had a Cronbach’s alpha of .69.   
 
3.5.2.2  Race-Based Medicine Behavioral Orientation 
A single item was used to measure RBM behavioral orientation.  The purpose of this item 
was to measure whether or not a respondent would use RBM if it was available.  The item used 
to measure this construct was one of the items developed for the RBM individual-level 
effectiveness scale: “If coronary artery disease drugs were made for use with different racial 
groups, I would prefer to use the one designed for my racial group.” 
 
3.5.2.3  Race-Based Medicine Population-Level Effectiveness 
A single item was used to measure RBM population-level effectiveness.  The purpose of 
this item was to measure the extent to which a respondent believes that RBM would be effective 
at the population-level by reducing health inequalities.  The item used to measure this construct 
is the following: “Drugs created for different races will reduce health inequalities in the United 
States.”  Although this item was intended to measure an underlying construct that was separate 
and apart from the four items used to measure RBM individual-level effectiveness, a factor 
analysis was conducted in order to assess the extent to which the RBM population-level 
 86 
 
effectiveness item was related to the RBM individual-level effectiveness scale.  The factor 
analysis suggested a one factor solution for all five items, although the RBM population-level 
effectiveness item’s factor loading was on the lower end of the five values.  This suggests that 
the RBM population-level effectiveness item is related to those items used to measure RBM 
individual-level effectiveness, although the underlying construct measured by this item may be 
somewhat different from that collectively measured by the other four items.   
Notably, the concept of “health inequalities” may not be a concept with which all 
Americans are familiar, therefore it is possible that the RBM population-level effectiveness item 
may not have measured what I had intended for it to measure.  However, in addition to the factor 
analysis suggesting that the item is related to the other RBM individual-level effectiveness items 
used in this study, when this item was added to the RBM individual-level effectiveness scale 
items in an internal consistency reliability analysis, good reliability was maintained for the 
sample as a whole, as well as for the white, black and Hispanic sub-samples (Cronbach’s alphas 
were the following: total sample = .78; whites = .79; blacks = .78; and Hispanics = .84).  
Therefore at the very least, the reliability analysis results suggest that the RBM population-level 
effectiveness item is reliable at measuring its underlying construct.   Once again, I should note 
that I was limited in the number of items that could be included in the survey and therefore was 







3.5.2.4  Personalized Genomic Medicine Individual-Level Effectiveness 
Four items were developed to measure PGM individual-level effectiveness.  Each of 
these items was developed to parallel a corresponding item in the RBM individual-level 
effectiveness scale. The purpose of developing these items was to measure respondents’ beliefs 
about the effectiveness of PGM at the individual clinical level.  The following are the four PGM 
individual-level effectiveness items that were developed by me with assistance from the Genetics 
& Stigma Study research team:  
(1) “We could do a better job of treating heart disease if drugs were developed based on 
individuals’ genes.” 
(2) “Medications would work better if they were created based on individuals’ genes.”  
(3) “In my opinion, we should only develop drugs that can be used by everyone 
regardless of their genetic make-up.” (reverse-coded) 
(4) “If heart disease drugs were made based on differences between everyone’s genes, I 
would prefer to use the one developed for my gene type.”   
Because the analyses for Aim 7 of this dissertation study include a comparison of RBM beliefs 
with PGM beliefs, conceptually and analytically it made sense to keep the same scale structure 
for PGM individual-level effectiveness as the one developed for RBM individual-level 
effectiveness.  Therefore, a scale comprising all four PGM-related items was constructed to 
parallel the RBM individual-level effectiveness scale without performing an additional factor 
analysis of these items.  Internal consistency reliability for the PGM individual-level 
effectiveness scale is good for the total sample and by race.  Cronbach’s alpha for the total 
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sample of respondents was .71.  For the white respondents, it was .68.  For the black 
respondents, it was .72.  An analysis of Cronbach’s alpha based on educational level indicated 
some differences.  For respondents with less than a high school education, Cronbach’s alpha was 
.76. For respondent with a high school diploma or the equivalent, it was .59.  For respondents 
with an Associate’s degree, it was .78. For those with a Bachelor’s degree it was .83.  Finally, for 
respondents with a graduate or professional degree, it was .64.   
 
3.5.2.5  Personalized Genomic Medicine Behavioral Orientation 
A single item was used to measure PGM behavioral orientation.  The purpose of this item 
was to measure whether or not respondents would use PGM, if it was available.  This item is one 
of the items developed for the PGM individual-level effectiveness scale and is the following: “If 
heart disease drugs were made based on differences between everyone’s genes, I would prefer to 
use the one developed for my gene type.”   
 
3.5.2.6  RBM-PGM Difference Score 
 The RBM-PGM individual-level effectiveness difference score and RBM-PGM 
behavioral orientation difference score were respectively created by subtracting each 
respondent’s PGM individual-level effectiveness belief scale score from his or her RBM 
individual-level effectiveness belief scale score, and subtracting each respondent’s PGM 
behavioral orientation score from his or her RBM behavioral orientation score.    A negative 
value for either measure indicated that the respondent endorsed RBM at a lower level than PGM, 
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while a positive value indicated that the respondent endorsed RBM at a higher level than PGM.  
The greater the absolute value of a difference score, the greater the magnitude of difference in 
endorsement level between the respective RBM and PGM measures.  The intent behind 
developing these two difference scores was to measure the magnitude and direction of 
differences in beliefs and attitudes between RBM and PGM for each respondent in the study 
sample. 
 
3.5.2.7  Item and Scale Validity 
Because the items and scales that were developed to measure these constructs are, to my 
knowledge, the first of their kind, my ability to evaluate the validity of these measures was 
somewhat limited.  Content validity, which according to DeVellis (2003) refers to the extent to 
which a set of items adequately reflects a content domain, was established by developing 
multiple items related to the RBM and PGM constructs of interest and submitting these items for 
review by Professor Phelan’s research team, who were all familiar with both RBM and PGM 
concepts and who had developed varying degrees of expertise in the broader domain of race, 
genetics and health. Research team members were asked to rate the various items. The items, 
their ratings and the reasons for why items received the ratings that they did were then discussed 
by the research team.  Highly rated items that received consensus agreement for content validity 
were the final items included in the survey.   
Criterion-related validity, that is, the extent to which items or scales have empirical 
associations with some “gold standard” measure of the construct of interest, could not be 
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evaluated because similar or related measures have not previously been developed and 
established for these constructs (DeVellis, 2003).   
Construct validity was also difficult to assess for these new measures.  Known-groups 
validation is one way to establish construct validity, which involves demonstrating that 
theoretically hypothesized differences in fact exist between two or more groups based on their 
scale scores (DeVellis, 2003).  In the case of the RBM-related measures, for example, 
theoretically we may expect that greater belief in race-related genetic differences would be 
associated with higher endorsement levels of RBM-related beliefs and attitudes.  If whites are 
more likely than blacks to believe that there are genetic differences between racial groups, then 
we would expect that whites would be more likely than blacks to endorse RBM beliefs and 
attitudes. Therefore, construct validity could be established if we could empirically show that 
whites are more likely to endorse the RBM dependent variables than blacks.  This analysis is in 
fact one that will be used in order to evaluate Hypothesis 1 (see p. 65), which proposes that 
whites will be more likely to endorse RBM-related beliefs and attitudes than blacks and 
Hispanics.  Although establishing construct validity for these new measures is not one of the 
aims of this dissertation, the results of the Hypothesis 1 analysis could help to establish construct 
validity for the RBM measures specifically.   
 
3.5.3  Potential Mediators 
3.5.3.1  Genetic Essentialist Beliefs  
Genetic essentialist beliefs were measured as an index comprising two items from the 
health vignette experiment.  The following are the two items that were used to measure this 
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construct: (1) “Of the following factors, which do you personally think is the most important in 
determining a person’s level of intelligence?”; and (2) “Of the following factors, which do you 
personally think is the most important in determining a person’s general level of health?”  The 
response categories for both items were the following: “Genetic factors”, “A person’s own 
decisions and actions”, and “Factors in a person’s social environment”.  Because the response 
format for these items were categorical, the responses were dichotomized by valuing “Genetic 
factors” at 1, with the other response categories made equal to 0.  Both items were combined to 
comprise an index with a value range from 0 to 2.  The two items that comprise this index were 
developed by Jo Phelan and her research team, of which I was a part.   
 
3.5.3.2  Explicit Racist Attitudes  
Explicit racist attitudes was measured by collapsing the following three items into a 
single continuous item that measures warm/cold attitudes towards blacks: “Do you feel warm, 
cold, or neither warm nor cold to blacks?”, “Do you feel extremely warm, moderately warm or a 
little warm toward blacks?”, and “Do you feel extremely cold, moderately cold or a little cold 
toward blacks?”  The response categories for the three were collapsed into the following 
continuum: 1 = “extremely cold”, 2 = “moderately cold”, 3 = “a little cold”, 4 = “neither warm 
nor cold”, 5= “a little warm”, 6 = “moderately warm”, and 7 = “extremely warm”.  These items 
were administered to the ANES Panel in October 2008 during a previous wave of the panel 
study, approximately 6 months prior to when data was collected for most of the other items used 




3.5.3.3  Implicit Racist Attitudes  
Implicit racist attitudes was measured with the Affect Misattribution Procedure (AMP) 
(Payne, Cheng, Govorun & Stewart, 2005).  The purpose of this measure is to assess the extent 
to which individuals hold racist attitudes towards African Americans while eliminating any 
social desirability factors that may modify how respondents answer more explicit items assessing 
attitudes towards African Americans.  The AMP has become an extremely popular tool used to 
measure implicit social cognition processes, as evidenced by the paper describing the AMP by 
Payne, Cheng, Govorun & Stewart (2005) having been cited 493 times through December 2013, 
according to the Google Scholar® database.  The AMP has been shown to produce strong effects 
(i.e., d = 1.25 – see Cohen (1977/1988) for interpreting effect sizes) as well as exhibit good 
internal consistency reliability (.69 < α < .90) (Payne et al., 2005), and its use in numerous 
studies with results that seem to be validated by other measures of implicit social cognition 
processes suggests that it is a valid measure of implicit attitudes.  It should be noted, however, 
that despite the test’s popularity, there has been some controversy surrounding whether the 
procedure adequately measures affect.  For example, three studies undertaken by Blaison and 
colleagues (2012) that used a modified AMP that allowed for assessing both affective and non-
affective underlying processes found that in all three studies, the AMP seemed to reflect only 
non-affective processes.   
The AMP was administered online during two previous waves of the ANES study in 
September and October of 2008. Respondents see photographs of a young male black or white 
face for 75 milliseconds, followed by a Chinese character for 100 milliseconds, followed by a 
black and white patterned screen.  Respondents then indicate whether they found the Chinese 
character to be pleasant or unpleasant. Twenty-four trials of black faces were intermixed with 24 
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trials of white faces. The AMP score is then the percent of characters associated with black faces 
that were judged to be unpleasant minus the percent of characters associated with white faces 
that were judged unpleasant. The greater the score, the more a respondent is judged to hold 
implicit racist attitudes towards African Americans.  Cronbach’s alpha for whites and Hispanics 
combined is .85.  For whites only, it is .80 and for Hispanics only it is .97.  
 
3.5.3.4  Genetic Essentialist Beliefs in Racial Differences 
 Genetic essentialist beliefs in racial differences was measured by a single item, which 
was the following: “There are very few genetic differences among racial groups.”  The response 
categories for this item were “strongly disagree” (1), “somewhat disagree” (2), “somewhat 
agree” (3), and “strongly agree” (4).  This item was reversed-coded in order for high scores to 
reflect endorsement of genetic essentialist beliefs in racial differences.  
 
3.5.4  Potential Moderator 
3.5.4.1  Vignette Acceptance 
Two items were used as a scale to measure the extent to which respondents accepted the 
information that was provided in the vignette he or she had received (Cronbach’s alpha = .73 for 
total sample; .65 for whites; .73 for blacks).  The two items were:  
(1) “In your opinion, the article provided an accurate account of the topics it discussed.”  
(2) “The article struck you as biased and inaccurate.” (reverse-coded)   
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The response categories for both items were 4 = “strongly agree”, 3 = “somewhat agree”, 2 = 
“somewhat disagree”, and 1 = “strongly disagree”.      
 
3.5.5  Covariates 
For Aims 1-3, which examine racial differences in baseline RBM attitudes and beliefs, I 
adjusted the multiple regression analyses to control for several socio-demographic variables that 
are potential confounders.  They are the following: sex (male = 1, female = 0); education (1 = 
“no formal education”, 2 = “1st, 2nd, 3rd or 4th grade”, 3 = “5th or 6th grade”, 4 = “7th or 8th grade”, 
5 = “9th grade”, 6 = “10th grade”, 7 = “11th grade”, 8 = “12th grade No Diploma”, 9 = “High 
school graduate—high school diploma or the equivalent”, 10 = “Some college, no degree”, 11 = 
“Associate degree”, 12 = “Bachelor’s degree”, 13 = “Masters degree”, 14 = “Professional or 
doctorate degree”); age (in years); and geographic region in which the respondent resided 
(dummy variables were created for the following regions: Northeast, Midwest, South, Southeast, 
Rocky Mountain/Southwest, and West).  Prior qualitative studies that examined racial 
differences in RBM-related beliefs and attitudes were concentrated in the Southeast region of the 
U.S.  Therefore, Southeast was set as the referent category for the geographic region dummy 
variables in order to see if people from other regions in the U.S. significantly differed in their 
RBM-related beliefs and attitudes than those from this region that was previously examined. 
For the multiple regression analyses in Aims 4-5, which examine the race vignette 
experiment’s effect on RBM attitudes and beliefs, confounding should not be an issue since the 
vignettes were randomly assigned.  However, in order to increase the precision of the estimates 
of the vignettes’ effects on RBM attitudes and beliefs, and to assess the generality of the effects 
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of the vignettes across sex, education and age, I controlled for these socio-demographic variables 
as well.  For these aims, I also controlled for white versus black race. In this case, 1 = black and 
0 = white. 
In the multiple regression analysis for Aim 6, I controlled for sex, education, age, and 
geographic region in order to avoid potential confounding.  I additionally controlled for type of 
race vignette received.  Although the vignettes are about race and genetics and none mention 
PGM, the discussion of genetics alone could potentially have some influence on beliefs about 
PGM, thereby necessitating adjustments of the analyses for race vignette received.  
 
3.5.6  Missing Values 
 Tables 3.4 and 3.5 present the number and proportions of missing values for each of the 
variables used for Aims 1-3 and Aims 4-7 respectively.  Many of the variables had no missing 
values while some had anywhere from 0.1 to 4.3 percent missing values.  The only variable with 
more than 4.3 percent missing values was implicit racist attitude (measured by the AMP), which 
had 9.9 percent of its values missing.  Because of the large proportion of values missing for this 
variable, the mean AMP value was substituted for missing values in order to minimize the 
number of cases dropped from the related analyses.  There were relatively low proportions of 
missing values for the remaining variables used in the dissertation’s analyses. Thus, cases with 





Table 3.4: Proportion of missing values for each item, scale and index used in the Part 1 
analyses for Aims 1-3. 
Variables n Total Values Missing Values  % Missing 
Race 411 411 0  0.0 
Sex 411 411 0 0.0 
Age 411 411 0 0.0 
Education 411 407 4 1.0 
Geographic Region 411 411 0 0.0 
RBM Individual-Level Effectiveness Scale 411 403 8 1.9 
RBM Item 1 - RBM treats heart disease 411 403 8 1.9 
RBM Item 2 - RBM medications work 
better 
411 403 8 1.9 
RBM Item 3 - Everyone should use the 
same drugs regardless of race 
411 404 7 1.7 
RBM Behavioral Orientation – RBM Item 4 - 
I prefer to use RBM 
411 403 8 1.9 
RBM population-level effectiveness – RBM 
Item 5 
411 403 8 1.9 
Genetic Essentialist Beliefs Index 411 396 15 3.7 
Genetic Essentialist Beliefs Item 1 - 
Genes are the most important cause of 
health 
411 401 10 2.4 
Genetic Essentialist Beliefs Item 2 - 
Genes are the most important cause of 
intelligence 
411 404 7 1.7 
Implicit Racist Attitude 365 329 36 9.9 




Table 3.5: Proportion of missing values for items and scales used in Parts’ 2 and 3’s 
analyses for Aims 4-7. 
Variables n Total Values Missing Values % Missing 
Race 632 632 0 0.0 
Sex 632 632 0 0.0 
Age 632 632 0 0.0 
Education 632 631 1 0.1 
Geographic Region 632 632 0 0.0 
Vignette Received 632 632 0 0.0 
Genetic Essentialist Beliefs in Racial 
Differences 
632 621 11 1.7 
Vignette Acceptance Scale 547 547 0 0.0 
Vignette Acceptance Item 1 547 547 0 0.0 
Vignette Acceptance Item 2 547 547 0 0.0 
RBM Individual-Level Effectiveness Scale 632 630 2 0.3 
RBM Item 1 - RBM treats heart disease 632 630 2 0.3 
RBM Item 2 - RBM medications work 
better 
632 628 4 0.6 
RBM Item 3 - Everyone should use the 
same drugs regardless of race 
632 630 2 0.3 
RBM Behavioral Orientation – RBM Item 4 - 
I prefer to use RBM 
632 625 7 1.1 
RBM Population-level Effectiveness – RBM 
Item 5 
632 626 6 0.9 
PGM Individual-level Effectiveness Scale 632 632 0 0.0 
PGM Item 1 – PGM treats heart disease 632 632 0 0.0 
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Table 3.5: Proportion of missing values for items and scales used in Parts’ 2 and 3’s 
analyses for Aims 4-7. 
Variables n Total Values Missing Values % Missing 
PGM Item 2 – PGM medications work 
better 
632 632 0 0.0 
PGM Item 3 – everyone should use same 
drugs regardless of genetic make-up 
632 632 0 0.0 
PGM Behavioral Orientation - PGM Item 4 – 
I prefer to use PM 
632 632 0 0.0 
 
3.6  Analyses 
SPSS Version 21.0’s Complex Sampling Module was used to perform the data analysis in 
order to estimate the correct standard errors for the telephone survey data, which has a complex 
survey design.  Depending on the aim, I used frequencies, crosstabulation and multiple linear 
regression analyses to assess each specific aim.  Results were weighted to account for under- and 
over-sampling of different households. The data were also adjusted for any non-response or non-
coverage that resulted from the sample design.  The following summarizes my general strategy 
for the analyses of the dissertation’s aims.  
Analysis of Aim 1.  In order to assess whether racial groups differed in their beliefs about 
RBM individual-level effectiveness, behavioral orientation and population-level effectiveness, I 
conducted frequencies and multiple linear regression analyses.  In the regression analyses, each 
of the RBM-related dependent variables was regressed on the race dummy variables and socio-
demographic control variables.  Multiple linear regression was also used to examine if there were 
interaction effects between race and most of the socio-demographic control variables (sex, 
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education, age), in order to assess the extent to which the differences between racial groups were 
modified by other social characteristics.  First, R2-change was assessed to see if the set of tested 
interactions as a group had a significant effect on each of the RBM dependent variables.  Those 
dependent variables for which R2-change was significant had the individual interaction terms 
examined to assess potential racial differences in the associations between the socio-
demographic variables and the dependent variable of interest.  The RBM dependent variables for 
which interaction effects were found then underwent race-specific multiple linear regression 
analyses in order to examine how each of the socio-demographic control variables may be 
differentially related to the dependent variables for each racial group. These analyses are 
discussed in detail in the methods section of Chapter 4 (pp. 127-131). 
Analysis of Aim 2. For this aim, I used multiple linear regression to examine whether 
there are racial differences in genetic essentialist beliefs, a potential mediator between race and 
RBM individual-level effectiveness, behavioral orientation and/or population-level effectiveness.  
Genetic essentialist beliefs was regressed on the race dummy variables, as well as the socio-
demographic control variables, in order to examine whether white respondents differ from black 
and Hispanic respondents on this construct.  Genetic essentialist beliefs was then tested as a 
mediator between RBM individual-level effectiveness, behavioral orientation and/or population-
level effectiveness and race. Genetic essentialist belief was only tested as a mediator for those 
dependent variables for which statistically significant racial differences were found in Aim 1.  I 
followed Baron and Kenny’s (1986) steps for testing mediation effects.  These analyses are 
discussed in greater detail in the methods section of Chapter 4 (pp. 127-131). 
Analysis of Aim 3. In this aim, I separately tested implicit racist attitudes and explicit 
racist attitudes as mediators between race and the RBM-related dependent variables.  Both 
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attitudinal constructs were only tested as mediators between the white and Hispanic respondents 
and both were only tested for the dependent variables that were endorsed by whites at greater 
levels than blacks and Hispanics in Aim 1. Once again, I followed Baron and Kenny’s (1986) 
steps for testing mediation effects.  
Analysis of Aim 4. In this aim, I assessed whether vignettes in the form of mock news 
articles that discuss different types of relationships between race and genes impact RBM beliefs 
and attitudes. I analyzed this aim in three parts.  First, I examined the means for RBM individual-
level effectiveness, behavioral orientation and population-level effectiveness by vignette arm in 
order to assess the extent to which the vignettes’ may have affected the dependent variables.  
Second, I calculated  R2-change to examine the overall impact of the vignette experiment 
on the RBM-related dependent variables in comparison to a model that only examined the impact 
of socio-demographic variables on the dependent variables.  How R2-change is calculated is 
discussed in further detail in the methods section of Chapter 5 (pp. 171-176).  
Third, if the change in R2 indicated that the vignettes had an overall effect on RBM 
beliefs and attitudes, then hypotheses 4a-4e, which test for individual vignettes’ effects on the 
dependent variables, were tested.  These hypotheses were tested using multiple linear regression.  
The different models constructed to test each hypothesis are discussed in the methods section of 
Chapter 5 (pp. 171-176). 
Analysis of Aim 5. In this aim, I assessed whether acceptance of the vignette modified 
the effect of the vignette received on RBM individual-level effectiveness, behavioral orientation 
and population-level effectiveness.  Potential interaction effects between vignette received and 
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acceptance of the vignette’s information were assessed using multiple linear regression.  Further 
details regarding Aim 5’s analysis are discussed in the Chapter 5 methods section (pp. 171-176).  
Analysis of Aim 6. For aim 6, I assessed whether there are racial differences in beliefs 
about PGM individual-level effectiveness and behavioral orientation.  Means were calculated, 
frequencies were examined and multiple linear regression was used to examine whether there are 
racial differences in PGM individual-level effectiveness and behavioral orientation beliefs and 
attitudes. These analyses are further discussed in the Chapter 6 methods section (pp. 252-256).     
Analysis of Aim 7.  The purpose of this aim is to compare PGM individual-level 
effectiveness and behavioral orientation beliefs and attitudes with RBM individual-level 
effectiveness and behavioral orientation beliefs and attitudes.  For this aim, I compared mean 
PGM individual-level effectiveness and behavioral orientation scores with mean RBM 
individual-level effectiveness and behavioral orientation scores for the sample as a whole, as 
well as for the white and black sub-samples.  This was done by comparing means and 
frequencies for PGM individual-level effectiveness and behavioral orientation scores with those 
for RBM individual-level effectiveness and behavioral orientation scores. These analyses were 
stratified by race vignette experiment condition.  A crosstabulation analysis among the 
respondents was also conducted between PGM and RBM individual-level effectiveness as well 
as PGM and RBM behavioral orientation, stratified by vignette condition and race.   
Student’s t-tests were conducted to assess whether the mean RBM-PGM individual-level 
effectiveness and behavioral orientation difference scores significantly differed from zero. The 
Student’s t-tests were separately conducted for each race vignette experiment condition in an 
effort to adjust for the potential effects of the vignettes on RBM- and PGM-related beliefs and 
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attitudes.  In addition, t-tests were separately conducted by race in order to assess potential 
differences between white and black respondents for the RBM-PGM difference scores by 
vignette condition. Both the RBM-PGM individual-level effectiveness and RBM-PGM 
behavioral orientation difference scores were regressed on race, adjusting for socio-demographic 
variables and the race vignette experiment.  In order to assess whether the race vignette 
experiment had differential effects on whites and blacks in the magnitude, and possibly, direction 
of respondents’ difference scores, RBM-PGM individual-level effectiveness and behavioral 
orientation difference scores were also separately regressed on race by race vignette interaction 
terms, adjusting for socio-demographic variables.   
 
3.7  Power 
Power calculations were made for Student’s t-tests, ANOVA, and multiple linear 
regression using power estimates obtained from tables developed by Cohen (1977/1988).  The 
main approach to most analyses undertaken for this dissertation study is multiple linear 
regression.  As such, I will provide evidence for most tested hypotheses using that approach.  
However, in certain instances, particularly those concerning comparisons by racial groups, the 
multiple linear regression power analyses do not adequately reflect the imbalance in the size of 
the racial groups, as well as the race vignette experiment conditions, examined in this study. 
Multiple regression power calculations are based on increments of explained variance.  While 
such calculations are valid, they do not capture the importance of group size.  In order to give 
some indication of power that does reflect group size, I have conducted  power analyses for 
Student’s t-tests and ANOVAs when necessary because these calculations account for group size 
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and provide a way to address group size imbalance when calculating power.  These power 
analyses will provide evidence as to which tests are likely to have more power, and which less, 
given group size and imbalance between groups.  Although calculating power estimates for 
Student’s t-tests or ANOVAs in lieu of multiple linear regression power estimates may 
overestimate the power of some of the multiple linear regression models (since such power 
calculations do not account for the inclusion of additional control variables), the extent to which 
power is affected by vast sample size difference between groups is likely better accounted for in 
mean-difference power estimates than multiple linear regression power estimates.  Student’s t-
test and ANOVA power estimates for multiple linear regression models are intended to 
approximate the extent to which the sample size for each racial group or each vignette condition 
was sufficient for finding small, medium and large effect sizes (see Cohen (1988) pp. 8-14, for a 
discussion on how to meaningfully interpret effect sizes).  Because group comparisons are 
central to many tests undertaken in this dissertation study, using t-test and ANOVA power 
calculations to assess relative power for some of the multiple linear regression analyses enables 
one to assess those instances in which power is relatively better, or relatively worse, given the 
data that I am working with to answer this dissertation study’s research questions.    
Tables 3.6 through 3.12 provide the power estimates by Aim for each Student’s t-test, 
ANOVA or multiple linear regression power calculation conducted for that particular Aim.  All 
analyses are based on a significance criterion alpha level of .05.  I will follow the conventional 
definition of sufficient power to detect an effect size as 80 or higher.  The alpha level for the 
Student’s t-tests is based on a two-tailed model.  Cohen’s (1977/1988) power tables for a two-
tailed t-test that compares the means of two different groups is based on the following formula: 
 
d = | mA – mB |  
   σ 
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In this formula, d represents effect size and follows conventional effect size definitions for t-tests 
as stated by Cohen: 
 
small: d = .20 
medium: d = .50 
large: d = .80 
 
mA and mB represent the respective means of groups A and B and σ represents the standard 
deviation of both samples.  Cohen’s power tables for t-tests require one to know all of the 
following in order to calculate power: sample size (n), effect size (d) and significance level (a), 
including whether a one- or two-tailed test will be done.  When the means of groups’ A and B 
are compared and the sample sizes of the two groups are unequal, a weighted mean sample size 
(n’) between the two groups is used instead of n in order to calculate power.  n’ was calculated 
using the following formula: 
 
 
 The ANOVA power calculation’s primary effect size index is f, which is defined as the 
standard deviation of k number of standardized population means (k in this case represents the 
number of group means that are compared in an ANOVA analysis).  f is related to d by the 
following formula: 
 
n' = 2nAnB  
        nA + nB 
d = 2f 
 105 
 
d in this case is similar to the d used to assess effect size in the Student’s t-test power 
calculation, however in the case of ANOVA, it represents the range of standardized means, 
meaning, the distance between the smallest and largest of the k means: 
 
Cohen notes that the values for effect size f are conventionally defined as the following: 
Small: f = .10 
Medium: f = .25 
Large: f = .40 
 
In order to assess the statistical power of an ANOVA analysis, F test power tables were used.  
The following are required in order to calculate an ANOVA power analysis: sample size (n), 
effect size (f), significance level (a), and degrees of freedom of the numerator of the F ratio (u, 
calculated as equal to k – 1).  
 Some of the multiple linear regression models used in this dissertation study were not 
primarily focused on comparing two or more groups of substantially unequal sample sizes.  In 
those cases, multiple regression power analyses following Cohen’s criteria and formulas for such 
analyses were appropriate.  Cohen notes that for the t-test and ANOVA power tables, the 
appropriate effect size index and sample size are sufficient to determine power of the analysis, 
however, in order to determine power for a multiple regression analysis, the noncentrality 
parameter of the noncentral F distribution, λ, must be used. λ is a function of the effect size index 
as well as the F ratio numerator and denominator degrees of freedom, otherwise known as u and 
d = mmax – mmin 
       σ 
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v.  u is set as the number of independent variables in the analysis and v  is calculated as n – u – 
1. In order to calculate λ, the following formula was used: 
 
According to Cohen, conventional definitions for multiple regression power analysis effect size 
are the following: 
Small: f2 = .02 
Medium: f2 = .15 
Large: f2 = .35 
 
In order to estimate multiple regression power, the following must be known: numerator degrees 
of freedom (u), denominator degrees of freedom (v), the noncentrality parameter of the 
noncentral F distribution (λ), and the significance level (a).   
 Tables 3.6-3.8 present the power analysis results for Aims 1-3 respectively. The results 
indicate that for Aim 1’s multiple linear regression analyses examining potential racial 
differences in RBM beliefs and attitudes (Models 1-6) that the power is good for detecting 
medium to large effect sizes (99).  Models 7-9, which are the race-specific models examining 
potential associations between certain socio-demographic variables and RBM beliefs and 
attitudes, show that power is good for detecting medium to large effects amongst the white sub-
sample, but not the black and Hispanic sub-samples.  Power calculation results for Aim 2’s 
examination of genetic essentialist beliefs as a potential mediator between race and RBM beliefs 
and attitudes also indicates that power is good for detecting medium to large effects.  The power 
calculation results for Aim 3 indicate that there is only enough power to detect large effect sizes 
λ = f2(u + v + 1) 
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for the analyses examining implicit and explicit racist attitudes towards African Americans as a 
possible mediator between race/ethnicity (whites versus Hispanics) and RBM beliefs and 
attitudes.  
Table 3.6: Power calculation analyses for Aim 1 multiple linear regression analyses. 
ANOVA power calculations used to assess power for multiple linear regression models examining 
racial differences in RBM beliefs and attitudes (nwhites = 336, nblacks = 46, nHispanics = 29). 














flarge = .40 
Models 1-6 411 3 .05 43 99 99 
Multiple linear regression power calculations used to assess power for race-specific models of RBM 
beliefs and attitudes regressed on socio-demographic variables. 















Model 7 (whites) 336 8 .05 41 99 99 
Model 8 (blacks) 46 8 .05 5 36 74 








Table 3.7: Power calculation analyses for Aim 2 multiple linear regression analyses. 
ANOVA power calculations used to assess power for multiple linear regression models examining 
genetic essentialist beliefs as a mediator between race and race-based medicine beliefs and attitudes 
(nwhites = 336, nblacks = 46, nHispanics = 29). 











flarge = .40 
Models 10-12 411 3 .05 43 99 99 
 
 
Table 3.8: Power calculation analyses for Aim 3 multiple linear regression analyses. 
Student’s t-test power calculations used to assess power for multiple linear regression models 
examining implicit and explicit racist attitudes as a mediator between race/ethnicity and race-based 
medicine beliefs and attitudes  
(nwhites = 336, nHispanics = 29). 
Model No. n n’ Alpha 
Level 
Power for 





dlarge = .80 




 Table 3.9 presents the power analyses results for Aim 4.  The results show that the power 
for testing possible racial differences in RBM beliefs and attitudes by race vignette condition is 
borderline adequate to good (67-89) for large effect sizes depending on the vignette condition to 
which respondents were assigned.  However, it should be noted that the vignette condition with 
the lowest power for detecting racial differences is the no-vignette control condition (Model 20), 
which is a replication of the analyses for detecting racial differences in RBM beliefs and 
attitudes examined in Aim 1 (models 1-6); as previously noted, the power for those models was 
sufficient for detecting medium to large effects.   Table 3.9 results also show that the power is 
good for detecting medium to large effect sizes in the analysis that examines the race vignette 
experiment’s overall effect on RBM beliefs and attitudes (Model 21), as well as for testing 
genetic essentialist beliefs in racial differences as a mediator of the race vignette experiment’s 
effect on RBM beliefs and attitudes (Model 22).  The power for models 23-27, which directly 
compare the effects of different vignette conditions on RBM beliefs and attitudes, is sufficient 
for detecting medium to large effect sizes.  
 Table 3.10 presents the power calculation results for Aim 5, which examines acceptance 
of the vignette message as a possible moderator between vignette received and RBM beliefs and 
attitudes.   The results show that power is good for detecting medium to large effect sizes for the 
race vignette experiment’s overall effect on the vignette acceptance scale.  Multiple linear 
regression models that examine the association between the vignette acceptance scale and RBM 
beliefs and attitudes by race vignette condition indicate that power is good for detecting medium 
to large effect sizes for all vignette conditions.  The results also show that the power is good for 
detecting medium to large effect sizes in the models examining the vignette acceptance scale as a 




Table 3.9: Power calculation table for Aim 4 multiple linear regression analyses. 
Student’s t-test power calculations used to assess power for multiple linear regression models 
examining racial differences in race-based medicine beliefs and attitudes by race vignette condition. 













Race Is Genetic 
Vignette (Nwhites = 114, 
Nblacks = 19) 
 
133 33 .05 13 51 89 
Model 17 
Genetic Health 
Difference Vignette  
(Nwhites = 143, Nblacks = 
16) 
 
159 29 .05 12 46 85 
Model 18 
Admixture Vignette  
(Nwhites = 108, Nblacks = 
13) 
 
121 23 .05 10 39 77 
Model 19 
Social Construction 
Vignette (Nwhites = 114, 
Nblacks = 19) 


























Table 3.9: Power calculation table for Aim 4 multiple linear regression analyses. 
ANOVA power calculations used to assess power for multiple linear regression models examining 
the overall effect of the race vignette experiment on race-based medicine beliefs and attitudes. 











for flarge = 
.40 
 
Model 21  
Race Vignette 
Experiment’s Overall 
Effect on RBM Beliefs 
and Attitudes 
632 5 .05 49 99 99 
Multiple linear regression power calculations used to assess power for testing genetic essentialist 
beliefs in racial differences as mediator between the race vignette experiment and race-based 
medicine beliefs and attitudes. 

























Table 3.9: Power calculation table for Aim 4 multiple linear regression analyses. 
Student’s t-test power calculation used to assess power for multiple linear regression models 
examining differences in the effects of specific race vignette conditions on race-based medicine 
beliefs and attitudes. 































Student’s t-test power calculation used to assess power for multiple linear regression models 
examining differences in the effects of specific race vignette conditions on race-based medicine 
beliefs and attitudes. 




































Table 3.9: Power calculation table for Aim 4 multiple linear regression analyses. 
ANOVA power calculations used to assess power for multiple linear regression models examining 















































Social Construction v. 
No-Vignette Control v. 
Admixture 




Race Is Genetic v. 
Genetic Health 



















Table 3.10: Power calculation table for Aim 5 multiple linear regression analyses. 
ANOVA power calculation used to assess power for multiple linear regression model examining the 
effects of the race vignette experiment on the vignette acceptance scale. 

















Effect on Vignette 
Acceptance Scale 
631 5 .05 49 99 99 
Multiple linear regression power calculation used to assess power for race-based medicine beliefs 
and attitudes regressed on the vignette acceptance scale, by race vignette condition. 















Model 29  
Race Is Genetic 


























































Table 3.10: Power calculation table for Aim 5 multiple linear regression analyses. 
Student’s t-test power calculation used to assess power for multiple linear regression models 
comparing race vignette conditions’ effects, moderated by the vignette acceptance scale, on race-
based medicine beliefs and attitudes. 














Race Is Genetic v. 
Social Construction 





































Table 3.11 presents the power results for Aim 6’s multiple linear regression models that 
examine potential racial differences in PGM beliefs and attitudes.  The results indicate that 
power is good for detecting medium to large effect sizes in PGM beliefs and attitudes between 
the white and black respondents (Models 36-37).  Power is also good for detecting medium to 
large effect sizes in PGM beliefs and attitudes among the white sub-sample (Model 38) but is 
only good for detecting a large effect size among the black sub-sample (Model 39).  Table 3.12 




detecting anything from a small to a large effect in the Student’s t-test analysis that examines 
whether the magnitude of difference between RBM and PGM beliefs and attitudes significantly 
differs from 0 (Model 40).  The results also indicate that the power is good for detecting medium 
to large effect sizes in the multiple linear regression models (Models 41-42) that examine 
potential racial differences in the race vignette experiment’s overall effect on the magnitude of 
difference between RBM and PGM beliefs and attitudes.   
Table 3.11: Power calculation table for Aim 6 multiple linear regression analyses. 
Student’s t-test power calculation used to assess power for multiple linear regression model 
examining racial differences in personalized genomic medicine beliefs and attitudes (nwhites = 553, 
nblacks = 79). 









dlarge = .80 
Models 36-37 632 139 .05 38 99 99 
Multiple linear regression power calculation used to assess power for personalized genomic 
medicine beliefs and attitudes regressed on socio-demographic control variables and race vignette 
experiment, by race. 
















































Table 3.12: Power calculation table for Aim 7 Student’s t-tests, ANOVA and multiple 
linear regression analyses. 
Student’s t-test power calculation used to assess whether the race-based medicine-personalized 
genomic medicine difference scores for individual-level effectiveness and behavioral orientation 
differ from 0. 
















632 .05 99 99 99 
Student’s t-test power calculation used to assess power for multiple linear regression model 
examining racial differences in race-based medicine-personalized genomic medicine difference 
scores for individual-level effectiveness and behavioral orientation for the race vignette experiment 
overall. 














Race Vignette Experiment 


















In sum, most of the analyses have sufficiently large enough sample sizes to detect 
medium to large effect sizes.  In nearly all cases, however, small effect sizes may not be 
detected.  Because this dissertation study was part of the larger Genetics & Stigma Study, the 
overall design of the parent study had sample size needs that were different from this dissertation 
study.  Despite some of the power limitations of the analyses conducted for this dissertation 
study, the results, nonetheless, will provide new insight into the lay public’s conceptions 
regarding RBM and PGM, as this is the first nationally representative study to examine such 
conceptions.  Because most of the analyses in this study do have the power to detect medium to 
large effect sizes should they exist, this study’s findings will still provide significant insight into 
the relationship between self-identified race/ethnicity and RBM- and PGM-related beliefs and 
attitudes.  Although it would be ideal to have the ability to detect small effect sizes should they 
exist, Cohen notes that the concept of effect size is relative to the research questions at hand and 
requires some reflexive thought as to what extent different effect sizes provide meaningful 
evidence for conclusions made from the results.  Is a small difference between whites, blacks and 
Hispanics in RBM- or PGM-related beliefs and attitudes much more alarming than no difference 
at all? This is a question that requires further thought from various stakeholders in the debates 
surrounding the development and administration of RBM and PGM.  The detection of large, or 
even medium effect sizes, however, certainly would make interested parties pause to further 
consider the merits or concerns surrounding the implementation of RBM and PGM.  For this 
reason, the findings from this study - particularly those that are statistically significant as they 
would generally suggest a medium to large difference between the groups in question - will 
provide stakeholders with important information that should be considered as efforts continue to 






PART 1: RACE-BASED MEDICINE BELIEFS AND ATTITUDES 
 
 
4.1  Introduction: 
 To date, there has been little research examining lay beliefs and attitudes towards race-
based medicine (RBM). The research that is available suggests that beliefs about the 
effectiveness of RBM specifically differ by individuals’ racial or ethnic background (Bevan, 
Lynch, Dubriwny, Harris, Achter, et al., 2003; Condit, Templeton, Bates, Bevan & Harris, 2003; 
Marco, 2010).  To the extent that the development and promotion of RBM is meant to improve 
the delivery of and clinical response to medical care for racial and ethnic populations that have 
been traditionally burdened with poorer health outcomes, then better understanding whether the 
race or ethnicity of patients affects beliefs and attitudes about RBM – and more importantly, 
behavioral orientation towards using RBM – becomes critical for healthcare planning and policy 
purposes.  
In order to better understand beliefs and attitudes towards RBM, in particular whether 
race is associated with these beliefs and attitudes, this chapter will focus on three of this 
dissertation study’s aims.  
Aim 1. For Aim 1, I will examine whether racial groups differ in terms of beliefs about 
RBM’s individual-level effectiveness, behavioral orientation towards using RBM, and RBM’s 
population-level effectiveness. Previous research has found that blacks and Hispanics were more 
“suspicious” about RBM than whites for a variety of reasons, including concerns that RBM 





Marco, 2010). Therefore, I expect to find that whites are more likely than blacks and Hispanics 
to endorse RBM effectiveness beliefs and preferences for using RBM.  The hypothesis for this 
aim is the following:  
Hypothesis 1:  Whites are more likely than blacks and Hispanics to endorse beliefs 
relating to and attitudes towards RBM individual-level effectiveness, behavioral 
orientation and population-level effectiveness.  
Aims 2 and 3 are contingency aims that will only be examined for those RBM dependent 
variables for which racial differences are found in Aim 1. These aims look at two different 
potential mediators of racial differences in RBM-related beliefs and attitudes. 
Aim 2. If racial differences are found in Aim 1, Aim 2 will examine whether genetic 
essentialist beliefs explain any differences between racial groups in RBM-related individual-
level effectiveness, behavioral orientation and population-level effectiveness beliefs and 
attitudes.  I expect to find that genetic essentialist beliefs partially mediate an association 
between race and the RBM-related dependent variables, meaning, racial differences in RBM 
beliefs and attitudes are attributable in part to differences in genetic essentialist beliefs.  The 
theoretical foundation for this hypothesis is that people in socially privileged positions are more 
likely to endorse genetic essentialist beliefs in order to justify existing social hierarchies 
(Jayaratne et al., 2006; Nelkin & Lindee, 1995). The assumption here is that whites would be 
more likely to endorse genetic essentialist beliefs and that genetic essentialist beliefs would be 
positively associated with RBM beliefs and attitudes.   
Hypothesis 2: Genetic essentialist beliefs partially mediate the association between race 





level effectiveness belief.  Endorsement of genetic essentialist beliefs will be associated 
with endorsement of the three aforementioned RBM-related dependent variables.  
Aim 3. Finally, if whites are found to endorse RBM-related individual-level 
effectiveness, behavioral orientation and/or population-level effectiveness beliefs and attitudes at 
greater levels than blacks and Hispanics in Aim 1, then Aim 3 will examine whether implicit 
racist attitudes and explicit racist attitudes towards African Americans explain some of the 
differences in these beliefs and attitudes between whites and Hispanics. I expect to find that 
whites compared with Hispanics will hold more racist attitudes towards African Americans, and 
that these attitudes will be associated with greater endorsement of RBM’s effectiveness and 
preferences for using RBM.  Previous research has shown that whites hold more racist attitudes 
than Hispanics towards African Americans (Hunt, 2007).  There is also some evidence that has 
linked racist attitudes with beliefs in biological/essential racial differences (Kinder & Sanders, 
1996; Keller, 2005; Jayaratne et al., 2006).  In turn, belief in biological and essential racial 
differences may be associated with greater endorsement of RBM’s effectiveness and preferences 
for using it among those who assume that race-specific differences in the efficacy of biomedical 
treatments are due to biological differences between racial groups.  Aim 3’s hypotheses are in 
two parts: 
Hypothesis 3a:  Implicit racist attitudes and explicit racist attitudes towards African 
Americans will be associated with endorsement of RBM-related individual-level 
effectiveness, behavioral orientation and population-level effectiveness. 
Hypothesis 3b:  Implicit racist attitudes and explicit racist attitudes will mediate the 
relationship between race and RBM-related individual-level effectiveness, behavioral 





Hypothesis 3b will only be tested if the analysis for Hypothesis 3a indicates an association 
between implicit racist attitudes and/or explicit racist attitudes and the dependent variable that is 
being tested.  
 Note, a summary of Aims 1-3 and the rest of study’s aims, plus each aim’s hypotheses, 
can be found in Table 3.3 (p. 75). 
 
4.2  Research Design and Methods: 
4.2.1  Sample  
The sample for Aims 1 and 2 are the 411 self-identified white, black and Hispanic 
respondents who were randomized to the control arm of the health vignette experiment (see p. 55 
in Chapter 3 for a description of this experiment). The sample for Aim 3 is comprised of only the 
white and Hispanic respondents who were included in the Aims 1 and 2 sample (n = 365).    
Demographic characteristics for the sample used for Aims 1-3 are compared with 2010 
U.S. Census Data in Table 4.1 (U.S. Census Bureau, 2013). Correspondence with the Census 
was good for sex, education and age, however, the sample had a smaller proportion of Hispanic 
respondents and a higher proportion of white respondents. Hispanic ethnicity was measured 
separately from race in the Census but not in this survey, so it is possible that a portion of the 
non-Hispanic respondents would have reported Hispanic ethnicity in addition to their race if 
given the chance.  2010 Census results in fact show that 91.6 percent of people who identified as 
Hispanic or Latino, racially identified as only white (Humes, Jones and Ramirez, 2011).  All 





Table 4.1: Comparison of selected characteristics of Aims 1-3 sample (n = 411) with 
2010 United States Census data for individuals 18 or older. 
 n % 2010 Census % 
Race     
  White 336 81.8 72.4a 
  Black 46 11.2 12.6 
  Hispanic 
 
29 7.1 16.3 
Male  
 
192 46.7 49.2 
Age    
   18-44 175 42.5 48.1 
   45 to 64 156 38.1 34.2 
   65 and older 
 
80 19.4 17.2 
Educational attainment 
among those 25 or olderb 
   
  <HS 30 8.2 12.9 
  HS 187 50.8 48.1 
  Associate’s degree 31 8.4 9.1 
  Bachelor’s degree 79 21.5 19.4 
  Graduate degree 41 11.1 10.5 
a Hispanic ethnicity is measured separately from race in the Census. 






Table 4.2 is a comparison of selected characteristics of the sample by race/ethnicity. An 
analysis of the three race-specific samples shows that each group has more female than male 
respondents. The Hispanic group has a greater proportion of female respondents compared to the 
white and black sub-samples. A chi-square analysis, however, showed that there was no 
significant difference between racial groups in the proportion of male versus female respondents. 
With respect to age, the white sub-sample was somewhat older compared to the black and 
Hispanic sub-samples. The Hispanic sub-sample had no participants aged 65 or older. The lack 
of older Hispanic Americans in this sample may be due to a high proportion of older Hispanic 
Americans whose primary language is not English, and who therefore were unable to participate 
in an English-only survey.   An ANOVA was conducted assessing the relationship between race 
and age and notably, there is no statistically significant difference between the three racial 
groups for age (p = .075).  
The ANOVA comparing the three racial groups on educational attainment among sample 
respondents aged 25 years or older indicates a statistically significant difference between the 
three groups.   A greater proportion of the white respondents had a bachelor’s degree or higher 
compared with the Hispanic and black respondents. While 36.1 percent of white respondents had 
attained a bachelor’s or graduate degree, 25.0 percent of Hispanics had attained at least a 
bachelor’s degree and only 15.9 percent of blacks had attained at least a bachelor’s degree. 
Currently, there has not been an examination of the racial and ethnic breakdown of U.S. 
residents’ educational attainment according to the 2010 Census, however according to the 2000 
Census, 27.0 percent of whites and 10.4 percent of Hispanics had a bachelor’s degree or higher. 
Compared to 2000 Census figures, it seems that the white and Hispanic sub-samples were more 





in this sub-sample compared to the proportion of blacks based on the 2000 Census with a 
bachelor’s degree or higher are roughly similar (15.9 percent versus 14.3 percent respectively) 
(Bauman and Graf, 2003). In sum, although the descriptive statistics for the white and black sub-
samples are roughly similar to the proportions found in the general population based on 2010 
U.S. Census figures (with the notable exception of attained educational level for whites), the 
Hispanic sub-sample seemed proportionally to be younger, more female and more educated than 






Table 4.2: Comparison of selected characteristics of Aims 1-3 sample by race for 
individuals 18 or older (n = 411). 
  
Whites 















161 (47.9) 21 (45.7) 11 (37.9) Chi-square  
p-value = .777 
Age     
   18-44 137 (40.8) 22 (47.8) 16 (55.2) ANOVA 
   45 to 64 130 (38.7) 14 (30.4) 13 (44.8) p-value = .075 
   65 and older 
 
70 (20.8) 10 (21.7) 0 (0.0)  
Educational attainment 
among those 25 or older b 
    
    <HS 21 (7.0) 7 (15.9) 2 (8.3) ANOVA 
     HS 144 (47.7) 30 (68.2) 13 (54.2) p-value = .011 
     Associate’s degree 28 (9.3) -- 3 (12.5)  
     Bachelor’s degree 70 (23.2) 5 (11.4) 5 (20.8)  
     Graduate degree 39 (12.9) 2 (4.5) 1 (4.2)  
a Percentages may not always add up to 100 percent due to rounding purposes. 
b The Census only reports educational attainment for individuals aged 25 and older. Total number of respondents 









4.2.2  Measures 
The primary independent variable for Aims 1-3’s analyses is race. The three racial 
categories are white, black and Hispanic. All multiple regression analyses for Aims 1-3 were 
adjusted to control for possible confounding by the following socio-demographic variables: sex, 
age, educational attainment and geographic region (see p. 81 and p. 94 in Chapter 3 for an in-
depth description of the independent variable and covariates).  
The dependent variables that are analyzed in Aims 1-3 are the three RBM beliefs and 
attitudes variables. They are: RBM individual-level effectiveness, RBM behavioral orientation, 
and RBM population-level effectiveness (see pp. 82-85 in Chapter 3 for an in-depth description 
of the three dependent variable measures). 
In addition to the aforementioned independent and dependent variables, the analyses for 
Aim 2 include genetic essentialist beliefs, which is tested as a mediator between race and RBM 
beliefs and attitudes (see p. 90 in Chapter 3 for a description of how genetic essentialist beliefs 
was measured). Aim 3 separately tests explicit racist attitudes and implicit racist attitudes as 
mediators of potential racial differences in RBM beliefs and attitudes (see pp. 91-92 in Chapter 3 
for an in-depth description of how explicit and implicit racist attitudes were measured). 
 
4.2.3  Analyses 
SPSS Version 21.0’s Complex Sampling Module was used to perform the data analysis in 
order to estimate the correct standard errors for the survey data, which has a complex sampling 





analyses were used to assess each specific aim.  The following delineates the analyses for Aims 
1-3.  
Analysis of Aim 1. Several types of analyses were conducted in order to evaluate Aim 1, 
which assesses whether racial groups differ in their beliefs and attitudes regarding RBM 
individual-level effectiveness, behavioral orientation and population-level effectiveness.  First, 
frequencies analyses were conducted on the total sample as a whole and by race. Crosstabulation 
analyses were then conducted to examine the extent to which beliefs about RBM’s effectiveness 
at the individual level is consistent with attitudes towards using RBM. Multiple linear regression 
analyses were then conducted to assess potential racial differences in RBM beliefs and attitudes. 
Table 4.3 outlines the variables used for each Aim 1 regression analysis.  Models 1, 3 and 5 
tested whether there are differences in RBM beliefs among black and Hispanic respondents 
compared with white respondents by regressing each of the dependent variables on the race 
dummy variables as well as the control variables (sex, education, age and geographic region).   
Models 2, 4 and 6 tested to see if race interacts with any of the socio-demographic 
control variables. Before these models were analyzed, I first tested to see if the total set of 
interactions as a group was significantly associated with each of the RBM dependent variables.  
The interaction terms are race by each socio-demographic variable other than geographic region 
(i.e. black or Hispanic by gender, education and age).  For each RBM dependent variable, I 
constructed two multiple regression models to examine the set of interactions’ overall effect on 
RBM beliefs and attitudes.  The first model (“No Interactions”) only included all of the socio-
demographic variables that are potentially associated with RBM beliefs and attitudes.  Those 





(male = 1), education, age and geographic region (Northeast, Midwest, South, Rocky 
Mountain/Southwest, West, and Southeast, the last of which is the referent category).  In the 
second model (“Interactions”), I added the interaction terms – black*male, black*education, 
black*age, Hispanic*male, Hispanic*education, and Hispanic*age – to the variables used in the 
No Interactions model.  I then compared the R2 values for both models by subtracting the R2 
value for the No Interactions model from R2 for the Interactions model to evaluate whether 
overall the interactions had an effect on RBM individual-level effectiveness, behavioral 
orientation and population-level effectiveness.  R2 attributable to the interactions was calculated 
as: 
R2-change = R2Interactions - R2No Interactions   
If R2-change was significant for a particular RBM dependent variable, then the individual 
interaction term estimates would be examined.  The rationale for examining the interaction 
models was to see if there were additional social differences between racial groups. If interaction 
effects were found to be statistically significant between race and the socio-demographic 
variables, race-specific multiple regression analyses were then conducted to examine how each 
of the socio-demographic control variables may differentially be related to the dependent 








Table 4.3: Variables used in Aim 1 multiple regression models. 
Variable Type Models 1, 3, 5 Models 2, 4, 6 Models 7-9 
(Race-Specific Models) 














Race Race Socio-demographic variables 
Covariates 
 
Socio-demographic variables a Socio-demographic 
variables 
-- 





 The socio-demographic control variables are sex, education, age and geographic region. 
 
Analysis of Aim 2. Multiple linear regression was used to analyze Aim 2, which tests 
genetic essentialist beliefs as a mediator between race and RBM individual-level effectiveness, 
behavioral orientation, and population-level effectiveness beliefs and attitudes. First, I tested to 
see whether there are racial differences in genetic essentialist beliefs by regressing genetic 
essentialist beliefs on the race dummy variables and the socio-demographic control variables. If 
racial differences were found for genetic essentialist beliefs, then genetic essentialist beliefs was 
only tested as a mediator for the RBM dependent variables for which racial differences were 
found in Aim 1. The analysis of Aim 2 follows Baron and Kenny’s (1986) steps for testing 
mediation effects (see Table 4.4, Models 10-12). In these analyses, socio-demographic variables 






Table 4.4: Variables used in Aim 2 multiple regression models. 
Variable Type Model 10 Model 11a Model 12 








Independent Variable Race Race Race 
Covariates Socio-demographic controls b Socio-demographic controls Socio-demographic controls 
Mediator -- -- Genetic essentialist beliefs 
a
 Note, Model 11 is the same as Table 4.3’s Models 1, 3, 5. 
b
 The socio-demographic control variables are sex, education, age and geographic region. 
 
Analysis of Aim 3. In this aim, implicit racist attitudes and explicit racist attitudes were 
tested as mediators between race and the RBM dependent variables.  Both attitudinal constructs 
were tested as mediators for only the white and Hispanic respondents and both were only 
analyzed if whites were significantly more likely than Hispanics to endorse RBM individual-level 
effectiveness, behavioral orientation and/or population-level effectiveness in Aim 1. Baron and 
Kenny’s (1986) steps for testing mediation effects were again followed and socio-demographic 
variables that were found to be significant in the Aim 1 multivariate analyses were controlled 









Table 4.5: Variables used in Aim 3 multiple regression models. 
Variable Type Model 13 Model 14 a Model 15 
Dependent Variables Implicit Racist Attitudes/ 









Independent Variable Race  Race Race 
Covariates Socio-demographic controls b Socio-demographic controls Socio-demographic controls 
Mediators -- -- Implicit Racist Attitudes/ 
Explicit Racist Attitudes 
a
 Note, Model 14 is the same as Table 4.3’s Models 1, 3, 5. 
b
 The socio-demographic control variables are sex, education, age and geographic region. 
 
 
4.3  Results: 
4.3.1  Aim 1: Beliefs and Attitudes towards Race-Based Medicine  
4.3.1.1  Race-Based Medicine Individual-Level Effectiveness 
Table 4.6 presents frequencies for beliefs and attitudes towards RBM among the total 
sample. It shows that 38.5 percent of the total sample agreed with the belief that RBM is 
effective at the individual level, while 11.9 percent neither agreed nor disagreed with this belief, 
and 49.6 percent disagreed (total sample mean = 2.35, SE = .048). The results show that a 
majority of the respondents do not believe RBM is effective at the individual level.  
Table 4.6 also presents the frequencies for RBM individual-level effectiveness belief by 
race; the similar percentages of whites, blacks and Hispanics who agreed, disagreed or neither 





there is no association between race and this belief. Like the sample as a whole, the majority of 
white, black and Hispanic respondents do not believe RBM is effective at the individual level.  
Table 4.6:  Agreement/disagreement with RBM belief statements for total sample and by 
race/ethnicity. 
Dependent variables Total, % Whites, % Blacks, % Hispanics, % 
Race-based medicine is effective at 
individual level 
(n = 403) (n = 330) (n = 45) (n = 28) 
       Agree 38.5 38.8 37.8 39.3 
       Neither agree nor disagree 11.9 11.2 17.8 7.1 
       Disagree 49.6 50.0 44.4 53.6 
Prefer to use race-based medicine  (n = 402) (n = 329) (n = 45) (n = 28) 
       Strongly/somewhat agree 68.2 69.0 64.4 64.3 
       Strongly/somewhat disagree 31.8 31.0 35.6 35.7 
Race-based medicine is effective at 
population level 
(n = 403) (n = 329) (n = 45) (n = 29) 
       Strongly/somewhat agree 35.7 31.9 51.1 55.2 
       Strongly/somewhat disagree 64.3 68.1 48.9 44.8 
Note. All reported results are weighted. 
 
A multiple linear regression analysis of RBM individual-level effectiveness regressed on 
race, controlling for sex, age, education and geographic region was conducted to examine 





Standardized regression estimates (see Table 4.7, Model 1) confirm that there is no statistically 
significant difference among whites, blacks and Hispanics for RBM individual-level 
effectiveness belief. 
It should be noted that despite the lack of an association between race and RBM 
individual-level effectiveness belief, there were statistically significant associations between 
RBM individual-level effectiveness and both sex and education (Table 4.7, Model 1). Males 
were significantly more likely than females to believe that RBM is effective at the individual 
level (p < .05). Meanwhile, a positive association between education and RBM individual-level 
effectiveness indicates that the greater the educational attainment level of respondents, the more 
likely they were to believe RBM is effective at the individual level (p < .10). 
R2-change was then calculated for the RBM individual-level effectiveness multiple linear 
regression model that compared the effect of the race by socio-demographic variables interaction 
terms as a set with the model that did not have interactions. R2-change was statistically 
significant (p < .01), indicating that the interaction terms as a set have a significant effect on 
RBM individual-level effectiveness. Possible interaction effects between race and the socio-
demographic variables for RBM individual-level effectiveness belief were then examined in 
order to assess whether there were sex, age or education differences in associations with RBM 
individual-level effectiveness between racial groups. Table 4.7’s Model 2 shows significant 
interactions between the Hispanic dummy variable and both sex and age for RBM individual-
level effectiveness belief.  Race-specific regression analyses were conducted for RBM 
individual-level effectiveness to further explore these interactions. Table 4.8 presents the results 





socio-demographic control variables and the RBM dependent variables. The results from Model 
7 in Table 4.8 indicate that Hispanic men are more likely than Hispanic women to believe RBM 
is effective at the individual level (p < .10). Among whites, men also seem to be more likely than 
women to believe RBM is effective at the individual level (p < .10), although the magnitude of 
the estimate for whites was substantially less than that for the Hispanic sample. Black men and 
women did not differ in their beliefs about RBM individual-level effectiveness. 
Model 7 also shows that among whites (p < .10) and blacks (p < .05), education was 
positively associated with RBM individual-level effectiveness, indicating that the higher the 
educational-level background of white respondents, the more likely they were to endorse RBM 
individual-level effectiveness. There was no association between education and RBM individual-
level effectiveness among Hispanic respondents. 
Finally, the results show that the older Hispanic respondents were, the less likely they 
were to endorse RBM individual-level effectiveness beliefs (p <. 001), but there was no 
association between age and RBM individual-level effectiveness beliefs among the white and 
black respondents.  
Although race was not significantly associated with RBM individual-level effectiveness 
belief, a closer examination of potential interactions between race and other covariates in the 
model indicated that Hispanic and white respondents significantly differed in their associations 
between both sex and age and RBM individual-level effectiveness. Between whites and blacks, 
however, there did not seem to be any sex or age differences in RBM individual-level 
effectiveness belief. In addition, although there was a significant positive association between 





among Hispanics, the association among whites was not significantly different compared with 
Hispanics.  
Hypothesis 1 stated that there would be racial differences in RBM individual-level 
effectiveness belief such that whites would be more likely to endorse RBM individual-level 
effectiveness than blacks and Hispanics. While whites and blacks did not significantly differ in 
this belief, whites and Hispanics did significantly differ in so far as the associations between sex 
and age with RBM individual-level effectiveness for these two groups. Despite differences found 
between whites and Hispanics, the evidence does not indicate that overall, whites are more likely 
to endorse RBM individual-level effectiveness. Thus, Hypothesis 1 does not seem to be 






Table 4.7:  Standardized regression estimates for RBM beliefs and attitudes (n = 399). 
 
Independent variables 
Race-based medicine is 
effective at individual 
level 
Prefer to use race-based 
medicine 
Race-based medicine is 
effective at population 
level 


















































































































































Black*Male - -.171  
(.256) 
- -.430  
(.499) 
- .591  
(.350) 




- .797  
(.790) 
Black*Education - .059  
(.087) 
- .154  
(.164) 
- -.004  
(.102) 
Hispanic*Education - .047  
(.116) 
- -.092  
(.173) 
- .195  
(.138) 
Black*Age - .007  
(.009) 
- -.012  
(.016) 
- .024  
(.012)† 




- -.035  
(.020) 
R2 .046 .102 .045 .133 .086 .132 













is effective at 
individual level 
Prefer to use race-
based medicine 
Race-based medicine 








Male    
      White a .196 (.102)† .079 (.122) .062 (.107) 
      Black b -.123 (.223) -.423 (.514) .407 (.368) 
      Hispanic c 1.014 (.478)† 2.281 (.548)** 1.931 (.662)* 
Education    
      White  .048 (.026)† .069 (.032)* -.019 (.027) 
      Black .186 (.068)* .332 (.168)† .051 (.104) 
      Hispanic .180 (.123) .106 (.186) .079 (.151) 
Age    
      White .003 (.003) .011 (.003)** .004 (.003) 
      Black .009 (.007) .005 (.014) .023 (.011)† 
      Hispanic -.046 (.015)* -.042 (.020)† -.035 (.022) 
†P < .10, *P < .05, **P < .01, ***P < .001. Note: All reported results are weighted.  SE = standard error.   
a n for the white sample is 328.  b n for the black sample is 43.  c n for the Hispanic sample ranged from 28 to 29.  
 
4.3.1.2  Race-Based Medicine Behavioral Orientation 
Although the majority of the total sample of respondents, as well as white, black and 
Hispanic respondents, did not believe that RBM would be effective at the individual level, Table 
4.6 shows that the majority of the sample’s respondents (68.2 percent) indicated a preference for 





.068).  Because the proportion of respondents who positively indicated a preference for using 
RBM was so much greater than the proportion of those who endorsed RBM individual-level 
effectiveness, a crosstabulation analysis of RBM individual-level effectiveness by RBM 
behavioral orientation (Table 4.9) was undertaken to identify the proportion of respondents who 
do not believe RBM is effective at the individual level but would nonetheless prefer to use RBM 
if it was an available form of treatment.  Table 4.9 shows that of the 200 respondents who 
disagreed with the belief that RBM is effective at the individual level, 83 either somewhat or 
strongly agreed with the attitude that they would prefer to use RBM. This means that 41.5 
percent of those individuals who do not believe RBM would be effective at the individual level 
would still prefer to use RBM if it was available. 
Table 4.9: Crosstabulation of race-based medicine is effective at individual level by 
preference to use race-based medicine if it is available (n = 402). 
 
 




Race-based medicine is effective at the individual level 
 
Agree  




nor disagree  












146 (94.8) 44 (91.7) 83 (41.5) 273 (67.9) 
Strongly/somewhat 
disagreed 
8 (5.2) 4 (8.3) 117 (58.5) 129 (32.1) 






Model 3 in Table 4.7 (p. 137) is a multiple linear regression analysis of the relationship 
between race and RBM behavioral orientation, adjusted for sex, education, age and geographic 
region. The results of the model show that there is no association between race and behavioral 
orientation. In order to see if potential interaction effects between race and the socio-
demographic variables as a set had an effect on RBM behavioral orientation, R2-change was 
calculated between the multiple linear regression models that included and excluded the 
interaction terms. R2-change indicated that the set of interactions had a significant effect on 
RBM behavioral orientation (p < .01). Potential interaction effects between race and sex, 
education and age were then examined in order to identify which of the associations between 
RBM behavioral orientation and the latter three socio-demographic variables differed among 
white, black and Hispanic respondents. Model 4 in Table 4.7 (p. 137) shows statistically 
significant interaction associations between the Hispanic dummy variable and both sex and age, 
indicating that the relationship between sex and behavioral orientation, as well as age and 
behavioral orientation, are different between Hispanics and whites. Race-specific model results 
in Table 4.8 (p. 138) show that like RBM individual-level effectiveness, Hispanic males were 
more likely than Hispanic females to prefer the use of RBM (p < .01), but there was no 
significant difference between white males and females or black males and females.  
Education and RBM behavioral orientation were significantly associated among whites 
such that as educational attainment level increased, whites were more likely to prefer to use 
RBM. This also seemed to be the case for blacks (p < .10) but not for Hispanics. 
The race-specific RBM behavioral orientation models also show that as age increased for 





for white respondents, they were more likely to prefer to use RBM (p  < .01). There was no 
association between age and RBM behavioral orientation among black respondents. 
Although the Aim 1 results show no overall racial differences for RBM behavioral 
orientation, upon closer examination, the interaction models and race-specific multiple linear 
regression models show some differences, particularly between whites and Hispanics. However, 
because the results do not show that whites are more likely to prefer to use RBM than blacks and 
Hispanics, the results do not show support for Hypothesis 1 with respect to RBM behavioral 
orientation.  
  
4.3.1.3  Race-Based Medicine Population-Level Effectiveness 
Similar to the RBM individual-level effectiveness results for the total sample, the results 
presented in Table 4.6 show that only a minority of respondents (35.7 percent) believe in the 
possibility of RBM being effective at reducing population-level disparities (total sample mean = 
2.20, SE = .061). Unlike the findings for RBM individual-level effectiveness and behavioral 
orientation, Table 4.6 shows that there were differences in RBM population-level effectiveness 
belief among the three racial groups. While only 31.9 percent of whites sampled in the study 
believe RBM would reduce health inequalities, 51.1 percent of black respondents and 55.2 
percent of Hispanic respondents agreed with this belief. Multiple linear regression was used to 
examine whether race is significantly associated with RBM population-level effectiveness. After 
adjusting for sex, education, age and geographic region (Table 4.7, Model 5), positive 
associations were found for both the black and Hispanic variables (p < .05), indicating that both 





Sex, education, age and geographic region were not significantly associated with RBM 
population-level effectiveness belief.  
In order to see if potential interaction effects between race and the socio-demographic 
variables as a set had an effect on RBM population-level effectiveness, R2-change was calculated 
between the multiple linear regression models that included and excluded the interaction terms. 
R2-change indicates that the set of interactions had a significant effect on RBM population-level 
effectiveness (p < .01).  The individual interaction term estimates were then examined to see 
which socio-demographic variables were differentially associated with RBM population-level 
effectiveness by race.  The regression model shows possible associations between the black 
dummy variable and both gender (p < .10) and age (p < .10) for RBM population-level 
effectiveness.  
Race-specific regression analyses for whites and blacks (Table 4.8, Model 9), however, 
showed that there was no significant association between gender and RBM population-level 
effectiveness for whites or blacks, but there was a significant association among Hispanics 
indicating that males were more likely than females to believe that RBM has the potential to 
improve health inequalities (p < .05). With respect to the race by age interaction effect, there was 
no significant association between age and beliefs about RBM’s effect on health inequalities 
among white respondents. There was, however, a positive association for black respondents (p < 
.10), indicating that the older the black respondents were the more likely they were to believe 
that RBM would reduce population-level health inequalities.   
In sum, Hispanics and blacks differed from whites in their belief that RBM would be 





not in the expected direction. Thus, Hypothesis 1 is not supported for RBM population-level 
effectiveness. 
 
4.3.1.4  Summary of Aim 1 Results 
For Aim 1, I hypothesized that whites would be more likely than blacks and Hispanics to 
endorse RBM individual-level effectiveness, behavioral orientation and population-level 
effectiveness beliefs and attitudes. The results from this study indicate that there are no overall 
racial differences in endorsement levels of RBM individual-level effectiveness and behavioral 
orientation, however, interaction effects were found between the Hispanic dummy variable and 
sex and age for both dependent variables. Hispanics significantly differed from whites with 
respect to the relationship between sex and age and the two aforementioned RBM dependent 
variables, indicating tangential support for Hypothesis 1 with respect to the existence of 
differences between whites and Hispanics for these two RBM dependent variables. However, I 
could not conclude that whites overall were more likely than Hispanics to endorse these beliefs 
and attitudes.  
Despite the lack of overall racial differences for these two RBM dependent variables, 
racial differences were found for RBM population-level effectiveness belief, although not in the 
expected direction. Hypothesis 1 proposed that whites would be more likely than blacks and 
Hispanics to endorse RBM population-level effectiveness, however, the results indicated the 
opposite – white respondents were less likely than blacks and Hispanics to believe that RBM 





that there are some racial differences in RBM beliefs and attitudes, although not in the expected 
directions.  
 
4.3.2  Aim 2: Genetic Essentialist Beliefs as Potential Mediator 
The purpose of Aim 2 is to examine whether genetic essentialist beliefs help explain 
racial differences in RBM beliefs and attitudes, but only for RBM dependent variables for which 
overall racial differences were found in Aim 1. Because overall differences were found between 
whites, blacks and Hispanics for RBM population-level effectiveness (even though they were not 
in the expected direction), Aim 2 analyses are warranted.  
Table 4.10 (p. 145) presents race-specific frequencies for genetic essentialist beliefs.  The 
frequencies analysis shows 6 percent of whites, 7 percent of blacks, but no Hispanics indicated 
that genes are the most important factor for determining both health and intelligence.  Thirty-four 
percent of whites, 33 percent of blacks and 19 percent of Hispanics indicated that genes were the 
most important factor in determining either health or intelligence, but not both.  Sixty percent of 
whites, 61 percent of blacks and 81 percent of Hispanics did not believe genes were the most 
important factor in determining either health or intelligence.  A multiple linear regression model 
was then constructed where genetic essentialist beliefs, an index variable based on two items (see 
p. 90 in Chapter 3 for description), was regressed on race and adjusted for sex, education, age 
and geographic region.  Table 4.11 (p. 146) shows that whites were significantly more likely than 
Hispanics to endorse genetic essentialist beliefs (p < .05). Black and white respondents, however, 
























(% of total 
respondents) 



























Does not believe 
genes are most 
























Table 4.11: Standardized regression estimates for genetic essentialist beliefs regressed on 




Genetic essentialist beliefs 
Model 10 
β (SE) 
Intercept .025 (.249) 
Black .021 (.151) 
Hispanic -.231 (.100)* 
Male .008 (.076) 
Education .016 (.020) 
Age .003 (.002) 
Northeast .161 (.120) 
Midwest .158 (.131) 
South .109 (.113) 
Rocky Mountain/Southwest .163 (.167) 
West .297 (.140)* 
†P < .10, *P < .05, **P < .01, ***P < .001.  
 
According to Baron and Kenny’s steps for testing mediation effects, because there was a 
statistically significant race-specific difference in genetic essentialist beliefs, genetic essentialist 
beliefs can be tested as a mediator between race and RBM population-level effectiveness. Table 
4.12’s Model 11 shows the regression estimates for RBM population-level effectiveness belief 





Hispanics were significantly more likely to endorse RBM population-level effectiveness. Table 
4.12’s Model 12 shows the results of testing genetic essentialist beliefs as a mediator between 
race and RBM population-level effectiveness.  The results show that the addition of genetic 
essentialist beliefs into the regression model only slightly attenuates the association between the 
Hispanic dummy variable and the black dummy variable and RBM population-level 
effectiveness.  Genetic essentialist beliefs was not significantly associated with RBM population-
level effectiveness (β = .023, SE = .089).  Baron and Kenny note that in order for a variable to be 
a mediator between two other significantly associated variables, the mediator must also be 
significantly associated with the dependent variable.  Because this is not the case for genetic 
essentialist beliefs and RBM population-level effectiveness, the results indicate that genetic 
essentialist beliefs do not mediate the association between race and RBM population-level 






Table 4.12: Multiple linear regression estimates testing genetic essentialist beliefs as a 
mediator between race and RBM population-level effectiveness. 
Independent 
Variables 
RBM population-level effectiveness 
regressed on race 
(n = 399) 
RBM population-level 
effectiveness regressed on race 
and genetic essentialist beliefs 








Intercept 1.917 (.332)*** 2.097*** (.075) 
Black .492 (.224)* .449 (.255)† 
Hispanic .679 (.327)* .627 (.321)† 
Male .137 (.110) -- a 
Education -.011 (.028) -- 
Age .005 (.003) -- 
Northeast .284 (.190) -- 
Midwest -.062 (.148) -- 
South -.169 (.192) -- 
Rocky 
Mountain/Southwest 
-.082 (.189) -- 
West .178 (.207) -- 
Genetic essentialist 
beliefs 
-- .023 (.089) 
†P < .10, *P < .05, **P < .01, ***P < .001. 
a
 Male, education, age and geographic region dummy variables were removed as covariates from Model 12 









4.3.3  Aim 3: Explicit and Implicit Racist Attitudes as Potential Mediators 
Aim 3 examines whether implicit racist attitudes and/or explicit racist attitudes mediate 
any significant associations between race and RBM individual-level effectiveness, behavioral 
orientation and/or population-level effectiveness beliefs. It should be noted that both the implicit 
racist attitudes and explicit racist attitudes constructs examine racist attitudes towards blacks, 
therefore, only white and Hispanic respondents would be included in this analysis.  I had 
proposed that this aim would only be examined if white respondents were found to endorse at 
least one of the three RBM-related dependent variables at greater levels than the black and 
Hispanic respondents in Aim 1.  Because whites did not endorse any of the RBM-related 
dependent variables at significantly greater levels than blacks and Hispanics, Aim 3 analyses 
were not warranted.  
 
4.4  Discussion 
The development of RBM continues to be a controversial endeavor in the U.S.  Many 
within the academic and clinical communities question the effectiveness of race-specific 
treatments and are concerned with numerous negative consequences, such as the 
(re)geneticization of race and its various social and political implications (Foster et al., 2001; 
Duster, 2005; Kahn, 2006; Ng et al., 2008; Phelan, Link and Feldman, 2013). However, there is 
scant knowledge about the American public’s beliefs and attitudes regarding RBM, both for the 
population as a whole and by the race and ethnicity of individuals. As the biomedical industry 





and attitudes, since public conceptions about RBM’s effectiveness could impact its acceptance 
and usage.  
 
4.4.1 Lay Beliefs about RBM’s Individual-Level Effectiveness and Preferences for Using 
RBM 
The results of this study show that a majority of respondents overall do not believe RBM 
is effective at either the individual or population levels. Despite these beliefs, a majority of the 
public would prefer to use race-specific drugs if they were available. One possible reason for this 
inconsistency between beliefs and behavior is that a portion of respondents who indicated a 
preference for using RBM would instead prefer either treatment based on individualized genetic 
testing or the usual course of treatment, if such options had been presented in our survey (Bevan 
et al., 2003). The substantial number of respondents who indicated a preference for using RBM 
even if they didn’t believe it was effective, however, could also reflect a desire to try treatments 
with potentially significant benefits, even if one’s initial instinct is to believe such treatments do 
not work.  It is also possible that some of the respondents, based on things that they have heard 
or learned over the years, may be socialized to believe that RBM is ineffective or otherwise 
“bad”, but when it comes down to making a concrete decision that they think would benefit 
them, they do not apply this acquired attitude to their behaviors.  The inconsistency between 
belief and behavior may also result from some respondents believing RBM is an attractive idea, 
but seemingly abstract.   
Another reason that could explain this inconsistency is the possibility that racial concepts 
can be situational or context-driven.  Morning (2009), in her study examining various 





respondents’ racial concepts was extremely sensitive to the measurement technique that was 
used. Racial concepts shifted depending on whether respondents answered open-ended questions 
asking them to define race, responded to true/false statements about race, or provided 
explanations for two real-life racial differentials.  Although only one type of measurement 
technique was used in this dissertation study of RBM-related beliefs and attitudes, it is possible 
that some respondents’ beliefs and attitudes are situationally affected, resulting in responses to 
belief items about the larger population that diverged from responses for a specific situation 
involving their own personal behavior.  
 The inconsistency between RBM beliefs and behavioral orientation was also seen in a 
previous U.S.-based study that found the majority of its respondents to be “suspicious” about 
RBM, but with a portion noting they would still use it if it was available (Bevan et al., 2003; 
Lynch & Dubriwny, 2006). Lynch and Dubriwny (2006) contend this inconsistency can be 
explained by their “double bind” theory that some individuals, in particular racial and ethnic 
minorities, dispute a genetic basis for race, however, their racial/ethnic identification places them 
in a double bind between choosing to use RBM — which may imply what they are disputing — 
or forgoing use of RBM, which could be perceived as denying their racial identity.  Racial or 
ethnic identification is a way for individuals to find common cause and to be socialized into the 
associated group’s culture (Lynch & Dubriwny, 2006).  Studies have shown that blacks have a 
greater degree of racial-ethnic identification than whites, which can explain why actions that 
could be perceived as denying one’s racial identity are often discouraged (Allen, Howard, & 
Grimes, 1997; Coard, Breland, & Raskin, 2001).  Therefore, although choosing to use or not use 
RBM each comes with perceived negative consequences for some people, ultimately, some will 





The discordant finding between RBM individual-level effectiveness belief and behavioral 
intentions is an important finding for which drug makers and providers should take note. Despite 
potentially negative public opinions towards RBM and its development, this finding suggests 
that there is an incentive for drug makers to continue to develop and market RBM because for 
the moment, the findings from this study indicate a large market of consumers who would be 
willing to use RBM.  
Hypothesis 1 contended that whites would be more likely to endorse RBM-related beliefs 
and attitudes since prior qualitative research (Bevan et al., 2003) indicated such differences exist. 
However, the results from this study did not support the hypothesis that blacks and Hispanics are 
less likely to endorse the belief that RBM is effective at the individual level and less likely to 
prefer to use RBM if it was available. Nearly equal proportions of whites, blacks and Hispanics 
agreed with the belief that RBM would be effective at the individual level (respectively, 38.5 
percent, 38.8 percent and 37.8 percent agreed with this belief). In addition, nearly equal 
proportions of whites, blacks and Hispanics agreed with the attitude that they would prefer to use 
RBM if it was available, with approximately two-thirds of each of the three racial groups 
indicating a preference to use RBM (69.0 percent of whites, 64.4 percent of blacks, and 64.3 
percent of Hispanics).  
Although no overall racial differences were found for RBM individual-level effectiveness 
and behavioral orientation, the findings show that sex moderates the relationship between race 
and both dependent variables. Hispanic males were more likely to believe RBM is effective at 
the individual level and more likely to prefer using RBM than Hispanic females, but no 





(although there seemed to be a trend that white males were more likely to endorse RBM 
individual-level effectiveness than white females). These interaction effects somewhat diverge 
from Bevan and colleagues’ study (2003) that found an interaction between sex and ethnicity in 
suspicions about RBM. In their study, Hispanic males were more suspicious about RBM than 
other ethnic and sex groups while European American males were the least suspicious. The 
reasons that could explain the sex differences between Hispanics, blacks and whites in this study 
are unclear, however, these differences suggest potential barriers to the widespread use of RBM, 
including different levels of willingness to use RBM by different populations, even though 
differences were not found overall by racial group.   
The focus of this analysis was race, however notably, some non-race-specific social 
differences were found, including a positive association between education – an important 
indicator of socioeconomic status – and both RBM individual-level effectiveness and behavioral 
orientation. The greater the educational level of respondents, the more likely they were to believe 
RBM is effective at the individual level and/or to prefer to use RBM. A possible explanation for 
these associations could be that genetic causal beliefs for extant inequalities resonate most 
strongly among those who occupy socially privileged positions because such beliefs can justify 
social hierarchies (Jayaratne et al., 2006; Nelkin & Lindee, 1995). Although RBM is not 
necessarily a genetic treatment, it implies genetic differences between racial groups. Notably, 
these results are in contrast to Shostak and colleagues’ (2009) finding that the socioeconomically 
advantaged were not more likely to endorse the belief that genetic make-up is important in 





An alternative, and potentially more plausible, explanation for the positive association 
between education and RBM individual-level effectiveness belief and behavioral orientation 
could be that higher educational attainment is associated with greater positive attitudes towards 
new scientific technologies, since there is evidence to suggest that greater scientific knowledge is 
associated with more positive attitudes towards science in general (Einsiedel, 1994; Evans & 
Durant, 1995). A test of this latter theory is beyond the scope of this study, but warrants further 
attention in future studies.  
It should be noted that a previous focus group study did find a main effect for race in data 
examining suspicious attitudes towards RBM (Bevan et al., 2003). This study found that African 
American, Hispanic and multiracial American participants were more “suspicious” of RBM than 
European American focus group participants.  Despite the many benefits associated with 
qualitative research data, the external generalizability of qualitative data findings is limited, 
therefore, one aim of this dissertation study was to examine whether such racial differences in 
RBM beliefs held up in an analysis of data collected from a nationally representative sample of 
Americans. The results of this study conflict with the prior qualitative study that found racial 
differences in RBM beliefs and attitudes (although it should be noted that the dependent 
variables in this study were slightly different than those used in the other study). This study’s 
findings suggest that in the U.S., whites, blacks and Hispanics may in fact hold similar overall 
beliefs and attitudes regarding the individual-level effectiveness of RBM and preferences for 
using RBM. Thus, concerns regarding differential acceptance levels of RBM by race/ethnicity, 
particularly lower acceptance among minority populations, may not be warranted (Bevan et al., 





4.4.2  Lay Beliefs about RBM and Health Inequalities  
Although there do not seem to be overall racial differences in RBM-related individual-
level effectiveness and behavioral orientation beliefs and attitudes, both black and Hispanic 
Americans endorsed to a greater extent than white Americans the belief that RBM would be 
effective at the population level.  In the ongoing debate over how to address growing health 
inequalities between minority and non-minority populations, this is an important public opinion 
finding that should be considered within the larger debate. Robert and Booske (2011) recently 
found that racial and ethnic minorities in the U.S. were more likely than non-Hispanic whites to 
believe that nearly all potential causes of individual-level health status (ranging from access to 
affordable health care, to stress, to having a job, to where a person lives) had strong influences 
on health status. Expanding on this finding, if racial and ethnic minority populations in the U.S. 
are more likely to believe that many, if not most, of the identified causal factors associated with 
health have strong influences on health status, then it is possible that these populations also 
believe that most of these identified causal factors have strong influences on the production of 
health inequalities.  This would be because less access to health-promoting causal factors of 
health status, and greater exposure to illness and disease-related causal factors combined should 
lead to population-level health inequalities.  Consequently, these beliefs may also make blacks 
and Hispanics more inclined to believe that greater availability of/access to treatments tailored to 
specific racial and ethnic populations would have a strong influence on reducing health 
inequalities, even if their instinct is to believe that such treatments should not work (as evidenced 
by low frequencies of blacks and Hispanics who believed RBM would be effective at the 





In this debate over identifying and implementing effective strategies to reduce health 
inequalities, public opinion from the populations that are disproportionately burdened with 
poorer health statuses and outcomes needs to be assessed in order to garner public support for 
identified strategies. If a majority of racial and ethnic minority populations are likely to believe 
that RBM could reduce health inequalities, then it is quite possible that they would be as likely – 
or more likely – than whites to support RBM as a tactic to reduce health inequalities.   
It should be noted that RBM has had a limited presence in the delivery of healthcare 
services, and although RBM knowledge levels were not assessed in this study, it would be 
reasonable to assume that the majority of the lay public is unfamiliar with the concept of RBM. 
Should the healthcare industry decide to promote RBM as a strategy for addressing racial and 
ethnic health inequalities, there will likely be efforts on both sides of the debate to better educate 
the public about RBM. Depending on which side of the debate is more effective at 
communicating its messages about RBM, these efforts could influence in different directions 
beliefs about RBM’s effectiveness at the individual- and population-levels and behavioral 
orientations towards using RBM. 
 
4.4.3  Factors Associated with Racial Differences in RBM Beliefs 
The purpose of Aims 2 and 3 was to examine factors that may help explain any racial 
differences found for RBM individual-level effectiveness, behavioral orientation and/or 
population-level effectiveness beliefs and attitudes.  Genetic essentialist beliefs and implicit and 
explicit racist attitudes were proposed as potential mediators of associations between race and 





variables for which racial differences were actually found (in the case of Aim 2) or if whites 
specifically were found to endorse one or more of the RBM-related dependent variables at 
greater levels than blacks and Hispanics (in the case of Aim 3). Because race was significantly 
associated with only RBM population-level effectiveness, genetic essentialist beliefs was 
examined as a mediator for only this dependent variable. The results show that while there was a 
significant difference between white and Hispanic respondents for genetic essentialist beliefs, it 
was not a mediator of racial differences found for RBM population-level effectiveness. Implicit 
and explicit racist attitudes were not examined because whites were not found to endorse RBM 
individual-level effectiveness, behavioral orientation or population-level effectiveness at greater 
levels than blacks or Hispanics. 
It should be noted that genetic essentialist beliefs and explicit and implicit racist attitudes 
were proposed as potential mediators between race and the RBM dependent variables because of 
prior research demonstrating that many non-Hispanic white Americans believe there is at least 
some genetic basis to race, and, research associating belief in biological/genetic differences 
between races with racist attitudes (Jayaratne et al., 2006; Kinder & Sanders, 1996; Keller, 2005; 
Sheldon, Jayaratne & Petty, 2007).  Because there is the belief among some scientists and 
members of the lay public who are familiar with RBM that its effectiveness is based on its ability 
to address biological or genetic differences between racial groups, this dissertation study 
hypothesized that genetic essentialist beliefs, explicit racist attitudes and implicit racist attitudes 
may therefore be mediators of possible racial differences among the lay public in RBM beliefs 
and attitudes. However, because there was no racial difference in beliefs about RBM’s 
effectiveness at the individual level, it seems possible that differences in beliefs about RBM’s 





could effectively treat entire populations of patients than belief differences regarding the 
effectiveness of all different types of population-level interventions for addressing health 
disparities. Simply put, blacks and Hispanics may differ from whites in their beliefs about the 
effectiveness of most previous and current efforts to address racial and ethnic health disparities, 
and consequently, such belief differences would not be modified by RBM as a strategy to 
address health disparities regardless of whether these groups believe RBM is clinically effective. 
This may explain why genetic essentialist beliefs were not found to be a mediator of racial 
differences in RBM population-level effectiveness belief, and why testing racist attitudes as a 
possible mediator was not even warranted.  
Alternatively, the term “health inequalities” may in and of itself be a concept with which 
there are differing levels of familiarity or understanding within the general population.  Because 
this concept was not defined to the survey participants, it is also possible that racial differences 
in RBM population-level effectiveness belief reflect racial differences in familiarity with the 
concept of health inequalities more so than differences in beliefs about RBM’s potential 
effectiveness at reducing health inequalities. 
 
4.4.4  Why don’t whites and blacks differ more? 
It should be noted that the only significant racial difference that was found was between 
whites, blacks and Hispanics for only RBM population-level effectiveness. The majority of both 
black and white respondents did not believe RBM would be effective at the individual level, but 
the majority of both groups indicated they would prefer to use RBM if it was available. The lack 





beliefs and behavioral orientation is surprising in light of the known differences between these 
two groups on many race-related beliefs, attitudes and policies (Bobo & Charles, 2009; Schoen, 
2012). Prior qualitative research on RBM-related beliefs and attitudes had also suggested that 
black-white differences would be found for RBM individual-level effectiveness and behavioral 
orientation in this study (Bevan et al., 2003; Condit et al., 2003; Marco, 2010). A simple 
explanation for the lack of difference between whites and blacks in this study could be that the 
black sample was relatively small and a larger sample perhaps would have found racial 
differences. Alternatively, it is possible that a lack of knowledge about RBM among most 
Americans regardless of race resulted in the limited diversity in beliefs about and attitudes 
towards RBM.  
However, if sample size and RBM knowledge levels were not meaningful limitations to 
the study, then it seems that white and black Americans indeed hold similar beliefs about and 
attitudes towards RBM.  One consequence of this is that industry-based RBM proponents may 
find a generally receptive patient population for the delivery of RBM.  However, it is possible 
that armed with more information, particularly information regarding the potential clinical, 
ethical and social costs and benefits associated with RBM, whites and blacks would begin to 
diverge in their beliefs and attitudes. Therefore, future research should consider assessing RBM 
knowledge levels, and if possible, the implications of an intervention that examines RBM beliefs 
and attitudes after respondents are exposed to varied pieces of information about RBM’s clinical, 
ethical and social costs and benefits. Ultimately, RBM proponents’ concerns about non-white 
populations’ receptiveness to using RBM may be unwarranted.  Meanwhile, RBM opponents 
may need to implement interventions to better communicate concerns associated with RBM if 






PART 2: VIGNETTE EXPERIMENT’S EFFECTS ON RACE-BASED 
MEDICINE BELIEFS AND ATTITUDES 
 
5.1 Introduction 
The previous chapter’s analysis of data examining beliefs about the effectiveness of RBM 
and attitudes towards using RBM indicates that there are few racial/ethnic differences in these 
beliefs and attitudes among white, black and Hispanic Americans.  Although this dissertation 
study was unable to collect data on RBM-related knowledge levels, presumably, RBM is a 
concept with which few Americans are familiar.  If low familiarity with RBM is part of the 
reason why there were few racial differences in RBM-related beliefs and attitudes, then one 
question that arises is whether racial differences in RBM-related beliefs and attitudes would 
begin to emerge depending on exposure to varying types of messages about the relationship 
between race and genes.  For many Americans, mass media has proven to be an important source 
of information about scientific studies and new medical technologies (Loo, Byrne, Hardin, 
Castro and Fisher, 1998; Moynihan et al., 2000; National Health Council, 1997; Sitthe-amorn 
and Ngamvithyapongse, 1998; Zaller, 1992).  Media coverage has also been shown to increase 
the importance of various topics in the public’s mind, although the evidence regarding whether 
mass media can substantively influence public attitudes about a topic is mixed (Fiske, 1987; 
Gerbner, Gross, Morgan & Signorielli, 1980; McCombs & Shaw, 1972).  This chapter seeks to 
evaluate the extent to which varying mass media messages about the relationship between race 





There have been several mass media studies that examined news media coverage of race 
and genetics. One mass media study showed that a substantial portion of newspaper articles 
present both the position that there is a genetic basis to race and that race is a social construct 
(Lynch & Condit, 2006).  However, these articles tended to be slanted in one of the two 
directions, and predominately towards the “race is genetic” direction.  Meanwhile, Phelan et al. 
(2013) in their analysis of newspaper articles about race and genetics generally, and race, 
genetics and health specifically, found that race and genetics articles that focused on health 
issues were significantly less likely to mention racism or discuss ethical issues than articles that 
were not focused on health. In addition, articles that discussed health were presented in much 
more positive terms (endorsing genetic causes of race-specific health differences) than articles 
that did not discuss health.   
Several studies examining mass media’s influence on beliefs about race and genetics 
generally, and race, genetics and health specifically, found that messages linking race, genes and 
health increased racist attitudes (Condit et al, 2004; Lynch et al., 2008; Parrott et al., 2005; 
Phelan, Link and Feldman, 2013).  Such evidence suggests the possibility that how race and 
genes are discussed in the news could also influence seemingly more innocuous beliefs and 
attitudes such as beliefs regarding the relationship between race and health-related applications 
like RBM, as well as attitudes towards using RBM.   
Exposing the lay public to varying messages about the relationship between race and 
genes, however, may not be enough to influence beliefs and attitudes regarding RBM.  The 
extent to which the public accepts or rejects these messages may also be a factor influencing 





public opinions, contends that subject matter that is unfamiliar or novel and less defined by prior 
conceptions and personal experiences will be more successful at shaping the public’s beliefs and 
attitudes than subject matter that is more familiar. This suggests that messages in the form of 
mock news articles about race and genes have the potential to shape conceptions of race and, in 
turn, RBM-related conceptions, if it is subject matter with which an individual has little to no 
familiarity. However, Zaller’s (1992) research on the effects of mass media on political 
campaigns shows that the public tends to resist arguments that are inconsistent with their own 
political predispositions.  Therefore, if the individual has some familiarity or specific opinions 
about the subject, in this case, conceptions of race and racial differences, then the extent to which 
one is likely to accept a mock news article’s message on this topic may have to do with the 
extent to which that message is consistent with his or her own beliefs about race and causes of 
racial differences.  
To date, there is little research examining mass media’s influence on RBM-related beliefs 
and attitudes.  One study of lay focus group participants responding to public messages about 
race-specific medications indicated that some of the lay public may be skeptical about messages 
that link race to genetics and health (Bates et al., 2004).  However, no study has examined the 
effects of varying mass media messages about the relationship between race and genetics on 
RBM-specific beliefs and attitudes. Therefore, the following is an analysis of findings from a 
vignette experiment examining the effects of mock news articles about different types of 
relationships between race and genes on RBM-related beliefs and attitudes. This race vignette 
experiment comprises five conditions.  Respondents were randomized either to read one of four 
different vignettes that varied in their message about the relationship between race and genes or 





Chapter 3, the vignettes were mock news articles with one of the following four messages: there 
is a genetic basis to race (a.k.a., the race is genetic vignette); racial categories are socially 
produced with no genetic basis (a.k.a., the social construction vignette); there are genetic 
markers for race but tests show most people are of mixed genetic ancestry (a.k.a., the admixture 
vignette); or, a gene has been found that disproportionately raises the risk of a heart attack 
among African Americans (a.k.a.. the genetic health difference vignette).  
Aim 4 examines the effects of this vignette experiment on RBM-related beliefs and 
attitudes. The hypotheses developed for this aim, which are described in detail on pp. 64-66 in 
Chapter 3, contend that the vignette experiment differentially affected beliefs about whether 
there is a genetic basis to race, in turn influencing beliefs and attitudes regarding RBM’s 
effectiveness and preferences for using RBM.  The following are Aim 4’s hypotheses: 
Hypothesis 4a: There will be no significant difference in endorsement of RBM 
individual-level effectiveness, behavioral orientation and population-level effectiveness 
beliefs and attitudes between the race is genetic and genetic health difference vignettes. 
 
Hypothesis 4b:  The race is genetic and genetic health difference vignettes will be 
associated with greater endorsement of RBM individual-level effectiveness, behavioral 
orientation and population-level effectiveness beliefs and attitudes than the admixture 






Hypothesis 4c: There will be no significant difference for RBM individual-level 
effectiveness, behavioral orientation and population-level effectiveness beliefs and 
attitudes between the social construction vignette and control condition.  
 
Hypothesis 4d: The admixture vignette will be associated with greater endorsement of 
RBM individual-level effectiveness, behavioral orientation and population effectiveness 
beliefs and attitudes than the social construction vignette and the control condition. 
 
Hypothesis 4e: The race is genetic and genetic health difference vignettes will be 
associated with greater endorsement of RBM individual-level effectiveness, behavioral 
orientation and population-level effectiveness than the social construction vignette or the 
control condition. 
Aim 4’s hypotheses predict that the race is genetic and genetic health difference vignettes 
would be the most likely to increase the belief that there is a genetic basis to race, and would 
thereby be associated with higher endorsement levels of RBM-related beliefs and attitudes.  They 
also predict that the social construction vignette and control condition are less likely to be 
associated with the belief that there is a genetic basis to race and therefore would be associated 
with lower endorsement levels of RBM-related beliefs and attitudes.  Because the admixture 
vignette message has the potential to influence opposing beliefs regarding whether there is a 
genetic basis to race, Aim 4’s hypotheses predict that the admixture vignette would be associated 
with RBM-related beliefs and attitudinal endorsement levels that are somewhere between those 
of the predicted levels for the race is genetic/genetic health difference vignettes and the social 





Aim 5 examines the extent to which acceptance or rejection of the assigned vignette’s 
message moderates the relationship between vignette received and RBM-related beliefs and 
attitudes. The following are Aim 5’s hypotheses: 
Hypothesis 5a: There will be a significant difference between the social construction and 
race is genetic vignettes in the association between vignette acceptance and RBM 
individual-level effectiveness, behavioral orientation and population-level effectiveness 
beliefs and attitudes such that greater vignette acceptance will be associated with lower 
RBM belief levels for the social construction vignette while greater vignette acceptance 
will be associated with higher RBM belief levels for the race is genetic vignette. 
 
Hypothesis 5b: There will not be a significant difference between the genetic health 
difference vignette and the race is genetic vignette in the association between vignette 
acceptance and RBM individual-level effectiveness, behavioral orientation and 
population-level effectiveness beliefs and attitudes.  Greater vignette acceptance should 
be associated with greater endorsement of RBM individual-level effectiveness, 
behavioral orientation and population-level effectiveness beliefs and attitudes for both 
vignettes. 
 
Hypothesis 5c:  There will be a significant difference between the admixture vignette and 
the race is genetic vignette in the association between vignette acceptance and RBM 
individual-level effectiveness, behavioral orientation and population-level effectiveness 
beliefs and attitudes.  Greater acceptance of the admixture vignette will be associated 





orientation and population-level effectiveness beliefs and attitudes while greater 
acceptance of the race is genetic vignette will be associated with higher endorsement of 
these attitudes and beliefs. 
Note, Hypotheses 5a through 5c only test acceptance of each vignette in comparison to the race 
is genetic vignette.  The hypotheses do not additionally test acceptance of the social 
construction, admixture and genetic health difference vignettes with each other.   I decided to 
only test hypotheses that compare the race is genetic vignette with the other three vignette 
conditions because the race is genetic message continues to be a controversial and contested 
message, while the social construction, admixture and genetic health difference vignette 














*Note: Dashed lines from the admixture vignette indicate that the pathway to belief that race is or is not 
genetically-based is unclear, with the vignette possibly leading study participants in either direction. 
 
Figure 5.1: Race vignette experiment flow chart of the hypothesized causal pathways 
from assigned vignette condition to beliefs about the relationship between race and 
genetics, to beliefs about RBM, accounting for vignette message acceptance.  
 
Figure 5.1 is a chart of the hypothesized causal pathways flowing from the race vignette 
experiment’s four vignette conditions to beliefs about the relationship between race and genes 
and, finally, to RBM-related beliefs and attitudes.  The chart includes the hypothesized effect of 
vignette message acceptance on these causal pathways, suggesting that the hypothesized 
association between a vignette condition, race and genetics belief and RBM belief/attitude is 
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The following describes the research design and methods used to analyze the race 
vignette experiment’s effects on RBM-related beliefs and attitudes.  This is followed with a 
presentation of the results for Aims 4 and 5 and then a discussion of the findings.    
 
5.2  Research Design and Methods  
5.2.1  Sample 
The sample used for Aims 4-5’s analyses comprises 631 self-identified white and black 
adults aged 18 years of age or older who were randomized to the race vignette experiment (see 
pp. 60-63 in Chapter 3 for an in-depth description of this experiment).  Only white and black 
respondents from the race vignette experiment were included in the sample because there were 
too few Hispanics, Asians and respondents self-identifying as “other” to be included in analyses 
examining racial similarities and differences in the RBM dependent variables within the vignette 
experiment.  
Descriptive statistics for race, sex, education, income and age for each vignette condition 
in the sample are reported in Table 5.1.  Respondents were randomized to the vignette 
conditions, thus, the socio-demographic characteristics for each vignette condition should be 
roughly comparable.  ANOVA and Chi-square analyses were performed for each socio-
demographic characteristic in order to assess whether there were any differences between 
vignette conditions.  Table 5.1 shows that there were no significant differences between vignette 
conditions for race, sex, education and age.  A comparison of the demographic characteristics for 





tended to be somewhat more educated than the U.S. population as a whole (U.S. Census Bureau, 
2013).  
 
Table 5.1: Descriptive statistics for Aims 4-5 sample (nTOTAL = 631) by vignette condition 
and comparison with 2010 United States Census data for individuals aged 18 or older. 
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Race       Chi-square  
p = .889  
  
White 114 (86) 143 (90) 108 (89) 114 (86) 74 (87) 72.4 a 
Black 19 (14) 16 (10) 13 (11) 19 (14) 11 (13) 12.6 
 
       
Sex       Chi-square  
p = .110  Male 73 (55) 88 (55) 59 (49) 49 (37) 39 (46) 49.2 
Female 60 (45) 71 (45) 62 (51) 84 (63) 46 (54) 50.8  
 
       
Education b       ANOVA  
p = .210 <High School 4 (3) 23 (14) 9 (7) 8 (6) 0 (0) 12.9 
High School Degree 
or Equivalent 
80 (60) 62 (39) 60 (50) 78 (59) 40 (47) 48.1 
Associates Degree 14 (11) 16 (10) 10 (8) 13 (10) 11 (13) 9.1 
Bachelors Degree 23 (17) 43 (27) 26 (21) 19 (14) 23 (27) 19.4 
Graduate Degree 12 (9) 15 (9) 13 (11) 14 (11) 11 (13) 10.5 
 
       
Age       ANOVA  
p = .441 18-44 66 (50) 76 (48) 45 (37) 47 (35) 32 (38) 48.1 
45-64 48 (36) 57 (36) 54 (45) 61 (46) 40 (47) 34.7 
65 & older 19 (14) 26 (16) 22 (18) 25 (19) 13 (15) 17.2  
a
 These percentages do not add up to 100 percent because they represent a percentage of the entire U.S. population, which 
includes individuals who self-identify as part of another racial group(s). 
b
 Educational attainment is reported only for individuals aged 25 years or older, consistent with the U.S. Census’s reporting of 








5.2.2  Measures 
The primary independent variable for Aims 4-5 is race vignette.  For this analysis, 
“dummy” variables were created. Dummy variables were created for all four vignettes to which 
respondents were randomized in this experiment – the race is genetic, social construction, 
admixture, and genetic health difference vignettes.  The control condition was used as the 
referent category for the dummy variables except when indicated in analyses that did not involve 
the control condition.  Although respondents were randomized to the vignette conditions, all 
multivariate analyses were controlled for race, sex, education and age in order to increase the 
precision of the estimates (see p. 94 in Chapter 3 for a complete description of the covariates). 
The dependent variables that are analyzed in Aims 4-5 are the three RBM beliefs and 
attitude variables. They are: RBM individual-level effectiveness, RBM behavioral orientation, 
and RBM population-level effectiveness (see pp. 84-87 in Chapter 3 for an in-depth description 
of the three dependent variable measures). 
In addition to the aforementioned independent and dependent variables, the analyses for 
Aim 4 include testing genetic essentialist beliefs in racial differences as a potential mediator of 
the race vignette experiment’s effects on RBM beliefs and attitudes, if there is evidence to 
indicate that the vignette experiment overall had an effect on these dependent variables.  A single 
item was used to measure genetic essentialist beliefs in racial differences (see p. 93 in Chapter 3 
for a description of this measure).  The analyses for Aim 5 include the vignette acceptance scale, 
which was analyzed as a potential moderator of vignette received in the examination of possible 
differences in RBM beliefs and attitudes based on assigned vignette condition.  Two items were 
used to measure the extent to which respondents accepted the information that was provided in 





the two items (see p. 93 in Chapter 3 for an in-depth description of the vignette acceptance 
scale).  
 
5.2.3  Analyses 
SPSS Version 21.0’s Complex Sampling Module was used to perform the data analysis in 
order to estimate the correct standard errors for the survey data, which has a complex sampling 
design.  Depending on the aim, means, multiple linear regression and R2Vignettes analyses were 
used to assess each specific aim.  The following is a description of the analyses for Aims 4-5.  
Analysis of Aim 4. In this aim, I assessed whether mock news articles that discuss 
different types of relationships between race and genes impact RBM beliefs and attitudes. This 
aim was analyzed in several parts.  First, I examined the means for RBM individual-level 
effectiveness, behavioral orientation and population-level effectiveness by vignette arm in order 
to assess the extent to which the vignettes’ effects may have resulted in differences in the 
dependent variables. Because respondents were randomized to each vignette, presumably the 
potential impact of other variables did not account for any large differences between vignettes. 
Second, I examined to see if differences in RBM beliefs and attitudes arose between blacks and 
whites based on the race vignette condition to which they were assigned.  This was done by 
regressing RBM individual-level effectiveness, behavioral orientation and population-level 
effectiveness on race, controlling for potential confounding effects of socio-demographic 
variables (sex, education and age).  These regression analyses were done separately by race 





Third, I constructed two multiple regression models to examine the race vignette 
experiment’s overall effect on RBM beliefs and attitudes.  The first model (No Vignettes model) 
only included all of the socio-demographic variables that are potentially associated with RBM 
beliefs and attitudes (Table 5.2, Model 21).  Those variables in this model are race (whites and 
blacks only), sex, education and age.  In the second model (Vignettes model), I added the 
vignette dummy variables – race is genetic, social construction, admixture, and genetic health 
difference – to the variables used in the No Vignettes model.  I then compared the R2 value for 
both models by subtracting the R2 value for the No Vignettes model from R2 for the Vignettes 
model to evaluate whether overall the vignettes had an effect on RBM individual-level 
effectiveness, behavioral orientation and population-level effectiveness.  R2 attributable to the 
vignettes was calculated as: 
R2-change = R2Vignettes - R2No Vignettes   
Fourth, if the change in R2 (i.e., R2-change) indicated that the vignettes had an overall 
effect on RBM beliefs and attitudes, then I would test genetic essentialist beliefs in racial 
differences as a potential mediator of the vignette experiment’s effect on RBM beliefs and 
attitudes.  To do this, I would follow Baron and Kenny’s (1986) steps for testing mediators using 
multiple linear regression, where RBM individual-level effectiveness, behavioral orientation 
and/or population-level effectiveness would be regressed on the race vignette experiment dummy 
variables and the genetic essentialist beliefs in racial differences measure, controlling for race, 
sex, education and age (Table 5.2, Model 22). 
Fifth, if the change in R2 (i.e., R2-change) indicated that the vignettes had an overall 





effects on the dependent variables, would also be tested.  To do this, I would construct five 
different multiple regression models that only tested the effect on the dependent variables of 
those vignettes specified in a particular hypothesis.  Table 5.2’s Models 23-27 outline the 
variables used for Hypotheses 4a-4e.  Note that the hypotheses are based on the causal pathways 
flow chart presented in Figure 5.1, which suggests that vignette received affects belief in a 
genetic basis to race, which in turn affects belief in RBM’s effectiveness at the individual and 
population levels as well as preferences for using RBM.   
In Hypothesis 4a, only the race is genetic versus the genetic health difference vignettes’ 
effects on the dependent variables were examined, thus, a dummy variable for the two vignettes 
(race is genetic was the referent category) and the socio-demographic  variables were included in 
the model.   
For Hypothesis 4b, I created two dummy variables for the race is genetic, genetic health 
difference and admixture vignettes, setting the admixture vignette as the referent category. The 
RBM dependent variables will be regressed on the two dummy variables and the socio-
demographic variables.   
Hypothesis 4c required that I compare the social construction vignette with the no-
vignette control condition.  The effect of those two conditions on RBM beliefs and attitudes will 
be compared by creating a dummy variable with the control condition as the referent category 
and entering this dummy variable along with the socio-demographic variables in a multiple 
linear regression model. 
For Hypothesis 4d, two dummy variables were created for the social construction 





the referent category.  The admixture vignette will be set as the referent category because the 
hypothesis specifically compares that vignette to both the social construction vignette and the 
control condition.  The RBM dependent variables will then be regressed on both dummy 
variables and the socio-demographic variables in order to compare the effect of the admixture 
vignette condition with the social construction and control conditions. 
Hypothesis 4e, which hypothesizes that the race is genetic and genetic health difference 
vignettes are associated with greater endorsement of RBM beliefs and attitudes than the social 
construction vignette or the no-vignette control condition, will have three dummy variables 
created for the race is genetic, genetic health difference and social construction vignette 
conditions using the control condition as the referent category.  The RBM dependent variables 
will be regressed on the dummy variables and socio-demographic control variables in order to 
compare each vignette’s association with the dependent variables with each other. 
All of the three aforementioned sets of analyses will be conducted on the total sample, as 





Table 5.2: Variables used in Aims 4 and 5 multiple linear regression models. 
Variable 
Types 














































































































-- -- -- 
Moderator -- -- -- -- -- -- Vignette 
acceptance * 
vignettes 
a  The socio-demographic  variables are sex, education and age. 
b  The socio-demographic  variables are race (black/white), sex, education and age. 
 
Analysis of Aim 5. In this aim, I assessed whether acceptance of the vignette modified 
the effect of the vignette received on RBM individual-level effectiveness, behavioral orientation 
and population-level effectiveness.  Before testing vignette acceptance as a moderator, I first 
conducted an ANOVA analysis setting vignette acceptance as the covariate and vignette received 
as the factor.  If the ANOVA indicated a significant association between vignette acceptance and 





Baron and Kenny (1986, p. 1175) contend that when the independent variable is 
categorical (in this case vignette received) and the tested moderator is continuous (in this case, 
the vignette acceptance scale), and it is assumed that the relationship between the independent 
variable (i.e., moderator) and dependent variable is linear, it is appropriate to use multiple linear 
regression to test to see if a variable is a moderator.  As part of the process to test vignette 
acceptance as a moderator of the effects of the race vignette experiment on RBM beliefs and 
attitudes, multiple linear regression models (Table 5.2, Models 28-32) were first conducted to 
assess the association between the vignette acceptance scale and RBM-related beliefs and 
attitudes for each of the race vignette conditions.  Three vignette dummy variables were then 
created to compare the race is genetic vignette with the social construction, admixture and 
genetic health difference vignette, with the race is genetic vignette condition serving as the 
referent category for all three dummy variables.  The race is genetic vignette was compared with 
each of the remaining vignette conditions for Hypotheses 5a through 5c because I had proposed 
that this vignette would be the least accepted vignette of the four vignette conditions due to the 
controversial nature of the vignette’s message.   
The potential interaction between the vignette acceptance scale and each vignette dummy 
variable was then tested in separate models.  RBM individual-level effectiveness, behavioral 
orientation and population-level effectiveness were separately regressed on the vignette dummy 
variable that was being tested, the vignette acceptance scale and the interaction term between 
these two variables (Table 5.2, Models 33-35).  Each model was adjusted for race, sex, education 
and age.  In addition to testing vignette acceptance as a moderator of vignette condition received 
for the RBM dependent variables, vignette acceptance frequencies were analyzed in order to 





5.3  Results 
5.3.1  Aim 4: Vignette Experiment’s Effects on Race-Based Medicine Beliefs and Attitudes 
5.3.1.1  Vignettes’ Effects on Race-Based Medicine Individual-Level Effectiveness  
Table 5.3 presents the means, standard errors and 95% confidence intervals for RBM 
individual-level effectiveness by vignette type and race.  The means for RBM individual-level 
effectiveness for the total sample by vignette type did not vary by much, ranging from a low of 
2.44 for the social construction vignette, to 2.53 for race is genetic, 2.54 for the control group, 
2.56 for admixture, and 2.59 for genetic health difference.  For just the white sub-sample, the 
means also varied little, ranging from a low of 2.46 for the social construction vignette to a high 
of 2.65 for the admixture vignette.  The means for the black sample, however, were somewhat 
lower than those for the white sample and had greater variation, ranging from a low of 1.85 for 
the admixture vignette to 2.20 for race is genetic, 2.20 for genetic health difference, 2.37 for 
social construction, and 2.50 for the control group.  Thus, while the mean for RBM individual-
level effectiveness among the white sample was approximately the mid-point for the range of 
values regardless of vignette condition (mid-point being 2.5 on a scale of 1 to 4), for black 
respondents it seemed that exposure to any mock news article about race and genetics, regardless 
of how the relationship between the two are conveyed, lowered endorsement of RBM individual-
level effectiveness belief.  In addition, it is notable that the highest mean score for RBM 
individual-level effectiveness among white respondents was for those assigned to the admixture 
vignette, however, black respondents assigned to this same vignette condition were associated 





Figure 5.2 is a line chart presenting the mean scores for RBM individual-level 
effectiveness by vignette condition and race.  The chart shows that the means do not seem to 
vary much by vignette condition for the total sample and white sub-sample, but the means for the 
black sub-sample are slightly lower for the race is genetic and genetic health difference vignette 





Table 5.3: Means, standard errors, and 95% confidence intervals for RBM individual-level 





Race Is Genetic 
n 133 114 19 
Mean 2.53 2.58 2.20 
SE .068 0.73 .106 
95% CI 
 
(2.39, 2.66) (2.44, 2.73) (1.99, 2.41) 
Social Construction 
n 133 114 19 
Mean 2.44 2.46 2.37 
SE .062 .069 .131 
95% CI 
 
(2.32, 2.57) (2.32, 2.59) (2.11, 2.63) 
Admixture 
n 120 107 11 
Mean 2.56 2.65 1.85 
SE .082 .068 .314 
95% CI 
 
(2.40, 2.73) (2.52, 2.79) (1.22, 2.46) 
Genetic Health Difference 
n 159 143 16 
Mean 2.59 2.63 2.21 
SE .097 .100 .321 
95% CI 
 
(2.39, 2.79) (2.43, 2.83) (1.57, 2.84) 
Control 
n 84 73 11 
Mean 2.54 2.55 2.50 
SE .078 .088 .157 







Figure 5.2: Line chart marking mean scores for RBM individual-level effectiveness by 
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Table 5.4: Multiple linear regression estimates for RBM individual-level effectiveness 
regressed on race, adjusting for socio-demographic covariates, by vignette condition. 












 n = 133 n = 132 n = 118 n = 159 n = 83 
 β (SE)  β (SE) β (SE) β (SE) β (SE) 


















































†P < .10, *P < .05, **P < .01, ***P < .001. 
 
Table 5.4 shows that whites and blacks assigned to the race is genetic and admixture 
vignette conditions significantly differed in their endorsement of RBM individual-level 
effectiveness. Blacks were significantly less likely than whites to endorse RBM individual-level 
effectiveness after exposure to either the race is genetic vignette (p < .05) or the admixture 
vignette (p < .01).    
Table 5.5 shows the estimates, standard errors and R2 values for the two RBM individual-




whether the vignette experiment as a whole had an effect on RBM beliefs and attitudes for the 
total sample.  R2Change’s p-value was >.10 for the two models, indicating that the vignette 
experiment as a whole did not have a statistically significant effect on RBM individual-level 
effectiveness belief for the total sample.    
The p-value of R2Change was also calculated for both the white and black sub-samples for 
RBM individual-level effectiveness belief (see Tables 5.6 and 5.7 respectively).  For both 
subsamples, R2Change was not statistically significant at the .05 level, indicating that the vignette 
experiment did not have an effect on RBM individual-level effectiveness belief among either the 














Table 5.5: Multiple linear regression estimates, standard errors, and R2 for RBM 
individual-level effectiveness regressed on socio-demographic variables, with and without 
vignette variables for the total sample (n = 626). 
 βNOVIG 
a
 SENOVIG βVIG b SEVIG  
Intercept 1.955*** .261 1.955*** .279 
Black -.321** .113 -.315** .117 
Sex .060 .072 .049 .074 
Education .050* .023 .049* .023 
Age .001 .002 .002 .002 
Race is Genetic -- -- .006 .105 
Social Construction -- -- -.071 .108 
Genetic Health Difference -- -- .050 .126 
Admixture -- -- .033 .115 
R2 for model .050  .054  
†P < .10, *P < .05, **P < .01, ***P < .001. 
a
 “NOVIG” refers to multiple linear regression model without vignette dummy variables. 
b








Table 5.6: Multiple linear regression estimates, standard errors, and R2 for RBM 
individual-level effectiveness regressed on socio-demographic  variables, with and without 
vignette variables for the white sample (n = 547) 
 βNOVIG 
a
 SENOVIG βVIG b SEVIG  
Intercept 2.115*** .275 2.078*** .295 
Sex .068 .076 .056 .078 
Education .033 .024 .032 .024 
Age .002 .003 .002 .003 
Race is Genetic -- -- .044 .116 
Social Construction -- -- -.071 .118 
Genetic Health Difference -- -- .095 .133 
Admixture -- -- .119 .116 
R2 for model .014  .024  
†P < .10, *P < .05, **P < .01, ***P < .001. 
a
 “NOVIG” refers to multiple linear regression model without vignette dummy variables. 
b










Table 5.7: Multiple linear regression estimates, standard errors, and R2 for RBM 
individual-level effectiveness regressed on socio-demographic variables, with and without 
vignette variables for the black sample (n = 79) 
 βNOVIG 
a
 SENOVIG βVIG b SEVIG  
Intercept -.358 .690 .039 .618 
Sex .122 .183 .213 .196 
Education .271*** .069 .259*** .062 
Age -.033 .006 -.006 .006 
Race is Genetic -- -- -.241 .221 
Social Construction -- -- -.122 .240 
Genetic Health Difference -- -- -.164 .292 
Admixture -- -- -.539† .297 
R2 for model .236  .301  
†P < .10, *P < .05, **P < .01, ***P < .001. 
a
 “NOVIG” refers to multiple linear regression model without vignette dummy variables. 
b
 “VIG” refers to multiple linear regression model with vignette dummy variables. 
 
The testing of genetic essentialist beliefs in racial differences as a mediator between the 
race vignette experiment and RBM individual-level effectiveness was contingent on R2Change 
being statistically significant, thereby indicating that the vignettes had an effect on RBM 
individual-level effectiveness belief.  Because this was not the case, genetic essentialist beliefs in 




hypotheses that would only be tested if R2Change was statistically significant.  Because R2Change 
was not statistically significant for the total sample, or even the white and black sub-samples, 
Hypotheses 4a-4e were not tested for RBM individual-level effectiveness belief.  None of the 
models for the total sample, white or black sub-samples indicated statistically significant 
differences between any of the vignette conditions and the control condition, however, it is 
notable that the estimate for the admixture vignette dummy variable in the black sub-sample 
regression model indicated that black respondents who received the admixture vignette were less 
likely to endorse RBM individual-level effectiveness belief than those who were assigned to the 
control condition (p < .10).  
 
5.3.1.2  Vignettes’ Effects on Race-Based Medicine Behavioral Orientation  
Table 5.8 shows the means, standard errors and 95% confidence intervals for RBM 
behavioral orientation by vignette type and race. For the total sample, the means for RBM 
behavioral orientation ranged from a low of 3.04 for the admixture vignette, to 3.07 for the social 
construction vignette, 3.08 for the genetic health difference vignette, 3.12 for the race is genetic 
vignette and 3.26 for the control condition.  These means indicate that respondents on average 
preferred to use RBM regardless of the type of vignette they received.   
The range of mean RBM behavioral orientation scores by vignette type was similar for 
the white sub-sample, ranging from a low of 3.11 for the genetic health difference vignette to a 
high of 3.26 for the control condition.  However, the means show a different story for the black 
sub-sample.  The RBM behavioral orientation mean for the black sub-sample’s control condition 




the means for the other four vignette conditions were lower, ranging from 2.14 for the admixture 
vignette to 2.55 for the race is genetic vignette, 2.72 for the genetic health difference vignette, 
and 2.79 for the social construction vignette.   
Figure 5.3 is a line graph that shows the mean scores for RBM behavioral orientation by 
vignette type and race.  The chart visually shows that the means for this construct do not seem to 
vary much by vignette type for the total sample or the white sub-sample, but it also shows that 
the means are slightly lower for the race is genetic, social construction and genetic health 





Table 5.8: Means, standard errors, and 95% confidence intervals for RBM behavioral 




Race Is Genetic 
n 131 114 19 
Mean 3.12 3.22 2.55 
SE .103 .105 .217 
95% CI 
 
(2.92, 3.32) (3.01, 3.43) (2.12, 2.98) 
Social Construction 
n 133 114 19 
Mean 3.07 3.12 2.79 
SE .088 .091 .271 
95% CI 
 
(2.90, 3.25) (2.94, 3.30) (2.25, 3.32) 
Admixture 
n 120 107 11 
Mean 3.04 3.15 2.14 
SE .112 .090 .476 
95% CI 
 
(2.82, 3.26) (2.97, 3.33) (1.20, 3.08) 
Genetic Health Difference 
n 158 142 16 
Mean 3.08 3.11 2.72 
SE .127 .131 .424 
95% CI 
 
(2.12, 2.98) (2.85, 3.37) (1.89, 3.56) 
Control 
n 82 71 11 
Mean 3.26 3.26 3.22 
SE .106 .112 .308 







Figure 5.3: Line chart marking mean scores for RBM behavioral orientation by vignette 
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Table 5.9: Multiple linear regression estimates for RBM behavioral orientation regressed 
on race, adjusting for socio-demographic covariates, by vignette condition. 
 














 n = 132 n = 132 n = 118 n = 158 n = 82 



















































†P < .10, *P < .05, **P < .01, ***P < .001. 
 
Table 5.9 shows that blacks and whites assigned to the race is genetic and admixture 
vignettes significantly differed in their endorsement of RBM behavioral orientation. Just like the 
results for RBM individual-level effectiveness, blacks were significantly less likely than whites 
to prefer to use RBM following exposure to either the race is genetic vignette (p < .05) or the 




In order to examine whether the vignettes as a group had an overall effect on mean 
endorsement levels for RBM behavioral orientation among the sample as a whole, as well among 
the white and black sub-samples, R2Change was assessed once again for the two multiple linear 
regression models.  Table 5.10 shows the estimates, standard errors and R2 values for the two 
regression models.  R2Change’s p-value was >.10 for the two models, indicating that the vignette 
experiment as a whole did not have a statistically significant effect on RBM behavioral 
orientation for the total sample. 
The statistical significance of R2Change was also calculated for both the white and black 
sub-samples for RBM behavioral orientation (see Tables 5.11 and 5.12 respectively).  For both 
sub-samples, R2Change was not statistically significant at the .05 level, indicating that the vignette 
experiment as a whole did not have an effect on RBM behavioral orientation among either the 











Table 5.10: Multiple linear regression estimates, standard errors, and R2 for RBM 
Behavioral Orientation regressed on socio-demographic  variables, with and without 
vignette variables for the total sample (n = 626) 
 βNOVIG 
a
 SENOVIG βVIG b SEVIG  
Intercept 2.953*** .339 3.158*** .361 
Black -.483** .173 -.492** .172 
Sex .142 .098 .145 .100 
Education .005 .030 .001 .030 
Age .002 .003 .002 .003 
Race is Genetic -- -- -.138 .145 
Social Construction -- -- -.166 .141 
Genetic Health Difference -- -- -.206 .165 
Admixture -- -- -.233 .149 
R2 for model .042  .048  
†P < .10, *P < .05, **P < .01, ***P < .001. 
a
 “NOVIG” refers to multiple linear regression model without vignette dummy variables. 
b









Table 5.11: Multiple linear regression estimates, standard errors, and R2 for RBM 
behavioral orientation regressed on socio-demographic  variables, with and without 
vignette variables for the white sample (n = 542). 
 βNOVIG 
a
 SENOVIG βVIG b SEVIG  
Intercept 3.169*** .349 3.320*** .379 
Sex .180† .101 .181† .103 
Education -.019 .030 -.022 .031 
Age .002 .003 .002 .003 
Race is Genetic -- -- -.060 .155 
Social Construction -- -- -.142 .150 
Genetic Health Difference -- -- -.164 .171 
Admixture -- -- -.120 .146 
R2 for model .014  .018  
†P < .10, *P < .05, **P < .01, ***P < .001. 
a
 “NOVIG” refers to multiple linear regression model without vignette dummy variables. 
b











Table 5.12: Multiple linear regression estimates, standard errors, and R2 for RBM 
behavioral orientation regressed on socio-demographic  variables, with and without 
vignette variables for the black sample (n = 79). 
 βNOVIG 
a
 SENOVIG βVIG b SEVIG  
Intercept -.166 1.063 .519 .859 
Sex .017 .284 .117 .323 
Education .298*** .104 .284** .086 
Age -.003 .009 -.005 .010 
Race is Genetic -- -- -.584 .354 
Social Construction -- -- -.466 .417 
Genetic Health Difference -- -- -.367 .454 
Admixture -- -- -.999* .457 
R2 for model .139  .221  
†P < .10, *P < .05, **P < .01, ***P < .001. 
a
 “NOVIG” refers to multiple linear regression model without vignette dummy variables. 
b
 “VIG” refers to multiple linear regression model with vignette dummy variables. 
 
The testing of genetic essentialist beliefs in racial differences as a mediator between the 
race vignette experiment and RBM behavioral orientation was contingent on R2Change being 
statistically significant, thereby indicating that the vignettes had an effect on RBM behavioral 
orientation.  Because this was not the case, genetic essentialist beliefs in racial differences was 




only be tested if R2Change was statistically significant.  Because R2Change was not statistically 
significant for the total sample, or even the white and black sub-samples, Hypotheses 4a-4e were 
not tested for RBM behavioral orientation.  It should be noted that although none of the vignettes 
were significantly different from the control condition in RBM behavioral orientation among the 
total sample and white sub-sample, some differences were seen among the black sub-sample.  
All of the vignettes seemed to be associated with lower RBM behavioral orientation means 
compared to the control condition, although only the estimate for the admixture vignette dummy 
variable was statistically significant (p < .05). 
 
5.3.1.3  Vignettes’ Effects on Race-Based Medicine Population-Level Effectiveness  
Table 5.13 presents the means, standard errors and 95% confidence intervals for RBM 
population-level effectiveness belief by vignette type and race. For the total sample, the means 
for RBM population-level effectiveness ranged from a low of 2.27 for the control group, to 2.28 
for the admixture vignette, 2.29 for the genetic health difference vignette, 2.39 for the social 
construction vignette and 2.42 for the race is genetic vignette.  Once again, the RBM population-
level effectiveness means by vignette type for the white sub-sample are similar to those for the 
total sample. For the white sub-sample the means ranged from a low of 2.24 for the control 
group, to 2.34 for the genetic health difference vignette, 2.37 for the admixture vignette, 2.41 for 
the social construction vignette, to 2.45 for the race is genetic vignette.  However, again, the 
RBM population-level effectiveness means by vignette type were somewhat different for the 
black sub-sample.   These means ranged from a low of 1.60 for the admixture vignette, to 1.86 




race is genetic vignette to 2.48 for the control group.  Notably, the means for RBM population-
level effectiveness among black respondents randomized to the admixture and genetic health 
difference vignettes indicated that blacks somewhat to strongly disagreed with the belief that 
RBM would mitigate health inequalities following exposure to one of those two vignette 
messages.   
Figure 5.4 is a line chart presenting the mean scores for RBM population-level 
effectiveness by vignette condition and race.  The chart shows, once again, that the means did 
not vary much by vignette condition for the total sample and white sub-sample.  The black sub-
sample’s means were slightly lower for the genetic health difference vignette condition, 
substantially lower for the admixture vignette condition, and slightly higher for the control 




Table 5.13: Means, standard errors, and 95% confidence intervals for RBM population-





Race Is Genetic 
n 133 114 19 
Mean 2.42 2.45 2.26 
SE .097 .106 .238 
95% CI 
 
(2.23, 2.61) (2.24, 2.66) (1.79, 2.73) 
Social Construction 
n 133 114 19 
Mean 2.39 2.41 2.25 
SE .108 .107 .405 
95% CI 
 
(2.18, 2.60) (2.20, 2.62) (1.45, 3.05) 
Admixture 
n 119 106 13 
Mean 2.28 2.37 1.60 
SE .104 .104 .288 
95% CI 
 
(2.08, 2.49) (2.16, 2.57) (1.03, 2.17) 
Genetic Health Difference 
n 159 143 16 
Mean 2.29 2.34 1.86 
SE .115 .122 .280 
95% CI 
 
(2.06, 2.52) (2.10, 2.58) (1.30, 2.41) 
Control 
n 81 71 11 
Mean 2.27 2.24 2.48 
SE .112 .114 .400 






Figure 5.4: Line chart marking mean scores for RBM population-level effectiveness by 
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Table 5.14: Multiple linear regression estimates for RBM population-level effectiveness 
regressed on race, adjusting for socio-demographic covariates, by vignette condition. 
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†P < .10, *P < .05, **P < .01, ***P < .001 
 
Table 5.14 shows that black respondents were significantly less likely than white 
respondents to endorse RBM’s effectiveness at reducing population-level health inequalities after 
exposure to the admixture vignette (p <.05). Although not significant at the .05-level, blacks also 
seemed to be less likely than whites to endorse RBM population-level effectiveness after 




Table 5.15: Multiple linear regression estimates, standard errors, and R2 for RBM 
population-level effectiveness regressed on socio-demographic variables, with and without 
vignette variables for the total sample (n = 622) 
 βNOVIG 
a
 SENOVIG βVIG b SEVIG  
Intercept 2.289*** .377 2.221*** .396 
Black -.278 .173 -.286† .169 
Sex -.020 .101 -.019 .101 
Education -.009 .032 -.007 .032 
Age .004 .003 .004 .003 
Race is Genetic -- -- .153 .156 
Social Construction -- -- .103 .163 
Genetic Health Difference -- -- .011 .162 
Admixture -- -- -.020 .156 
R2 for model .016  .022  
†P < .10, *P < .05, **P < .01, ***P < .001. 
a
 “NOVIG” refers to multiple linear regression model without vignette dummy variables. 
b
 “VIG” refers to multiple linear regression model with vignette dummy variables. 
 
In order to examine whether the vignettes as a group had an overall effect on mean 
endorsement levels for RBM population-level effectiveness among the sample as a whole, as 
well as among the white and black sub-samples, R2Change was assessed once again.  Table 5.15 
shows the estimates, standard errors and R2 values for the two regression models.  R2Change’s p-
value was >.10 for the two models, indicating that the vignette experiment as a whole did not 
have a statistically significant effect on RBM population-level effectiveness for the total sample. 
The statistical significance of R2Change was also calculated for both the white and black 




For both sub-samples, R2Change was not statistically significant at the .05 level, indicating that the 
vignette experiment as a whole did not have an effect on RBM population-level effectiveness 
among either the white or black respondents.  
Table 5.16: Multiple linear regression estimates, standard errors, and R2 for RBM 
population-level effectiveness regressed on socio-demographic variables, with and without 
vignette variables for the white sample (n = 544) 
 βNOVIG 
a
 SENOVIG βVIG b SEVIG  
Intercept 2.384*** .399 2.237*** .427 
Sex .008 .107 .005 .107 
Education -.022 .034 -.019 .034 
Age .004 .004 .004 .004 
Race is Genetic -- -- .196 .161 
Social Construction -- -- .147 .165 
Genetic Health Difference -- -- .097 .168 
Admixture -- -- .090 .160 
R2 for model .009  .013  
†P < .10, *P < .05, **P < .01, ***P < .001. 
a
 “NOVIG” refers to multiple linear regression model without vignette dummy variables. 
b











Table 5.17: Multiple linear regression estimates, standard errors, and R2 for RBM 
population-level effectiveness regressed on socio-demographic variables, with and without 
vignette variables for the black sample (n = 79). 
 βNOVIG 
a
 SENOVIG βVIG b SEVIG  
Intercept .714 1.128 1.092 1.106 
Sex -.108 .325 -.101 .337 
Education .157 .104 .138 .104 
Age -.003 .011 .000 .009 
Race is Genetic -- -- -.092 .469 
Social Construction -- -- -.253 .515 
Genetic Health Difference -- -- -.524 .474 
Admixture -- -- -.757 .465 
R2 for model .046  .118  
†P < .10, *P < .05, **P < .01, ***P < .001. 
a
 “NOVIG” refers to multiple linear regression model without vignette dummy variables. 
b
 “VIG” refers to multiple linear regression model with vignette dummy variables. 
 
The testing of genetic essentialist beliefs in racial differences as a mediator between the 
race vignette experiment and RBM population-level effectiveness was contingent on R2Change 
being statistically significant, thereby indicating that the vignettes had an effect on RBM 
population-level effectiveness belief.  Once again, because this was not the case, genetic 
essentialist beliefs in racial differences was not tested as a mediator.  In addition, hypotheses 4a-
4e are contingency hypotheses that would only be tested if R2Change was statistically significant.  
Because R2Change was not statistically significant for the total sample, or the white and black sub-





 In sum, Aim 4’s results indicate that the race vignette experiment did not have a 
statistically significant effect on RBM individual-level effectiveness, behavioral orientation or 
population-level effectiveness for the sample as a whole or by race.  Because of the experiment’s 
lack of overall effect, genetic essentialist beliefs in racial differences was not tested as a 
mediator, and Hypotheses 4a through 4e, which separately test each vignette condition’s effect 
on RBM beliefs and attitudes, were not tested.  There were, however, statistically significant 
differences between the white and black respondents for the race is genetic vignette’s effect on 
RBM individual-level effectiveness and behavioral orientation, and for the admixture vignette’s 
effect on all three RBM dependent variables.  
 
5.3.2  Aim 5: Acceptance of Vignette and its Effects on Race-Based Medicine Beliefs and 
Attitudes 
The purpose of Aim 5 is to assess the extent to which acceptance of the information 
provided in the vignette modified the relationship between the vignette received and RBM 
beliefs and attitudes.  Exposure to one mock news article that discusses the relationship between 
race and genetics may not be enough to influence beliefs and attitudes about RBM.  Instead, 
respondents’ acceptance of the information provided in the vignette as true or plausible may be 
the more salient factor influencing RBM beliefs and attitudes as measured by this experiment.   
I first conducted an ANOVA to see if there is a significant association between vignette 
received and the vignette acceptance scale.  The association between the two variables was 
significant (p < .001), indicating that vignette acceptance has the potential to moderate the 




Table 5.18 presents frequencies for the range of values for the vignette acceptance scale 
for each of the experiment’s vignette conditions, overall and by race. The table shows that 
relatively small proportions of respondents either somewhat-strongly rejected the message in the 
vignette they received – only 7.5 percent of total respondents assigned to the social construction 
vignette, 8.1 percent assigned to the genetic health difference vignette, 13.1 percent of 
respondents assigned to the admixture vignette, and 16.5 percent of respondents assigned to the 
race is genetic vignette either somewhat or strongly rejected the vignette’s message.  The greater 
difference in the vignette acceptance scale appeared to be in the proportion of respondents who 
somewhat or strongly accepted the vignette’s message as accurate.  While 73.7, 73.8 and 81.2 
percent of the respective admixture, genetic health difference and social construction vignette 
respondents somewhat to strongly accepted the vignette’s message as accurate, only 57.9 percent 
of the race is genetic vignette respondents indicated this belief.   
Notably, there were some differences in vignette acceptance scale frequencies between 
white and black respondents assigned to each condition.  Black respondents assigned to the 
genetic health difference vignette had relatively lower vignette acceptance levels than white 
respondents assigned to that condition (respectively 56.3 versus 75.5 percent).  Black 
respondents also accepted the social construction vignette at a higher level than whites (89.5 
versus 79.8 percent).  Noticeably, exactly the same proportion of whites and blacks somewhat to 










































































































































a P-value = .000 for ANOVA to test for differences in vignette acceptance by vignette received for total sample (n = 
548). 
b Vignette acceptance scale range for this was 3.0-4.0. 
c Vignette acceptance scale value for this was 2.5. 
d Vignette acceptance scale range for this was 1.0-2.0. 
 
The following are the results for Aim 5’s hypotheses that propose that vignette acceptance 






5.3.2.1  Acceptance of Vignette’s Effect on RBM Individual-Level Effectiveness: Social 
Construction Versus Race is Genetic Vignettes 
I proposed three hypotheses that separately compared the social construction, genetic 
health difference and admixture vignettes with the race is genetic vignette, testing to see if 
vignette acceptance moderates the relationship between vignette type and RBM individual-level 
effectiveness.  Hypothesis 5a contends that there will be a significant difference between the 
social construction and race is genetic vignettes in the association between the vignette 
acceptance scale and RBM individual-level effectiveness.  For the social construction vignette, 
higher vignette acceptance is hypothesized to be associated with lower endorsement of RBM 
individual-level effectiveness, but for the race is genetic vignette, higher vignette acceptance is 
hypothesized to be associated with greater endorsement of RBM individual-level effectiveness.   
Hypothesis 5a was tested by regressing RBM individual-level effectiveness on the social 
construction dummy variable (with the race is genetic vignette as the referent category), vignette 
acceptance scale and the interaction term between the two variables. The multiple linear 
regression model was also adjusted for race, sex, education and age.  Table 5.19 presents the 
estimates and standard errors for this regression model.  The estimate for the interaction term 
between the social construction dummy variable and vignette acceptance scale indicates that 
vignette acceptance does in fact moderate the relationship between type of vignette received 
(social construction versus race is genetic) and RBM individual-level effectiveness (β = -.381, 






Table 5.19: Multiple linear regression estimates, standard errors, and R2 for models 
examining vignette acceptance as moderator of social construction versus race is genetic 
vignettes on RBM individual-level effectiveness (n = 265). 
 β SE β SE
 
 
Intercept 1.536*** .340 .993** .323 
Social Construction 
Vignette 
-.129 .096 1.009** .358 
Black -.233* .103 -.220† .113 
Sex .091 .095 .063 .094 
Education .052† .027 .056* .027 
Age -.002 .003 -.003 .003 
Vignette Acceptance .194** .060 .389*** .078 
Social Construction * 
Vignette Acceptance 
-- -- -.381** .121 
R2 for model .085 .118 
†P < .10, *P < .05, **P < .01, ***P < .001. 
 
Separate regression models were then conducted with the social construction vignette 
respondents and the race is genetic vignette respondents to assess their respective associations 
between the vignette acceptance scale and RBM individual-level effectiveness.  Table 5.20 
presents the results of these models.  The vignette-specific regression models indicate that 
vignette acceptance was not associated with RBM individual-level effectiveness for respondents 
who received the social construction vignette, however, it was positively associated with RBM 
individual-level effectiveness for respondents who received the race is genetic vignette (p < 




idea that there is a genetic basis to race, as discussed in this mock news article, were also more 
likely to believe that RBM is effective at the individual level.  Acceptance of the concept of race 
as being socially constructed, as described in the social construction vignette, seemed to have no 
association with RBM individual-level effectiveness belief.  Hypothesis 5a contended, in part, 
that lower vignette acceptance would be associated with greater endorsement of RBM 
individual-level effectiveness among social construction vignette respondents, however, this was 
not the case. Despite the lack of support for this part of the hypothesis, the results indicate that 
vignette acceptance does moderate the relationship between type of vignette received and RBM 




Table 5.20: Multiple linear regression estimates by vignette condition for RBM individual-
level effectiveness regressed on the vignette acceptance scale. 
 Race Is Genetic 
                             
(n = 133) 
Social 
Construction 
(n = 132) 
Genetic Health 
Difference 
(n = 159) 
Admixture 
                             
(n = 118) 
 β SE β SE β SE β SE 
Intercept .204 .372 2.975*** .479 1.395* .587 2.412*** .529 
Black -.270† .137 -.020 .153 -.476 .354 -.806** .290 
Sex .114 .121 .146 .137 -.080 .176 .157 .143 
Education .117** .038 -.011 .040 .061 .052 .039 .043 
Age .001 .004 -.009* .004 .012* .005 .002 .005 
Vignette 
Acceptance 
.367*** .070 -.008 .090 .038 .167 -.100 .110 
R2 .237 .063 .111 .169 




5.3.2.2  Acceptance of Vignette’s Effect on RBM Individual-Level Effectiveness: Genetic Health 
Difference Versus Race is Genetic Vignettes 
Hypothesis 5b contends that there will not be a significant difference between the genetic 
health difference and race is genetic vignettes. It was hypothesized that for both vignettes, 
greater vignette acceptance will be associated with greater RBM individual-level effectiveness 
belief. Table 5.21 shows that the interaction term for the genetic health difference dummy 
variable (with race is genetic as the referent category) and the vignette acceptance scale variable 
indicates that there may be differences in the association between vignette acceptance and RBM 
individual-level effectiveness for respondents who received the genetic health difference vignette 
when compared to those who received the race is genetic vignette (β = -.297, SE = .174, p < .10).  
This difference, however, was not statistically significant, thereby technically indicating support 
for Hypothesis 5b that there is no significant difference between the two vignettes in the 
association between vignette acceptance and RBM individual-level effectiveness. 
The separate regression models examining the association between vignette acceptance 
and RBM individual-level effectiveness for the genetic health difference and race is genetic 
vignettes show that while vignette acceptance is significantly associated with RBM individual-
level effectiveness for the race is genetic respondents, there was no association between the two 
for respondents assigned to the genetic health difference vignette.  Therefore, although the 
interaction term between the vignette acceptance scale and the vignette dummy variable was not 
statistically significant, indicating support for Hypothesis 5b, the lack of association between 
vignette acceptance and RBM individual-level effectiveness for the genetic health difference 
vignette respondents also indicates that vignette acceptance may in fact moderate the relationship 




Table 5.21: Multiple linear regression estimates, standard errors, and R2 for models 
examining vignette acceptance as moderator of genetic health difference versus race is 
genetic vignettes on RBM individual-level effectiveness (n = 292). 
 β SE β SE
 
 
Intercept .869* .393 .433 .405 
Genetic Health Difference 
Vignette 
-.007 .110 .861† .517 
Black -.295 .181 -.319† .180 
Sex .037 .115 .018 .111 
Education .076* .037 .076* .037 
Age .007* .004 .007† .004 
Vignette Acceptance .200* .101 .361*** .073 
Genetic Health Difference * 
Vignette Acceptance 
-- -- -.297† .174 
R2 for model .127 .141 
†P < .10, *P < .05, **P < .01, ***P < .001. 
 
 
5.3.2.3  Acceptance of Vignette’s Effect on RBM Individual-Level Effectiveness: Admixture 
Versus Race is Genetic Vignettes 
Hypothesis 5c contends that there will be a significant difference between the admixture 
and race is genetic vignettes in the association between vignette acceptance and RBM 
individual-level effectiveness.  It proposes that greater acceptance of the admixture vignette will 
be associated with lower endorsement of RBM individual-level effectiveness, while greater 
acceptance of the race is genetic vignette will be associated with higher endorsement of RBM 
individual-level effectiveness.  Table 5.22 presents the results of the multiple linear regression 




RBM individual-level effectiveness.  The estimate for the interaction term between vignette 
acceptance and the admixture vignette dummy variable (with the race is genetic vignette as the 
referent category) indicates that vignette acceptance does moderate the relationship between the 
two variables (β = -.458, SE = .130, p < .001).   
Table 5.22: Multiple linear regression estimates, standard errors, and R2 for models 
examining vignette acceptance as moderator of admixture versus race is genetic vignettes on 
RBM individual-level effectiveness (n = 251). 
 β SE β SE
 
 
Intercept 1.363*** .371 .694† .399 
Admixture Vignette -.006 .099 1.338*** .369 
Black -.494** .171 -.505** .169 
Sex .173† .101 .138 .099 
Education .070* .032 .074* .033 
Age .002 .003 .001 .003 
Vignette Acceptance .125 .076 .363*** .074 
Admixture * Vignette 
Acceptance 
-- -- -.458*** .130 
R2 for model .140 .183 
†P < .10, *P < .05, **P < .01, ***P < .001. 
 
Separate regression models were then conducted with the admixture vignette respondents 
and the race is genetic vignette respondents to assess their respective associations between the 
vignette acceptance scale and RBM individual-level effectiveness.  Table 5.20 presents the 
results of these models.  The vignette-specific regression models indicate that vignette 




received the admixture vignette, however, it was positively associated with RBM individual-
level effectiveness for respondents who received the race is genetic vignette (p < .001). Among 
the race is genetic respondents, those who were more likely to accept the idea that there is a 
genetic basis to race, as discussed in this mock news article, were more likely to believe that 
RBM is effective at the individual level.  Acceptance of the concept of racial admixture, as 
described in the admixture vignette, seemed to have no association with RBM individual-level 
effectiveness belief.  Hypothesis 5c contended, in part, that lower vignette acceptance would be 
associated with greater endorsement of RBM individual-level effectiveness among admixture 
vignette respondents, however, this was not the case. Despite the lack of support for this part of 
the hypothesis, the results indicate that vignette acceptance does moderate the relationship 
between type of vignette received and RBM individual-level effectiveness for admixture versus 
race is genetic vignettes.  Hypothesis 5c is therefore otherwise supported by the findings. 
 
5.3.2.4  Acceptance of Vignette’s Effect on RBM Behavioral Orientation: Social Construction 
Versus Race is Genetic Vignettes 
Hypothesis 5a was tested for RBM behavioral orientation by regressing RBM behavioral 
orientation on the social construction dummy variable (with the race is genetic vignette as the 
referent category), vignette acceptance scale and the interaction term between the two variables. 
The multiple linear regression model was also adjusted for race, sex, education and age.  Table 
5.23 presents the estimates and standard errors for this regression model.  The estimate for the 
interaction term between the social construction dummy variable and vignette acceptance scale 




received (social construction versus race is genetic) and RBM behavioral orientation (β = -.510, 
SE = .184, p < .01).  
Table 5.23: Multiple linear regression estimates, standard errors, and R2 for models 
examining vignette acceptance as moderator of social construction versus race is genetic 
vignettes on RBM behavioral orientation (n = 264). 
 β SE β SE
 
 
Intercept 2.961*** .550 2.240*** .619 
Social Construction 
Vignette 
-.065 .133 1.457* .577 
Black -.500* .194 -.481* .185 
Sex .164 .142 .128 .142 
Education -.021 .035 -.016 .033 
Age .002 .004 .000 .004 
Vignette Acceptance .103 .090 .365** .128 
Social Construction * 
Vignette Acceptance 
-- -- -.510** .184 
R2 for model .054 .082 
†P < .10, *P < .05, **P < .01, ***P < .001. 
 
Separate regression models were then conducted with the social construction vignette 
respondents and the race is genetic vignette respondents to assess their respective associations 
between the vignette acceptance scale and RBM behavioral orientation.  Table 5.24 presents the 
results of these models.  The vignette-specific regression models indicate that vignette 
acceptance was not associated with RBM behavioral orientation for respondents who received 




orientation for respondents who received the race is genetic vignette (p < .01). Among the race 
is genetic respondents, those who were more likely to accept the idea that there is a genetic basis 
to race, as discussed in this mock news article, were more likely to prefer to use RBM.  
Acceptance of the concept of race as being socially constructed, as described in the social 
construction vignette, seemed to have no association with preference for using RBM.  
Hypothesis 5a contended, in part, that lower vignette acceptance would be associated with 
greater preference for using RBM among social construction vignette respondents, however, this 
was not the case. Despite the lack of support for this part of the hypothesis, the results indicate 
that vignette acceptance does modify the relationship between type of vignette received and 





Table 5.24: Multiple linear regression estimates by vignette condition for the vignette 
acceptance scale regressed on RBM behavioral orientation. 
 Race Is Genetic 
                             
(n = 132) 
Social 
Construction 
(n = 132) 
Genetic Health 
Difference 
(n = 158) 
Admixture 
                             
(n = 118) 
 β SE β SE β SE β SE 
Intercept 2.028* .815 4.198*** .705 2.847** .946 2.553*** .665 
Black -.658** .247 -.207 .283 -.400 .459 -.988* .430 
Sex .024 .195 .350† .192 .064 .243 .340† .187 
Education .014 .052 -.072 .045 .002 .073 .008 .056 
Age -.001 .007 -.001 .006 .003 .007 .008 .006 
Vignette 
Acceptance 
.380** .123 -.142 .127 .025 .199 -.015 .123 
R2 .120 .071 .020 .179 




5.3.2.5  Acceptance of Vignette’s Effect on RBM Behavioral Orientation: Genetic Health 
Difference Versus Race is Genetic Vignettes 
Hypothesis 5b contends that there will not be a significant difference between the genetic 
health difference and race is genetic vignettes in the association between vignette acceptance and 
RBM behavioral orientation. It was hypothesized that for both vignettes, greater vignette 
acceptance will be associated with greater preference for using RBM. Table 5.25 shows that the 
interaction term for the genetic health difference dummy variable (with race is genetic as the 
referent category) and the vignette acceptance scale variable indicates that there is no significant 
difference in the association between vignette acceptance and RBM behavioral orientation for 
respondents who received the genetic health difference vignette when compared to those who 
received the race is genetic vignette (β = -.360, SE = .230, p = .120).  The lack of significant 
difference between the two vignettes in the association between vignette acceptance and RBM 
behavioral orientation indicates support for Hypothesis 5b. 
Notably, the separate regression models examining the association between vignette 
acceptance and RBM behavioral orientation for the genetic health difference and race is genetic 
vignettes show that while vignette acceptance is significantly associated with RBM behavioral 
orientation for the race is genetic respondents (p < .01), there was no association between the 
two for respondents assigned to the genetic health difference vignette.  Therefore, although the 
interaction term between the vignette acceptance scale and the vignette dummy variable was not 
statistically significant, indicating support for Hypothesis 5b, the lack of association between 
vignette acceptance and RBM behavioral orientation for the genetic health difference vignette 
respondents also indicates that vignette acceptance may in fact moderate the relationship 




Table 5.25: Multiple linear regression estimates, standard errors, and R2 for models 
examining vignette acceptance as moderator of genetic health difference versus race is 
genetic vignettes on RBM behavioral orientation (n = 290). 
 β SE β SE
 
 
Intercept 2.523*** .648 1.993** .714 
Genetic Health Difference 
Vignette 
-.118 .151 .936 .698 
Black -.500* .251 -.529* .241 
Sex .065 .167 .042 .161 
Education .005 .050 .005 .049 
Age .002 .005 .002 .005 
Vignette Acceptance .175 .132 .371** .129 
Genetic Health Difference * 
Vignette Acceptance 
-- -- -.360 .230 
R2 for model .051 .063 
†P < .10, *P < .05, **P < .01, ***P < .001. 
 
 
5.3.2.6  Acceptance of Vignette’s Effect on RBM Behavioral Orientation: Admixture Versus Race 
is Genetic Vignettes 
Hypothesis 5c contends that there will be a significant difference between the admixture 
and race is genetic vignettes in the association between vignette acceptance and RBM behavioral 
orientation.  It proposes that greater acceptance of the admixture vignette will be associated with 
lower endorsement of RBM behavioral orientation, while greater acceptance of the race is 
genetic vignette will be associated with higher endorsement of RBM behavioral orientation.  




as a moderator of the association between vignette type and RBM behavioral orientation.  The 
estimate for the interaction term between vignette acceptance and the admixture vignette dummy 
variable (with the race is genetic vignette condition as the referent category) indicates that 
vignette acceptance does moderate the relationship between vignette received and RBM 
behavioral orientation (β = -.359, SE = .176, p < .05).   
Table 5.26: Multiple linear regression estimates, standard errors, p-values and R2 for 
models examining vignette acceptance as moderator of admixture versus race is genetic 
vignettes on RBM behavioral orientation (n = 250). 
 β SE β SE
 
 
Intercept 2.402*** .547 1.876** .664 
Admixture Vignette -.149 .137 .906† .535 
Black -.778** .265 -.786** .258 
Sex .201 .144 .175 .142 
Education .010 .040 .013 .039 
Age .004 .005 .003 .005 
Vignette Acceptance .158 .100 .345** .126 
Admixture * Vignette 
Acceptance 
-- -- -.359* .176 
R2 for model .117 .131 
†P < .10, *P < .05, **P < .01, ***P < .001. 
 
Separate regression models were then conducted with the admixture vignette respondents 
and the race is genetic vignette respondents to assess their respective associations between the 
vignette acceptance scale and RBM behavioral orientation.  Table 5.24 presents the results of 




associated with RBM behavioral orientation for respondents who received the admixture 
vignette, however, it was positively associated with RBM behavioral orientation for respondents 
who received the race is genetic vignette (p < .01). Among the race is genetic respondents, those 
who were more likely to accept the idea that there is a genetic basis to race, as discussed in this 
mock news article, were more likely to prefer to use RBM.  Acceptance of the concept of racial 
admixture, as described in the admixture vignette, seemed to have no association with preference 
for using RBM.  Hypothesis 5c contended, in part, that lower vignette acceptance would be 
associated with greater preference for using RBM among admixture vignette respondents, 
however, this was not the case. Despite the lack of support for this part of the hypothesis, the 
results indicate that vignette acceptance does modify the relationship between type of vignette 
received and RBM behavioral orientation for admixture versus race is genetic vignette types.  
Hypothesis 5c is therefore supported by the findings. 
 
5.3.2.7  Acceptance of Vignette’s Effect on RBM Population-Level Effectiveness: Social 
Construction Versus Race is Genetic Vignettes 
Hypothesis 5a was tested for RBM population-level effectiveness by regressing RBM 
population-level effectiveness on the social construction dummy variable (with the race is 
genetic vignette as the referent category), vignette acceptance scale and the interaction term 
between the two variables. The multiple linear regression model was also adjusted for race, sex, 
education and age.  Table 5.27 presents the estimates and standard errors for this regression 
model.  The estimate for the interaction term between the social construction dummy variable 




relationship between type of vignette received (social construction versus race is genetic) and 
RBM population-level effectiveness (β = -.569, SE = .212, p < .01).  
 
Table 5.27: Multiple linear regression estimates, standard errors, and R2 for models 
examining vignette acceptance as moderator of social construction versus race is genetic 
vignettes on RBM population-level effectiveness (n = 265). 
 β SE β SE
 
 
Intercept 2.941*** .545 2.131*** .549 
Social Construction 
Vignette 
-.081 .144 1.615* .654 
Black -.190 .254 -.170 .239 
Sex .171 .144 .128 .141 
Education -.113* .044 -.107* .042 
Age .004 .004 .003 .004 
Vignette Acceptance .135 .107 .431** .123 
Social Construction * 
Vignette Acceptance 
-- -- -.569** .212 
R2 for model .052 .084 
†P < .10, *P < .05, **P < .01, ***P < .001. 
 
Separate regression models were then conducted with the social construction vignette 
respondents and the race is genetic vignette respondents to assess their respective associations 
between the vignette acceptance scale and RBM population-level effectiveness.  Table 5.28 
presents the results of these models.  The vignette-specific regression models indicate that 




who received the social construction vignette, however, it was positively associated with RBM 
population-level effectiveness for respondents who received the race is genetic vignette (p < 
.001). Among the race is genetic respondents, those who were more likely to accept the idea that 
there is a genetic basis to race, as discussed in this mock news article, were more likely to 
believe that RBM could be effective at reducing health inequalities.  Acceptance of the concept 
of race as being socially constructed, as described in the social construction vignette, seemed to 
have no association with belief regarding RBM’s effectiveness at the population level.  
Hypothesis 5a contended that lower vignette acceptance would be associated with endorsement 
of RBM population-level effectiveness among social construction vignette respondents, 
however, this was not the case. Despite the lack of support for this part of the hypothesis, the 
results indicate that vignette acceptance does moderate the relationship between type of vignette 
received and RBM population-level effectiveness.  Hypothesis 5a is therefore supported by the 





Table 5.28: Multiple linear regression estimates by vignette condition for the vignette 
acceptance scale regressed on RBM population-level effectiveness. 
 Race Is Genetic 
                             
(n = 133) 
Social 
Construction 
(n = 132) 
Genetic Health 
Difference 
(n = 159) 
Admixture 
                             
(n = 117) 
 β SE β SE β SE β SE 
Intercept 2.070** .761 3.754*** .744 .884 .767 2.199** .679 
Black -.276 .237 -.074 .409 -.555† .305 -.709* .281 
Sex .050 .171 .231 .225 -.267 .197 .036 .185 
Education -.074 .066 -.152* .061 .091 .059 .052 .047 
Age -.004 .005 .009 .006 .013* .006 .007 .006 
Vignette 
Acceptance 
.463*** .126 -.110 .171 .019 .186 -.238† .126 
R2 .117 .088   .129 .149 
†P < .10, *P < .05, **P < .01, ***P < .001. 
 
5.3.2.8  Acceptance of Vignette’s Effect on RBM Population-Level Effectiveness: Genetic Health 
Difference Versus Race is Genetic Vignettes 
Hypothesis 5b contends that there will not be a significant difference between the genetic 
health difference and race is genetic vignettes in the association between vignette acceptance and 
RBM population-level effectiveness. It was hypothesized that for both vignettes, greater vignette 




effective at reducing health inequalities. Table 5.29 shows that the interaction term for the 
genetic health difference dummy variable (with race is genetic as the referent category) and the 
vignette acceptance scale variable indicates that there is no significant difference in the 
association between vignette acceptance and RBM population-level effectiveness for 
respondents who received the genetic health difference vignette when compared to those who 
received the race is genetic vignette (β = -.372, SE = .229, p = .106).  The lack of significant 
difference between the two vignettes in the association between vignette acceptance and RBM 
population-level effectiveness indicates support for Hypothesis 5b. 
Once again, notably, the separate regression models examining the association between 
vignette acceptance and RBM population-level effectiveness for the genetic health difference 
and race is genetic vignettes show that while vignette acceptance is significantly associated with 
RBM population-level effectiveness for the race is genetic respondents (p < .001), there was no 
association between the two for respondents assigned to the genetic health difference vignette.  
Therefore, although the interaction term between the vignette acceptance scale and the vignette 
dummy variable was not statistically significant, indicating support for Hypothesis 5b, the lack 
of association between vignette acceptance and RBM behavioral orientation for the genetic 
health difference vignette respondents also indicates that vignette acceptance may in fact 







Table 5.29: Multiple linear regression estimates, standard errors and R2 for models 
examining vignette acceptance as moderator of genetic health difference versus race is 
genetic vignettes on RBM population-level effectiveness (n = 292). 
 β SE β SE
 
 
Intercept 1.425* .619 .871 .650 
Genetic Health Difference 
Vignette 
-.211 .152 .880 .690 
Black -.258 .223 -.288 .215 
Sex -.071 .150 -.096 .146 
Education .017 .052 .017 .050 
Age .004 .005 .004 .005 
Vignette Acceptance .245† .130 .450** .135 
Genetic Health Difference * 
Vignette Acceptance 
-- -- -.372 .229 
R2 for model .058 .073 
†P < .10, *P < .05, **P < .01, ***P < .001. 
 
5.3.2.9  Acceptance of Vignette’s Effect on RBM Population-Level Effectiveness: Admixture 
Versus Race is Genetic Vignettes 
Hypothesis 5c contends that there will be a significant difference between the admixture 
and race is genetic vignettes in the association between vignette acceptance and RBM 
population-level effectiveness.  It proposes that greater acceptance of the admixture vignette will 
be associated with lower endorsement of RBM population-level effectiveness, while greater 
acceptance of the race is genetic vignette will be associated with higher endorsement of RBM 
population-level effectiveness.  Table 5.30 presents the results of the multiple linear regression 




RBM population-level effectiveness.  The estimate for the interaction term between vignette 
acceptance and the admixture vignette dummy variable (with the race is genetic vignette 
condition as the referent category) indicates that vignette acceptance does moderate the 
relationship between vignette received and RBM population-level effectiveness (β = -.648, SE = 
.190, p = .001).   
Table 5.30: Multiple linear regression estimates, standard errors and R2 for models 
examining vignette acceptance as moderator of admixture versus race is genetic vignettes on 
RBM population-level effectiveness (n = 250). 
 β SE β SE
 
 
Intercept 2.107*** .593 1.160† .630 
Admixture Vignette -.195 .147 1.707** .553 
Black -.406† .243 -.421† .226 
Sex .085 .147 .034 .139 
Education -.006 .051 -.001 .047 
Age .003 .005 .002 .005 
Vignette Acceptance .098 .113 .439** .131 
Admixture * Vignette 
Acceptance 
-- -- -.648** .190 
R2 for model .045 .097 
†P < .10, *P < .05, **P < .01, ***P < .001. 
 
Separate regression models were then conducted with the admixture vignette respondents 
and the race is genetic vignette respondents to assess their respective associations between the 
vignette acceptance scale and RBM population-level effectiveness.  Table 5.28 presents the 




acceptance was negatively associated with RBM behavioral orientation for respondents who 
received the admixture vignette (β = -.238, SE = .126, p = .062). Although it was not statistically 
significant at the .05-level, admixture vignette respondents who were more likely to accept the 
concept of admixture, as described in the vignette, were less likely to endorse RBM’s potential 
effectiveness at reducing health disparities.  Vignette acceptance was positively associated with 
RBM population-level effectiveness for respondents who received the race is genetic vignette (p 
< .001). Among the race is genetic respondents, those who were more likely to accept the idea 
that there is a genetic basis to race, as discussed in the vignette, were more likely to endorse 
RBM population-level effectiveness.  The results indicate that vignette acceptance does moderate 
the relationship between type of vignette received and RBM population-level effectiveness for 
admixture versus race is genetic vignette types, thus, Hypothesis 5c for RBM population-level 
effectiveness is supported by the findings. 
 
5.3.3  Summary of Results 
 Because of the substantial number of results presented in this chapter examining the race 
vignette experiment’s effects on RBM-related beliefs and attitudes, Tables 5.31-5.34 respectively 
summarize the results for the following: the vignettes’ effects on RBM beliefs and attitudes by 
vignette condition for total respondents, as well as by race, in each condition; racial differences 
in RBM beliefs and attitudes by vignette condition; the vignette acceptance scale’s association 
with RBM beliefs and attitudes by vignette condition; and interaction effects between vignette 




Table 5.31:  Summary of statistically significant and non-significant findings for vignette 
condition’s effect (compared to no-vignette control condition), and effect of overall race 
vignette experiment, on RBM individual-level effectiveness, behavioral orientation and 
population-level effectiveness, for total respondents and by race in each vignette condition 
(see Tables 5.5-5.7, 5.10-5.12, 5.15-5.17 for full results). 












R2Change for Race 
Vignette Experiment  
RBM Individual-Level Effectiveness 
Whites NS a NS NS NS NS 
Blacks NS NS † NS 
Total NS NS NS NS 
RBM Behavioral Orientation 
Whites NS NS NS NS NS 
Blacks NS NS * NS 
Total NS NS NS NS 
RBM Population-Level Effectiveness 
Whites NS NS NS NS NS 
Blacks NS NS NS NS 
Total NS NS NS NS 
a NS = Not Significant. 





Table 5.32: Summary of statistically significant and non-significant findings for white-
black racial differences in RBM individual-level effectiveness, behavioral orientation and 
population-level effectiveness by race vignette experiment vignette condition (see Tables 5.4, 
5.9 and 5.14 for full results). 












(Whites v. Blacks) 
 
* NS a ** NS NS 
RBM Behavioral 
Orientation 
(Whites v. Blacks) 
 
* NS * NS NS 
RBM Population-
Level Effectiveness 
(Whites v. Blacks) 
NS NS * † NS 
a NS = Not Significant. 














Table 5.33: Summary of statistically significant and non-significant findings for RBM 
individual-level effectiveness, behavioral orientation and population-level effectiveness 
regressed on the vignette acceptance scale, by vignette condition (see Tables 5.20, 5.24 and 
5.28 for full results). 







*** NS a NS NS 
RBM Behavioral 
Orientation 
** NS NS NS 
RBM Population-Level 
Effectiveness 
*** NS NS † 
a NS = Not Significant. 





Table 5.34: Summary of statistically significant and non-significant findings for RBM 
individual-level effectiveness, behavioral orientation and population-level effectiveness 
regressed on interaction between the vignette acceptance scale and vignette condition (with 
the race is genetic vignette as referent category) (see Tables 5.19, 5.21-5.23, 5.25-5.27, 5.29-
5.30 for full results). 
 Vignette Acceptance * 
(Race Is Genetic v. 
Social Construction) 
Vignette Acceptance * 
(Race Is Genetic v. 
Genetic Health 
Difference) 
Vignette Acceptance * 













** NS ** 
a NS = Not Significant. 




5.4  Discussion 
Because RBM has not been broadly integrated into the U.S. healthcare system, 
presumably, most participants in the vignette experiment had little to no familiarity with RBM.  
If this is the case, then it is possible that their beliefs about RBM’s effectiveness and attitudes 
towards using RBM could be affected by information communicated to them about the 
relationship between race and genetics.  I therefore examined whether or not the race vignette 
experiment had an effect on RBM-related beliefs and attitudes, and if it did, to what extent the 
experiment affected these beliefs and attitudes.  
The results of the race vignette experiment’s effect on RBM beliefs and attitudes were 
mixed.  At first glance, it seems that the vignettes did not affect RBM beliefs and attitudes on the 
sample as a whole.  According to the R2Change values, the addition of the vignette experiment to 
the multiple linear regression models for each RBM dependent variable indicated that the 
experiment as a whole did not have an effect on RBM beliefs and attitudes.  The total sample 
means for RBM individual-level effectiveness, behavioral orientation and population-level 
effectiveness also did not substantially differ by vignette.  The lack of difference between means 
by vignette condition was also the case for the white sub-sample, however for the black sub-
sample, some of the vignette conditions were associated with substantially lower means for the 
RBM dependent variables compared to the other conditions in the race vignette experiment. This 
indicates that the vignettes may in fact have had differential effects on RBM beliefs and attitudes 
depending on the race of the respondent.  Furthermore, the results from the vignette acceptance 
analyses showed that acceptance of the race is genetic vignette was strongly associated with 




race and genes can affect RBM beliefs and attitudes.  The following is a discussion of the results 
of the race vignette experiment’s effect on RBM beliefs and attitudes. 
 
5.4.1 Race Vignette Experiment’s Effects on RBM Beliefs and Attitudes 
I hypothesized in Aim 4 that the vignette experiment would affect RBM-related beliefs 
and attitudes to the extent that respondents would vary in their endorsement of these constructs 
depending on the type of vignette they had received.  Aim 4 results, however, indicated that 
overall the vignette experiment did not have a significant effect on RBM individual-level 
effectiveness, behavioral orientation or population-level effectiveness for the sample as a whole 
or by race.  Because the experiment overall did not have statistically significant effects on the 
RBM dependent variables, genetic essentialist beliefs in racial differences was not tested as a 
mediator, and hypotheses predicting significant differences between individual vignette 
conditions were not tested.   
The means by vignette condition for the total sample did not significantly vary for any of 
the three RBM dependent variables.  Why this was the case warrants some attention, particularly 
because in a related study of the race vignette experiment’s impact on beliefs in essential racial 
differences (Phelan, Link and Feldman, 2013; Phelan, Link, Johnson and Yang, under review), 
beliefs in essential racial differences did vary depending on the vignette condition to which study 
participants were assigned. This study by Phelan and colleagues showed that exposure to the 
race is genetic, admixture and genetic health difference vignettes resulted in greater beliefs in 
essential racial differences among white study participants when compared to those assigned to 




level of essential racial differences beliefs was higher than that of the white participants, 
however, exposure to the vignette conditions resulted in approximately similar means for these 
beliefs when compared to the white participants. This indicates that the race vignette experiment 
had approximately the same effect on belief in essential racial differences regardless of whether 
the respondents were white or black. An analysis of a potential interaction effect between race 
and the vignettes found that there was no interaction effect for race among the vignette 
conditions, thereby verifying that the vignette experiment had similar effects on beliefs in 
essential racial differences for white and black study participants. The results of this related 
study by Phelan and colleagues suggest that the vignette experiment would have a similar effect 
on RBM-related beliefs and attitudes, since I initially proposed that conceptions regarding 
RBM’s effectiveness are predicated on conceptions regarding the genetic or biological basis of 
racial categories, as indicated by Figure 5.1’s causal pathway chart (p. 167).  However, notably, 
the results in Chapter 4’s analysis of baseline-level beliefs and attitudes regarding RBM showed 
that genetic essentialist beliefs was not significantly associated with RBM beliefs and attitudes.  
This finding may explain, in part, the reason why the race vignette experiment did not seem to 
have any overall effect on RBM-related beliefs and attitudes.   
The results of the race vignette experiment’s effect on RBM-related beliefs and attitudes 
instead indicate that lay conceptions regarding RBM’s effectiveness and preferences for using 
RBM, may not necessarily be directly related to beliefs in a genetic basis to race. Perhaps some 
respondents interpreted RBM’s effectiveness to be related to factors other than – or in addition to 
– genes, such as the environment or personal behaviors. It is also possible that because much of 
the public is unfamiliar with the concept of RBM, some of the respondents simply had not 




conceptions of RBM may not have been influenced by exposure to mass media messages that are 
not directly related to the subject of RBM.   
Another possible reason for the vignette experiment’s lack of effect on respondents’ 
RBM-related beliefs and attitudes is that they needed to be exposed to similar mass media 
messages on more than one occasion in order for the messages to have an effect on these 
conceptions (see Chong & Druckman, 2010 for more on differential effects of single versus 
multiple exposures to media messages over time on public opinion). The race vignette 
experiment only examined the effect of a single exposure to the vignette on RBM beliefs and 
attitudes. Content analyses of news stories about race and genes indicate that there have been a 
number of news stories in recent years with similar content to that used in this experiment. 
Therefore, it is plausible to infer that the public would be exposed to a particular message on 
more than one occasion, thereby possibly increasing the potential effect of such messages 
repeated over time on RBM beliefs and attitudes (Caulfield & Harry, 2008; Condit & Lynch, 
2006; Phelan, Link & Feldman, 2013). It should be noted, however, that in Phelan and 
colleagues’ (2013) related study of the race vignette experiment’s effect on beliefs in essential 
racial differences, a single exposure to the assigned vignette was enough to result in significant 
differences in these beliefs depending on the vignette conditions to which respondents were 
assigned.   It is possible that this effect after a single exposure may be due to the fact that the 
items used to measure essential racial differences belief were more familiar to respondents than 
those used to measure RBM beliefs and attitudes. Therefore, in order to better understand the 
extent to which varying messages about race and genes may affect RBM-related beliefs and 
attitudes, further research examining the effects of multiple exposures to a given message about 




Notably, the race vignette experiment’s overall lack of influence on RBM-related beliefs 
and attitudes seemed to be driven by the white sub-sample. The means for the RBM-related 
dependent variables did not vary much by vignette condition for the white sub-sample. However, 
the findings showed that after exposure to either the race is genetic vignette or the admixture 
vignette, there were statistically significant differences between whites and blacks for the RBM-
related dependent variables.  Blacks were significantly less likely than whites to endorse RBM 
individual-level effectiveness, behavioral orientation and population-level effectiveness after 
being exposed to the admixture vignette and significantly less likely to endorse RBM individual-
level effectiveness and behavioral orientation following exposure to the race is genetic vignette. 
Although the R2Change statistics had indicated that the race vignette experiment overall did not 
affect RBM-related beliefs and attitudes among the black sub-sample, the means for RBM 
individual-level effectiveness, behavioral orientation and population-level effectiveness were 
relatively lower for black respondents assigned to the race is genetic and admixture vignettes 
than those for black respondents assigned to the social construction vignette, genetic health 
difference vignette and control condition. The lack of statistically significant findings for the 
race vignette experiment’s overall impact on black respondents’ RBM beliefs and attitudes may 
be the result of small sample sizes for blacks who participated in the vignette experiment, which 
affected the statistical power of the analytical models (Cohen, 1977/1988).  
It is unclear why the race is genetic message seemed to lower endorsement of RBM 
beliefs and attitudes for black respondents. If black respondents had on average rejected this 
vignette message, then lower endorsement of RBM beliefs and attitudes could be explained as a 
possible negative response to the vignette’s message, with black respondents not endorsing RBM 




But, the mean for vignette acceptance among black respondents indicated that on average, blacks 
tended to accept this message. Multiple linear regression results also indicated that there were no 
significant differences in vignette acceptance rates for the various vignette conditions among 
black respondents, although it is possible that because of the small sample size for the black 
population in this study, the analyses were unable to detect differences that nonetheless exist.  
Among black respondents, the admixture vignette was also associated with lower 
endorsement of RBM-related beliefs and attitudes. This is in contrast to Phelan et al.’s (under 
review) findings that the admixture vignette led to increased belief in essential racial differences. 
It seems that black respondents may have focused on the message that race is clinal and that 
most Americans are of mixed race, when evaluating the ideas of whether or not RBM could be 
effective and preferences for using RBM. This idea of believing that RBM could not be effective 
because most Americans are of mixed race is not necessarily inconsistent with also believing that 
there is a genetic basis to race (which is also suggested by the admixture vignette).  This could 
explain why black respondents assigned to the admixture vignette condition simultaneously 
believed RBM is not effective but also had an increased belief in essential racial differences (as 
found in the Phelan et al. study) following exposure to the vignette. 
The consequence of this finding that the race is genetic and admixture vignettes could 
lower black respondents’ endorsement of the three RBM dependent variables is that how the 
relationship between race and genes is discussed in the news has the potential to affect RBM-
specific beliefs and attitudes among the black population in the U.S.  Notably, Phelan, Link and 
Feldman (2013) and Phelan, Link, Johnson and Yang (under review) respectively showed that 




following the completion of the Human Genome Project, and that a substantial portion of these 
articles were about direct-to-consumer ancestry tests/admixture testing.  In addition to Phelan et 
al.’s (2013) finding that articles about race and genetics have been on the rise during the past two 
to three decades, there is also evidence to suggest that messages similar to the race is genetic 
vignette had specifically been on the rise during and following the completion of the Human 
Genome Project.  Condit and Lynch’s (2006) content analysis of articles about race and genes 
showed that there was a rise in articles that were slanted towards the position that there is a 
genetic basis to racial categories in the years during and following the completion of the Human 
Genome Project.  
The increase in news stories presenting messages similar to those presented in the race is 
genetic and admixture vignettes suggests that the American public has been increasingly exposed 
to news stories that have the potential to decrease belief in RBM’s effectiveness and preferences 
for using RBM among non-Hispanic black Americans specifically.  If the intent behind 
developing and integrating RBM into the practice of medicine is to improve race-specific health 
inequalities (which is an argument that is meant to particularly resonate among racial and ethnic 
minorities who carry the burden of poorer health outcomes),  then RBM supporters would need 
to take note that the black population in the U.S. may be less receptive towards using RBM 
depending on the extent to which they are exposed to mass media messages about race and 
genetics that are similar to those presented in the race is genetic and admixture vignettes.  
The results examining the race vignette experiment’s effects on RBM-related beliefs and 
attitudes indicate that single exposure to the assigned vignette condition had no effect for the 




to have some effect on RBM-related beliefs and attitudes for the black sub-sample, although not 
in expected directions. These findings suggest that while white and black Americans may not 
significantly differ in their beliefs about RBM’s individual-level effectiveness or behavioral 
orientation (as indicated by the results in Chapter 4), mass media coverage of the relationship 
between race and genes may differentially affect these beliefs and attitudes depending on 
whether an individual identifies as white or black.  
 
5.4.2 Vignette Acceptance as Moderator 
Aim 5 hypothesized that acceptance or rejection of the messages communicated 
regarding the relationship between race and genes would have differential effects on RBM-
related beliefs and attitudes depending on the vignette condition to which respondents were 
assigned.  The results indicated support for Aim 5’s hypotheses. Based on the findings, vignette 
acceptance is a moderator of type of vignette received and RBM beliefs and attitudes.  
Notably, a significantly smaller proportion of respondents accepted the race is genetic 
vignette message in comparison to the other three vignette messages (57.9 percent for the race is 
genetic vignette, versus, 73.7 percent for the admixture vignette, 74.4 percent for the genetic 
health difference vignette and 81.3 percent for the social construction vignette). This suggests 
lower social acceptability of the race is genetic vignette’s message and as such, can be 
characterized as the comparatively more controversial conception of race.  The controversial 
nature of the race is genetic message may have influenced respondents assigned to this vignette 
to think more critically about their conceptions of race, consequently sensitizing respondents to 




Hypotheses 5a and 5c predicted that higher vignette acceptance would be associated with 
lower endorsement of RBM individual-level effectiveness, behavioral orientation and 
population-level effectiveness for respondents respectively randomized to the social construction 
and admixture vignettes, while higher vignette acceptance would be associated with higher 
endorsement of the three RBM dependent variables for those who were randomized to the race is 
genetic vignette.  Because the social construction vignette specifically rejects the notion that 
there are genetic differences between racial groups, and the admixture vignette message can be 
interpreted to mean that most people – at least in the United States – are of mixed genetic 
heritages, the two hypotheses contended that greater acceptance of these vignette messages 
would lead to the belief that RBM should not be effective, since RBM implies that there are 
genetically distinct racial groups.  Along these lines, hypotheses 5a and 5c predicted that greater 
acceptance of the race is genetic vignette message would be positively associated with the three 
RBM dependent variables because if there are distinct genetic differences between racial groups, 
then variations in treatment effectiveness depending on patients’ racial heritages seem plausible.  
However, while the results indicated that hypotheses 5a and 5c were correct in predicting 
that vignette acceptance is positively associated with the RBM dependent variables for 
respondents assigned to the race is genetic vignette, for respondents assigned to the social 
construction and admixture vignettes, vignette acceptance had no association with RBM beliefs 
and attitudes.  Because the messages expressed in the latter two vignettes did not speak directly 
to the concept of RBM, it is possible that some respondents did not make a connection between 
these two messages and conceptions regarding RBM.  Meanwhile, as previously noted, the 
controversial nature of the race is genetic message could have prompted respondents assigned to 




The controversy surrounding the race is genetic message could explain why there was a strong 
association between vignette acceptance and the RBM dependent variables only for respondents 
exposed to the race is genetic vignette and not the social construction or admixture vignettes. 
While the findings indicated that vignette acceptance moderated the association between 
the vignette experiment and RBM beliefs and attitudes, only acceptance or rejection of the more 
controversial race is genetic vignette message influenced the RBM dependent variables, whereas 
acceptance or rejection of the less controversial social construction and admixture vignette 
messages seemed to have no systematic influence on RBM beliefs and attitudes. Although 
different types of messages regarding the relationship between race and genetics have been 
presented in the mass media over the years, a previous mass media study of race and genetics 
news stories has shown that while both the position that race is genetic and that race is socially 
constructed can be found in the news media, presentations of this subject have tended to be 
slanted in the direction that there is a genetic basis to race (Condit & Lynch, 2006). Because this 
particular conception of race and genes has been dominant in the more recent news media, and, 
this vignette experiment indicated that more than half of the race is genetic vignette respondents 
accepted the vignette’s message as accurate, it is possible that increasing coverage of articles 
discussing the relationship between race and genes has led to increasing beliefs that RBM is 
effective among those who have followed mass media’s coverage of news about race and 
genetics generally, as well as RBM-related news specifically. 
Hypothesis 5b predicted that there would be no difference in the association between 
vignette acceptance and RBM beliefs and attitudes for respondents assigned to the genetic health 




health difference vignette implies, albeit indirectly, that there is some genetic basis to racial 
difference (in this case a health-related difference) and therefore, just like as was predicted for 
the race is genetic vignette, greater acceptance of this vignette would be associated with greater 
endorsement of RBM beliefs and attitudes.  Statistically, the results indicated support for this 
hypothesis – the interaction terms in the multiple linear regression models showed that there was 
no significant difference between the race is genetic and genetic health difference vignettes in 
the association between vignette acceptance and RBM-related beliefs and attitudes. However, 
vignette acceptance was not significantly associated with any of the three RBM dependent 
variables among the genetic health difference vignette respondents, whereas they were 
significantly associated with all three RBM dependent variables for the respondents assigned to 
the race is genetic vignette. Therefore, despite the lack of significant difference between these 
two vignettes, unlike the race is genetic vignette, the results for the genetic health difference 
vignette indicate that there was no clear evidence to suggest that mass media coverage of race-
specific genetic health differences would be associated with greater endorsement of RBM’s 
effectiveness at the individual and population levels and preferences for using RBM.  
Prior research on mass media’s effects on public opinion has shown that the public is 
more likely to accept messages that are consistent with their own beliefs and reject messages that 
are inconsistent. McQuail (1979) in his study of mass media effects on public opinion contends 
that media campaigns that are the most successful tend to be those that either reinforce existing 
beliefs and attitudes or only slightly redirect these beliefs and attitudes. Highly slanted messages 
that do not reinforce one’s beliefs and attitudes, therefore, are less likely to produce change. 
Zaller (1992) notes that with respect to political campaigns, the public tends to resist arguments 




conceptions of race are political may vary depending on the context, race-related policies and the 
attitudes and beliefs that result in support or opposition to these policies are most certainly 
political.  Thus, it is possible that just like mass media effects on lay political opinions, much of 
the public would resist mass media messages about race that are inconsistent with their own 
conceptions of race.  This may partially explain why rejection of the controversial position that 
there is a genetic basis to race was strongly associated with RBM-related beliefs and attitudes, 
but this was not the case for respondents assigned to the social construction, admixture or even 
genetic health difference vignettes.  
In sum, the vignette experiment’s effect on RBM-related beliefs and attitudes seemed to 
vary depending on the race of the respondents. The vignette experiment had no effect on white 
respondents’ RBM-related beliefs and attitudes, but there was some evidence to suggest 
differences in the vignettes’ effects on RBM-related beliefs and attitudes among the black 
respondents, albeit in an unexpected direction. These findings differ from those found by Phelan 
and colleagues regarding the vignette experiment’s effects on essential racial differences beliefs.  
While in Phelan et al.’s study single exposure to mass media messages about race and genetics 
seemed to increase or decrease belief in essential racial differences depending on the type of 
message that was presented, a single exposure to such messages did not, in turn, influence beliefs 
about RBM in this dissertation study for the white sub-sample, which suggests that belief in 
essential racial differences may not be associated with RBM beliefs and attitudes among the 
white sub-sample, at least not after a single exposure to a message about race and genes.   
RBM-related beliefs and attitudes among the black sub-sample, on the other hand, 




unexpected directions. For both vignettes, these messages seemed to lower belief in RBM’s 
effectiveness and preferences for using RBM, which is in opposition to the vignettes’ effects of 
increasing belief in essential racial differences for the same sample in Phelan and colleagues’ 
studies (2013, under review).  This finding also suggests that there may not be a positive 
association between belief in essential racial differences and RBM-related beliefs and attitudes 
for black Americans, indicating that factors other than beliefs about the relationship between race 
and genes influence black Americans’ beliefs regarding RBM’s effectiveness and preferences for 
using RBM.  Why there would be a discrepancy between whites and blacks for mass media’s 
effects on RBM beliefs and attitudes is an area that warrants further research, as mass media is a 
major source of information on new science and biomedical research findings and their 
applications for the lay public (Condit, 2007; Condit & Bates, 2005; Condit, Parrott & Harris, 
2002; Conrad, 1997; Loo et al., 1998; National Health Council, 1997; Moynihan et al., 2000; 






PART 3: PERSONALIZED GENOMIC MEDICINE BELIEFS AND 
ATTITUDES 
 
6.1  Introduction 
 The findings from Chapter 4’s analysis of RBM beliefs and attitudes showed that whites, 
blacks and Hispanics did not significantly differ in their beliefs regarding the effectiveness of 
RBM and attitudes towards using RBM, with the exception of belief in RBM’s ability to address 
health inequalities. Chapter 5 expanded on this finding of relatively few racial differences in 
RBM-related beliefs and attitudes by examining the extent to which a vignette experiment 
involving mock news articles about different relationships between race and genes had an effect 
on RBM-related beliefs and attitudes and whether there were racial differences in this effect.  
The findings showed that while the vignette experiment did not have an overall effect on RBM 
beliefs and attitudes among the white sub-sample, it did seem to have an effect on the black sub-
sample, as evidenced by lower mean endorsement levels for RBM beliefs and attitudes among 
black respondents exposed to the race is genetic and admixture vignettes compared to the other 
vignette conditions.  This suggests possible racial differences in RBM-related beliefs and 
attitudes in the future if the American public becomes more familiar with RBM and continues to 
be exposed to mass media messages about the relationship between race and genes. This chapter 
expands this body of new research regarding RBM-related beliefs and attitudes by examining the 
extent to which white and black Americans hold similar or different views regarding the 




chapter will also present findings from analyses comparing white and black respondents’ beliefs 
and attitudes regarding PGM with their beliefs and attitudes regarding RBM.   
A better understanding of Americans’ beliefs and attitudes regarding PGM provides an 
important context by which RBM beliefs and attitudes can be evaluated.  We would expect for 
there to be differences between the two, with Americans supporting PGM at greater levels 
because it is tailored to the genomic profiles of individuals rather than to the (controversial and 
contested) genomic profiles of racial or ethnic populations.  However, it is possible that 
Americans would endorse the effectiveness of and preferences for using RBM and PGM at equal 
levels.  Perhaps Americans in general are equally wary of, or enthusiastic about, any new and 
less familiar form of health technology, whether it is a medication that is allegedly more 
effective in a specific racial or ethnic group, or a medication that is based on new genomic 
research findings.  This final results chapter therefore seeks to better understand Americans’ 
beliefs and attitudes regarding RBM by comparing them with those related to PGM.   
There have been several studies that have examined lay conceptions regarding PGM.  
Bevan et al. (2003) in their study of lay beliefs regarding RBM, PGM or the usual course of 
treatment found that when given the choice, 75 percent of study participants preferred to use 
treatments based on individualized genetic testing (i.e., PGM), while 9 percent said they would 
prefer the usual course of treatment.  Only 4 percent said they would prefer to use RBM.  In a 
more recent vignette experiment study, Butrick and colleagues (2011) similarly found that 
respondents were more likely to support use of conventional treatments (i.e., the usual course of 
treatment) than RBM. However, although respondents viewed conventional treatment and PGM 




reluctant than whites to indicate a preference to use PGM compared to conventional treatment. 
The primary reason cited for this reluctance was lack of trust in their physicians. 
Haddy et al.’s (2010) focus group study of members of the public who had a chronic 
medical condition and/or had family members with a chronic medical condition were asked 
about their views on the implementation of PGM.  Overall, participants believed that PGM had 
the potential to improve treatments, but they were concerned about issues of storage and privacy 
of genetic information, as well as the costs involved with PGM.  Rogausch and colleagues’ 
(2006) study of attitudes towards pharmacogenetic testing among German asthma and chronic 
pulmonary disease patients found that 96 percent of study participants appreciated the 
availability of pharmacogenetic testing for diseases like asthma, but 35 percent were fearful of 
potential adverse results, and 36 percent were concerned about privacy issues surrounding the 
results.  They also found social differences in attitudes – females were more likely to have 
fearful attitudes towards pharmacogenetic testing than males, while younger participants were 
more likely to be hopeful about the usefulness of pharmacogenetic testing.  Meanwhile, 
Almarsdóttir and colleagues (2005) found that focus group participants in their study on PGM 
attitudes were generally concerned about the ethical implications of pharmacogenomic drug 
development and use, mostly with respect to equitable access to these drugs and implications for 
local and global health inequalities.  
The literature indicates that there are various social differences in beliefs and attitudes 
regarding PGM. Although the literature is relatively thin regarding potential racial differences in 
PGM-specific beliefs and attitudes, there have been several studies that have examined racial and 




study that examined whites’ and African Americans’ attitudes towards Alzheimer’s disease 
genetic testing found that African Americans overall were less interested in getting tested, 
endorsed fewer reasons for pursuing genetic testing and anticipated fewer negative consequences 
from a negative test result, although this difference may be due more to lower knowledge levels 
and awareness of Alzheimer’s disease among African Americans compared to whites (Hipps et 
al., 2003). Another study that examined white, black and Latina women’s attitudes towards 
genetic testing for various types of cancers found that Latina and black women were more 
concerned than white women about genetic testing abuses, and Latina women were more likely 
than white and black women to agree with statements asserting the disadvantages of genetic 
testing (Thompson et al., 2003).  Sussner, Thompson, Valdimarsdottir, Redd and Jandorf’s 
(2008) study examining the relationship between acculturation and attitudes towards genetic 
testing found that among Latinos and Latinas in the U.S., higher levels of acculturation were 
associated with greater familiarity with genetic testing, greater perceived benefits and lower 
likelihood to cite perceived barriers.   
Prior studies examining racial differences in genetic testing attitudes generally, as well as 
several that have examined racial differences in PGM beliefs and attitudes more specifically, 
indicate that blacks and other racial and ethnic minority populations would be less likely to 
prefer to use PGM than whites, and potentially less likely to endorse PGM’s effectiveness. Other 
studies, however, have suggested that blacks and other racial/ethnic minority groups have at 
times been found to hold favorable beliefs and attitudes with respect to the safety and clinical 
effectiveness of PGM specifically, and other genetic biomedical applications more generally, 
finding little differences in attitudes towards PGM and genetic testing between differing racial 




which there are regional differences associated with genetic testing attitudes found that attitudes 
towards genetic disease testing and ancestry testing were largely due to geographic differences, 
and these differences were not more strongly associated with race/ethnicity, sex, age, educational 
attainment, religion or previous experience with genetic testing/counseling (Jonaissaint et al., 
2010).   
Because to date there has not been a nationally representative study examining beliefs 
and attitudes regarding PGM, as the first nationally representative study of these beliefs and 
attitudes, the following presents important insight into whether racial differences do exist 
regarding PGM-related beliefs and attitudes as well as how they compare with those regarding 
RBM. The following describes the aims that are examined in this chapter:    
Aim 6.  Aim 6 examines whether there are racial differences in PGM individual-level 
effectiveness and behavioral orientation beliefs and attitudes.  Past research has shown some 
racial differences in genetic technology-related beliefs and attitudes.  Differences in genetic 
testing rates among different racial and ethnic groups have been reported (Singer, Antonucci & 
Van Hoewyk, 2004). Because PGM requires genetic testing in order for treatment to be 
personalized to one’s genetic profile, if there currently are racial and ethnic differences in 
utilization of genetic technology, it is possible that there are racial and ethnic differences in 
beliefs about PGM’s effectiveness.  According to Singer and colleagues (2004), although whites 
were more likely to express an interest in using genetic testing, blacks were more likely to 
express specific preferences for using prenatal and adult genetic testing than whites.  However, 
blacks may also hold other beliefs and attitudes that conflict with or over-ride these attitudes in 




medical authority (Hipps et al., 2003; Robert, 2011; Thompson et al., 2003). Despite the mixed 
findings from prior studies regarding racial differences in PGM-specific and related beliefs and 
attitudes, because it has been shown that concerns like cost, discrimination and medical mistrust 
are held by blacks regarding health care and health-related technologies more broadly, it seems 
logical to predict that blacks would be less likely to endorse the effectiveness of PGM and less 
likely to prefer using PGM than whites.  
Hypothesis 6: Whites will be more likely than blacks to endorse the individual-level 
effectiveness of PGM and prefer to use PGM. 
Aim 7.   Aim 7 compares PGM individual-level effectiveness belief and behavioral 
orientation with RBM individual-level effectiveness belief and behavioral orientation.  Much of 
the support among researchers and clinicians for RBM has been grounded in the belief that it is 
an acceptable interim alternative until a system based on PGM can be realized (Burchard et al., 
2003; Risch et al., 2002).  There is currently very little data that examines public beliefs about 
PGM on its own and in comparison to RBM.  Because some in the biomedical industry support 
the idea of RBM as an interim alternative for PGM, it seems reasonable to examine the extent to 
which the public varies in its degree of support for these two forms of medicine.  Two studies 
that examined beliefs and attitudes regarding both RBM and PGM found that respondents 
overwhelmingly preferred PGM in comparison to RBM (Bevan et al., 2003; Butrick et al., 2011). 
I therefore expected to find that respondents in this dissertation study also endorsed PGM beliefs 




Hypothesis 7: PGM individual-level effectiveness and behavioral orientation 
endorsement levels will be greater than those for RBM individual-level effectiveness and 
behavioral orientation.   
 
6.2  Research Design and Methods 
6.2.1  Sample 
 The sample used to analyze Aims 6 and 7 was the same as that used to examine Aims 4 
and 5 in Chapter 5. Once again, this sample was comprised of 632 non-Hispanic white and non-
Hispanic black adults aged 18 or older who were assigned to the race vignette experiment (see 
pp. 168-170 in Chapter 5 to review the details regarding this sample).   
 
6.2.2  Measures 
 The primary independent variable for these analyses is race. The two racial categories are 
white and black.  A dummy variable was created with white as the referent category. All multiple 
regression analyses for Aim 6 were adjusted to control for possible confounding by the following 
socio-demographic variables: sex (male = 1, female = 0), age, educational attainment and 
geographic origin (see p. 81 and p. 94 in Chapter 3 for an in-depth description of the independent 
variable and covariates). Because the respondents were also exposed to vignettes that discussed 
genetics - albeit in the context of race and not PGM - the multiple linear regression analyses 
were also adjusted for vignette received (race is genetic, social construction, admixture and 
genetic health differences) to control for possible confounding as a result of vignette exposure 
(see p. 81 in Chapter 3 for an in-depth description of the race vignette experiment dummy 




effectiveness and PGM behavioral orientation.  Aim 7 analyses also included RBM individual-
level effectiveness and RBM behavioral orientation as dependent variables, as well as the RBM-
PGM individual-level effectiveness difference score and RBM-PGM behavioral orientation 
difference score (see pp. 82-89 in Chapter 3 for an in-depth description of the dependent 
variables used for these analyses).  
 
6.2.3  Analyses 
Analysis of Aim 6. For aim 6, I assessed whether there are racial differences in beliefs 
about PGM individual-level effectiveness and behavioral orientation.  Frequencies and means 
were calculated and multiple linear regression was used to examine whether there are racial 
differences in PGM individual-level effectiveness and behavioral orientation beliefs and attitudes 
(see Table 6.1, Model 35).   The multiple linear regression model was adjusted to control for 
socio-demographic variables (sex, education, age and geographic region) and the vignette 
experiment dummy variables in order to reduce the effect of potential confounding on the 
dependent variables. Although the vignettes used in the race vignette experiment focused on the 
relationship between race and genes and did not discuss PGM, it is possible that some of the 
vignettes could have residual effects on PGM-related beliefs and attitudes. Therefore, all of the 
multiple linear regression analyses that involved the PGM dependent variables were adjusted to 
control for the race vignette experiment.  
Interaction terms were then created between race and each socio-demographic control 
variable other than geographic region.  One reason for why potential interaction effects were 
examined between race and various socio-demographic variables is because prior research has 




variables such as age and sex (Rogausch et al., 2006).  It is possible that these two variables 
would be differentially associated with PGM beliefs and attitudes depending on the race or 
ethnicity of individuals.  Additionally, I wanted to examine whether socioeconomic status (as 
measured by education) would have a differential level of association with the PGM dependent 
variables for white versus black respondents.  It is possible that PGM endorsement among blacks 
may vary differently compared to whites depending on their educational backgrounds.  These 
interaction terms were entered into multiple linear regression models for PGM individual-level 
effectiveness and behavioral orientation in order to assess whether whites and blacks differ in 
terms of the relationships between sex, education and age and both dependent variables (see 
Table 6.1, Model 37).  Model 37 was also adjusted to control for vignette experiment condition. 
Separate analyses were then conducted for the white and black sub-samples, this time examining 
the socio-demographic control variables as independent variables (see Table 6.1, Models 38 and 





Table 6.1: Variables used in Aim 6 multiple linear regression models. 
Variable 
Type 










































































































 The socio-demographic variables are sex (male =1, female = 0), education, age and geographic region.  
b





Analysis of Aim 7.  The purpose of this aim is to compare PGM individual-level 
effectiveness and behavioral orientation beliefs and attitudes with its RBM-related counterparts.  
For this aim, I compared means and frequencies for PGM individual-level effectiveness and 
behavioral orientation scores with those for RBM individual-level effectiveness and behavioral 
orientation scores. These analyses were stratified by race vignette experiment condition as well 
as race.  A crosstabulation analysis among the respondents was also conducted between PGM 
and RBM individual-level effectiveness as well as PGM and RBM behavioral orientation, 
stratified by vignette condition and race, in order to evaluate concordance in beliefs and attitudes 
between the two respective sets of measures. 
Student’s t-tests were conducted to assess whether the mean RBM-PGM individual-level 
effectiveness and behavioral orientation difference scores significantly differed from zero 
(Model 40). Student’s t-tests on the RBM-PGM difference scores allows for us to see if on 
average, the magnitude of difference between individual respondents’ RBM and PGM scores 
were significantly different from zero.  Student’s t-tests were conducted on the RBM-PGM 
difference scores in lieu of paired t-tests between the respective RBM and PGM variables 
because the SPSS Complex Samples module, which was used for all analyses in this dissertation 
study, does not allow for paired t-test analyses.  Due to the complex sampling design of the 
survey, the basic SPSS software package could not be used on the study’s data set.  The 
Student’s t-tests were separately conducted for each race vignette experiment condition in an 
effort to adjust for the potential effects of the vignettes on RBM- and PGM-related beliefs and 
attitudes.  In addition, t-tests were separately conducted by race in order to assess potential 
differences between white and black respondents for the RBM-PGM difference scores by 




Both the RBM-PGM individual-level effectiveness and RBM-PGM behavioral 
orientation difference scores were then regressed on race, adjusting for socio-demographic 
variables and the race vignette experiment, in order to evaluate whether whites and blacks 
significantly differed overall in their difference scores (see Table 6.1, Model 41).  If whites and 
blacks significantly differed in this analysis, then that would show that the amount of difference 
between endorsement levels of RBM and PGM beliefs and attitudes was substantially different 
between white and black Americans despite any potential effects of the vignette experiment on 
endorsement of these two constructs.  
In order to assess whether the race vignette experiment had differential effects on whites 
and blacks in the magnitude, and possibly, direction of respondents’ difference scores, RBM-
PGM individual-level effectiveness and behavioral orientation difference scores were also 
separately regressed on race by race vignette interaction terms, adjusting for socio-demographic 
variables (see Table 6.1, Model 42). If the results of this analysis examining potential interaction 
effects between race and the race vignette experiment on the difference between respondents’ 
RBM and PGM scores were significant, then that would indicate that whites and blacks differ in 
the effect of mass media exposure to messages about race and genes on both RBM and PGM 








6.3  Results 
6.3.1  Aim 6: Beliefs and Attitudes towards Personalized Genomic Medicine 
6.3.1.1  Personalized Genomic Medicine Individual-Level Effectiveness 
 Table 6.2 presents the frequencies, means and standard errors for PGM individual-level 
effectiveness for the sample as a whole as well as by race.  The frequencies show that 
approximately twenty percent more of the white sub-sample in comparison to the black sub-
sample endorsed the belief that PGM would be effective at the individual level (76.9 percent of 
whites versus 57.0 percent of blacks).  The mean PGM individual-level effectiveness scores were 
3.00 (SE = .035) for the white sub-sample and 2.70 (SE = .122) for the black sub-sample, based 
on a range of 1 to 4. 
Table 6.2: Frequencies, means and standard errors for PGM individual-level 
effectiveness belief for total sample and by race: United States, 2009. 
Dependent variables Total, % Whites, % Blacks, % 
Personalized genomic medicine is effective at 
individual level 
(n = 632) (n = 553) (n = 79) 
       Agree 74.4 76.9 57.0 
       Neither agree nor disagree 11.1 10.3 17.7 
       Disagree 14.5 12.8 25.3 





Table 6.3 presents the multiple linear regression models that examined whether or not 
there are racial differences in PGM individual-level effectiveness belief. Model 36 in Table 6.3 
shows that after controlling for sex, education, age, geographical region and the race vignette 
experiment, black respondents were significantly less likely than white respondents to endorse 
PGM individual-level effectiveness (p < .05).  Notably, Model 36 also showed that education 
was positively associated with PGM individual-level effectiveness, indicating that the greater the 
education level of respondents, the more likely they were to endorse PGM’s effectiveness at the 
individual level.   
Table 6.3: PGM individual-level effectiveness regressed on race and race by socio-
demographic variables interaction terms, adjusting for vignette received, for total sample 
(n = 628). 
 Model 36 Model 37 
 β SE β SE 
Intercept 2.496*** .240 2.609*** .245 
Black -.273* .109 -1.602† .822 
Male .030 .067 .022 .069 
Education .052* .021 .043† .022 
Age .003 .002 .003 .002 
Admixture Vignette -.317** .104 -.318** .104 
Social Construction Vignette .190* .093 -.200* .095 




Table 6.3: PGM individual-level effectiveness regressed on race and race by socio-
demographic variables interaction terms, adjusting for vignette received, for total sample 
(n = 628). 
 Model 36 Model 37 
 β SE β SE 
Genetic Health Difference Vignette -.121 .114 -.122 .114 
Northeast -.109 .135 -.115 .136 
Midwest .004 .091 .001 .092 
South -.016 .109 -.016 .107 
Rocky Mountain/Southwest -.013 .125 -.024 .126 
West  -.088 .106 -.089 .107 
Black * Male -- -- .099 .197 
Black * Education -- -- .130† .068 
Black * Age -- -- .000 .005 
Note. All reported results are weighted.  SE = standard error. 
†P < .10, *P < .05, **P < .01, ***P < .001.  
 
 Table 6.3’s Model 37 shows the estimates and standard errors for the model that tests 
possible interaction effects between race and several socio-demographic variables (sex, 
education and age) for PGM individual-level effectiveness.  Model 37 results indicate one 
possible interaction effect between race and education, although this was not significant at the 
.05-level. The separate multiple linear regression models for the white and black sub-samples 




associated with PGM individual-level effectiveness for the white sub-sample, this association 
was not statistically significant at the .05-level.  There was, however, a statistically significant 
positive association between education and PGM individual-level effectiveness for the black 
sub-sample (p < .05). This indicates that the greater the level of educational attainment for the 
black sub-sample, the more likely they were to endorse the belief that PGM would be effective at 
the individual level.  
Notably, black respondents exposed to the race is genetic vignette and admixture vignette 
were significantly less likely than black respondents in the control condition to endorse the belief 
that PGM is effective at the individual level (p < .01). White respondents assigned to the 
admixture vignette were also less likely than white control group respondents to endorse PGM 
individual-level effectiveness belief, however, the race is genetic vignette did not seem to have 
an effect on PGM individual-level effectiveness belief for the white respondents exposed to that 
vignette. The results for the descriptive statistical and multiple linear regression analyses 
collectively indicate support for Hypothesis 6, which predicted that whites would be more likely 












Table 6.4: PGM individual-level effectiveness regressed on socio-demographic variables, 
adjusting for vignette received, by race. 
 Model 38 
White 
(n = 549) 
Model 39 
Black 
(n = 79) 
 β  SE β  SE 
Intercept 2.557*** .244 1.805** .621 
Male .020 .069 .431* .180 
Education .043† .022 .130* .049 
Age .003 .002 -.002 .005 
Admixture Vignette -.227* .096 -1.066** .308 
Social Construction Vignette -.178† .095 -.333 .292 
Race Is Genetic Vignette -.124 .098 -.956*** .256 
Genetic Health Difference Vignette -.104 .122 -.124 .249 
Northeast -.093 .144 -.242 .268 
Midwest .002 .100 .058 .206 
South .037 .107 -.228 .216 
Rocky Mountain/Southwest -.039 .130 .831† .488 
West  -.114 .111 .302 .309 
Note. All reported results are weighted.  SE = standard error. 





6.3.1.2  Personalized Genomic Medicine Behavioral Orientation 
 Table 6.5 presents frequencies, means and standard errors for PGM behavioral 
orientation.  The results show that 92.7 percent of the white sub-sample either somewhat or 
strongly agreed with the attitude that they would prefer to use PGM, while 75.9 percent of the 
black sub-sample somewhat or strongly agreed with this attitude. The mean score for PGM 
behavioral orientation for whites was 3.43 (SE = .045), while for blacks it was substantially 
lower at 3.03 (SE = .165).  
 
Table 6.5: Frequencies, means and standard errors for PGM behavioral orientation for 
total sample and by race: United States, 2009. 
Dependent variables Total, % Whites, % Blacks, % 
Prefer to use personalized genomic medicine (n = 629) (n = 550) (n = 79) 
       Somewhat/Strongly Agree 90.6 92.7 75.9 
       Somewhat/Strongly Disagree 9.4 7.3 24.1 
      Mean (SE) 3.38 (.046) 3.43 (.045) 3.03 (.165) 
 
 Model 36 in Table 6.6 shows that black respondents were, in fact, significantly less likely 
than white respondents to prefer to use PGM (p < .05).  Model 37 in Table 6.6 presents the 
results of the full multiple linear regression model for PGM behavioral orientation that includes 
the interaction terms for race by the socio-demographic variables. The results from this model 




.05). Models 38 and 39 in Table 6.7 present the results for PGM behavioral orientation regressed 
on the socio-demographic variables for the white and black sub-samples respectively.  The 
results show that while there was no association between education and PGM behavioral 
orientation for the white sub-sample, there was a significant positive association between the two 
variables for the black sub-sample indicating, once again, that as educational level attainment 
increased, preferences for using PGM also increased for the black sub-sample but not the white 
sub-sample. 
Table 6.6: PGM behavioral orientation regressed on race and race by socio-demographic 
variables interaction terms, adjusting for vignette received, for total sample (n = 625). 
 Model 36 Model 37 
 β SE β SE 
Intercept 3.369*** .310 3.576*** .327 
Black -.380* .150 -2.724** .024 
Male .044 .090 .038 .091 
Education .013 .025 -.003 .027 
Age .004 .003 .004 .003 
Admixture Vignette -.304* .122 -.304* .118 
Social Construction Vignette -.197† .107 -.223* .106 
Race Is Genetic Vignette -.355** .116 -.350** .110 




Table 6.6: PGM behavioral orientation regressed on race and race by socio-demographic 
variables interaction terms, adjusting for vignette received, for total sample (n = 625). 
 Model 36 Model 37 
 β SE β SE 
Northeast -.092 .157 -.097 .157 
Midwest -.015 .100 -.013 .100 
South -.070 .129 -.068 .125 
Rocky Mountain/Southwest -.008 .130 -.027 .129 
West  -.361* .164 -.355* .166 
Black * Male -- -- .083 .284 
Black * Education -- -- .215* .089 
Black * Age -- -- .004 .006 
Note. All reported results are weighted.  SE = standard error. 











Table 6.7: Personalized genomic medicine behavioral orientation regressed on socio-
demographic variables, adjusting for vignette received, by race. 
 Model 38 
White 
(n = 546) 
Model 39 
Black 
(n = 79) 
 β SE β SE 
Intercept 3.500*** .320 1.928* .725 
























































Note. All reported results are weighted.  SE = standard error. 
†P < .10, *P < .05, **P < .01, ***P < .001.  
 
It is notable, once again, that black respondents exposed to the race is genetic (p < .001) 
or admixture (p < .05) vignettes were significantly less likely than black respondents in the 




also seem to be less likely than white control group respondents to prefer to use PGM, however, 
this was not significant at the .05-level.  Geographic region in which the respondents reside did 
not seem to be associated with PGM behavioral orientation, with the exception of white 
respondents residing in the West coast.  White respondents from the West coast were 
significantly less likely than white respondents from the Southeast to prefer to use PGM. 
Once again, the results for the descriptive statistical and multiple linear regression 
analyses indicate support for Hypothesis 6, which predicted that a greater portion of white 
respondents would prefer to use PGM compared to black respondents. 
 
6.3.2  Aim 7: Comparison of Personalized Genomic Medicine Beliefs and Attitudes with Race-
Based Medicine Beliefs and Attitudes 
6.3.2.1  PGM versus RBM Individual-Level Effectiveness 
In order to compare endorsement levels between PGM individual-level effectiveness and 
RBM individual-level effectiveness, Tables 6.8-6.12 present the means and standard errors for 
the two constructs by race vignette condition as well as by race.  Figures 6.1-6.5 chart the means 
for the total sample and the white and black sub-samples for each of their respective tables.  The 
results indicate that PGM individual-level effectiveness sample means were somewhat to 
substantially higher than those for RBM individual-level effectiveness for each of the vignette 
conditions.  This was case for the total sample in each experimental condition as well as for the 




Table 6.8: Means and standard errors for RBM individual-level effectiveness and PGM 
individual-level effectiveness beliefs among the race vignette experiment control group. 
 RBM Individual-Level 
Effectiveness 
 PGM Individual-Level 
Effectiveness 
 n  SE  n  SE 
Total 84 2.54 .078  85 3.15 .067 
Whites 73 2.55 .088  74 3.15 .074 
Blacks 11 2.50 .168  11 3.16 .125 
 
 
Figure 6.1: Means for total race vignette experiment control group and by race for RBM 


















Table 6.9: Means and standard errors for RBM individual-level effectiveness and PGM 
individual-level effectiveness beliefs among the social construction vignette condition. 
 RBM Individual-Level Effectiveness  PGM Individual-Level Effectiveness 
 n  SE  n  SE 
Total 133 2.44 .062  133 2.93 .057 
Whites 114 2.46 .070  113 2.95 .062 




Figure 6.2: Means for total social construction vignette sample and by race for RBM 


















Table 6.10: Means and standard errors for RBM individual-level effectiveness and PGM 
individual-level effectiveness beliefs among the race is genetic vignette condition. 
 RBM Individual-Level Effectiveness  PGM Individual-Level Effectiveness 
 n  SE  n  SE 
Total 133 2.53 .068  133 2.93 .071 
Whites 114 2.58 .073  114 3.02 .068 
Blacks 19 2.20 .086  19 2.39 .117 
 
 
Figure 6.3: Means for total race is genetic vignette sample and by race for RBM individual-


















Table 6.11: Means and standard errors for RBM individual-level effectiveness and PGM 
individual-level effectiveness beliefs among the admixture vignette condition. 
 RBM Individual-Level Effectiveness  PGM Individual-Level Effectiveness 
 n  SE  n  SE 
Total 120 2.56 .082  121 2.82 .081 
Whites 107 2.65 .068  108 2.90 .060 
Blacks 13 1.85 .122  13 2.16 .102 
 
 
Figure 6.4: Means for total admixture vignette sample and by race for RBM individual-


















Table 6.12: Means and standard errors for RBM individual-level effectiveness and PGM 
individual-level effectiveness beliefs among the genetic health difference vignette condition. 
 RBM Individual-Level Effectiveness  PGM Individual-Level Effectiveness 
 n  SE  n  SE 
Total 159 2.59 .097  159 3.02 .085 
Whites 143 2.63 .100  143 3.02 .093 
Blacks 16 2.21 .311  16 3.04 .111 
 
Figure 6.5: Means for total genetic health difference vignette sample and by race, for RBM 


















Next, to examine the proportions of those who endorsed or did not endorse RBM 
individual-level effectiveness versus PGM individual-level effectiveness, I examined the 
frequencies for both measures.  Table 6.13 presents the frequencies and means for both measures 
by race vignette condition and race.   Greater proportions of both white and black respondents 
assigned to the social construction vignette, genetic health difference vignette and control 
condition believed that PGM would be effective at the individual level compared to the 
proportions who believed RBM would be effective at the individual level. In fact, at least 3 out 
of 4 white and black respondents assigned to one those three vignette conditions endorsed 
PGM’s individual-level effectiveness, whereas approximately half or fewer white and black 
respondents endorsed RBM’s individual-level effectiveness after exposure to one of these three 
vignette conditions.  Notably, while similar proportions of white respondents assigned to the 
race is genetic or admixture vignette conditions endorsed these two beliefs in comparison to 
white respondents assigned to the other three vignette conditions, substantially smaller 
proportions of black respondents assigned to these two vignettes endorsed PGM individual-level 
effectiveness (respectively 20.0 and 23.1 percent) compared to both the proportion of white 
respondents in the race is genetic or admixture vignette conditions, as well as the proportion of 
black and white respondents assigned to the other three vignette conditions.  In the case of black 
respondents assigned to the admixture vignette, a smaller proportion of black respondents in fact 
endorsed PGM individual-level effectiveness (23.1 percent) compared to the proportion of black 
respondents that endorsed RBM individual-level effectiveness (30.8 percent).   The results 
indicate that the vignette experiment had some effect on black respondents’ endorsement of 
PGM individual-level effectiveness in comparison to RBM individual-level effectiveness, but 




If only the means and frequencies for the total sample of respondents were examined, the 
results show support for Hypothesis 7, which predicted that mean endorsement levels of PGM’s 
effectiveness at the individual level would be greater than mean endorsement levels of RBM’s 
effectiveness at the individual level.  This was the case across the board for all vignette 
conditions.  However, when we look at the means and frequencies by race, we see that for black 
respondents assigned to the admixture vignette, this was not the case.  Although the mean for 
PGM individual-level effectiveness was higher than that of RBM individual-level effectiveness 
for black respondents assigned to the admixture vignette, the frequencies indicated that a smaller 
portion of black respondents endorsed PGM individual-level effectiveness (23.1 percent) 
compared to RBM individual-level effectiveness (30.8 percent).   




Table 6.13: Frequencies and means for PGM individual-level effectiveness versus RBM 
individual-level effectiveness by race vignette experiment condition for total sample as well 







































(n = 85) (n = 84) (n = 74) 
 
(n = 73) (n = 11) 
 









3.5 6.0 2.7 6.8 9.1 0 
Disagree 
 
8.2 44.0 9.5 43.8 0.0 45.5 
 3.15 2.54 3.15 2.55 3.16 2.50 
Social 
Construction  
(n = 133) (n = 133) (n = 114) (n = 114) (n = 19) (n = 20) 
Agree 
 





9.8 21.1 10.5 19.3 10.5 30.0 
Disagree 
 
13.5 42.9 13.2 43.0 10.5 45.0 




(n = 133) (n = 133) (n = 115) (n = 114) (n = 20) (n = 19) 
Agree 
 





11.3 12.8 11.3 12.3 15.0 15.8 
Disagree 21.8 43.6 14.8 38.6 65.0 73.7 
 2.93 2.53 3.02 2.58 2.39 2.20 
 
 




Table 6.13: Frequencies and means for PGM individual-level effectiveness versus RBM 
individual-level effectiveness by race vignette experiment condition for total sample as well 





































Admixture (n =121) (n = 121) (n = 108) (n = 107) (n = 13) (n = 13) 
Agree 
 





14.0 10.7 11.1 12.1 38.5 0.0 
Disagree 
 
15.7 35.5 13.0 30.8 38.5 69.2 




(n = 159) (n = 159) (n = 144) (n = 143) (n = 16) (n = 16) 
Agree 
 





13.8 8.8 13.2 9.8 25.0 6.3 
Disagree 
 
11.3 39.0 12.5 36.4 0.0 62.5 






Table 6.14: Race-based medicine individual-level effectiveness crosstabulated with 
personalized genomic medicine individual-level effectiveness for the total sample, by race 
and vignette condition. 













































Control Group  n = 85   n = 74   n = 11  
Agree 48.2 1.2 1.2 48.6 0.0 1.4 45.5 9.0 0.0 
Neither Agree 
Nor Disagree 
5.9 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 
Disagree 34.1 2.4 7.1 32.4 2.7 8.1 45.5 0.0 0.0 
Social 
Construction 
 n = 133   n = 114   n = 19  
Agree 32.3 1.5 2.3 34.2 1.8 1.8 21.1 0.0 5.3 
Neither Agree 
Nor Disagree 
16.5 3.0 1.5 14.0 3.6 1.8 31.6 0.0 0.0 
Disagree 27.8 5.3 9.8 28.1 5.3 9.6 26.3 5.3 10.5 
Race Is 
Genetic 
 n = 134   n = 115   n = 19  
Agree 40.3 2.2 0.7 46.1 2.6 0.9 10.5 0.0 0.0 
Neither Agree 
Nor Disagree 
7.5 3.7 1.5 7.0 3.5 1.7 10.5 5.3 0.0 




Table 6.14: Race-based medicine individual-level effectiveness crosstabulated with 
personalized genomic medicine individual-level effectiveness for the total sample, by race 
and vignette condition. 













































Admixture  n = 121   n = 107   n = 13  
Agree 47.1 3.3 3.3 51.4 1.9 3.7 7.7 15.4 0.0 
Neither Agree 
Nor Disagree 
8.2 1.7 0.8 9.3 1.9 0.9 0.0 0.0 0.0 
Disagree 14.9 9.1 11.6 15.0 7.5 8.4 15.4 23.1 38.5 
Genetic Health 
Difference 
 n = 159   n = 143   n = 16  
Agree 49.7 2.5 0.0 51.0 2.8 0.0 31.3 0.0 0.0 
Neither Agree 
Nor Disagree 
5.7 0.6 2.5 5.6 0.7 2.8 6.3 0.0 0.0 





 A crosstabulation analysis was conducted between responses for RBM individual-level 
effectiveness and PGM individual-level effectiveness by vignette condition as well as race. Table 
6.14 presents the results of this analysis for the two measures.  For the total sample and white 
sub-sample, we see that the majority of respondents within each vignette condition agreed with 
the belief that PGM is effective at the individual level, although among those who agreed with 
this belief there was variation in the extent to which respondents agreed or disagreed with RBM 
individual-level effectiveness belief.  The range by vignette of white respondents who agreed 
that both RBM and PGM are effective at the individual level was from 32.3 percent (social 
construction vignette) to 49.7 percent (genetic health difference vignette).  
 There was fairly large variability between vignette conditions with respect to black 
respondents’ concordance in beliefs between RBM and PGM individual-level effectiveness. The 
percentage of black respondents who agreed that both RBM and PGM are effective at the 
individual level ranged from a low of 7.7 percent (admixture vignette) to a high of 45.5 percent 
(control group).  Meanwhile, the percentage of black respondents who disagreed with both RBM 
and PGM individual-level effectiveness beliefs varied even more by vignette condition, ranging 
from as low as 0 percent concordant disagreement with both beliefs (the control group and 
genetic health difference vignette) to as high as 68.4 percent concordant disagreement with both 
beliefs (the race is genetic vignette).  
In order to assess to what extent individual respondents’ PGM and RBM individual-level 
effectiveness beliefs differed, the RBM-PGM individual-level effectiveness difference score was 
calculated for each respondent.  A positive difference score means that respondents on average 




difference score means respondents on average believed PGM is more effective than RBM.  The 
larger the absolute value of a difference score, the greater the difference in belief in RBM’s and 
PGM’s effectiveness at the individual level.  Tables 6.15-6.19 present means, standard deviations 
and Student’s t-test statistics for the RBM-PGM individual-level effectiveness difference score 
for each of the race vignette experiment’s conditions.  Because an inspection of the means for 
each measure indicated that the vignette experiment may have had an effect on blacks’ individual 
and comparative endorsement of the two measures, these analyses were intentionally separated 
by vignette condition.   
Tables 6.15-6.19 t-test results indicate that the mean difference scores significantly 
differed from 0 for the total sample and the white and black sub-samples for each vignette 
condition.  The only exception was black respondents assigned to the admixture vignette 
condition, whose mean difference score did not significantly differ from 0 at the .05-level but 
indicated that there likely was some difference between the two scores (p < .10).  All of the mean 
values for the RBM-PGM individual-level effectiveness difference scores were negative 
indicating that on average, white and black respondents, regardless of the vignette condition to 









Table 6.15: Means, standard deviations, and Student’s t-test statistic for RBM-PGM 
individual-level effectiveness difference score, for total control group sample and by race. 
 n  Standard 
Deviation 
t 
Total  85 -.6104 .783 -7.145*** 
Whites   73 -.6037 .819 -6.292*** 
Blacks 12 -.6546 .444 -4.888* 




Table 6.16: Means, standard deviations, and Student’s t-test statistic for RBM-PGM 
individual-level effectiveness difference score, for total social construction vignette sample 
and by race. 
 n  Standard 
Deviation 
t 
Total  133 -.4936 .742 -7.680*** 
Whites   113 -.4933 .763 -6.871*** 
Blacks 19 -.4954 .608 -3.552** 







Table 6.17: Means, standard deviations, and Student’s t-test statistic for RBM-PGM 
individual-level effectiveness difference score, for total race is genetic vignette sample and 
by race. 
 n  Standard 
Deviation 
t  
Total  133 -.3971 .755 -6.060*** 
Whites   114 -.4331 .779 -5.934*** 
Blacks 19 -.1854 .236 -3.429* 




Table 6.18: Means, standard deviations, and Student’s t-test statistic for RBM-PGM 
individual-level effectiveness difference score, for total admixture vignette sample and by 
race. 
 n  Standard 
Deviation 
t  
Total  120 -.2609 .686 -4.165*** 
Whites   107 -.2537 .684 -3.841*** 
Blacks 13 -.3188 .565 -2.036† 






Table 6.19: Means, standard deviations, and Student’s t-test statistic for RBM-PGM 
individual-level effectiveness difference score, for total genetic health difference vignette 
sample and by race. 
 n  Standard 
Deviation 
t  
Total  159 -.4315 .965 -5.641*** 
Whites   143 -.3876 .898 -5.161*** 
Blacks 16 -.8266 1.182 -2.795* 
†P < .10, *P < .05, **P < .01, ***P < .001.  
 
 Table 6.20 presents the estimates and standard errors for the RBM-PGM individual-level 
effectiveness difference score regressed on race, adjusting for socio-demographic variables and 
the race vignette experiment (Model 41). Because the frequencies for the two measures in Table 
6.13 indicated that there may be a race by race vignette experiment interaction effect for 
comparative endorsement levels of RBM and PGM individual-level effectiveness beliefs, the 
RBM-PGM individual-level effectiveness difference score was also regressed on race by race 
vignette experiment interaction terms, adjusting for the same socio-demographic variables 
(Model 42). The results for both models indicate that overall, there was no significant difference 
between white and black respondents in the degree to which their RBM and PGM individual-
level effectiveness beliefs differed, and there was no interaction effect between race and race 





Table 6.20: RBM-PGM individual-level effectiveness difference score regressed on race 
and race by race vignette experiment interactions terms, adjusting for sex, age, and 
education (n = 625). 
 Model 41 Model 42 
 β SE β SE 
Intercept -.520 .280 -.534† .287 
Black -.053 .100 -.067 .163 
Male .014 .065 .009 .065 
Age -.002 .002 -.001 .002 
Education -.001 .024 -.001 .024 
Admixture Vignette .345** .107 .345** .119 
Social Construction Vignette .113 .107 .100 .120 
Race Is Genetic Vignette  .206† .106 .164 .119 
Genetic Health Difference 
Vignette 
.168 .114 .205† .123 
Black * Admixture Vignette -- -- -.009 .255 
Black * Social Construction 
Vignette 
-- -- .077 .226 
Black * Race Is Genetic 
Vignette 
-- -- .303 .187 
Black * Genetic Health 
Difference Vignette 
-- -- -.362 .330 
†P < .10, *P < .05, **P < .01, ***P < .001.  
 
6.3.2.2  PGM versus RBM Behavioral Orientation 
Means, frequencies, crosstabulation, Student’s t-test and multiple linear regression 




and RBM behavioral orientation.  Tables 6.21 – 6.25 present the means and standard errors for 
RBM behavioral orientation and PGM behavioral orientation by race vignette experiment 
condition and race. Figures 6.6-6.10 chart the means for the total sample and the white and black 
sub-samples for each of the respective tables.  The results indicate that PGM behavioral 
orientation sample means were somewhat to substantially higher than those for RBM behavioral 
orientation for each of the vignette conditions other than the race is genetic vignette condition. 
For this latter vignette condition, the PGM behavioral orientation means were slightly higher 
than the RBM behavioral orientation means for the total vignette sample and the white sub-
sample. However for the black respondents assigned to this vignette, the PGM behavioral 
orientation mean was lower than the mean for RBM behavioral orientation.  The results overall 
indicate support for Hypothesis 7, which hypothesized that PGM behavioral orientation 
endorsement levels will be greater than those for RBM behavioral orientation. But, while this 
was uniformly the case for white respondents regardless of the vignette condition to which they 
were exposed, vignette condition did seem to have an effect on the direction of RBM versus 




Table 6.21: Means and standard errors for RBM behavioral orientation and PGM 
behavioral orientation for the race vignette experiment control condition. 
 RBM Behavioral Orientation  PGM Behavioral Orientation 
 n  SE  n  SE 
Total 85 3.26 .076  85 3.57 .076 
Whites 71 3.26 .112  74 3.58 .080 
Blacks 11 3.22 .332  11 3.51 .148 
 
Figure 6.6: Means for total race vignette experiment control condition sample and by race, 



















Table 6.22: Means and standard errors for RBM behavioral orientation and PGM 
behavioral orientation for the social construction vignette condition. 
 RBM Behavioral Orientation  PGM Behavioral Orientation 
 n  SE  n  SE 
Total 133 3.07 .088  131 3.40 .068 
Whites 114 3.12 .091  111 3.40 .071 
Blacks 19 2.79 .262  19 3.39 .189 
 
Figure 6.7: Means for total social construction vignette sample and by race, for RBM 




















Table 6.23: Means and standard errors for RBM behavioral orientation and PGM 
behavioral orientation for the race is genetic vignette condition. 
 RBM Behavioral Orientation  PGM Behavioral Orientation 
 n  SE  n  SE 
Total 132 3.12 .103  133 3.24 .102 
Whites 112 3.22 .104  114 3.39 .083 
Blacks 19 2.55 .201  19 2.36 .193 
 
 
Figure 6.8: Means for total race is genetic vignette sample and by race, for RBM behavioral 



















Table 6.24: Means and standard errors for RBM behavioral orientation and PGM 
behavioral orientation for the admixture vignette condition. 
 RBM Behavioral Orientation  PGM Behavioral Orientation 
 n  SE  n  SE 
Total 120 3.04 .112  121 3.30 .103 
Whites 107 3.15 .090  108 3.39 .075 
Blacks 13 2.14 .244  13 2.52 .144 
 
 
Figure 6.9: Means for total admixture vignette sample and by race, for RBM behavioral 




















Table 6.25: Means and standard errors for RBM behavioral orientation and PGM 
behavioral orientation for the genetic health difference vignette condition. 
 RBM Behavioral Orientation  PGM Behavioral Orientation 
 n  SE  n  SE 
Total 158 3.08 .127  159 3.44 .121 
Whites 142 3.11 .131  143 3.44 .133 
Blacks 16 2.72 .431  16 3.49 .161 
 
 
Figure 6.10: Means for total genetic health difference vignette sample and by race, for RBM 




















Table 6.26 reports the frequencies for PGM and RBM behavioral orientation by race 
vignette experiment condition for the total sample and by race. The frequencies results are 
similar to the results for the two measures’ means. For all five vignette conditions, a higher 
proportion of the total sample and white sub-sample indicated preferences to use PGM compared 
to the proportion of both samples that preferred to use RBM.  Notably, for the black sub-sample, 
preferences for using PGM were higher than preferences for using RBM among respondents 
assigned to the social construction vignette, admixture vignette, genetic health difference 
vignette and control condition. The frequencies for the two measures were reversed, however, for 
black respondents assigned to the race is genetic vignette. For this sub-sample there was a 
substantially smaller proportion of black respondents who indicated a preference for using PGM 





Table 6.26: Frequencies for PGM behavioral orientation versus RBM behavioral 

































Control Group (n = 85) (n = 82) (n = 73) (n = 72) (n = 11) (n = 11) 
Somewhat/Strongly 
Agree 
98.8 85.4 98.6 86.1 100.0 45.5 
Somewhat/Strongly 
Disagree 
1.2 14.6 1.4 13.9 0.0 54.5 
 3.57 3.26 3.58 3.26 3.51 3.22 
Social Construction (n = 130) (n = 133) (n = 112) (n = 114) (n = 20) (n = 20) 
Somewhat/Strongly 
Agree 
93.1 77.4 92.9 80.7 90.0 55.0 
Somewhat/Strongly 
Disagree 
6.9 22.6 7.1 19.3 10.0 45.0 
 3.40 3.07 3.40 3.12 3.39 2.79 
Race Is Genetic (n = 133) (n = 131) (n = 114) (n = 112) (n = 20) (n = 20) 
Somewhat/Strongly 
Agree 
81.2 76.3 88.6 78.6 35.0 60.0 
Somewhat/Strongly 
Disagree 
18.8 23.7 11.4 21.4 65.0 40.0 




Table 6.26: Frequencies for PGM behavioral orientation versus RBM behavioral 

































Admixture (n = 121) (n = 121) (n = 108) (n = 107) (n = 14) (n = 14) 
Somewhat/Strongly 
Agree 
90.9 80.2 93.5 85.0 64.3 42.9 
Somewhat/Strongly 
Disagree 
9.1 19.8 6.5 15.0 35.7 57.1 
 3.30 3.04 3.39 3.22 2.36 2.55 
Genetic Health 
Difference 
(n = 160) (n = 158) (n = 143) (n = 143) (n = 16) (n = 16) 
Somewhat/Strongly 
Agree 
92.5 76.6 92.3 76.9 100.0 75.0 
Somewhat/Strongly 
Disagree 
7.5 23.4 7.7 23.1 0.0 25.0 






Table 6.27: RBM behavioral orientation crosstabulated with PGM behavioral orientation 





PGM Behavioral Orientation 

























Control Group n = 82 n = 71 n = 11 
Somewhat/Strongly 
Agree 
84.1 1.2 84.5 1.4 81.8 0.0 
Somewhat/Strongly 
Disagree 
14.6 0.0 14.1 0.0 18.1 0.0 
Social Construction n = 131 n = 112 n = 19 
Somewhat/Strongly 
Agree 
77.1 1.5 81.3 0.9 52.6 5.3 
Somewhat/Strongly 
Disagree 
15.3 6.1 11.6 6.3 36.8 5.3 
Race Is Genetic n = 131 n = 111 n = 20 
Somewhat/Strongly 
Agree 
71.8 4.6 78.4 0.9 35.0 25.0 
Somewhat/Strongly 
Disagree 
9.9 13.7 11.7 9.0 0.0 40.0 
Admixture n = 120 n = 106 n = 14 
Somewhat/Strongly 
Agree 
79.2 1.7 84.0 1.9 42.9 0.0 
Somewhat/Strongly 
Disagree 




Table 6.27: RBM behavioral orientation crosstabulated with PGM behavioral orientation 





PGM Behavioral Orientation 



























n = 157 n = 142 n = 15 
Somewhat/Strongly 
Agree 
76.4 0.6 76.8 0.7 73.3 0.0 
Somewhat/Strongly 
Disagree 
16.6 6.4 15.5 7.0 26.7 0.0 
 
Table 6.27 presents the results of RBM behavioral orientation crosstabulated with PGM 
behavioral orientation by race vignette experiment condition and race. Although among whites 
the vast majority of respondents, regardless of vignette condition, agreed that they would prefer 
to use both RBM and PGM, among blacks, there was much greater variability between vignette 
conditions.  Preferences for using both RBM and PGM ranged from a low of 35.0 percent (race 
is genetic vignette) to 81.8 percent (control group) among the black respondents. Rejecting the 
use of either RBM or PGM also varied from 0 percent (control group and genetic health 
condition vignette) to 40.0 percent (race is genetic vignette).  The results therefore indicate some 
type of interaction effect between race and the vignette experiment for concordance in attitudes 




Tables 6.28-6.32 present means, standard deviations and Student’s t-test statistics for the 
RBM-PGM behavioral orientation difference score for each of the race vignette experiment’s 
conditions.  Once again, a positive mean value for the difference score indicates that respondents 
on average preferred to use RBM over PGM, and a negative mean value indicates that 
respondents on average preferred to use PGM over RBM.  
The mean values for the RBM-PGM behavioral orientation difference score for white 
respondents were negative for all vignette conditions, indicating that on average, white 
respondents preferred to use PGM over RBM regardless of the vignette condition to which they 
were assigned. For black respondents, the means for the RBM-PGM behavioral orientation 
difference score were negative for all vignette conditions except the race is genetic vignette.  For 
this latter vignette, the mean was positive (.1922), indicating that black respondents assigned to 
this particular vignette on average preferred to use RBM over PGM.   
The t-test results for the white sub-sample were statistically significant for each of the 
vignette conditions, indicating that the mean difference scores for behavioral orientation 
significantly differed from 0.  This suggests that regardless of the vignette condition, white 
respondents were significantly more likely to prefer to use PGM over RBM.  The t-tests for the 
black sub-sample, however, indicated that the vignette experiment had an effect on the extent to 
which respondents’ PGM and RBM behavioral orientation scores differed. The t-test results for 
respondents assigned to the social construction vignette and the genetic health difference 
vignette were statistically significant, suggesting that black respondents assigned to those two 
vignette conditions had significantly greater preferences for using PGM compared to RBM. 




different from 0 for respondents assigned to admixture, race is genetic, and the control group 
vignette conditions.  The results of the Student’s t-test analyses suggest a possible interaction 
effect between race and the race vignette experiment for differences between preferences for 
using PGM versus RBM. 
Table 6.28: Means, standard deviations, and Student’s t-test statistic for RBM-PGM 
behavioral orientation difference score, for total control group sample and by race. 
 n  Standard 
Deviation 
t  
Total  82 -.3298 .897 -3.328** 
Whites   71 -.3359 .934 -3.029** 
Blacks 11 -.2911 .632 -1.528 
†P < .10, *P < .05, **P < .01, ***P < .001.  
 
Table 6.29: Means, standard deviations, and Student’s t-test statistic for RBM-PGM 
behavioral orientation difference score, for total social construction vignette sample and by 
race. 
 n  Standard 
Deviation 
t 
Total  130 -.3164 .871 -4.141*** 
Whites   111 -.2658 .815 -3.432** 
Blacks 19 -.6086 .670 -3.963** 






Table 6.30: Means, standard deviations, and Student’s t-test statistic for RBM-PGM 
behavioral orientation difference score, for total race is genetic vignette sample and by 
race. 
 n  Standard 
Deviation 
t  
Total  132 -.1286 .803 -1.839† 
Whites   112 -.1841 .692 -2.815** 
Blacks 19 .1922 .348 2.408† 
†P < .10, *P < .05, **P < .01, ***P < .001.  
 
 
Table 6.31: Means, standard deviations, and Student’s t-test statistic for RBM-PGM 
behavioral orientation difference score, for total admixture vignette sample and by race. 
 n  Standard 
Deviation 
t  
Total  120 -.2427 .787 -3.381** 
Whites   106 -.2251 .685 -3.384** 
Blacks 13 -.3837 1.153 -1.199 










Table 6.32: Means, standard deviations, and Student’s t-test statistic for RBM-PGM 
difference score, for total genetic health difference vignette sample and by race. 
 n  Standard 
Deviation 
t  
Total  158 -.3704 1.388 -3.355** 
Whites   142 -.3260 1.374 -2.827** 
Blacks 16 -.7688 1.370 -2.246* 
†P < .10, *P < .05, **P < .01, ***P < .001.  
 
 Table 6.33 presents the results for the RBM-PGM behavioral orientation difference score 
regressed on race (Model 41). The estimate for the black dummy variable was not statistically 
significant, indicating that overall, blacks and whites did not significantly differ in the magnitude 
of the difference scores, even after controlling for the race vignette experiment.  In Model 42, the 
RBM-PGM behavioral orientation difference score is regressed on race by race vignette 
experiment interaction terms in order to see if there were racial differences in the vignette 
experiment’s effect on differences in preferences for using RBM versus PGM.  Despite there 
seeming to be an interaction effect between race and race vignette experiment according to the 
descriptive statistical analyses, the results of Table 6.33’s Model 42 indicate that there was no 







Table 6.33: RBM-PGM behavioral orientation difference score regressed on race and race 
by race vignette experiment interactions terms, adjusting for sex, age, and education (n = 
618). 
 Model 41 Model 42 
 β SE β SE 
Intercept -.116 .286 -.188 .287 
Black -.109 .143 .023 .222 
Male .107 .082 .094 .081 
Age -.003 .003 -.003 .002 
Education -.008 .025 -.005 .025 
Admixture Vignette .080 .120 .108 .126 
Social Construction Vignette .028 .123 .075 .133 
Race Is Genetic Vignette  .187 .118 .142 .125 
Genetic Health Difference 
Vignette 
-.063 .140 -.010 .151 
Black * Admixture Vignette -- -- -.214 .438 
Black * Social Construction 
Vignette 
-- -- -.331 .318 
Black * Race Is Genetic 
Vignette 
-- -- .317 .326 
Black * Genetic Health 
Difference Vignette 
-- -- -.437 .403 









6.4  Discussion 
6.4.1  Personalized Genomic Medicine Beliefs and Attitudes 
Findings from prior studies have been mixed as far as evidence indicating that there are 
racial differences regarding PGM-related beliefs and attitudes.  Some studies have suggested that 
blacks and other racial/ethnic minority groups have at times been found to hold favorable beliefs 
and attitudes with respect to the safety and clinical effectiveness of PGM specifically, and other 
genetic biomedical applications more generally.  One focus group study that examined potential 
racial differences in PGM-related beliefs and attitudes found that black study participants 
generally believed PGM would lead to fewer side effects and less trial and error when 
prescribing, which were beliefs that were not discussed to the same extent among whites in the 
study (Marco, 2010).  Bevan et al.’s (2003) study examining attitudes towards PGM and RBM 
found that blacks, like whites, overwhelmingly supported using PGM over RBM if given the 
choice. Another study that employed a randomized vignette experimental design to compare and 
contrast PGM-, RBM- and conventional medicine-related beliefs and attitudes found few racial 
differences in PGM and RBM-related beliefs and attitudes (Butrick et al., 2011).  In contrast to 
prior studies that have suggested that blacks and other racial and ethnic minority populations 
hold favorable beliefs and attitudes regarding PGM, other studies did find racial differences to 
indicate more negative attitudes towards PGM-related issues, including genetic testing among 
racial and ethnic minority respondents compared to whites respondents (Hipps et al., 2003; 
Thompson et al., 2003).   
The results from this dissertation study indicate white and black Americans generally 




towards PGM among white and black Americans in this study, racial differences were found in 
beliefs regarding the effectiveness of PGM and orientation towards using PGM. The evidence 
also suggests that whites systematically endorse PGM’s individual-level effectiveness and 
preferences for using PGM at higher levels than blacks.  Notably, more than half of the black 
sub-sample endorsed PGM’s effectiveness at the individual level, however, this was substantially 
less than the proportion of whites who endorsed PGM individual-level effectiveness. In fact, 
there was a 20 percentage point difference in the proportion of whites (76.9 percent) versus the 
proportion of blacks (57.0 percent) who endorsed PGM’s individual-level effectiveness. A 
multiple linear regression analysis confirmed that whites were significantly more likely than 
blacks to endorse PGM’s individual-level effectiveness. Even greater proportions of both sub-
samples indicated a preference for using PGM, although once again, there was a substantial 
difference between the proportion of whites (92.7 percent) and the proportion of blacks (75.9 
percent) who indicated that they would prefer to use RBM.  Multiple linear regression results 
again showed that whites were significantly more likely to prefer to use PGM than blacks.  
The finding that a greater proportion of whites and blacks would prefer to use PGM 
compared to the proportion of both sub-samples that endorse PGM’s individual-level 
effectiveness is similar to the finding in Chapter 4’s examination of baseline RBM-related beliefs 
and attitudes, which showed that substantially more white and black respondents indicated they 
would prefer to use RBM compared to the number of respondents who endorsed RBM’s 
effectiveness at the individual level. However, unlike the findings in Chapter 4 that showed few 
differences among whites, blacks and Hispanics regarding RBM individual-level effectiveness 




and black respondents regarding PGM individual-level effectiveness belief and behavioral 
orientation.  
Another notable finding was the interaction effect between race and education for both 
PGM individual-level effectiveness belief (p < .10) and PGM behavioral orientation (p < .05). As 
educational attainment increased for the black sub-sample, there was a greater likelihood of 
endorsing PGM’s effectiveness and preferring to use PGM. However, there was no association 
between education and PGM beliefs and behavioral orientation among the white sub-sample. 
Although this interaction effect does not account for the overall racial difference seen in these 
two PGM-related constructs, it does suggest that a variety of socio-economic indicators are at 
play in understanding the extent to which Americans of different backgrounds endorse the 
potential effectiveness of PGM and their orientation towards using PGM if it was available. This 
latter finding may warrant future inquiry as it taps in to not only racial and socio-economic 
differences specific to PGM-related beliefs and attitudes, but possibly also differences in beliefs 
and attitudes relating to medicine and health care more generally.  The race-education interaction 
suggests that less-educated black Americans may be more resistant towards using new 
biomedical treatments and technologies, even if such treatments and tools are personalized to 
meet the health-related needs of individuals.    
Why there would be overall differences between white and black Americans regarding 
PGM-specific beliefs and attitudes also deserves some attention.  As previously noted, several 
studies have shown that blacks and other racial and ethnic minority groups have more concerns 
about PGM specifically - and genetic research and testing more broadly - than whites in the U.S 




including cost, discrimination and physician mistrust related to the prescription and use of PGM 
and genetic testing. Although these concerns were specific to PGM, genetic testing and related 
research, notably, they are similar to concerns that have been expressed by black Americans and 
other racial and ethnic minority groups about health care and health research more broadly 
(Hunt, 2007; Lillie-Blanton, Brodie, Rowland, Altman & McIntosh, 2000; Popay et al., 2003; 
Rigby, Soss, Booske, Rohan & Robert, 2009; Robert, 2011; Schnittker, Freese & Powell, 2000).  
Mistrust towards medical authority remains especially salient for blacks in the U.S., and these 
feelings of mistrust towards the medical establishment have perhaps carried over into beliefs 
about the effectiveness of new biomedical applications and preferences for using these news 
tools and treatments, even if such technologies are tailored to the genomic profile of individuals 
(Jacobs, Rolle, Ferrans, Whitaker & Warnecke, 2006; LaVeist, Nickerson & Bowie, 2000).   The 
findings in this study confirm the white-black disparity in endorsement of PGM and health-
related genetic applications seen in several other studies.  Although respondents were not 
specifically asked about perceived benefits and concerns regarding PGM in this study, these 
findings indicate that nationally, black Americans may have more concerns than whites 
regarding PGM.  
In the context of the larger debate regarding causes of, and solutions to address, racial 
health disparities in the U.S. and globally, the finding that whites are more likely than blacks to 
endorse the effectiveness of PGM and indicate a preference to use PGM, has several 
implications. First, with respect to the efforts to make PGM the paradigm for how medicine is 
practiced, health care providers and related stakeholders may face some challenges as far as 
encouraging black Americans – and potentially other racial and ethnic minority populations – to 




of the black respondents did not believe PGM would be effective at the individual level, and 1 
out of 4 black Americans indicated that they would not prefer to use PGM. The benefits of 
personalizing medical care based on individuals’ genomic profiles may seem obvious to health 
care providers who are familiar with not only the epidemiological evidence that shows poorer 
morbidity and mortality outcomes among racial and ethnic minorities, but also the medical 
evidence that available treatments are often less effective among these populations. These 
benefits, however, may not be particularly evident to the lay public.  Blacks’ and other racial and 
ethnic minorities’ concerns regarding the effectiveness and use of PGM, as cited in previous 
qualitative studies examining the American lay public’s beliefs and attitudes regarding PGM, 
may be similar to, if not consistent with, their concerns overall regarding access to and the 
quality of health care in general. 
This last point leads to the second implication of the finding that whites and blacks differ 
in their beliefs and attitudes regarding PGM. If health care providers, public health planners, 
policy makers and other related stakeholders are facing similar belief and attitudinal barriers 
regarding PGM to those regarding health promotion and health care more generally, then the 
paradigm shift towards PGM as the standard of medical care may have minimal benefits towards 
improving disparities in health outcomes if there are not concurrent efforts to address the larger 
concerns that minority populations continue to face. These concerns include cost, discrimination, 
and mistrust towards medical authority, all of which have been cited in previous studies 
examining beliefs and attitudes regarding PGM and genetic testing specifically, and access to 
and the quality of health care more broadly (Hipps et al., 2003; Robert & Booske, 2011; 




In the context of efforts to improve racial and ethnic health inequalities, these findings 
provide insight in to some of the challenges that health care providers and other stakeholders 
may face even as new treatments and biomedical technologies are introduced to improve the 
delivery of medicine to racially, ethnically, and genomically diverse populations.   If PGM is 
indeed the future of medicine, then it is worthwhile to better understand the race-specific 
differences between blacks and whites that lead to half of black Americans not believing PGM 
would be effective at the individual level and one quarter not wanting to use PGM. Future 
research may therefore be warranted to examine reasons for why blacks in the U.S. are less likely 
to endorse PGM effectiveness and use PGM than whites.  
 
6.4.2  Comparing Personalized Genomic Medicine and Race-Based Medicine Individual-Level 
Effectiveness Beliefs 
 Bevan and colleagues in their 2003 study comparing beliefs and attitudes regarding 
RBM, PGM and the usual course of treatment found that study respondents of all racial and 
ethnic backgrounds overwhelmingly supported PGM (75 percent of total sample) over RBM (4 
percent) or the usual course of treatment (9 percent).  In order to see if the results of a nationally 
representative sample of Americans would support or contradict the findings of Bevan et al.’s 
focus group study on RBM- and PGM-related beliefs and attitudes, I compared the RBM- and 
PGM-related beliefs and attitudes of black and white respondents in this study.  The results of 
this dissertation study, in fact, support Bevan et al.’s findings that white and black Americans 
endorsed PGM at greater levels than RBM.  
 The findings showed that regardless of the vignette to which respondents were exposed, 




than RBM individual-level effectiveness. Means, frequencies and Student’s t-tests of RBM-PGM 
individual-level effectiveness difference scores collectively indicated that a greater proportion of 
white and black respondents believed PGM is effective at the individual level compared to RBM. 
However, for the black respondents, exposure specifically to the admixture or race is genetic 
vignettes seemed to be associated with lower mean scores for PGM individual-level 
effectiveness compared to mean scores for black respondents assigned to the other vignettes. It is 
unclear as to why this would be the case since both vignettes specifically discussed the 
relationship between race and genetics, which is at most, tangentially related to PGM.  
Nonetheless, the lower means and smaller difference between PGM and RBM individual-level 
effectiveness beliefs among black respondents exposed to the admixture or race is genetic 
vignettes is worth noting because it suggests for one, that mass media messages about race and 
genetics can have an effect on PGM-related beliefs even though the topic is not directly related, 
and two, that such messages can have differential effects on PGM-related beliefs depending on 
the race or ethnicity of individuals.  Also notable is the question of why messages that imply (in 
the case of the admixture vignette) or state (in the case of the race is genetic vignette) that there 
is some genetic basis to the concept of race would cause black respondents to be less likely to 
endorse PGM’s individual-level effectiveness than respondents not exposed to such messages. 
The lower RBM individual-level effectiveness scores for black respondents assigned to the race 
is genetic and admixture vignette conditions could potentially be explained by a rejection of the 
race is genetic message and an interpretation of the admixture message that while there is some 
genetic basis to race, most Americans are of mixed race and therefore race-targeted 
pharmaceutical products are unlikely to be clinically effective for most Americans.  However, 




remains unclear as to why there would be lower belief levels for PGM’s individual-level 
effectiveness compared to those for the other three vignette conditions. Because there has been a 
steady increase in the volume of mass media messages about race and genetics, further research 
may also be warranted to examine mass media’s effect on PGM-related beliefs and attitudes with 
a particular focus on potential racial differences as a consequence of these media messages 
(Phelan et al., 2013; Phelan et al., under review).   
 As predicted in Hypothesis 7, the total sample’s means for PGM individual-level 
effectiveness were higher than its means for RBM individual-level effectiveness. This was the 
case regardless of the race of respondents or the vignette condition to which they were assigned. 
A plausible explanation for this difference is that a sizable portion of respondents are hesitant to 
endorse the idea that effective treatments can be developed for different racial groups, 
considering the fact that the idea of a biological or genetic basis to race remains highly 
controversial. Meanwhile regarding PGM, many may infer that treatments personalized to 
individuals’ genomic profiles are logically more likely to be effective than treatments designed 
for much broader populations of people, however such populations are defined. A combination 
of these two beliefs should subsequently lead to greater endorsement of PGM individual-level 
effectiveness than RBM individual-level effectiveness. 
 Although the results from this study showed that whites on average endorse PGM 
individual-level effectiveness belief at significantly higher levels than blacks, they also showed 
that whites and blacks did not significantly differ in the magnitude (or direction) of RBM-PGM 




Bevan et al.’s (2003) study that both white and black respondents are more likely to believe that 
PGM is effective at the individual level than RBM.  
 
6.4.3  Comparing Personalized Genomic Medicine and Race-Based Medicine Behavioral 
Orientations 
 The results for comparing PGM behavioral orientation with RBM behavioral orientation 
indicate that there are some differences between whites and blacks in their orientation towards 
using PGM versus RBM, although multiple linear regression results did not confirm that there 
was an overall racial difference in magnitude or direction of the degree of difference in 
behavioral orientation levels for PGM versus RBM.  Whites consistently indicated higher mean 
preference levels for using PGM than RBM regardless of the race vignette experiment condition 
to which they were assigned. Black respondents had higher mean preference levels for using 
PGM compared to RBM for all vignette conditions except the race is genetic vignette.  For this 
latter vignette condition, the mean score for PGM behavioral orientation was lower than the 
mean for RBM behavioral orientation. Although the Student’s t-test results for white 
respondents’ RBM-PGM behavioral orientation difference scores indicated that the scores were 
significantly different from 0 for all five vignette experiment conditions, black respondents’ t-
test results indicated that their behavioral orientation difference scores were only significantly 
different from 0 for those who were assigned to the social construction or genetic health 
difference vignette conditions.  
On the one hand, these results suggest that differing mass media messages about race and 
genetics have the ability to increase or decrease the degree of difference in preference levels for 




comparison to whites. This was the case for not only the analytical comparisons between RBM 
and PGM behavioral orientation but also comparisons between RBM and PGM individual-level 
effectiveness beliefs.  On the other hand, the sample sizes for black respondents in each vignette 
condition were small with limited statistical power to detect differences in the Student’s t-test 
results. Although it is possible that increasing the sample sizes for black respondents would not 
lead to different results, it is also possible that true differences in PGM versus RBM behavioral 
orientations, regardless of the vignette condition to which black respondents were exposed, were 
not evident for the control, race is genetic vignette or admixture vignette conditions because of 
the small sample sizes for black respondents. Because weak statistical power tends to attenuate 
true differences if such differences exist, it is possible that the lack of statistically significant 
differences between RBM and PGM behavioral orientation for black respondents assigned to the 
control, race is genetic vignette or admixture vignette conditions is a result of the small sample 
sizes.  If that is in fact the case, then differences in orientations towards using RBM and PGM 
actually exist among black respondents regardless of their exposure to messages about the 
relationship between race and genetics.   
Hypothesis 7 predicted that respondents would be more likely to prefer to use PGM than 
RBM. The findings from this study confirmed that this was the case for the white respondents, 
but it was not consistently the case for black respondents depending on the race vignette 
experiment condition to which they were assigned. 
************************************************************* 
 In the context of the debate regarding how best to address health inequalities, there is 




diverse racial and ethnic populations (Collins, 1999; Davies, 2006; Vera-Ramirez et al., 2010; 
Winkelmann and Herrington, 2010). If PGM is the future of medicine, then it is crucial to better 
understand and address the reasons for why some black Americans may be skeptical about the 
effectiveness of PGM and reluctant to use PGM.  This study, as the first nationally representative 
study to examine beliefs and attitudes regarding both RBM and PGM, confirms previous 
exploratory studies that indicated that black Americans and other racial and ethnic minority 
populations are less likely to endorse PGM’s effectiveness and less likely to prefer to use PGM 
compared to white Americans. More research, however, is needed to both better understand and 





Chapter 7:  
DISCUSSION 
 
7.1  Introduction 
As efforts continue to develop PGM as an important component – if not the standard – of 
medicine, efforts to develop and market RBM as an acceptable “interim” alternative for PGM 
also continue.  RBM remains as controversial today as it did when BiDil was first proposed, and 
then approved, as the U.S.’s first race-targeted medication.  Many within the academic and 
clinical communities question the effectiveness of race-specific treatments and are concerned 
with numerous negative consequences, such as the (re)geneticization of race and its various 
social and political implications (Foster, Sharp & Mulvihill, 2001; Duster, 2005; Kahn 2006a, 
2006b; Ng et al., 2008; Phelan et al., 2013).   Furthermore, there is the question of whether the 
future of diagnostic tools and drug development is truly about treating the individual patient or if 
it is increasingly more about treating populations.  This question is due to the continued focus on 
the development of RBM and no clear indication that individual genomic maps will be used for 
personalizing treatments in the near future.  If the for-profit pharmaceutical industry remains 
concerned about increasing its market share, then it makes sense for the industry to focus on 
developing drugs and diagnostic tools that are supposedly effective for use by large-scale 
populations, such as those defined by race or ethnicity.  This strategy, however, is in conflict 
with the idea of treating the individual, which is the goal of PGM.  Therefore, not only is it likely 
that the development of RBM will continue, but unless something prompts a large-scale 
paradigmatic shift away from developing RBM, it is possible that this “interim” form of PGM 




individuals’ genomes has dropped dramatically in recent years, thus, it is possible that a 
concerted effort to use individual genomic maps to guide the development of pharmaceutical 
products could prompt a shift away from RBM towards PGM. This effort, however, remains to 
be seen. 
Consequently, as RBM continues to develop, questions of whether the lay public believes 
RBM could be effective and whether the public would be willing to use RBM remain relevant.   
RBM’s uptake by patients will be affected by the extent to which the lay public believes RBM 
could be clinically effective and whether they would prefer to use RBM over currently available 
forms of treatments.   Furthermore, proponents of RBM qualify its value by asserting that RBM 
will help address racial and ethnic health disparities through the development of diagnostic tools 
and treatments that more effectively address the health and medical needs of racial and ethnic 
minority populations.  Regardless of one’s position regarding RBM, this argument causes both 
proponents and opponents of RBM alike to pause and consider the argument’s merits.  As the 
health divide continues to persist between white and racial and ethnic minority Americans, 
increased availability of and access to quality health care treatments for underserved populations 
are among the many needs that must be met in order to address disparities and improve 
population health.  However, there is scant knowledge about the American public’s beliefs and 
attitudes regarding RBM, both for the population as a whole and by the race and ethnicity of 
individuals.  As the biomedical industry moves forward to develop RBM, consideration must be 
given to the American public’s beliefs and attitudes, since public conceptions about RBM’s 




This dissertation study examined several questions related to public conceptions 
regarding RBM and its relationship to PGM.  Does the American public believe RBM could be 
an effective form of treatment?  Would they use RBM?  Do they believe RBM would help 
address racial and ethnic health disparities?  Are there racial and ethnic differences in these 
beliefs and attitudes?  Can mass media influence RBM-related beliefs and attitudes? And finally, 
how do lay conceptions regarding RBM compare to those of PGM?   
This dissertation study was divided into three parts, with each part building on the other 
two to provide a fuller picture of Americans’ conceptions regarding RBM and its relationship to 
PGM.  In Part 1, I examined white, black and Hispanic Americans’ beliefs and attitudes 
regarding RBM.  Aim 1 examined whether there were racial differences in these beliefs and 
attitudes, and Aims 2 and 3 respectively examined whether genetic essentialist beliefs and racist 
attitudes helped explain potential racial differences in RBM beliefs and attitudes.  The findings 
from Part 1 showed that the majority of white, black and Hispanic Americans did not believe 
RBM would be effective at the clinical level, but a majority of all three sampled groups would 
prefer to use RBM if it were available.  The only racial difference that was found for RBM-
related beliefs and attitudes measured in this study was that greater proportions of black and 
Hispanic respondents than white respondents believed RBM would be effective at reducing 
health inequalities.   
Part 2 examined the effect of a vignette experiment involving different mock newspaper 
articles about the relationship between race and genes on RBM-related beliefs and attitudes.  Part 
2 built on the findings from Part 1 by examining the extent to which baseline-level conceptions 




genes.  Aim 4 examined whether experimentally varying information about the degree of genetic 
similarity between races affects RBM beliefs and attitudes and Aim 5 examined whether 
acceptance of the information provided in the vignette was associated with differences in these 
beliefs and attitudes.  The main finding from Part 2 was the racial difference in the vignette 
experiment’s effect. The vignette experiment did not have an effect on white respondents’ beliefs 
and attitudes regarding RBM, however, it did affect RBM-related beliefs and attitudes of black 
respondents such that mean endorsements of RBM’s effectiveness and behavioral orientation 
towards using it were lower for black respondents assigned to the race is genetic or admixture 
vignettes than for black respondents assigned to the social construction vignette, genetic health 
difference vignette or no-vignette control condition.   
Part 3 built on the findings of Parts 1 and 2 by examining how the American public’s 
beliefs and attitudes regarding RBM compared to corresponding beliefs and attitudes regarding 
PGM.  Aim 6 examined whether or not there are racial differences in beliefs and attitudes 
regarding PGM and Aim 7 examined how RBM beliefs and attitudes compared to those related 
to PGM.  The findings from Part 3 showed that both white and black Americans generally held 
favorable beliefs and attitudes towards PGM, however, significantly greater proportions of 
whites believed PGM would be clinically effective and indicated a preference for using PGM 
compared to blacks in this study.  Part 3’s findings also showed that respondents generally 
favored PGM over RBM in terms of both clinical effectiveness and preferences for using either 
type of treatment, however for black respondents, exposure to either the race is genetic or 
admixture vignettes seemed to decrease the magnitude of difference in endorsement levels for 




Collectively, the findings from this dissertation study both diverged from, and confirmed, 
findings from prior studies that examined racial and ethnic differences in RBM- and PGM-
related beliefs and attitudes.  The results of this dissertation study were discussed in detail in 
their respective individual study chapters.  The following, therefore, is a discussion that 
highlights and integrates the major themes and key findings that emerged from this dissertation. 
 
7.2  (Lack of) Racial Differences in Race-Based Medicine Conceptions 
 Part 1 showed that there was no significant difference between whites, blacks and 
Hispanics in their belief regarding RBM’s individual-level effectiveness and preference for using 
RBM.  All three groups examined in this study negatively appraised RBM’s individual-level 
effectiveness at equal levels, but, generally equal proportions of all three groups also indicated a 
preference for using RBM.   This lack of racial difference in beliefs and attitudes regarding RBM 
diverges from prior studies (Bevan et al., 2003; Condit et al., 2003; Marco, 2010) that examined 
similar RBM constructs.  While the prior studies of racial and ethnic differences in RBM beliefs 
and attitudes conducted by Bevan and colleagues (2003), Condit and colleagues (2003) and 
Marco (2010) provided rich and valuable information related to the rationales behind Americans’ 
beliefs and attitudes regarding RBM, they could not evaluate the prevalence of these beliefs and 
attitudes among the general population.  By surveying a nationally representative sample of 
Americans, this study is the first to show that white, black and Hispanic Americans hold equally 
prevalent negative beliefs regarding RBM’s clinical effectiveness, but also equally prevalent 




 The question of why white, black and Hispanic Americans do not differ in these two 
constructs deserves some attention, as most prior research on RBM conceptions indicated that 
blacks and Hispanics should be less likely than whites to endorse RBM’s clinical effectiveness 
and less likely to prefer to use RBM.  A simple explanation for the lack of difference could be 
that the black and Hispanic sub-samples were relatively small and larger samples perhaps would 
have detected racial differences.  
One study conducted by Butrick and colleagues (2011) had a similar finding to this study 
of equally negative attitudes towards RBM among white and non-white study participants.  They 
note that possible reasons behind the negative appraisal of RBM among the non-white 
respondents in their study relate to reasons identified in prior studies of RBM beliefs and 
attitudes, such as historical and contemporary racial discrimination and the belief that race is a 
poor proxy for underlying biology.  They hypothesize that an awareness of these same reasons 
may also contribute to whites’ negative attitudes towards RBM, but that an additional reason for 
their negative attitudes would be a possible lack of racial identity because they are part of the 
racial majority in the U.S.  Butrick and colleagues argue that if one is not distinctly aware of his 
or her identity as being part of a racial group, then RBM may seem irrelevant as well.  This 
theory that they put forth could explain the lack of racial differences in these RBM belief and 
attitudinal measures. 
If sample size was not a meaningful limitation to the external generalizability of this 
dissertation study, then it seems that white and black Americans indeed hold similar beliefs 
about and attitudes towards RBM.  One implication of this finding is that industry-based RBM 




of the race or ethnicity of patients.  Despite there being, on average, negative beliefs about the 
clinical effectiveness of RBM, there were also uniformly high preference indications for using 
RBM.  However, it is possible that armed with more information, particularly information 
regarding the potential clinical, ethical and social costs and benefits associated with RBM, 
whites and blacks would begin to diverge in their beliefs and attitudes.  This seemed to be the 
case based on the results of Part 2’s race vignette experiment’s effect on RBM beliefs and 
attitudes.  Although the sample only included white and black respondents and none of the 
vignettes specifically discussed RBM, the results indicated that while whites’ beliefs and 
attitudes regarding RBM were not affected by the different types of mock news articles 
discussing varied relationships between race and genes, blacks more negatively appraised 
RBM’s individual-level effectiveness and indicated lowered preference levels for using RBM if 
they were exposed to the race is genetic vignette or the admixture vignette. 
Ultimately, RBM proponents’ concerns about non-white populations’ receptiveness to 
using RBM may be unwarranted.  Meanwhile, RBM opponents may need to implement 
interventions to better communicate concerns associated with RBM if one of their goals is to 
garner lay support for rejecting efforts to develop and promote RBM in the U.S.   
 
7.3  Discordance between Effectiveness Beliefs and Behavioral Orientation 
For both RBM and PGM, the results showed that substantially greater proportions of 
respondents indicated a preference for using RBM or PGM compared to the proportions who 
respectively endorsed RBM’s or PGM’s individual-level effectiveness.  These results were 




ineffective, then that person would not prefer to use the treatment.  However, the substantial 
numbers of respondents who indicated a preference for using RBM or PGM, even if they didn’t 
believe one form of treatment or the other was effective, could reflect a desire to try treatments 
with potentially significant benefits, even if one’s initial instinct is to believe such treatments do 
not work.   
Regarding RBM specifically, it is possible that some of the respondents, based on things 
that they have heard or learned over the years, have been socialized to believe that RBM is 
ineffective or otherwise “bad”, but when it comes down to making a concrete decision that they 
think would benefit them, they do not apply this acquired belief to their behaviors.  The 
inconsistency between RBM beliefs and behavioral orientation was seen in a previous U.S.-
based study that found the majority of its respondents to be “suspicious” about RBM, but with a 
portion noting they would still use it if it was available (Bevan et al., 2003; Lynch & Dubriwny, 
2006).  Lynch and Dubriwny (2006) explain this inconsistency through their “double bind” 
theory that some individuals, in particular racial and ethnic minorities, dispute a genetic basis for 
race, however, their racial/ethnic identification places them in a double bind between choosing to 
use RBM — which implies what they are disputing — or forgoing use of RBM, which could be 
perceived as denying their racial identity.  Racial or ethnic identification is a way for individuals 
to find common cause and to be socialized into the associated group’s culture (Lynch & 
Dubriwny, 2006).  Studies have shown that blacks have a greater degree of racial identification 
than whites, which can explain why actions that could be perceived as denying one’s racial 
identity are often discouraged (Allen, Howard, & Grimes, 1997; Coard, Breland, & Raskin, 




consequences for some people, ultimately, some will still choose using RBM as the lesser of two 
“evils”.  
The inconsistency between effectiveness belief and behavior may also result from some 
respondents believing RBM and/or PGM are attractive ideas, but seemingly abstract.  Therefore, 
while individuals may find it difficult to assess the effectiveness of either form of treatment, they 
are open to using one or the other if the clinical tools and treatments were available. The 
discordant findings between RBM and PGM individual-level effectiveness beliefs and behavioral 
orientation are important findings for which drug makers and providers should take note. Despite 
some negative public opinions towards RBM specifically, this finding suggests that there is an 
incentive for drug makers to continue to develop and market RBM since there seems to be a 
potentially large market of consumers who would be willing to use RBM. Regarding PGM, even 
though there is a portion of the American public – particularly among blacks Americans – who 
do not believe PGM would be effective at the individual level, nearly all of the white 
respondents and a majority of the black respondents surveyed in this study indicated a preference 
for using PGM if it were available.   
These findings clearly indicate that regardless of Americans’ beliefs in the clinical 
effectiveness of treatments, there is a willingness to try new types of medical treatments, even 
when the treatments may be considered controversial and are associated with serious ethical, 
social, and/or scientific concerns.  The pharmaceutical industry and other stakeholders who 
support and/or have something to gain from the development and implementation of RBM or 
PGM can take solace in the fact that even if the lay American public holds concerns regarding 




not be the true barriers to treatment adherence.  Health care providers, researchers and other 
stakeholders who are concerned about the social, ethical, scientific and medical implications of 
such treatments, may need to focus their interventions on addressing these concerns at levels that 
are in addition to the patient level, such as government agencies (e.g., NIH, FDA), the 
pharmaceutical industry, and medical providers.  
 
7.4  Mass Media Effects on Race-Based Medicine Beliefs and Attitudes 
 The findings from Part 2 showed that exposure to messages about race and genetics can 
differentially affect beliefs and attitudes regarding RBM depending on the race of individuals.  A 
single exposure to different mock news articles about the relationship between race and genetics 
had no effect on white respondents’ beliefs and attitudes regarding RBM, however, it had an 
unexpected effect on black respondents’ beliefs and attitudes regarding RBM.  The admixture 
vignette, which, depending on how the concept of admixture is interpreted, may suggest to some 
that there’s a genetic basis to race, and the race is genetic vignette, which explicitly states that 
there is a genetic basis to race, both seemed to lower belief in RBM’s individual-level 
effectiveness, preferences for using RBM and belief in its ability to improve health inequalities 
among the black respondents compared to the social construction, genetic health difference and 
no-vignette control conditions.  This result was surprising in light of the results from related 
studies using the race vignette experiment that showed that these two vignettes were associated 
with relatively higher mean belief in essential racial differences among the black (and white) 
study participants, compared to mean belief in essential racial differences for those assigned to 




Yang, under review).  Because RBM implies that there is some genetic, or at least underlying 
biological, basis to race, I had proposed that exposure to information suggesting or stating that 
there is a genetic basis to race would increase beliefs in RBM’s individual-level effectiveness 
and preferences for using RBM.  However, the results show that a single exposure to vignettes 
with these messages on average had the opposite effect on black study respondents, and no effect 
on white respondents.  Why this is the case deserves some attention. 
 Regarding the white respondents, it is possible that there was a disconnect between the 
idea that there is a genetic basis to the race concept and reasons for why race-specific prescribing 
might be clinically effective.  A lack of familiarity and consideration of why diagnostic tools and 
treatments may be differentially effective between different racial groups perhaps led the white 
study respondents to believe that RBM could be effective for reasons other than genetic 
differences, such as health behavior differences or differences in environmental exposures that 
could affect treatment effectiveness.  It is also possible that a single exposure to the assigned 
vignette condition was not enough to influence white respondents’ RBM beliefs and attitudes. 
Prior studies have shown that messages are more likely to be processed and interpreted if they 
come from multiple sources, indicating that a single exposure may not be enough (Harkins & 
Petty, 1981, 1987).   Although Phelan and colleagues’ studies showed that a single exposure to 
the vignettes in this experiment was enough to influence belief in essential racial differences, 
because none of the vignettes were directly related to the concept of RBM, it is possible that 
additional exposure to a vignette’s message, or media messages specifically about RBM, are 




 It is also unclear as to why black respondents assigned to the race is genetic and 
admixture vignettes on average had more negative appraisals of RBM compared to black 
respondents assigned to the other vignette conditions.  Lower endorsement of these measures can 
possibly be explained as negative responses to these vignettes’ messages as a means to reject the 
idea that there is a genetic basis to racial differences.  However, Part 2’s vignette acceptance 
measure indicated that on average, black respondents accepted these vignettes’ messages, and, as 
previously noted, both messages increased belief in essential racial differences.  
Specifically regarding the admixture vignette, it is possible that the vignette’s message 
that most Americans are of mixed race may have led black respondents to believe that RBM 
could not be effective because it assumes that people can be easily categorized into distinct racial 
groups.   At the same time, the vignette’s message may simultaneously be reinforcing the idea 
that there is a genetic basis to race, as evidenced by the findings of the related study by Phelan et 
al. (under review).  If that is the case, that could plausibly explain the reason for why black 
respondents assigned to the admixture vignette condition in this study had more negative 
appraisals of RBM while also indicating greater belief is essential racial differences in Phelan et 
al.’s (under review) study.   
One implication of the finding that the race is genetic and admixture vignettes could 
lower black respondents’ endorsement of the three RBM dependent variables is that how the 
relationship between race and genes is discussed in the news has the potential to affect RBM-
specific beliefs and attitudes among the black population in the U.S.  Notably, the two related 
studies by Phelan and colleagues respectively showed that the number of articles about race and 




Human Genome Project (HGP), and that a substantial portion of these articles were about direct-
to-consumer ancestry tests/admixture testing. In addition to Phelan et al.’s (2013) finding that 
articles about race and genetics have been on the rise during the past two to three decades, there 
is also evidence to suggest that messages similar to the race is genetic vignette had specifically 
been on the rise during and following the completion of the HGP.  Condit and Lynch’s (2006) 
content analysis of articles about race and genes showed that there was a rise in articles that were 
slanted towards the position that there is a genetic basis to racial categories in the years during 
and following the completion of the HGP.  
The increase in news stories presenting messages similar to those presented in the race is 
genetic and admixture vignettes suggests that the American public has been increasingly exposed 
to news stories that have the potential to decrease belief in RBM’s effectiveness and preferences 
for using RBM among non-Hispanic black Americans specifically.  If the intent behind 
developing and integrating RBM into the practice of medicine is to improve race-specific health 
inequalities, which is an argument that is meant to particularly resonate among racial and ethnic 
minorities who carry the burden of poorer health outcomes,  then RBM supporters would need to 
take note that black Americans may be less receptive towards using RBM depending on the 
extent to which they are exposed to mass media messages about race and genetics that are similar 
to those presented in the race is genetic and admixture vignettes.  
The results examining the race vignette experiment’s effects on RBM-related beliefs and 
attitudes suggest that while white and black Americans may not significantly differ in their 
beliefs about RBM’s individual-level effectiveness or behavioral orientation (as indicated by the 




differentially affect these beliefs and attitudes depending on the self-identified race or ethnicity 
of individuals.  
  
7.5  Race-Based Medicine and the Health Disparities Debate 
The findings from Part 1 showed that there were racial differences in the belief that RBM 
would be effective at reducing health inequalities.  I had hypothesized that whites would be more 
likely to believe that RBM would be effective at reducing health inequalities based on prior 
studies indicating that white Americans had more favorable appraisals of RBM’s clinical 
effectiveness than black, Hispanic and other racial and ethnic minority populations.  The results, 
however, showed the opposite to be true – blacks and Hispanics indicated a significantly greater 
belief in RBM’s ability to reduce health inequalities than whites in this study. 
In the ongoing debate over how to address growing health inequalities between minority 
and non-minority populations, this is an important finding that should be considered within the 
larger debate.  Past research has shown that blacks, Hispanics and other racial and ethnic 
minorities are more likely to believe that these populations are medically underserved compared 
to non-Hispanic white Americans (Lillie-Blanton et al., 2000).  If this has continued to be the 
case, it is possible that blacks and Hispanics are generally of the belief that any intervention 
meant to improve the health of racial and ethnic minorities, even controversial ones such as 
RBM, is better than the current state of affairs.   
In this debate over identifying and implementing effective strategies to reduce health 




poorer health statuses and outcomes needs to be assessed in order to garner public support for 
identified strategies. If a majority of racial and ethnic minority populations are likely to believe 
that RBM could reduce health inequalities, then it is quite possible that they would be as likely – 
or more likely – than whites to support RBM as a tactic to reduce health inequalities.   
It should be noted that RBM has had a limited presence in the delivery of healthcare 
services, and although RBM knowledge levels were not assessed in this study, it would be 
reasonable to assume that the majority of the lay public is unfamiliar with the concept of RBM. 
Should the healthcare and pharmaceutical industry decide to promote RBM as a strategy for 
addressing racial and ethnic health inequalities, there will likely be efforts on both sides of the 
debate to better educate the public about RBM.  Depending on which side of the debate is more 
effective at communicating its RBM-related messages, these efforts could influence in different 
directions beliefs about RBM’s effectiveness at the individual and population levels and 
behavioral orientations towards using RBM. 
 
7.6  Personalized Genomic Medicine and the Health Disparities Debate 
In the context of the larger debate regarding causes of, and solutions to address, racial 
health disparities in the U.S. and globally, the finding that whites are more likely than blacks to 
endorse the effectiveness of PGM and indicate a preference to use PGM, has several 
implications.  First, the medical community and other relevant stakeholders who support a 
paradigm shift towards PGM as the standard of clinical medicine may face challenges in 
encouraging black Americans, and possibly other racial and ethnic minority populations, to use 




effective, and approximately 1 out of every 4 said they would not prefer to use PGM.  While the 
benefits of personalizing medical care based on genomic profiles may seem obvious to health 
care providers, they may not be particularly evident to the lay public.  Prior studies of blacks’ 
and other minority populations’ conceptions regarding PGM and genetic testing indicated 
concerns such as cost, discrimination, and mistrust in medical authority (Hipps et al, 2003; 
Thompson et al., 2003).  These same concerns, however, have been expressed by blacks 
regarding health care more broadly (Lillie-Blanton et al., 2000; Robert & Booske, 2011).  The 
similarity in black Americans’ concerns regarding PGM specifically and health care in general 
suggests that a paradigm shift towards PGM as the standard of medical care may have minimal 
benefits towards improving health inequalities if there are not concurrent efforts to address the 
larger concerns that minority populations continue to face, including communicating these 
efforts with racial and ethnic minority populations.  
In the context of efforts to improve racial and ethnic health inequalities, these findings 
provide insight in to some of the challenges that health care providers and other stakeholders 
may face even as new treatments and biomedical technologies are introduced to improve the 
delivery of medicine to racially, ethnically, and genomically diverse populations.  If PGM is 
indeed the future of medicine, then it is worthwhile to better understand the race-specific 
differences between blacks and whites that lead to nearly half of black Americans not believing 
PGM would be effective at the individual level and one quarter not wanting to use PGM. 
Focusing on the improvement of diagnostic tools and treatments, while important as far as 
advancing the quality of care potentially available to the public, may be moot for those who 
cannot access care because of any number of financial, social, cultural, linguistic, geographic or 




warranted to better understand the reasons for why a substantial portion of black Americans may 
not believe PGM would be effective and would not prefer to use PGM.     
   
7.7  Americans Prefer Personalized Genomic Medicine over Race-Based Medicine 
 The results from Part 3 of this dissertation clearly show that white and black Americans 
prefer PGM over RBM.  This finding is not surprising.  A plausible explanation for this 
difference is that a sizable portion of respondents are hesitant to endorse the idea that effective 
treatments can be developed for different racial groups, considering the fact that the idea of a 
biological or genetic basis to race remains highly controversial.  Meanwhile, many may infer that 
treatments personalized to individuals’ genomic profiles are more likely to be effective than 
treatments designed for much broader populations of people, however such populations are 
defined. A combination of these two beliefs may subsequently have led to greater endorsement 
of PGM over RBM beliefs and attitudes.  These findings confirm those of prior studies that 
indicated a substantial preference for PGM over RBM (Bevan et al., 2003; Butrick et al., 2011).  
As previously noted, although both whites and blacks held more favorable beliefs and attitudes 
towards PGM compared to RBM, blacks’ endorsement of PGM was more tempered than that of 
whites.  Proponents of PGM, therefore, should consider moving cautiously towards 
implementing PGM with Americans, particularly black Americans who reportedly have noted 
several concerns regarding PGM or genetic testing in general (Hipps, 2003; Schulz, Caldwell & 





7.8  Strengths and Limitations of the Study 
 This dissertation was the first nationally representative study of Americans’ beliefs and 
attitudes regarding RBM and PGM.  However, the study was not without its limitations.  
Although I was involved with the design and implementation of this study as a graduate research 
assistant working with Professor Phelan as the Principal Investigator, the Genetics & Stigma 
Study had research aims and hypotheses that were separate and apart from those that I developed 
for this dissertation study.  Therefore, the primary purpose behind the design of the survey and 
vignette experiment was to meet the research aims of the Genetics & Stigma Study.   I was 
fortunate to have the opportunity to insert items for measures that I had developed with 
assistance and support from the research study’s team, however, there was a limit to the number 
of items that I could include in the survey.  Consequently, items such as measures of RBM and 
PGM knowledge levels, which would have been useful covariate measures to control for in the 
linear regression models, and additional items to measure RBM and PGM behavioral orientation 
and RBM population-level effectiveness, could not be included in the survey.  Despite the lack 
of knowledge level measures, the concepts of RBM and PGM were briefly explained to all 
respondents prior to the section that included these items.  Furthermore, the way the items are 
worded, the concepts are explained rather than simply referenced (e.g., “If there were different 
drugs for people of different racial groups, I would want to use the race-specific drug.”).  
Therefore, it is possible that differences in familiarity with the concepts of RBM and/or PGM did 
not have strong effects on beliefs and attitudes related to these concepts because all respondents 




In addition, it would have been interesting to examine the effect of an RBM-specific 
vignette in the race vignette experiment on RBM-related beliefs and attitudes for comparison 
with the effects of the other vignettes, however, the limited sample size and needs of the 
Genetics & Stigma Study meant this was not possible to do.   
A final limitation was the small number of black and Hispanic respondents who 
participated in the study.  Despite a two-tiered sampling framework that included an oversample 
of households from telephone exchanges in neighborhoods believed to be more densely 
populated with black and Hispanic families, the sample sizes for these two groups still ended up 
being relatively small for my analytical needs.  Consequently, I did not have the statistical power 
needed in some of the analyses to detect potential differences between racial and ethnic groups, 
even for large effect sizes.   
Despite these limitations, there were a number of strengths to this study that must be 
noted.  This dissertation study is the first nationally representative study of RBM- and PGM-
related beliefs and attitudes, providing findings with good external generalizability to the greater-
U.S. population of white, black and Hispanic Americans.  Prior studies were mostly exploratory 
and limited to certain geographic regions of the U.S.  The findings from this study are the first to 
quantitatively measure beliefs and attitudes regarding RBM and PGM among white, black and 
Hispanic individuals residing across the U.S.  Notably, some of the findings regarding racial 
differences in RBM beliefs and attitudes – or more precisely, a lack there of – diverge from prior 
exploratory studies examining racial differences and similarities regarding RBM beliefs and 
attitudes.  These findings therefore provide a new perspective on the lay public’s conceptions 




This study is also the first to experimentally measure the effects of varying information 
about the relationship between race and genes on RBM-related beliefs and attitudes.  Because 
RBM is a fairly new concept of which most of the mainstream public may have little to no 
awareness, it is likely that one of the primary sources of information about or relating to RBM 
will come from mass media.  Therefore, experimentally measuring the effects of mock news 
articles about race and genes on the lay public’s conceptions regarding RBM provides important 
insight into how different segments of the public may change their RBM-related beliefs and 
attitudes as they are exposed to various types of information on concepts related to RBM.   
Another strength of this study was the development of new measures to evaluate the lay 
public’s beliefs and attitudes regarding RBM and PGM.  These measures were developed based 
on themes that emerged from the relevant literature and were refined in consultation with the 
members of the Genetics & Stigma Study research team, many of whom were familiar with the 
academic literature on RBM specifically, and race and genes more generally, in addition to mass 
media representations of both concepts.  This aided the validity of the measures for this study.  
The reliability analyses for all of the measures were also adequate to very good for the sample as 
a whole and by race.  Prior studies (Bevan et al., 2003; Butrick et al., 2011; Condit et al., 2003; 
Marco, 2010) had measured RBM individual-level effectiveness and behavioral orientation 
beliefs and attitudes, but this was the first study to measures beliefs about RBM’s effectiveness 
at addressing health inequalities in the U.S.  Because RBM has been promoted by a number of 
scholars, scientists and segments of the pharmaceutical industry as a solution to the persistent 
problem of racial and ethnic health disparities, information on the extent to which the lay public 
believes this would be possible should be of interest to various stakeholders in the debates 




Finally, other strengths of this study relate to its research design.  The anonymity of 
participating in an internet-based study that asks questions about sensitive topics like race 
reduces the potential for social desirability bias, which is more likely to occur in in-person or 
telephone surveys.  There is also a convenience factor for internet-based surveys.  Respondents 
can log on to initiate and complete their surveys at times that are convenient for them (provided 
that it is done within the designated data collection time period).  This is more difficult to do 
with telephone and in-person survey research studies.  The convenience of the internet-based 
survey format for this study likely increased the overall response rate compared to potential 
response rates had the survey been administered by telephone or in-person.    
 
7.9  Directions for Future Research 
 I believe this dissertation study provides significant insight into the lay American public’s 
conceptions regarding RBM and its relationship to PGM.  However, some of the findings point 
to the need for future research.  Despite the lack of racial differences in RBM individual-level 
effectiveness belief and behavioral orientation, exposure to the race survey vignette experiment 
indicated that differences in these beliefs and attitudes began to emerge between white and black 
respondents.  Although none of the vignettes directly discussed RBM, exposure to the race is 
genetic or admixture vignettes seemed to lower black respondents’ belief in RBM’s effectiveness 
at the clinical level and their preferences for using RBM compared to exposure to one of the 
other vignettes or assignment to the no-vignette condition.  This was not the case for the white 
respondents in this study.  Because exposure to only tangentially-related topics in the vignette 




RBM, future research should be considered to examine the effect of exposure to mass media 
stories that specifically discuss RBM on RBM-related beliefs and attitudes.  In particular, it 
would be interesting to examine the effect of varying discussion on the social, ethical and 
scientific issues surrounding RBM on RBM beliefs and attitudes.  Caulfield and Harry (2008) 
showed that there were a substantial number of news articles about BiDil in 2007 that provided a 
variety of perspectives on the topic, including varying levels of discussion regarding the 
scientific, social and ethical controversies surrounding the drug.  This one study provides 
evidence of not only the prevalence of news stories on RBM in recent years but the variety of 
ways in which the topic is discussed in the news.  An examination of the influence of similar 
news stories on RBM beliefs and attitudes would enable us to better understand the effects of 
mass media on RBM-related conceptions.  
 It is also possible that a single exposure to the vignettes in the race survey experiment 
was not enough to influence RBM-related beliefs and attitudes. Perhaps, greater differences in 
RBM-related beliefs and attitudes would have emerged depending on the race of respondents 
and/or type of vignette received from an experiment that involved multiple exposures to the same 
vignette message over time. Future research may therefore want to examine the effect of multiple 
exposures to a vignette’s message over time on RBM-related beliefs and attitudes. 
Future studies may also want to assess the possible reasons for why respondents endorsed 
RBM’s and PGM’s effectiveness and behavioral orientation towards using either form of 
treatment.  Although assessing the extent to which respondents endorsed these beliefs and 




attitudes regarding race-targeted and personalized pharmacogenomic medicine, better 
understanding the reasons behind these beliefs and attitudes is needed as well.   
 
7.10  Conclusion 
 The HGP’s mapping of the human genome has significantly advanced not only our 
knowledge of human beings’ genetic make-up, but also applications of that knowledge in 
meaningful ways, most notably, medical advances in the field of pharmacogenomics.  However, 
promises of a medical system based on PGM have been slow to develop.  Consequently, RBM 
has been touted as an acceptable interim alternative to PGM, where medicine is tailored based on 
supposed biological or genetic similarities in populations rather than on the genomic profiles of 
individuals.  Because the concept of race and the extent to which there is or is not a genetic basis 
to the concept are controversial and contested, RBM has also been controversial, attracting both 
opponents and proponents of its development and implementation.  Without question, race has 
held, and continues to hold, a prominent place in American history and society.  Racial 
differences, historically and currently, exist in not only socio-economic and health outcomes, but 
also in beliefs and attitudes regarding a host of policy issues related to these differences in 
outcomes (Hunt, 2007; Lillie-Blanton et al., 2000; Robert and Booske 2011).  Because RBM 
implies that there is some genetic, or at least biological, basis to race, it is natural to predict that 
there would be racial differences in beliefs regarding RBM’s effectiveness and intentions to use 
RBM, in part because prior research has shown racial differences in how race is conceptualized 
(Dubriwny, Bates & Bevan, 2004; Jayaratne et al., 2009; Sheldon, Jayaratne, Feldbaum et al., 




attitudes regarding RBM, particularly those of racially and ethnically diverse Americans, enables 
both proponents and opponents of RBM to better understand the extent to which Americans 
would use RBM and believe in its effectiveness, and then plan accordingly.   
 I believe the data from this dissertation study greatly expands our understanding of RBM 
and PGM beliefs and attitudes, racial and ethnic differences and similarities in these beliefs and 
attitudes, and media influences on RBM-specific beliefs and attitudes.  As the first nationally 
representative study of Americans’ RBM- and PGM-related beliefs and attitudes, this study 
provides insight into Americans’ conceptions of RBM and PGM that could not be captured from 
previously conducted exploratory studies.  Key findings such as preferences for using RBM or 
PGM exceeding belief in either form of treatment’s individual-level effectiveness, and more 
favorable appraisals for PGM compared to RBM, confirmed prior qualitative studies of these 
topics.  However, the finding that whites, blacks and Hispanics do not significantly differ in their 
belief in RBM’s individual-level effectiveness or preferences for using RBM, diverge from prior 
exploratory studies that suggested that black, Hispanic and other racial and ethnic minorities 
were less likely to believe in RBM’s clinical effectiveness or be willing to use RBM than whites.  
These new findings are important to the extent that they not only suggest that whites are as likely 
as blacks and Hispanics to question race-targeted treatments, but also that there may be less 
opposition from racial and ethnic minority Americans to using race-targeted treatments than 
previously thought.   
The data also showed that a single exposure to different mock news articles about the 
relationship between race and genes was associated with racial differences in RBM-related 




black Americans’ RBM conceptions.  If RBM continues to be developed and integrated into the 
practice of medicine, it is likely that there will be diverse media coverage of this topic. 
Depending on the extent to which different racial and ethnic populations are exposed to mass 
media coverage of RBM or race and genetics, as well as how these topics are presented in mass 
media messages, we may in fact see racial differences begin to emerge in beliefs and attitudes 
regarding RBM.  This study was only able to evaluate the effect of mock news articles on 
relationships between race and genes that were not RBM-specific.  As noted previously, in order 
to truly get a sense of the extent to which Americans would believe RBM is effective and would 
in fact use RBM, then future research should consider an examination of RBM beliefs and 
attitudes following exposure to information specifically about RBM, including variations in 
coverage of some of the ethical, social and scientific issues associated with RBM.    
These findings should also be considered in the context of the larger debate regarding 
causes of and solutions to health disparities.  Proponents of RBM as an interim form of PGM 
view these two types of treatments as key solutions to addressing race-specific health inequalities 
(Burchard et al., 2003; Nguyen et al., 2007; Risch et al., 2002).  The results from this dissertation 
study suggest that despite beliefs from the majority of sampled respondents that RBM is not 
clinically effective, the majority were, in fact, open to using RBM.  To the extent that race- and 
ethnicity-targeted diagnostic tools and treatments can be clinically effective, particularly for 
health conditions and diseases for which racial and ethnic minority populations have traditionally 
experienced poorer outcomes, then an openness to using RBM regardless of the patient’s race or 
ethnicity means that RBM does have the potential to provide great benefits.  Notably, however, 
even if RBM can improve the quality of diagnostic tools and treatments available for 




economic, social and cultural barriers to care that racial and ethnic minority populations continue 
to face. As such, even if RBM is integrated into the practice of medicine, its effectiveness at 
addressing health inequalities may be limited. 
Finally, the social cost of RBM’s potential to re-inscribe biological and genetic 
conceptions of race should not be ignored.  Phelan, Link and Feldman (2013) in a related study 
showed that a single exposure to the genetic health difference vignette was associated with a 
higher belief in essential racial differences than exposure to the social construction vignette or 
assignment to the no-vignette condition.  In fact, this level of essential racial differences belief 
was as high as that following exposure to the race is genetic vignette.  Although not examined in 
this study, the findings from Phelan and colleagues suggest that exposure to positive mass media 
messages about RBM, or more salient, public awareness that RBM exists and has been integrated 
into the practice of medicine, have the potential to increase belief in essential racial differences 
because RBM implies that there is some biological or genetic difference between racial groups.  
To the extent that such a belief, in turn, could lead to an increase in prejudicial attitudes or 
discrimination against racial and ethnic minority populations is a grave concern that leads us 
back to the question of whether RBM is a necessary path that medical research and development 
should follow, particularly when there are other known barriers to the receipt of quality, effective 
health care that have not been adequately addressed.   
This dissertation study attempted to provide a fuller picture of the extent to which 
Americans believe in the effectiveness of RBM and PGM, whether they would be open to using 
either, and whether mass media has the potential to influence changes in these beliefs and 




is the hope that clinical tools and treatments can be developed to personalize treatments for 
individuals based on their unique genomic profiles as well as other factors that contribute to the 
health, wellness, diseases susceptibility and effectiveness of treatments for diverse individuals.  
However, PGM has been slow to progress and RBM has been promoted as an acceptable 
alternative to conventional forms of treatment that have at times been met with varying levels of 
success for different racial and ethnic populations.  Better understanding of the public’s beliefs 
and attitudes regarding these two emerging forms of clinical care will enable stakeholders to 
identify the extent to which the public supports RBM and PGM and what challenges may lie 
ahead.  As the first nationally representative study of Americans’ conceptions regarding RBM 
and PGM, this study will hopefully inspire stakeholders in the debate surrounding RBM to better 
consider the diversity of beliefs and attitudes regarding RBM in their decisions to continue its 
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HEALTH VIGNETTE EXPERIMENT SURVEY 
 
 
First we have some questions about your opinion of the article. 
 
 
I1. In your opinion, did the article give an accurate description of the causes of [“major 
depressive disorder”/“coronary artery disease”/“obesity”]? 
  
The article strongly overemphasized [1] as a cause of [2]. .....................................................5 
The article somewhat overemphasized [1] as a cause of [2] ...................................................4 
The article put the right amount of emphasis on [1] as a cause of [2] ....................................3 
The article somewhat underemphasized [1] as a cause of [2] .................................................2 
The article strongly underemphasized [1] as a cause of [2] ....................................................1 
 
[1 = “stress and pressure in the environment”/ “a person’s own decisions and actions”/ 
“genetic factors”] 
[2 = “major depressive disorder”/ “coronary artery disease”/ “obesity”] 
 
 
I2. The article struck you as biased and inaccurate.   
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
 
Next we have some more general questions about [“major depressive disorder.”/“coronary artery 
disease.”/“obesity.”]  Remember, there are no right or wrong answers.  We are only interested in 
what you think. 
 
 
I3.  Of the following factors, which do you personally think is the most important cause of 
[“major depressive disorder”/“coronary artery disease”/“obesity”]?   
   
 Genetic factors .......................................................................1  
 A person’s own decisions and actions ...................................2 







I4.  Of the following factors, which do you personally think is the most important in determining 
a person’s general level of health?   
   
 Genetic factors .......................................................................1  
 A person’s own decisions and actions ...................................2 
 Factors in a person’s social environment ..............................3 
 
 
I5.  Of the following factors, which do you personally think is the most important in determining 
a person’s level of intelligence?   
   
 Genetic factors .......................................................................1  
 A person’s own decisions and actions ...................................2 
 Factors in a person’s social environment ..............................3 
 
 
I6.  Of the following factors, which do you personally think is the most important in determining 
how successful a person is in life? 
 
 Genetic factors .......................................................................1  
 A person’s own decisions and actions ...................................2 
  Factors in a person’s social environment ..............................3 
 
 
I7.  In your opinion, how likely is it that a child of a person with [“major depressive 
disorder”/“coronary artery disease”/“obesity”] would develop the same condition? 
 
 Very likely .............................................................................4 
 Somewhat likely ....................................................................3 
  Somewhat unlikely ................................................................2 
 Very unlikely .........................................................................1 
 
 
I8.  In your opinion, how strongly does [“major depressive disorder”/“coronary artery 
disease”/“obesity”] run in families? 
 
 Very strongly .........................................................................4 
 Somewhat strongly ................................................................3 
  Not very strongly ...................................................................2 






I9.  [“Major depressive disorder”/“Coronary artery disease”/“Obesity”] can be treated 
effectively. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
  
I10.  [“Major depressive disorder”/“Coronary artery disease”/“Obesity”] is likely to go away on 
its own, even without treatment. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I11.  It is unlikely that a person with [“major depressive disorder”/“coronary artery 
disease”/“obesity”] will ever be completely free of this condition. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I12.  Even if a person has been free of [“major depressive disorder”/“coronary artery 
disease”/“obesity”] for years, the condition might return at any time. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I13.  Even if [“the symptoms of major depressive disorder are controlled”/ “the symptoms of 
coronary artery disease are controlled”/ “an obese person’s weight is controlled”], the person will 
always remain vulnerable to this condition.  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 






I14. A person can be permanently cured of [“major depressive disorder”/“coronary artery 
disease”/“obesity”]. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I15.  A person who has [“had major depressive disorder”/“had coronary artery disease”/“been 
obese”] needs to [“be treated for”/“maintain careful control of their weight”] their whole life, or 
the condition may return. 
      
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I16.  Even if a person’s [“symptoms of major depressive disorder are eliminated”/“symptoms of 
coronary artery disease are eliminated”/“obesity is kept under control”], the underlying condition 
will always remain within the person. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I17.  How serious do you consider [“major depressive disorder”/“coronary artery 
disease”/“obesity”] to be? 
 
Extremely serious................................................4 
Very serious ........................................................3 
Moderately serious ..............................................2 
Not very serious ..................................................1 
 
I18.  How upset would you be if a loved one [“developed major depressive disorder”/“developed 
coronary artery disease”/“became obese”]? 
 
Extremely upset ..................................................4 
Very upset ...........................................................3 
Moderately upset .................................................2 




I19.  A person [“with major depressive disorder”/“with coronary artery disease”/“who is obese”] 
can overcome this condition if they take the right actions. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I20.  When you think of a person who [“has major depressive disorder”/“has coronary artery 
disease”/“is obese”], how different do you think they are from other people? 
 
Very different ......................................................4 
Somewhat different .............................................3 
Not very different ................................................2 
Not different at all ...............................................1 
 
I21.  Although a person [“with major depressive disorder”/“with coronary artery disease”/“who 
is obese”] may seem just like everyone else, they are actually different in important ways. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I22.  Someone with arthritis or a broken leg has just one thing wrong with them, but a person 
who [“has major depressive disorder”/ “has coronary artery disease”/“is obese”] is very different 
from other people.  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I23.  Although they may be like other people in many ways, there is something about people 
[“with major depressive disorder”/“with coronary artery disease”/“who are obese”] that is 
fundamentally different from other people.  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 






When you think of people [“with major depressive disorder”/“with coronary artery 












I24. Disgusted by them 
I25. Sympathy for them 
I26. Pity toward them 
I27. Anger toward them 
I28. Annoyed with them 
 
 
I29.  A person [“with major depressive disorder”/“with coronary artery disease”/“who are 
obese”] has no one to blame but themselves. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I30.  A person [“with major depressive disorder”/“with coronary artery disease”/“who are 
obese”] probably did something to cause this condition. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I31. It is a person’s own fault if they [“develop major depressive disorder”/“develop coronary 
artery disease”/“become obese”].  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 









I32.  I can understand why a person [“with major depressive disorder”/“with coronary artery 
disease”/“who is obese”] would feel embarrassed about having this condition.   
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
 
I33.  If a person [“has major depressive disorder”/“has coronary artery disease”/“is obese”], how 
responsible are the parents for causing the condition? 
 
Very responsible .................................................4 
Somewhat responsible ........................................3 
Not very responsible ...........................................2 
Not responsible at all ..........................................1 
 
I34.  It is largely the fault of the parents if a person [“develops major depressive 
disorder”/“develops coronary artery disease”/“becomes obese”]. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
Listed below are several pairs of words.  For each pair, please select a point on the grid that best 
describes how you think about people [“with major depressive disorder”/“with coronary artery 
disease”/“who are obese”]. 
 
 
1 2 3 4 5 6 7 
       
 
I35. LAZY               ___   ___    ___   ___   ___   ___   ___ INDUSTRIOUS 
 
 
I36. GOOD SELF-       POOR 
      CONTROL ___   ___    ___   ___   ___   ___   ___ SELF-CONTROL 
 





I38. COMPETENT ___   ___    ___   ___   ___   ___   ___ INCOMPETENT 
 
I39. DANGEROUS ___   ___    ___   ___   ___   ___   ___ SAFE 
 
I40. GOOD     ___   ___    ___   ___   ___   ___   ___ BAD 
 
I41. UNPLEASANT  ___   ___    ___   ___   ___   ___   ___ PLEASANT 
 
I42. POWERFUL ___   ___    ___   ___   ___   ___   ___ POWERLESS 
 
I43. SICKLY  ___   ___    ___   ___   ___   ___   ___ HEALTHY 
 
I44. LIKABLE ___   ___    ___   ___   ___   ___   ___ UNLIKABLE 
 
I45. DISREPUTABLE___   ___    ___   ___   ___   ___   ___ REPUTABLE 
 
I46. NORMAL ___   ___    ___   ___   ___   ___   ___ ABNORMAL 
          
 
I47.  People would look down on you if you married someone [“with major depressive 
disorder”/“with coronary artery disease”/“who is obese”].  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I48.  Your status in the eyes of others would be lowered if your main romantic involvement in 
life were with someone [“with major depressive disorder”/ “with coronary artery disease”/“who 
is obese”]. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 








I49.  People would make fun of you if most of your friends [“had major depressive disorder”/ 
“had coronary artery disease”/“were obese”]. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I50.  [“Major depressive disorder”/“Coronary artery disease”/“Obesity”] is a medical condition. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I51.  A person with [“major depressive disorder”/“coronary artery disease”/“obesity”] should 
seek professional help for this condition. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
 
I52.  A person with [“major depressive disorder”/“coronary artery disease”/“obesity”] should 
take prescription medications for this condition. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I53.  A person with [“major depressive disorder”/“coronary artery disease”/“obesity”] should 
take steps to control the condition. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 





I54.  Please indicate whether you would like to see more or less government spending for the 
prevention and treatment of [“major depressive disorder”/“coronary artery disease”/“obesity”]. 
Remember that if you say “much more,” it might require a tax increase to pay for it. 
Spend much more ...............................................5 
Spend more .........................................................4 
Spend the same as now .......................................3 
Spend less............................................................2 
Spend much less ..................................................1 
 
I55.  How willing would you personally be to pay $300 more a year in taxes to find a way to 
prevent [“major depressive disorder”/“coronary artery disease”/“obesity”]? 
 
Definitely willing ................................................4 
Probably willing ..................................................3 
Probably not willing ............................................2 
Definitely not willing ..........................................1 
 
I56.  On the whole, do you think it should or should not be the government’s responsibility to 
provide health care for persons [“with major depressive disorder”/ “with coronary artery 
disease”/“who are obese”]?  
 
Definitely should be ............................................4 
Probably should be ..............................................3 
Probably should not be........................................2 




I57.  On the whole, do you think it should or should not be the government’s responsibility to 
provide disability benefits for persons [“with major depressive disorder”/ “with coronary artery 
disease”/“who are obese”]? 
 
Definitely should be ............................................4 
Probably should be ..............................................3 
Probably should not be........................................2 









I58.  A person [“with major depressive disorder”/ “with coronary artery disease”/“who is obese”] 
should have to pay extra for their health insurance. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I59.  Employers should be allowed to deny people [“with major depressive disorder”/ “with 
coronary artery disease”/“who are obese”] a job because of their condition. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I60.  If someone [“with major depressive disorder”/ “with coronary artery disease”/“who is 
obese”] needs a kidney transplant, they should be given a lower priority on the waiting list than 
someone [“without major depressive disorder”/“without coronary artery disease”/ “who is not 
obese”]. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I61.  [“A person with major depressive disorder”/“A person with coronary artery disease”/“An 
obese person”] should be required to get treatment for their condition in order to get health 
insurance. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 











I62.  A person [“with major depressive disorder”/“with coronary artery disease”/“who is obese”] 
should seriously consider not having any children.  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I63. A couple [“who both have major depressive disorder”/“who both have coronary artery 
disease”/“who are both obese”] should seriously consider not having any children. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
 
I64.  I would prefer not to spend time around [“a person with major depressive disorder”/“a 
person with coronary artery disease”/“an obese person”].  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I65.  I would rather not work with a person [“with major depressive disorder”/“with coronary 
artery disease”/“who is obese”]. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I66.  I would prefer that members of my family not get romantically involved with a person 
[“with major depressive disorder”/“with coronary artery disease”/“who is obese”]. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 





I67.  I would prefer that members of my family not marry a person [“with major depressive 
disorder”/“with coronary artery disease”/“who is obese”]. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I68.  I can understand why someone would prefer not to spend time around [“a person with 
major depressive disorder”/“a person with coronary artery disease”/“an obese person”].  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 




I69.  I would prefer that members of my family not get romantically involved with someone 
whose parent [“has major depressive disorder”/“has coronary artery disease”/“is obese”].  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I70.  I would prefer that members of my family not marry a person whose parent [“has major 
depressive disorder”/“has coronary artery disease”/“is obese”]. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I71.  How willing would you be to spend time around [“a person with major depressive 
disorder”/“a person with coronary artery disease”/“an obese person”]? 
 
Definitely willing ................................................4 
Probably willing ..................................................3 
Probably unwilling ..............................................2 







The following questions ask about race-based medicine.  Race-based medicine customizes 
medical treatments for specific racial groups.  For example, the drug BiDil was developed by a 
company for use among only African Americans as a treatment for heart failure. 
 
Even if you are unfamiliar with these topics, we are interested in your opinions.  
 
I72.  We could do a better job of treating coronary artery disease if drugs were developed for 
specific racial groups. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 





I73.  Medications would work better if they were created for use in specific racial groups. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I74.  In my opinion, we should only develop drugs that can be used by everyone regardless of 
their race.  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
I75.  If coronary artery disease drugs were made for use with different racial groups, I would 
prefer to use the one designed for my racial group. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 





I76.  Drugs created for different races will reduce health inequalities in the United States. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 




Now we have some questions about you and people you know: 
 
I77.  [“To your knowledge, have you or any close family members had major depressive 
disorder”/“To your knowledge, have you or any close family members had coronary artery 





I78.  [“To your knowledge, have any close friends of yours had major depressive disorder”/“To 
your knowledge, have any close friends of yours had coronary artery disease”/“Have any close 





I79.  How often do you read a traditional newspaper (one that is printed with ink on paper and 
NOT counting what you read online)? 
 
Every day ............................................................5 
A few times a week .............................................4 
Once a week ........................................................3 
Less than once a week.........................................2 
Never ...................................................................1 
 
I80.  How often do you watch news programs on television? 
 
Every day ............................................................5 
A few times a week .............................................4 
Once a week ........................................................3 






I81.  How often do you read news stories online? 
 
Every day ............................................................5 
A few times a week .............................................4 
Once a week ........................................................3 
Less than once a week.........................................2 
Never ...................................................................1 
 
I82.  How often do you attend religious services, watch religious programs on television or listen 




At least once a month ..........................................3 




I83.  What country were you born in? 
 
United States .......................................................1 
Other country ......................................................2 
 
I84.  To the best of your memory, the article you read placed the most emphasis on which of the 
following factors as the basic root cause of  [“major depressive disorder”/ “coronary artery 
disease”/“obesity”]? 
 
Genetic Factors ...................................................3 
A person’s own decisions and 
actions .............................................................2 
Factors in a person’s social 
environment, such as stress and 
pressure ...........................................................1 
 
Thank you for answering our questions about the news article.  That article was constructed from 
a variety of different news articles and reflects only one viewpoint among many views on this 
issue 
 
For more information about [“major depressive disorder”/“coronary artery disease”/“obesity”], 
please refer to the [“National Alliance on Mental Illness website at http://www.nami.org.”/ 
“American Heart Association’s website at http://www.americanheart.org.”/ “Centers for Disease 







RACE VIGNETTE EXPERIMENT SURVEY 
 
You will read a news article that we have provided for you. Most of the survey will consist of 
questions related to topics discussed in the article. You will also be asked some questions about 
topics not related to the article.  
 
Please answer the following questions about racial issues in the U.S. 
 
R1. Racial problems in the U.S. are rare, isolated situations. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R2. Talking about racial issues causes unnecessary tension. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R3.  Racism is a major problem in the U.S. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R4.  It is important for public schools to teach about the history and contributions of racial and 
ethnic minorities. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 








R5.  It is important for political leaders to talk about racism to help work through or solve 
society’s problems. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R6.  Racism may have been a problem in the past, it is not an important problem today. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R7.  Racial and ethnic minorities in the U.S. have certain advantages because of the color of their 
skin. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R8. In your opinion, the article provided an accurate account of the topics it discussed.   
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R9.   In your opinion, did the article overemphasize, underemphasize or provide a balanced 
account of [“The degree to which people have mixtures of different racial backgrounds”/ “the 
degree to which racial groups are genetically similar”/ “the degree to which racial groups are 
genetically different”/ “the importance of genes in causing racial differences in heart attacks”]?   
 
Strongly overemphasized [1] ..............................5 
Somewhat overemphasized [1] ...........................4 
Put the right amount of emphasis on 
[1] ...................................................................3 
Somewhat underemphasized [1] .........................2 







[Please populate 1 in the R9 answer options by using the following: 
 
If admixture vignette, insert “the degree to which people have mixtures of difference racial 
backgrounds”. 
If social construction vignette, insert “the degree to which racial groups are genetically 
similar”. 
If race is genetic vignette, insert “the degree to which racial groups are genetically different”. 
If genetic health difference vignette, insert “the importance of genes in causing racial 
differences in heart attacks”.] 
 
 
R10.  The article struck you as biased and inaccurate.  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
 
[Please treat R11-13 and R14-18 as two sets, and randomize and record order.] 
 
R11. Each racial group has a different profile of genetic risks for disease. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R12.  A person’s race can tell a doctor a lot about his or her genetic risk for many diseases. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
  
R13.  Racial groups have different genetic risks for most diseases. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 






R14.  In terms of biological differences between people, race is a meaningless concept. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R15.  Although black and white people may be alike in many ways, there is something about 
black people that is fundamentally different from white people.  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R16.  Different racial groups are all basically alike “under the skin.” 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R17.  There are very few genetic differences among racial groups. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R18.  When you compare black and white people, you think they are:  
 
Very similar ........................................................4 
Somewhat similar................................................3 
Not very similar ..................................................2 










R19.  Think about the various racial and ethnic groups within the U.S. including Whites, African 
Americans, Asian Americans, Hispanics, Native Americans and so on.  To what extent do you 
agree with the following statement? 
 
Individuals who belong to the same racial or ethnic group tend to be fairly similar to one another.   
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R20.  Now think only about racial and ethnic minority groups within the U.S. such as African 
Americans, Asian Americans, Hispanics, and Native Americans.  To what extent do you agree 
with the following statement? 
 
Racial and ethnic minority groups in the U.S. are very distinct and very different from one 
another. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R21.  Think about Whites in the U.S. compared to racial and ethnic minority groups.  To what 
extent do you agree with the following statement? 
 
Whites as a group are very distinct and different from racial and ethnic minority groups.  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
 
On average, black people in the U.S. have worse jobs, income, and housing than white people. 
There are many possible explanations for these differences.   How much do you think these 
differences are… 
 






R22. …due to racial discrimination? 
R23. …because most African Americans have less in-born ability to learn? 
R24. …because most African Americans have less in-born drive to succeed? 
 
 
On average, black people in the U.S. have worse health and shorter life-expectancy than whites.  
There are many possible explanations for these differences.  How much do you think these 
differences are . . . 
 
 Very much Some Not much Not at all 
 
 
R25. …due to genetic differences between blacks and whites? 
R26. …due to racial discrimination? 
 
 
African-Americans are much more likely to be arrested, jailed and imprisoned in the U.S. than 
are whites.  There are many possible explanations for these differences.  How much do you think 
these differences are . . .  
 
 Very much Some Not much Not at all 
 
 
R27. …due to racial discrimination? 
R28. …due to genetic differences between blacks and whites in their tendency toward violence? 
 
 
People of African descent dominate many sports, such as basketball, football and running events.  
There are many possible explanations for these differences.  How much do you think these 
differences are . . . 
 
 Very much Some Not much Not at all 
 
 









For the following two questions, please choose the number from 1 to 7 that best represents your 
feelings. 
 
R30. In general, how close do you feel to black people? 
 
___ ___ ___ ___ ___ ___ ___ 
1 2 3 4 5 6 7 
Not at all 
close 










R31.  In general, how close do you feel to white people? 
 
___ ___ ___ ___ ___ ___ ___ 
1 2 3 4 5 6 7 
Not at all 
close 









R32.  How would you feel about having a close relative or family member marry a black person? 
 
Strongly favor .....................................................5 
Favor ...................................................................4 
Neither favor nor oppose ....................................3 
Oppose ................................................................2 










R33.  How would you feel about having a close relative or family member marry a white person? 
 
Strongly favor .....................................................5 
Favor ...................................................................4 
Neither favor nor oppose ....................................3 
Oppose ................................................................2 
Strongly oppose ..................................................1 
 
R34.  If you could find the housing that you would want and like, would you rather live in a 
neighborhood where: 
 
All your neighbors belong to your own racial group ...............................4 
Most of your neighbors belong to your own racial group ........................3 
About half of your neighbors belong to your own racial 
group ........................................................................................................2 
Most of your neighbors do not belong to your own racial 
group ........................................................................................................1 
 
R35.  Suppose you were thinking of adopting a child out of foster care.  Suppose you were 
introduced to a child who is of a different race from you, and you were thinking of adopting this 
child.  Would the race of the child be a concern for you in thinking about whether to adopt the 
child? 
 
Major concern .....................................................3 
Minor concern .....................................................2 
No concern ..........................................................1 
 
R36.  How would it make you feel to receive a blood transfusion from someone who is of a 
different race than you? 
 
Very uneasy ........................................................3 
Somewhat uneasy................................................2 
Not uneasy at all..................................................1 
 
R37.  How would it make you feel to receive an organ transplant from someone who is of a 
different race than you? 
 
Very uneasy ........................................................3 
Somewhat uneasy................................................2 





The following questions ask about race-based medicine and personalized medicine.  Race-based 
medicine customizes medical treatments for specific racial groups.  For example, the drug BiDil 
was developed by a company for use among only African Americans as a treatment for heart 
failure.  Personalized medicine is individualized medical care based on a person’s genetic 
profile.  Whereas race-based medicine is medical care that is customized to meet the needs of 
specific racial groups, personalized medicine is medical care that is customized to meet the needs 
of individual people based on their genetic differences. 
 
Even if you are unfamiliar with these topics, we are interested in your opinions.  
 
 
[Please treat R38-42 and R43-46 as two sets, and randomize and record order.] 
 
R38.  We could do a better job of treating heart disease if drugs were developed for specific 
racial groups. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R39.  Medications would work better if they were created for use in specific racial groups. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R40.  In my opinion, we should only develop drugs that can be used by everyone regardless of 
their race.  
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R41.  If heart disease drugs were made for use with different racial groups, I would prefer to use 
the one designed for my racial group. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 





R42.  Drugs created for different races will reduce health inequalities in the United States. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
 
R43.  We could do a better job of treating heart disease if drugs were developed based on 
individuals’ genes. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R44.  Medications would work better if they were created based on individuals’ genes. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R45.  In my opinion, we should only develop drugs that can be used by everyone regardless of 
their genetic make-up.  
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 
R46.  If heart disease drugs were made based on differences between everyone’s genes, I would 
prefer to use the one developed for my gene type. 
 
Strongly agree .....................................................4 
Somewhat agree ..................................................3 
Somewhat disagree .............................................2 
Strongly disagree ................................................1 
 





R47.  Are the people that you are acquainted with . . .  
 
Almost all the same race as you ......................................5 
Mostly the same race as you ...........................................4 
About evenly divided between the same race 
as you and other races .....................................................3 
Mostly a different race than you .....................................2 
Almost all a different race than you ................................1 
 
R48.  How often do you read a traditional newspaper (one that is printed with ink on paper and 
NOT counting what you read online)? 
 
Every day ............................................................5 
A few times a week .............................................4 
Once a week ........................................................3 
Less than once a week.........................................2 
Never ...................................................................1 
 
R49.  How often do you watch news programs on television? 
 
Every day ............................................................5 
A few times a week .............................................4 
Once a week ........................................................3 
Less than once a week.........................................2 
Never ...................................................................1 
 
R50.  How often do you read news stories online? 
 
Every day ............................................................5 
A few times a week .............................................4 
Once a week ........................................................3 
Less than once a week.........................................2 
Never ...................................................................1 
 
R51.  How often do you attend religious services, watch religious programs on television or 




At least once a month ..........................................3 







R52.  What country were you born in? 
 
United States .......................................................1 
Other country ......................................................2 
 
 
Now we have a few more questions about what you remember about the article you read. 
 
 
R53.  To what extent did the article emphasize genetic similarities or differences between people 
of different racial backgrounds? 
 
strong emphasis on genetic similarities between people of 
different racial backgrounds ..................................................................1 
some emphasis on genetic similarities between people of 
different racial backgrounds ..................................................................2 
some emphasis on genetic differences between people of 
different racial backgrounds ..................................................................3 
strong emphasis on genetic differences between people of 
different racial backgrounds ..................................................................4 
article did not discuss genetic similarities or differences 
between people of different racial backgrounds ...................................5 
 
R54.  According to the article: 
 
it is very easy to divide people into distinct races on the 
basis of their genes .............................................................................1 
it is somewhat easy to divide people into distinct races on 
the basis of their genes .......................................................................2 
 it is somewhat hard to divide people into distinct races on 
the basis of their genes .......................................................................3 
it is very hard to divide people into distinct races on the 
basis of their genes .............................................................................4 
article did not discuss whether people can be divided into 
distinct races on the basis of their genes ............................................5 
 
R55. To the best of your memory, the main point of the article you read was that: 
 
people of different racial groups are genetically similar .......................1 
people of different racial groups are genetically different ....................2 
people’s genes usually show that they have a mixture of 








Thank you for answering our questions about the news article.  That article was constructed from 











HEALTH VIGNETTE EXPERIMENT CONTROL CONDITION VIGNETTES 
 
Please read the following news article. You will be able to go back and re-read the article if you 
wish as you complete the survey. 
 
 
Major Depressive Disorder focus of New Research Initiative 
 
 The National Alliance for Mental 
Illness has awarded several grants for the 
Depression Research Centers Initiative. The 
project will provide a network for research 
on the causes and treatment of major 
depressive disorder. 
 
 Center investigators will meet 
regularly and share information with each 
other, as well as provide training for 
research fellows.  
 
 Dr. Bruce Firman of Columbia 
University is one of the grant recipients.  He 
is optimistic that the interaction among the 
centers will speed the growth of knowledge 
about major depressive disorder.  “This is a 
situation where the whole will be much 
more than the sum of its parts,” Dr. Firman 
said. 
 
 [DANIEL/KATHRYN] Link is also 
excited about this development.  “I am very 
anxious to get answers about how best to 
deal with my condition.  I just wish one of 







Coronary Artery Disease focus of New Research Initiative 
 
 The American Heart Association has 
awarded several grants for the Coronary 
Artery Disease Research Centers Initiative. 
The project will provide a network for 
research on the causes and treatment of 
coronary artery disease. 
 
 Center investigators will meet 
regularly and share information with each 
other, as well as provide training for 
research fellows.  
 
 Dr. Bruce Firman of Columbia 
University is one of the grant recipients.  He 
is optimistic that the interaction among the 
centers will speed the growth of knowledge 
about coronary artery disease.  “This is a 
situation where the whole will be much 
more than the sum of its parts,” Dr. Firman 
said. 
 
 [DANIEL/KATHRYN] Link is also 
excited about this development.  “I am very 
anxious to get answers about how best to 
deal with my condition.  I just wish one of 




Obesity focus of New Research Initiative 
 
 The American Obesity Association 
has awarded several grants for the Obesity 
Research Centers Initiative. The project will 
provide a network for research on the causes 
and treatment of obesity. 
 
 Center investigators will meet 
regularly and share information with each 
other, as well as provide training for 
research fellows.  
 
 Dr. Bruce Firman of Columbia 
University is one of the grant recipients.  He 
is optimistic that the interaction among the 
centers will speed the growth of knowledge 
about obesity.  “This is a situation where the 
whole will be much more than the sum of its 
parts,” Dr. Firman said. 
 
 [DANIEL/KATHRYN] Link is also 
excited about this development.  “I am very 
anxious to get answers about how best to 
deal with my condition.  I just wish one of 









RACE VIGNETTE EXPERIMENT VIGNETTES 
 
Please read the following news article. You will be able to go back and re-read the article if you 





Is it all black and white? Genes say ‘No’ 
 
 Most people think they know what 
race they belong to, and people tend to think 
of themselves as “100 percent” white or 
black or something else. 
 
 A recent study challenges that way 
of thinking. 
 
 Dr. Bruce Firman and other 
geneticists at Columbia University have 
developed a DNA test that measures a 
person’s racial ancestry.   
 
Results of the study were published 
yesterday in the journal Nature Genetics. 
 
 The test shows what continent a 
person’s ancestors came from.  These 
continents correspond to the major human 
population groups or races, those of “Native 
American, East Asian, South Asian, 
European, and sub-Saharan African” 
according to Dr. Firman. 
 
 If a person is of mixed race, the test 
shows the percentage of each race in a 
person’s genetic background.  
 
It turns out that mixed ancestry is 
very common, said Dr. Firman.  About 10 
percent of European-Americans have some 
African ancestry, and African-Americans, 
on average, have about 17 percent European 
ancestry. 
 
 When people are told the results of 
their DNA test, they are usually quite 
surprised.  Most learn that they share genetic 
markers with people of different skin colors.   
 
Some “black” subjects in the study 
found that as much as half of their genetic 
material came from Europe and some from 
Asia.  One “white” subject learned that 14 
percent of his DNA came from Africa and 6 
percent from East Asia. Very few were 100 
percent anything. 
 
 “The main outcome is that we are 
breaking down an either-or classification,” 
Dr. Firman said.  Instead of people being 
considered either black or white, the test 
shows a continuous spectrum of ancestry 





[Social Construction Vignette] 
 
Is race real?  Genes say ‘No’  
 
 Most people would agree it is easy to 
tell at a glance if a person is Caucasian, 
African or Asian.   
 
But a recent study suggests that it is 
not so easy to make these distinctions when 
one probes beneath surface characteristics 
and looks for DNA markers of “race.”  
 
 Results of the study were published 
yesterday in the journal Nature Genetics.  
The study was conducted by Dr. Bruce 
Firman and other geneticists at Columbia 
University. 
 
Analyzing the genes of people from 
around the world, the researchers found that 
the people in the sample were about 99.9 
percent the same at the DNA level.  “That 
means that the percentage of genes that vary 
among humans is around .01 percent, or one 
in ten thousand.  This is a tiny fraction of 
our genetic make-up as humans,” noted Dr. 
Firman. 
   
The researchers also found that there 
is more genetic variation within each racial 
or ethnic group than there is between the 
average genomes of different racial or ethnic 
groups. 
 
Why the discrepancy between the 
ease of distinguishing “racial” groups 
visually and the difficulty of distinguishing 
them at a genetic level? 
 
Traits like skin and eye color, or 
nose width are controlled by a small number 
of genes.  Thus, these traits have been able 
to change quickly in response to extreme 
environmental pressures during the short 
course of human history. 
 
But the genes that control our 
external appearance are only a small fraction 
of all the genes that make up the human 
genome. 
 
Traits like intelligence, artistic talent 
and social skills are likely to be shaped by 
thousands, if not tens of thousands of genes, 
all working together in complex ways.  For 
this reason, these traits cannot respond 
quickly to different environmental pressures 
in different parts of the world.   
 
This is why the differences that we 
see in skin color do not translate into 
widespread biological differences that are 
unique to groups and why Dr. Firman says 
“the standard labels used to distinguish 








[Race Is Genetic Vignette] 
 
Is Race real?  Genes Say ‘Yes’  
  
 Most people would agree it is easy to 
tell at a glance if a person is Caucasian, 
African or Asian.   
 
A recent study suggests that the same 
racial groups we can identify do in fact 
correspond with broad genetic differences 
between groups. 
 
Results of the study were published 
yesterday in the journal Nature Genetics.  
The study was conducted by Dr. Bruce 
Firman and other geneticists at Columbia 
University. 
 
Dr. Firman says that racial 
differences exist because early humans in 
Africa spread throughout the world 40,000 
years ago, resulting in geographical barriers 
that prevented interbreeding.  On each 
continent, natural selection and the random 
change between generations known as 
genetic drift, caused peoples to diverge 
away from their ancestors, creating the 
major races.  
  
 The effects of this natural selection 
and genetic drift that have followed different 
pathways on each continent can be seen by 
looking at people from different racial 
groups as traditionally defined.  Certain skin 
colors tend to go with certain kinds of eyes, 
noses, skulls and bodies.   
 
When we glance at a stranger’s face 
we use those associations to guess what 
continent, or even what country, he or his 
ancestors come from – and we usually get it 
right. 
 
What Dr. Firman and his colleagues 
showed was that genetic variations that 
aren’t written on our faces – that can be seen 
only in our genes –   show similar patterns. 
   
The researchers sorted by computer a 
sample of people from around the world into 
five groups on the basis of genetic 
similarity.  The groups that emerged were 
native to Europe, East Asia, Africa, America 
and Australasia – the major races of 
traditional anthropology. 
 
Hence, Dr. Firman says, “race 
matches the branches on the human family 






[Genetic Health Difference Vignette] 
 
 Genes May Cause Racial Difference in Heart Attacks 
 
 
Doctors have long known that African 
Americans are prone to heart attacks. In fact, 
not only are African Americans more likely 
to suffer from heart attacks, their heart 
attacks are more likely to be fatal, compared 
to Caucasians. 
 
 A recent study suggests that genetics 
may help explain this racial difference. 
 
 Dr. Bruce Firman and other 
geneticists at Columbia University detected 
a version of a gene that raises the risk of 
heart attack in African-Americans by more 
than 250 percent.  That means the gene more 
than doubles the risk of heart attack in 
African-Americans.   
 
 Results of the study were published 
yesterday in the journal Nature Genetics.   
  
 The gene identified by the 
researchers is called leukotriene A4 
hydrolase.  The gene is involved in 
inflammation. 
 
 Inflammation, which we commonly 
see as swelling, redness and pain, is the 
process by which the body responds to 
injury or infection.  Inflammation is usually 
beneficial to health.  But new evidence 
shows that inflammation plays a key role in 
causing heart attacks.  Too much 
inflammation seems to damage the lining of 
artery walls and contribute to the buildup of 
fatty deposits (called plaque) inside the 
artery.   
 
 Plaques block the flow of blood 
through the arteries, leading to heart attacks.  
Inflammation can also cause plaques to 
burst, which scientists think is a cause of 
heart attacks. 
 
 Dr. Firman said that the gene they 
identified is much more strongly associated 
with heart attack in African-Americans than 
in Caucasians. 
 
  “These findings,” said Dr. Firman, 
“offer strong evidence that genetic factors 
are important in explaining the higher rates 
of heart attack in African Americans.” 
 
